Awakening expectations: exploring social and ethical issues surrounding the medical and non-medical uses of cognition enhancing drugs in the UK by Coveney, Catherine M.
Coveney, Catherine M. (2010) Awakening expectations: 
exploring social and ethical issues surrounding the 
medical and non-medical uses of cognition enhancing 
drugs in the UK. PhD thesis, University of Nottingham. 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/11671/1/C.Coveney_PhD_thesis_Nov_2010.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
· Copyright and all moral rights to the version of the paper presented here belong to 
the individual author(s) and/or other copyright owners.
· To the extent reasonable and practicable the material made available in Nottingham 
ePrints has been checked for eligibility before being made available.
· Copies of full items can be used for personal research or study, educational, or not-
for-profit purposes without prior permission or charge provided that the authors, title 
and full bibliographic details are credited, a hyperlink and/or URL is given for the 
original metadata page and the content is not changed in any way.
· Quotations or similar reproductions must be sufficiently acknowledged.
Please see our full end user licence at: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf 
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
   
 
 
 
 
 
 
Awakening Expectations: exploring social and ethical issues 
surrounding the medical and non-medical uses of cognition 
enhancing drugs in the UK 
 
 
Catherine M. Coveney, BSc, MA 
 
 
 
 
 
 
 
 
Thesis submitted to The University of Nottingham 
For the degree of Doctor of Philosophy 
 
November 2010 
 
 
   
1 
 
Abstract 
 
The aim of this thesis is to explore the social and ethical issues surrounding the use of 
neurotechnologies to control sleep and enhance cognition in British society. 
Empirically, the project is based on a case study of the wake-promoting drug 
modafinil. Data analysis involved the study of a corpus of 77 UK news articles and 40 
semi-structured interviews with three stakeholder groups: scientists and clinicians, 
shift workers and students. The analytical framework used was informed by previous 
work in both medical sociology and bioethics and developed using key concepts 
drawn from Science and Technology Studies.  Conceptualising modafinil as a 
sociotechnical object, different discourses surrounding sleep, cognitive enhancement 
and pharmaceutical use were explored to assess how sociotechnical spaces for 
µWKHUDS\¶DQGµHQKDQFHPHQW¶DUHEHLQJFRQVWUXFWHGDQGQHJRWLDWHGLQGLfferent 
domains of social life.  
 
The analysis of the ways in which modafinil use was positioned and of how various 
uses were negotiated in both media and stakeholder discourse shows how different 
groups can conceptualise the same technology in very different ways depending on 
who is doing the defining, how the users are imagined and the specific context of use. 
It was apparent that drugs contain not only technological scripts for how and by whom 
they are to be used, but also strong cultural scripts relating to legitimacy and 
acceptability of when, where, for what purpose they should be used.  Importantly, it 
demonstrates that although norms may overlap to some degree, there is no universal 
set of norms defining and delimiting how modafinil should be used in contemporary 
society.  
 
The adoption of an STS perspective, which takes a critical stance towards both 
technology and users, has shown how the adoption of a therapy-enhancement 
distinction devoid of context oversimplifies the debate around the use of drugs such as 
modafinil and does not capture the reality of stakeholder perspectives. 
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Chapter 1: Introduction 
 
Contextual background 
 
Throughout history, people in cultures and communities across the world have 
experimented with foods, herbs and drugs to alter their minds, bodies and 
performance (Wolpe, 2002; Flower, 2004). In the UK today, chemical modification of 
mood, enhancement of sex lives and control over reproduction are well established 
practices. Traditionally such drugs have been developed for medical conditions and 
are tightly regulated and controlled. Looking back to even the recent the past, in 
hospitals, prisons and asylums, it is evident that mental states can be altered 
WHFKQRORJLFDOO\WRPHHWVRFLDOJRDOVLQRUGHUWRSURWHFWVRFLHW\IURPWKHµGDQJHURXV¶
individual and to heal tKHµVLFN¶)RXFDXOW1977; 1989; 2001). Over the past century a 
whole host of mental pathologies have been defined, redefined and various labels 
gone in and out of fashion. 
 
Contemporary advances in neuroscience and genetics are increasing scientific 
understanding of the neural basis for cognition. The increasing knowledge of the 
working of the brain gives rise for the potential to further manipulate cognitive 
processes through medicinal chemistry. Such advances in neuropharmacology are 
yielding important treatments for a range of neurological diseases. There are several 
different compounds both on the market and in development that claim to alter 
cognitive function. Many of the drugs in development are targeted specifically as 
WKHUDSLHVIRUHVWDEOLVKHGPHGLFDOFRQGLWLRQVVXFKDV$O]KHLPHU¶VGLsease, narcolepsy 
and attention deficit/hyperactivity disorder (ADHD).  The current market for cognitive 
enhancing drugs is large with an estimated 750,000 people suffering from dementia in 
the UK in 2004. This figure is expected to increase by 2050 to over 34 million people 
worldwide (Jones, Morris & Nutt, 2005). This factor alone may be enough to mobilise 
further research and funds into cognitive neuroscience. However, many of these 
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treatments are also likely to have uses for people without disease or challenge 
disease categories.  
 
There are many non-prescription drugs and herbal remedies marketed for their 
cognitive enhancing effects. Gingko Biloba is one of the most popular natural 
remedies available and has a billion dollar market worldwide (Jones et al, 2005), 
despite little scientific evidence of its efficacy.  Over the past decade, 
neurotechnologies ± technologies which can be used to augment brain function in 
some way- have dominated the discussions of human enhancement which have 
orientated around the prospect of improving cognition or, put simply, achieving better 
brains through technology (Farah, 2002). Pharmaceutical enhancement is just one 
EUDQFKRIVHYHUDOWHFKQRORJLHVWKDWIDOOXQGHUWKHXPEUHOODRIµHQKDQFHPHQW
WHFKQRORJLHV¶7KHVHWHFKQRORJLes have the potential to be used to improve or modify 
a variety of human traits and have arisen from advances in different fields of science 
including genetics, robotics, neuroscience, and ageing research. There are different 
types of neurotechnology in development including brain-machine interfaces, the 
implantation of devices and tissue in neurosurgery and psychopharmacology (Farah et 
al, 2004; Miller & Wilsdon, 2006). Many of the neurotechnologies discussed are 
presented as theoretical possibilities of the future application of an ever-progressive 
neuroscientific understanding of the brain. It is in this respect that cognitive 
enhancement via psychopharmaceutical use stands out from the crowd. It has been 
argued that while many of the aforementioned neurotechnologies have a hypothetical 
potential to be used for cognitive enhancement, pharmacological enhancement has 
already begun (Farah, 2005; Chatterjee, 2004; Kramer, 1993; Hyman, 2006). 
 
Lifestyle drugs now and in the future 
 
According to Kramer (1993), we have already entered into an era where psychotropic 
drugs are used to treat mild symptoms and improve upon cognitive functioning and 
emotional states that are well within the range currently seen as normal. There are 
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several documented cases of drugs that were developed to treat specific diseases that 
KDYHUHSRUWHGO\FURVVHGRYHUIURPWKHUDSLHVWRFRPPRQXVDJHIRUµHQKDQFHPHQW¶
purposes; recent examples include Beta Blockers, Ritalin and Viagra.  Beta-blockers, 
medication for blood pressure regulation, are reportedly taken by public speakers and 
actors to hide flushing and other signs of nervousness whilst performing. Ritalin was 
developed to treat children with ADHD, but reportedly, is now widely used in children 
who do not qualify medically as ADHD sufferers, and by high school and college 
students as a study aid.  9LDJUDWKHµHUHFWLOHG\VIXQFWLRQ¶GUXJFRXOGDOPRVWEH
considered a household name and is often thought of as one of the first drugs 
VXFFHVVIXOO\PDUNHWHGWRWUHDWDµOLIHVW\OH¶FRQGLWLRQ The list of potential targets for 
therapeutic intervention is extensive, and includes behaviours from compulsive 
shopping, addictions such as smoking and alcohol to interventions that can make us 
µEHWWHUWKDQZHOO¶:KLWH 
 
As we look to the future, it is not only science fiction novels and films that portray 
visions of a society in which the minds and bodies of humans can be altered 
chemically for various ends. In recent years bioethical debates surrounding the 
acceptability of cognitive enhancement have been extensive and have caught the 
imagination of publics and professionals alike; sparking further debate in various 
arenas outside of academia from popular media1 to parliament (DTI, 2005; POST, 
2007). The off-label use of pharmaceuticals that are popXODUO\SHUFHLYHGDVµOLIHVW\OH
GUXJV¶VXFKDV5LWDOLQDQG9LDJUDKDVOHGWRVSHFXODWLRQWKDWQHZGUXgs will find 
common usage as performance enhancers rather than as treatments for disease. 
News media, fiction and policy debates perpetuate hopes and fears relating to the 
manipulation of human cognition at all stages of life. Such stories depict images of a 
future in which human behaviours can be pharmacologically controlled for ultimate 
performance and efficiency, from the playground to the sports field and the workplace 
to the retirement home. 
 
                                                          
1
 See appendix V. 
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New compounds are being manufactured and are in development that, reportedly 
have the potential to be used to enhance the cognitive abilities of the elderly, the 
workforce, school children, and anyone else for that matter. Examples of some such 
compounds are; Ampakines (being developed by Cortex Pharmaceuticals) for the 
WUHDWPHQWRI$O]KHLPHU¶VGLVHDVHWKDWFRXOGSRWHQWLDOO\EHXVHGDVDQPHPRU\
enhancers; CREB- based compounds (being developed by Helicon Therapeutics) for 
cognitive disorders such as post-traumatic stress disorder that may find uses amongst 
healthy people to improve or diminish memories; and modafinil (manufactured and 
sold by the company Cephalon) for the treatment of narcolepsy which has potential for 
promoting alertness in those without pathology.  
 
A recent report commissioned by the Office of Science and Technology (DTI, 2005) 
acknowledges the potential development of cognitive enhancement drugs and raises 
issues for the future. The report predictVWKDWµE\WKHHWKLFDOGHEDWHRYHUZKHWKHU
to use drugs to enhance performance in school children and in the workplace will 
SUREDEO\EHUHVROYHG¶7KHSRVVLELOLW\RIWKHXVHRIVXFKFRPSRXQGVEHFRPLQJ
widespread raises many important social and ethical issues that have received much 
attention within bioethics over recent years. Before going on to discuss the ethical 
debate in more depth, first it is necessary to explain what is meant by the term 
cognitive enhancement. 
 
What is cognitive enhancement? 
 
µ(QKDQFHPHQW¶LVDWHUPXVXDOO\XVHGZLWKLQELRHWKLFVWRUHIHUWRWKHXVHRIELRPHGLFDO
WRROVDQGWHFKQLTXHVWRLPSURYHWKHSHUIRUPDQFHFDSDFLWLHVRUIXQFWLRQLQJRIµQRUPDO¶
RUµKHDOWK\¶LQGLYLGXDOV0RUULVRQ:KHQWDONLQJDERXWWKHHQKDQFHPHQWRI
cognition specifically, several examples are regularly provided which include effects 
on memory, intelligence, linguistic skill, capacity to focus on intellectual tasks; and 
sense perception. Usually, cognitive enhancement is separated from mood 
enhancement and the use of anti-depressants and recreational drugs for this purpose. 
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However, individuals writing about cognitive enhancement often use slightly different 
definitions of the term and place different restrictions on the conditions of its use 
adding a further layer of complexity and confusion to the debate. 
 
For the most part, enhancement is defined as distinct from therapy and some 
indication is provided of how one should demarcate the two. This division is usually 
based upon the idea of health, normality or typical functioning. From this perspective, 
a therapeutic intervention will restore normal or typical functioning with the aim of 
returning an unhealthy person back to a healthy state whereas an enhancement will 
improve or extend the abilities or capacities of a healthy individual (who is already 
functioning normally) outside of this normal or typical range (3UHVLGHQW¶V&RXQFLORQ
Bioethics, 2002; Tannsjo, 2009; Greely et al, 2008; Hyman, 2006; Farah, 2002).  
 
Others use the term enhancement more broadly, understanding it simply as 
µLPSURYHPHQW¶WKHUHIRUHZKHQXVHGLWHQFRPSDVVHVWKHUDSHXWLFDVZHOOQRQ-
therapeutic effects (Conrad & Potter, 2006). In this view, every treatment is considered 
to be a form of enhancement (Synofzik, 2009) and any distinction between therapy 
and enhancement is thought of as either arbitrary and difficult to uphold or not 
analytically disjunctive. For instance, Chan and Harris (2006) claim that the distinction 
between therapy and enhancement is at best blurred, and at worst non-existent, 
especially in relation to mental capacities because the range and definition of what is 
QRUPDOLVVREURDGDQGFRPSOH[7KH\DUJXHWKDWWKLVUHQGHUVµDOPRVWDQ\DOWHUDWLRQ
LQH[SOLFDEOHDVHLWKHUWKHUDS\RUHQKDQFHPHQW¶ 
 
Problems with demarcating therapy (as the treatment of disease) and enhancement 
(as the improvement of a normal or healthy state) are regularly acknowledged within 
the bioethics literature.  The concepts of health, disease and levels of normal or typical 
functioning are difficult to establish (Cahill, 2005) and authors often accept that such 
definitions are historically situated, being both influenced and derived from 
contemporary socio-cultural values and norms (Esposito, 2005; Wolpe, 2002). 
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Examples given commonly to illustrate this point include homosexuality and hysteria, 
which, once thought of as medical conditions and subject to medical treatments, have 
since been de-medicalised (Conrad, 2007). Scholars acknowledge that the boundaries 
between what is considered therapeutic or enhancing have shifted over time and in all 
likelihood, will continue to shift in the future (Morrison, 2008; Pieters & Snelders, 
2009). Many scholars recognise that what medicine chooses to treat at any particular 
time and place in history is defined as disease, whilst the process of altering what it 
does not treat is defined as enhancement or abuse (Hyman, 2006; Glannon, 2006). In 
addition to this, how medicine draws distinctions between disease states and 
normality is often arbitrary and there are medical treatments for conditions that fall 
outside of health and disease definitions (abortion is commonly referred to as an 
example to illustrate this point) (Daniels, 2000).  
 
Some argue that despite this, it is necessary to maintain a therapy-enhancement 
GLVWLQFWLRQLQHWKLFDOGHEDWHVLQRUGHUWRDVVHVVKRZDSHUVRQV¶TXDOLW\RIOLIHFDQEH
improved without threats to health or resource consumption and in order to decide the 
proper limits to medicine and what should be treated (3UHVLGHQW¶V&RXQFLORQ
Bioethics, 2002; Tannsjo, 2009; Dees, 2004; Daniels, 2000). Therapy is therefore 
linked to the goals of the medical institution in healing or curing illness and disabilities 
where enhancement is thought of as going beyond this remit (Fukayama, 2002; 
Parens, 1998). In essence, then, enhancement is defined as any improvement or 
extension of capabilities or performance in the absence of clinically defined illness 
(Morrison, 2008; Esposito, 2005; Wolpe, 2002; Caplan & Elliot 2004; Farah et al, 
2004; Schermer et al. 2009). 
 
The following section provides an overview on the current debate on human 
enhancement within bioethics and highlights the need for further study in this area. 
There is a clear need for empirical research into how new technological innovations 
are framed by different groups and how this can influence how such technologies 
come to be positioned, accepted and resisted within society. The concept of human 
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enhancement and the social and ethical issues that it may give rise to will be 
investigated in this research, through a focus on cognitive enhancement by 
pharmacological intervention. This area of enhancement has been chosen as 
according to many commentators, the era of pharmaceutical enhancement may 
already be upon us. The purpose of this chapter is to introduce the social and cultural 
climate within which this research takes place, focusing on how cognitive 
enhancement is constructed within the emerging and heterogeneous field of 
neuroethics. 
 
Human enhancement and neuroethics  
 
In a paper discussing the history of bioethics Armstrong (2006) describes how 
bioethics arose from a shift in focus from advice on professional etiquette to the 
dangers posed by the medical profession on the wellbeing of the patient. Drawing 
DWWHQWLRQWRZRUNVVXFKDV,OOLFK¶V Medical Nemesis LQZKLFKGDQJHUVRUµWKUHDWV
WRKHDOWK¶ZHUHVDLGWRDULVHIURPHYHU\DVSHFWRIWKHFOLQLFDOHQFRXQWHU$UPVWURQJ
GHVFULEHVµWKHQHZWDVNRIHWKLFV¶DVEHLQJµWRSURWHFWWKHSDWLHQWIURPPHGLFLQHLWVHOI¶
VXFKDVµVLGH-effects of investigations and treatments, harms of radiation, 
substance-addicted doctors and dangers of antibiotic-UHVLVWDQWRUJDQLVPV¶
876).  
 
Over the past thirty years, a bioethical enterprise has proliferated and become 
professionally established DVDQµREMHFWLYH¶PHDQVWRDUELWUDWHFRQWHQWLRXVLVVXHV
arising from the prospect and development of new biomedical knowledge and 
technologies (Armstrong, 2006; Pellegrino, 1999; Rose, 2007; Rosenberg, 1999). In 
the late 1990s and into the early part of the 21st century it was the human genome 
SURMHFWDQGWKHµQHZJHQHWLFV¶ZKLFKVWLUUHGXSVWURQJUHDFWLRQVWRZDUGVWKHLGHDRI
human enhancement (Martin & Ashcroft, 2005). Hopes were raised for the medical 
applications of new genetic knowledge, for example, gene therapies that would cure 
all manner of diseases and disorders, whilst fears were voiced over the misuse of new 
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NQRZOHGJHDQGWHFKQRORJLHVWRIRUH[DPSOHFORQHKXPDQVRUFUHDWHµGHVLJQHU
EDELHV¶7KHIHDUVDURXQGWKHKXPDQJHQRPHSURMHFWKDYHVRIDUSroved to be 
unfounded. The hopes and promises are a still long way from being realised. 
However, the promises and perils of new technologies continue to fuel bioethical 
debates surrounding the idea and acceptability of human enhancement.  
 
The branch of phLORVRSK\NQRZQDVµQHXURHWKLFV¶LVDIDLUO\UHFHQWLQFDUQDWLRQGDWLQJ
back only a few years to around the turn of the 21st century. The term neuroethics is 
used to refer to the specific ethical issues surrounding manipulation of the human 
brain.  The emerging body of neuroethics literature discusses the potential ethical 
ramifications of a variety of neurotechnologies, both in existence and imaginary, from 
XVHRII05,VFDQVDVµGHWHFWRUV¶RIDEQRUPDOEUDLQIXQFWLRQLQJ,OOHVWRWKH
creation of posthXPDQµF\ERUJFLWL]HQV¶*UDy, 2002). 
 
It is generally accepted in the neuroethics literature, popular media (and at least some 
sections of the neuroscience community) that, in one respect or another, we do have 
access to psychopharmaceuticals that can produce cognitive enhancing effects in 
otherwise healthy persons. Substances commonly discussed include prescription 
medications that have the potential to be used off-label as enhancements such as 
modafinil, methyphenidate (Ritalin, Adderall), benzodiazepines, dextramphetamine, 
Donepezil, Rivastigmine, Galantamine, the CREB enhancer MEM1414 and CREB 
suppressors (Esposito, 2005). Sometimes non-prescription drugs such as caffeine, 
nicotine, alcohol and herbal medicines (Ginko) are also included in the repertoire of 
available cognition-enhancers.   
 
Further to proclaiming the availability of these various substances, the neuroethics 
literature is saturated with claims that pharmacologically induced cognitive 
enhancement is already being practiced by people of all ages and in several domains 
of social life, from the classroom to the workplace (Rose, 2007; Farah, 2004; Butcher, 
2003; Glannon, 2006; Greely et al. 2008; Hyman, 2006; Chan & Harris, 2006). Amid 
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claims of the reality and desirability of psychopharmaceutical use to achieve 
cognitively enhanced mental states is the assumption that the use of cognition 
enhancers will spread rapidly (Hyman, 2006; Chan & Harris, 2006; Butcher, 2003; 
Chatterjie, 2006; Wolpe, 2002). This assumption is often stated explicitly and as a 
matter of fact or agreement. For example, Farah (2002) states that: 
 
µHQKDQFHPHQWRIPRRGFRJQLWLRQDQGYHJHWDWLYHVWDWHVLQKHDOWK\SHRSOHLV
now a fact of life, and the only uncertainties concern the speed with which new 
and more appealing enhancement methods will become more available and 
DWWUDFWPRUHXVHUV¶ 
 
This is echoed by sociologist/ethicist Paul Root Wolpe (quoted in The Lancet, Butcher, 
ZKHQKHVD\VµZKDW¶VFRPLQJLVWKHZLGHDYDLODELOLW\RISRZHUIXOVSHFLILF
cognitLYHHQKDQFHPHQWV¶DGGLQJµZHZLOOHQWKXVLDVWLFDOO\HPEUDFHWKHVHWHFKQRORJLHV
HYHQDVZHDJRQLVHRYHUZKHWKHURUQRWZHVKRXOGGRVR¶ 
 
The assumption that there will be an inevitable increase in the pursuit of cognitive 
enhancement is deeply embedded in WKHOLWHUDWXUH7KLVµGLVFRXUVHRILQHYLWDELOLW\¶
contributes towards a vision of the future that seems inescapable. The assumption 
that there will be a high demand across society for psychopharmaceutical 
enhancement plays an important role in framing the issues arising in ethical 
discussions, which then focus on notions of free choice, coercion, safety and efficacy. 
The social and ethical issues raised will be returned to and discussed further in the 
next section. 
 
A literature search in early 2010 found over 300 articles published in the bioethics 
literature since 2002 specifically discussing the issues surrounding cognitive 
enhancement using pharmaceuticals2. A range of different ethical perspectives 
surrounding the potential implications of chemical performance enhancement are 
                                                          
2
 30 of these papers were chosen at random for a closer reading and the analysis presented below is based 
upon this sub-set of papers (see appendices for a list of papers). 
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SUHVHQWLQWKHVHGHEDWHV:KLOVWVRPHDUJXHWKDWDVDVSHFLHVKXPDQEHLQJVKDYHµD
FOHDUPRUDOGXW\WRHQKDQFH¶+DUULVRWKHUVGHEDWHZKHWKHUSKDUPDFRORJLFDO
enhancement should be seen as a legitimate lifestyle choice or as a misuse of 
prescription drugs (Racine & Forlini, 2010).  
 
Prospective uses for and users of cognitive enhancers 
 
Despite acknowledging some of the problems with doing so, the uses of cognition 
enhancing drugs are typically framed through a therapy- enhancement dichotomy in 
WKHQHXURHWKLFVOLWHUDWXUH,WLVFODLPHGWKDWFRJQLWLRQHQKDQFLQJµSURGXFWVDUH
JDLQ>LQJ@FXOWXUDODFFHSWDQFH¶0DKHUDQGVHYHUDOGLIIHUHQWW\SHVRIDFWXDORU
future user are depicted; some of these are outlined below.  How each domain might 
possess specific obligations, responsibilities, purposes for and objections towards 
enhancement is sometimes recognised by scholars who argue that a context specific 
approach to disentangle the complex social and ethical issues is both desirable and 
necessary (Synofzik, 2009; Schermer et al, 2009).  This section outlines some of the 
purported uses for and users of cognition enhancing drugs and the social and ethical 
issues that have been raised in each case.  
 
Therapeutic uses 
 
Neurological aQGSV\FKLDWULFSDWLHQWVDUHRIWHQUHIHUUHGWRDVEHLQJµLQQHHG¶RI
cognition enhancing drugs (Clausen, 2009; Maher, 2008; Nature, 2007; Sahakian & 
Morein- Zamir, 2007). Patients as users of cognition enhancing drugs are depicted as 
those with clinically defined illness who will derive some sort of therapeutic benefit 
from drug consumption. However, the increased tolerability of medications, increased 
public awareness of mental illness and the aggressive marketing of medications by 
pharmaceutical companies KDVEHHQOLQNHGWRµWKHZLGHVSUHDGXVHRI
psychopharmacology by people who would not have been considered ill twenty years 
DJR¶)DUDK6LQFHWKHILUVWHGLWLRQRIWKH'60LQLQH[FHVVRI
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categories of new mental illnesses have been conceived. It is argued that in labelling 
formerly normal states as disorders or diseases they become legitimate goals of 
pharmacotherapy (Schermer et al, 2009; Pieters & Snelders, 2009). Concerns are 
regularly raised in the literature over further medicalisation and pathologisation of 
human behaviours currently thought of as within the normal range (Farah et al, 2004). 
It is sometimes argued that medicalisation leads social factors to be downplayed as 
medicines come to be seen as the only solution for complex problems (Schermer et al, 
2009). 
 
Whether one is talking about therapy or enhancement in these cases is not always 
clear (Schermer et al, 2009) and it is also not clear the extent to which 
psychopharmaceuticals are prescribed off-label for so-called enhancement purposes. 
:ROSHDUJXHVWKDWµFOHDUO\VRPHRIWKHWRSVHOOLQJGUXJVLQWKHZRUOGDUHEHLQJ
used by patients that fit no traditional definition of pathology, but still see their own 
IXQFWLRQLQJLQWHUPVRIDGHILFLWWKDWWKHVHGUXJVDGGUHVV¶:hether further 
medicalisation of mental states should be thought of in positive or negative terms is 
questioned and debated.  
 
Surprisingly perhaps, therapeutic uses for already established clinical disorders are 
rarely problematised in this body of literature (Cahill, 2005; Farah et al, 2004). When 
concerns are raised, they tend to address issues of safety and efficacy. It has been 
argued that benefits should be weighed against short-term and long-term side-effects 
of the specific medication in question and these should be discussed between patient 
and doctor (Sahakian & Morein- Zamir, 2007).The proper role of medical professionals 
in the prescription of enhancement drugs is frequently raised as an issue that needs 
more discussion. Whereas some argue for a type of enhancement medicine where 
GRFWRUVEHFRPHPRUHOLNHµTXDOLW\RIOLIHFRQVXOWDQWV¶&KDWWHUMLH), others argue 
that the prescription of enhancing drugs by medical professionals to those without 
illness would not be appropriate as this would not entail a therapeutic relationship 
(Glannon, 2008). 
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There is also some debate over the philosophical concepts of authenticity and identity, 
and whether these concepts are threatened through the use of psychopharmacology 
(Elliott, 1999). Some studies and commentators argue that psychopharmacological 
DJHQWVKHOSDSHUVRQ¶VUHDOLGHQWLW\¶WRHPHUJH.UDPHURWKHUVDUJXHWKDW
concerns over authenticity are unfounded (Glannon, 2008). Bolt and Schermer (2009) 
report on interviews with adult ADHD users of medication to investigate concepts of 
identity and authenticity, concluding that individual views may vary depending upon 
different views of the self, personal identity and authenticity that one adopts.  
 
Between therapy and enhancement 
 
The use of cognition enhancers by some groups of people, such as shift workers, 
persons in the military and those within the criminal justice system, falls into a grey 
area between the two extremes of treatment and enhancement.   
 
Convicts 
 
As more of human functioning is being explained through the brain and its processes, 
more behaviours are understood as having a physical basis. Although not a central 
tenant of the neuroethics discourse, criminal behaviour is occasionally mentioned as 
something which could, in the future, come to be understood as a result of neural 
SDWKRORJ\*ODQQRQDQGWKHSURVSHFWRIµQHXUR-FRUUHFWLRQ¶)DUDKHWDO
Farah, 2005) is raised. This could potentially involve court-ordered intervention using 
pharmaceuticals or other types of neurotechnology with the goal of treating the convict 
in order to augment socially undesirable behaviour (Farah, 2002). Whether this type of 
use would be classed as therapy or enhancement is not clear. There are obviously 
different types of criminals and unlawful behaviours dependent upon social and 
cultural assumptions, conventions and expectations about how people ought to 
EHKDYH,QDGGLWLRQWKHFRQFHSWVRIµIUHHZLOO¶DQGµUHVSRQVLELOLW\¶IRURQH¶s behaviour 
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are essentially normative, making the use of cognition enhancers in this context a grey 
area (Glannon, 2006).  
 
Military personnel 
 
The use of cognition enhancing drugs by the military is typically presented as an 
established working practice (Greely et al, 2008; Glannon, 2006; Farah, 2005; Farah, 
2002; Wolpe, 2002). Military personnel are depicted as being sleep deprived and 
fatigued, operating in dangerous situations where they are under constant threat of 
serious harm, being killed, at risk of failing their mission, or causing the death of 
friendly soldiers. There is some debate as to whether military use of cognition 
enhancers should be considered medical or non-medical. For instance, Gebhardt 
(2004) discusses a story in a Dutch newspaper that reports on the trial of two marines 
who had been found asleep whilst on guard duty in Iraq. The debate focused on 
whether modafinil use should be allowed to suppress the need for sleep in military 
situations. In the Dutch case, evidently, objections were based upon concerns over 
the safety of off-label use of this medicine, referring to modafinil use in this context as 
µSUHYHQWDWLYHPHGLFLQH¶*HEKDUGW7KHGLOHPPDRIWHQUDLVHGLQWKH
military context is how available technology should be used to best effect in order to 
µSURWHFWFRPEDWDQWV¶LQWKHFDVH of emergency without exposing them to any 
unnecessary risks to health. 
 
In one sense, the use of cognition enhancing drugs is positioned as a type of therapy 
to repair degraded cognitive functioning rather than as an enhancing agent that would 
lead to the creation of a new breed of post-human super soldiers. In another, drugs 
DUHUHIHUUHGWRDORQJVLGHRWKHUµOLIHVXSSRUWHTXLSPHQW¶DQGWKRXJKWRIDVµDQRWKHU
FRPSRQHQWRIWKHZDUILJKWHUDUVHQDO¶5XVVR2IWHQVLWXDWLRQVDUHLPDJLQHG
where the use of cognition enhancing drugs seems the sensible action to take and it is 
argued that they could reasonably become the recommended course of action 
(Sahakian & Morein- Zamir, 2007; Russo, 2007). It has been argued that the use of 
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enhancement drugs would be ethical if taken in a context where it may save a 
soldier¶s life or contribute towards the success of the mission. Using this line of 
reasoning, the non-provision of an emergency supply of alertness-enhancing drugs, 
such as caffeine, to military persons in combat scenarios would warrant ethical 
consideration (Russo, 2007). 
 
When the use of cognition enhancing drugs is considered to be non-medical, concerns 
are raised that military personnel might be coerced into taking substances to alter their 
brain functioning, which could turn out to have harmful effects or be abused (Farah, 
2005; Russo, 2007). Overall, it is not clear whether ethicists believe that cognitive 
enhancement by military personnel should be endorsed. Although acknowledged to be 
controversial, it is however, often presented in a favourable light.  
 
Shift workers 
 
Likewise, some articles mention the treatment of shift workers suffering from a new 
clinically defined disorder, Shift Work Sleep Disorder (SWSD), with the drug modafinil, 
and accept this as a legitimate therapeutic use of the drug (Greely et al, 2008; 
Glannon, 2006). Despite this acceptance, in a minority of papers the concern is raised 
that in prescribing modafinil for SWSD doctors could be seen as being complicit in 
adapting workers to the demands of their employers and society (Schermer et al, 
2009).  
 
The non-medical use of the same substance by those who are considered to be 
normal and healthy but sleep deprived and tired is also raised as a possibility 
(Sahakian & Morein- Zamir, 2007). Western societies are commonly referred to as 
over-worked and chronically sleep deprived (Cahill, 2005). Interestingly, several 
specific occupational roles are repeatedly referred to by bioethicists discussing the 
potential benefits of a cognitively enhanced workforce. Typically, these include the 
drowsy doctor or surgeon on night call; airline pilots on transcontinental flights; air-
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traffic controllers who have to operate in a high stress environment; long-distance lorry 
drivers who drive through the night; nurses working long shifts; and ambitious 
professionals trying to pack more work into a day (e.g. Greely et al, 2008; Sahakian & 
Morein- Zamir, 2007; Glannon, 2008; Synofzik, 2009; Wolpe, 2002; Farah, 2002).   
 
Commentators write that cognition enhancing drugs are often already prescribed off-
label for persons working in these professions (Greely et al, 2008). For some, the 
benefits of this practice are clear- through the further use of cognition enhancing 
drugs, society could have safer flights, safer medical encounters and safer roads 
(Esposito, 2005; Wolpe; 2002; Farah, 2005; Sahakian & Morein- Zamir, 2007). The 
EHQHILWVRIFRJQLWLRQHQKDQFLQJGUXJVDUHGHVFULEHGDVKHOSLQJVKLIWZRUNHUVWRµEHWWHU
IRFXVSODQDQGUHPHPEHU¶6DKDNLDQ	0RUHLQ- Zamir, 2007) and stay awake on the 
drive home from work, thus reducing the incidence of road traffic accidents (Farah et 
al, 2004). The use of such substances is linked to an expected increase in workplace 
efficiency and productivity and so cognitive enhancement is thought to be in the 
interests of employers as well as employees. 
 
Often, the use of cognition enhancing drugs as a way to boost mental energy, 
alertness or performance is compared to the consumption of caffeine for the same 
purpose. This discursive strategy acts to frame the practice of cognitive enhancement 
as something which is already being practiced with little objection. Time and time 
DJDLQWKHUHDGHULVDVNHGTXHVWLRQVVXFKDVµZKRFRQVLGHUVDGRXEOHVKRWRI
espresso or a caffeine drink an unIDLUDGYDQWDJHDWZRUN"¶6\QRI]LNDQGLWLV
DVVXPHGWKDWFRJQLWLRQHQKDQFLQJGUXJVZLWKµVPDOORUQRVLGHHIIHFWVEXWZLWK
moderate enhancing effects that alleviate forgetfulness or enable one to focus better 
on the task at hand during a tiring day at work would be unlikely to meet much 
REMHFWLRQ¶6DKDNLDQ	0RUHLQ- Zamir, 2007; 1158).  
 
Others question whether the consumption of pharmaceuticals in order to boost 
workplace performance or maintain high levels of cognitive functioning is ethically 
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sound. Throughout the neuroethics discourse we are presented with an image of 
society that is skill driven and knowledge-based where one¶s success correlates with 
their cognitive abilities (Rose, 2002; Esposito, 2005, Glannon, 2008).  Enhanced 
cognitive capacities are thought of as a competitive good that can give some people 
an advantage over others in gaining employment, advancing careers and earning a 
KLJKHULQFRPH7DQQVMR%XWFKHU7REHµVPDUWHU¶WKDQRWKHUSHRSOHLV
considered to be an asset in many situations and it is assumed that those who are not 
enhanced could be disadvantaged. Fears are voiced that if usage grows in the 
workplace, employees could feel compelled to take cognition enhancing drugs in order 
to remain competitive or simply to just keep up (Cahill, 2005; Glannon, 2008). The 
ethical issues raised therefore include concerns over unequal access, cost barriers, 
coercion or pressure to enhance and the potential for substance abuse (Greely et al, 
2008; Hyman, 2006; Wolpe, 2002). Policy mechanisms are frequently suggested as a 
way to protect against these scenarios.  
 
Enhancement uses 
 
Commentators claim that ADHD medications, such as Ritalin and Adderall and the 
QDUFROHSV\PHGLFDWLRQPRGDILQLODUHWKHGUXJVPRVWFRPPRQO\XVHGE\µhealthy, 
QRUPDOSHRSOH¶LQRUGHUWRJDLQPRUHWLPHLPSURYHWKHLUFRJQLWLYHDELOLWLHVDQGERRVW
their performance and productivity (Farah, 2002; Greely et al, 2008; Glannon, 2006; 
%XWFKHU+\PDQ)RULQVWDQFH&DKLOOZULWHVµWKHNH\to limitless 
productivity, energy, focus and just plain feeling good every single day can now be 
found in 100-PJFDSVXOHVRIPRGDILQLO¶2IWHQXWRSLDQVFHQDULRVDUHLPDJLQHGE\
ethicists to depict how individuals and society could benefit from cognitive 
enhancement. For example, Chan and Harris (2006) imagine a world in which: 
 
µ«LQWHOOHFWXDOSHUIRUPDQFHLVURXWLQHO\ERRVWHGE\SKDUPDFRORJLFDORU
computer-based technologies, assisting people to greater fulfilment of their 
SRWHQWLDOLQDOODUHDVRIOLIH¶(Chan & Harris, 2006: 365). 
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The concerns raised in this context of use frequently focus on safety and efficacy of 
drug consumption in those without illness (Williams & Martin, 2009; Chatterjie, 2009; 
Oliveria, 2009; Schermer et al, 2009). It is also feared that users could suffer from 
OLIHVW\OHDGGLFWLRQDVLWLVDVVXPHGWKDWDIWHUKDYLQJH[SHULHQFHGWKHµSRZHURI
artificially augmented mental faculties, who would voluntarily give up such 
FDSDELOLWLHV"¶&KDQ	+DUULV363). Again, concerns over authenticity, agency 
and identity emerge; views are often polarised as to whether the use of drugs changes 
or undermines who a person is and their responsibility for their actions (Hyman, 2006; 
Glannon, 2006). 
 
Despite such fears and concerns, there are calls from prominent ethicists and those 
ZLWKLQWKHQHXURVFLHQFHFRPPXQLW\IRUWKHSUHVXPSWLRQWKDWµPHQWDOO\FRPSHWHQW
DGXOWVVKRXOGEHDEOHWRHQJDJHLQFRJQLWLYHHQKDQFHPHQWXVLQJGUXJV¶*UHHO\et al, 
2008; 703; Harris, 2007b; Harris, 2009; Bostrom, 2007). Throughout the neuroethics 
discourse is the expectation that if healthy individuals and society can be protected 
against the risks of enhancement through appropriate legislative acts- those risks 
being harms to health, coercion and abuse- the benefits for society will be raised 
levels of attainment and productivity, health and overall wellbeing. As mentioned 
above, these expectations feed into a rather utopian vision of the future such as that 
imagined by Greely et al (2008) who say: 
 
µ«LQDZRUOGLQZKLFKhuman workspans and lifespans are increasing, cognitive 
enhancement tools- including the pharmacological- will be increasingly useful 
for improved quality of life and extended work productivity, as well as to stave 
off normal and pathological age-related cognitive declines. Safe and effective 
FRJQLWLYHHQKDQFHUVZLOOEHQHILWERWKWKHLQGLYLGXDODQGVRFLHW\¶ 
 
Ethicists do acknowledge that the drugs available today may have limited efficacy or 
unknown side-effects (see: Rose, 1993; Chan & Harris, 2006; Hyman, 2006; Wolpe, 
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2002) and occasionally, someone will question whether these drugs are actually 
HIILFDFLRXVHQRXJKWREHFDOOHGµHQKDQFHPHQWV¶+RZHYHUHWKLFDOGLVFXVVLRQVWHQGWR
be based on the assumption that efficacious drugs free of unwanted side effects will 
become available. Therefore, questions around safety and efficacy are made to 
appear somewhat superfluous in the face of frequent claims that new, safer and more 
HIIHFWLYHHQKDQFHPHQWGUXJVDUHµFRPLQJVRRQ¶DOORZLQJVXFKLVVXHVWREHGLVPLVVHG
as pragmatic rather than ethical concerns.  
 
Although it is often claimed that enhancement drugs will appeal to all healthy people, 
three specific groups stand out in the literature. Healthy people are usually exemplified 
through the image of older people, academics and students. 
 
Older people 
 
Current research into finding better treatments for dementia is often cited, and 
assumptions are made that at least some of these products will have applications as 
enhancements for normal memory in those who are middle and old aged (Farah, 
2005; Glannon, 2006). It is claimed that there will be a broad appeal and high demand 
for cognitive enhancing drugs amongst older people experiencing normal age-related 
cognitive decline (Greely et al, 2008; Farah, 2002). It is assumed this group will be 
most interested in memory enhancement (Farah et al, 2004). In this domain, concerns 
DUHUDLVHGRYHUWKHXQNQRZQFRQVHTXHQFHVRUSRWHQWLDOµKLGGHQFRVWV¶RI
enhancement (Glannon, 2006). 
 
Academics 
 
Some articles refer to cognition enhanFLQJGUXJVDVµSURIHVVRUV¶OLWWOHKHOSHUV¶
(Sahakian & Morein- Zamir, 2007) and it is claimed that there is already a significant 
amount of drug taking among academics with the goal of improving cognitive 
performance or stamina (Maher, 2008). Somewhat controversially, academics are 
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GHSLFWHGDVXVLQJWKHVHGUXJVWRLQFUHDVHWKHLUDELOLWLHVWREHFRPHµPRUHWKDQHTXDO¶
(Nature, 2009). Apparently, Professor Michel Jouvet, director of the French laboratory 
that developed modafinil remarked that he took the drug to increase his own 
productivity (Dorozynski, 1989; quoted in Cahill, 2005).  A paper by Sahakian & 
Morein- Zamir (2007; 1159) cites data from an anonymous questionnaire in which a 
µ8.SURIHVVRU¶H[SODLQVKRZVKHREWDLQHGPRGDILQLORQWKH,QWHUQHWDQGXVHs it 
µIRUWQLJKWO\WRHQKDQFHSURGXFWLYLW\DQGIRULPSRUWDQWLQWHOOHFWXDOFKDOOHQJHV¶7KH
HIIHFWVRIWKHGUXJDUHGHVFULEHGDVµPLOGEXWYHU\YDOXDEOH¶LQµLQFUHDVLQJPHQWDO
HQHUJ\¶DQGLPSURYLQJµVXVWDLQHGKDUGWKLQNLQJ¶%RVWURPDUJXHVWKDWµDQ\WKing 
that can help our brains deal better with the complex challenges of the 21st century is 
QRWRQO\WREHZHOFRPHGEXWDFWLYHO\VRXJKW¶1DWXUH 
 
Students 
 
University students are depicted as both existing and imagined future users of 
cognition enhancing drugs for distinctly non-medical purposes, to enable them to 
study longer, perform all-night study sessions, boost alertness in lectures, and 
improve exam grades (Nature, 2009). Much of this literature originates in the USA and 
is based around the use of Ritalin (methylphenidate) by students as a means to 
increase concentration, alertness and improve academic performance3. Claims are 
frequently made that an ever-increasing percentage of students are obtaining 
neuropharmaceuticals either illegally or by false diagnosis and using these substances 
to improve their academic performance (Sahakian & Morein- Zamir, 2007; Volkow & 
Swanson, 2007; Chan & Harris, 2006; Greely et al, 2008; Cahill, 2005; Butcher, 2003; 
Farah et al, 2004; Farah, 2002; Schermer et al, 2009; Forlini & Racine, 2009). 
 
This practice is constructed as a significant social problem on RQHKDQGDQGDVµROG
QHZV¶DURXWLQHSUDFWLFHZKLFKKDVDOZDys and will always go on, on another. 
However, it is rarely recognized in the literature that despite a certain percentage of 
                                                          
3
 For example, in one study Teter et al, (2006) found that 8.3% of college students admitted to the illicit use 
of prescription stimulants in their lifetime, in other studies the percentages cited vary. 
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students reportedly taking cognition enhancing drugs, the remaining body of students 
have (presumably) chosen not to take this route- assuming of course that 
neuropharmaceuticals are as widely available on college campuses as this literature 
would have us believe. Whilst a few commentators maintain that cognition enhancing 
drugs should be available to students without prescription, arguing that the benefits of 
such drugs outweigh the risks they pose, (e.g. John Harris, quoted in THES, 2009; 
10), others raise concerns over the use of such substances in competitive situations 
for example, during examinations (Sahakian & Morein-Zamir, 2007) where even small 
improvements in performance could translate into substantial benefits.  Ethical 
questions are then raised in relation to autonomy and freedom to choose versus 
pressure to enhance (Farah, 2004; Esposito, 2005; Forlini and Racine, 2009) and 
notions of fair play and equality.  
 
Others fear that such substances could be abused, lead to addiction or dependency in 
vulnerable people or put users at risk of adverse medical consequences (Volkow & 
Swanson, 2007) and argue that cognition enhancing drugs should not be freely 
available to the student population. The use of drugs by studHQWVLQµHOLWHXQLYHUVLWLHV¶
is commonly framed as a negative practice that should not be encouraged (Synofzik, 
2009; Sahakian & Morein- Zamir, 2007). However, this is also a grey area, as some 
substances are compared to caffeine and thought to be just the next step in an 
already acceptable and established practice of cognition enhancement. In an 
interesting study, Forlini and Racine (2009) interviewed students, parents and 
healthcare providers about their perspectives on cognition enhancement using 
neuropharmaceuticals. They found that despite valuing the same ethical principles (of 
autonomy and liberty) at a normative level, attitudes towards cognitive enhancement 
did vary significantly between groups being shaped by the social context of the 
individual and their personal values.  
 
 
 
29 
 
Abuse 
 
In discussions of the use of cognition enhancers by healthy children and 
sportspersons, the use of these substances are positioned as illegitimate. In these 
contexts the use of psychopharmaceutical drugs is usually referred to as abuse of 
medicine rather than therapy or enhancement and it is typically argued that cognition 
enhancing drugs should not be used. 
 
Children 
 
Usually, discussions about cognitive enhancement in children focus on the prevalence 
of ADHD and the use [or as it is often claimed, the overuse] of drugs such as Ritalin to 
alter socially undesirable behaviour (Conrad, 2007; Singh, 2003). Children are treated 
as a special case, because they are thought of as not capable of making their own 
informed choices (Greely et al; 2008). Over-zealous parents are imagined as feeding 
their children medication in order to boost their capabilities in the classroom (Hyman, 
)DUDK)DUDKZULWHVWKDWµDFFRUGLQJWRVRPHH[SHUWV
pharmacological enhancement RIFKLOGUHQ¶VDWWHQWLRQLVURXWLQHLQVRPHFRPPXQLWLHV¶
(2002; 1124). Some suspect that this process is also being encouraged by teachers 
VHHNLQJµPRUHRUGHUO\FODVVURRPV¶*UHHO\et al, 2008). Attention is then focused on 
the consequences of using medical technologies to deal with social problems with 
questions raised over the use of medicine to transform, alter and enhance bodies 
rather than ameliorate suffering. Apparently, US courts have already heard cases 
where parents were coerced into medicating their children by schools for attentional 
G\VIXQFWLRQ2¶/HDU\FLWHGLQ)DUDK Fears are raised that the use of 
neurotechnologies could narrow the range of acceptable human behaviours by shifting 
the line separating the normal, desirable and healthy from the deviant, pathological 
and sick. 
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The discourse is often quite socially deterministic as assumptions are made that the 
use of cognition enhancers by children would be of benefit to them academically 
speaking and also to their teachers by improving behavioural standards. For instance, 
Farah et al FODLPVWKDWµWHDFKHUVZLOOILQGHQKDQFHGSXSLOVPRUHUHFHSWLYH
WROHDUQLQJ¶DQG*UHHO\et al (2008; 704) write that liberal use of cognition enhancers 
µZRXOGEHH[SHFWHGWRHQFRurage classroom order and raise standardised measures 
RIVWXGHQWDFKLHYHPHQWERWKRIZKLFKDUHLQWKHLQWHUHVWVRIVFKRROV¶+RZHYHUMXVW
EHFDXVHDFKLOGLVFKHPLFDOO\µHQKDQFHG¶GRHVQRWPHDQWKDWWKH\ZLOOEHDXWRPDWLFDOO\
interested in school work. This line of argument implies that children who do not 
behave in school have something wrong with their brains rather than considering that 
they might be bored, have ulterior motives for their behaviour or choose not to pay 
attention. For example, how would a substance that enhances attention make a child 
more µreceptive to learning¶ in a history class when they are more interested in 
celebrities, fashion and music than immigration patterns during World War II? One 
cannot assume that the child will use their enhanced mental capacities for the benefit 
of their school work. 
 
The consensus seems to be that children should not be allowed access to cognition 
enhancing pharmaceuticals not only because they are thought not able to make their 
own informed choices but also for fear of adverse health risks, increased pressure to  
perform and coercion to enhance (Hyman, 2006; Wolpe, 2002).  
 
Athletes  
 
Athletes are mentioned as one group who could potentially abuse new and emerging 
cognition enhancing drugs.  The use of such substances in a competitive sporting 
situation is only very occasionally explored and questioned by ethicists (Wolpe, 2002; 
Nature, 2007). For instance, an editorial piece in Nature (2007) raises the possibility 
that in the future, the rules on pharmacological enhancement in sports could be 
FKDQJHG,WVWDWHVWKDWµE\WKHHQGRIWKLVFHQWXU\WKHXQHQKDQFHGERG\RUPLQGPD\
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ZHOOEHYDQLVKLQJO\UDUH¶DQGWKXVDUJXHVWKDWµDVSKDUPDFRORJLFDOHQKDQFHPHQW
becomes everyday, views of bodily enhancement may evolve sufficiently for sporting 
UXOHVWRFKDQJHRQWKDWWRR¶+RZHYHULQJHQHUDOWKHFRQVHQVXVVHHPVWR
be that cognitive performance enhancement in a sporting context should be seen 
much the same as other types of physical performance enhancement.  In sports, 
accomplishments are usually valued for the natural talent, luck or effort of an individual 
(Synofzik, 2009). Any type of chemical performance enhancement in sports would 
give competitors an unfair or unnatural advantage over others so be considered 
cheating because it is against the rules (Greely et al, 2008).  
 
Social science meets neuroethics 
 
As a branch of moral philosophy, neuroethics could be considered as aiming to draw 
on relevant facts and articulate relevant ethical principles in order to evaluate ethical 
concerns raised in relation to new neurotechnologies by means of rational argument 
(Farah et al., 2004). The philosophical thesis that there is a logical distinction between 
IDFWVDQGYDOXHVRUZKDWµLV¶DQGZKDWµRXJKW¶WREHFDQEHWUDFHGEDFNWR+XPH¶V
(1739) Treatise (Miller & Wendler, 2006). This thesis argues facts and values are 
fundamentally and functionally different. Facts are understood as descriptive and 
objective, whereas values are seen as subjective and evaluative and used to express 
emotions, attitudes, advice and so on. Descriptive and empirical data may be drawn 
upon in the philosophical reasoning of a situation, however, such evidence alone 
cannot be used to properly solve a normative problem. There are various views on the 
value of upholding a fact-value distinction within bioethics and a range of perspectives 
and positions have been adopted (see: Alveraz, 2001; Callahan, 1999; Herrera, 2008; 
Lopez, 2004; Solomon, 2005). Without delving too far into the long-running 
philosophical debate about the difference between facts and values, whether a 
distinction between the two should be upheld and the value of empirical research in 
ethical debates, this section briefly outlines the position adopted in this study.  
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Recent social research has demonstrated how social contexts can shape the way 
bioethical problems and their solutions are imagined (Busby, 2006; Hedgecoe, 2001; 
Wainwright, et al, 2006). For example, in their paper discussing the bioethics of 
infectious diseases, Tausig et al. (2006) explain that if bioethicists took sociological 
theories into account regarding disease causation as opposed to reliance on the 
biomedical model of disease different ethical considerations would come into focus. In 
a cross-cultural study investigating the role of bioethics in the development of 
biobanks, Salter and Jones (2005) found that central ethical principles were 
interpreted differently depending on the cultural context. Forlini and Racine (2009) 
argue that the broader social context is important for understanding how and why 
perspectives about cognitive enhancement diverge. In a study investigating 
perceptions towards the use of methyphenidate by students, they found that despite 
holding liberal individualistic values and viewing autonomy as a guiding ethical 
principle, attitudes towards enhancement varied significantly between groups 
depending on their specific social context. They conclude that it is unclear whether the 
issue of choice to enhance can be discussed outside of specific social contexts. 
 
 In another example, a study researching the ethical issues surrounding assisted 
conception, (Edwards, cited in Haimes, 2007) found that informants located ethical 
complexities raised by assisted conception within complex family relationships. If the 
existing scenario posed no concern, then parallels drawn with assisted contraception 
were also accepted and vice versa. They argue that new problems are understood 
and contextualised through existing cultural reference points which can act to resolve 
ethical dilemmas. However, the same ethical issues can be located within different 
contexts by different actors and have different implications and meanings. Haimes 
(2002) argues that it is these differences that are open to empirical investigation and 
that empirical study can stimulate further questions about the ethical context of the 
technology.  
 
33 
 
As many those within the field of neuroethics also acknowledge, the very facts that 
FRXQWDVµUHOHYDQW¶LQHWKLFDOGHEDWHVDUHWKHPVHOYHVVRFLDOO\KLVWRULFally, culturally 
(and politically) constituted and situated (Turner, 2009). It has been argued that there 
is a tendency within bioethical debates to transform problems into representations of 
problems that make them easier to solve (European Commission, 2006). 
Consequently, the complex dynamic and structured nature of social and institutional 
challenges which such scenarios entail, remain hidden (Manson, 2006). Critics of the 
field suggest that the ethical debate so far has been dominated by review articles 
seeking to summarise current neuroscientific debates and suggest ways in which 
ethical analyses of their content and implications might prove useful (Martin & 
Ashcroft, 2005). These debates focus on expectations of future drugs or on extreme 
cases rather than presenting a realistic discussion of those presently available. For 
instance, Schermer et al. (2009) argue that a significant part of this debate suffers 
from inflated expectations and technology hype. They conclude that further discussion 
of the advantages and limitations of enhancers is needed on a collective social level.  
 
Therefore, social scientific studies of ethically contentious issues have revealed that 
there can be multiple perspectives on ethical issues and have demonstrated that 
ethical principles can also be of an ambivalent nature (Bauman 1993; Haimes, 2002; 
Lopez, 2004). Social research can reveal how ethical dilemmas present themselves, 
are understood and played out in social context and how the same action can be 
interpreted differently depending upon its social location (De Vries et al, 2007; 
Haimes, 2002; Hedgecoe, 2001; Racine, 2008). Therefore, empirical social science 
research can engage with bioethical debates through the study of contextualised 
scenarios to  illustrate how bioethical problems are both generated, framed and 
shaped by different cultural frameworks, structures and institutions (Conrad, 2001; De 
Vries et al, 2007; Haimes, 2002; Hoffmaster, 2001; Locke, 2001; Rosenberg, 1999; 
Salter & Jones, 2005). The empirical study of detailed and contextualised cases can 
identify discourses outside of bioethical accounts and illustrate the agency of different 
actors in constructing, choosing and shaping alternative futures. The position adopted 
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in this research follows that outlined by Haimes (2002) in that social science research 
can usefully contribute to, engaging with rather than simply informing, the ethical 
debate surrounding cognitive enhancement. 
 
Rationale for this research 
 
To summarise, the neuroethical discourse around psychopharmaceutical 
enhancement is based upon the claim that cognitive enhancement of the healthy is 
already happening, despite limited empirical evidence available. The discourse 
generates several expectations: that the use of psychopharmaceuticals will spread to 
more people; this widespread usage will change the way we live our modern lives; and 
that the future will bring new ways of enhancing, controlling and reading the brain.  In 
framing cognitive enhancement in this way it appears that an increase in the pursuit of 
human enhancement is inevitable. 
 
Whilst therapeutic uses are generally accepted on the ground of patient benefits, 
enhancement uses are debated. There are also some cases in which the consensus 
seems to be that the use of cognition enhancing drugs would be abuse as opposed to 
therapy or enhancement and, in these cases, commentators argue that cognition 
enhancing drugs should not be used. Overall, issues conceptualised as warranting 
ethical deliberation in the neuroethics literature can be divided into two main 
categories; those that concern practical and regulatory matters of enhancement such 
as safety, efficacy and access to neurotechnologies with enhancement potential; and 
those of a philosophical nature, concerning for example, possible threats to the 
concepts of authenticity, identity and human nature (Illes, 2006; Parens, 2006). There 
is also a third type of debate that could be broadly termed social, which includes 
issues of medicalisation, understandings of health, illness, therapy and enhancement 
and socio-cultural change. 
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The ways in which uses of these drugs and their users are imagined and framed in 
neuroethical debates therefore influences which social and ethical issues are given 
priority and which are not. The key point to take from the snap-shot of neuroethics 
presented here is that in framing the enhancement debate in this way, ethicists are 
actively involved in the construction of particular neurofutures. The way bioethicists 
position themselves as ethical experts able to sift through the issues and concerns 
raised by new technologies using rational thinking and informed reasoning in order to 
provide value-free evaluations of how, when and if enhancement technologies should 
be used and by whom is therefore problematic. 
 
However, few studies have taken a social science standpoint or investigated use of 
neuropharmaceuticals from the perspective of various stakeholders. Instead, as I have 
attempted to show in the above analysis, arguments tend to depend on extreme or 
typified cases which act to construct a particular kind of ethical problem and resolution 
(Elliott, 1999; Singh, 2005). As such it is difficult to ascertain from these ethical 
debates how cognitive enhancement technologies are (or will be) used and how their 
use will be understood, positioned and negotiated by prospective users in the context 
of their everyday lives.  
 
Modafinil as a case study 
 
As cognitive enhancement is a relatively broad topic it was necessary to choose a 
case study to provide a focus for investigation.  Modafinil belongs to the class of 
FRJQLWLRQHQKDQFHUVNQRZQDVµZDNHIXOQHVVDJHQWV¶,W LVDµHXURJLF¶GUXJWKDW
SURPRWHVDURXVDORUµFDOPZDNHIXOQHVV¶&HSKDORQ) enabling the user to be 
awake for days at a time. The exact mechanism of action it uses to promote a state of 
wakefulness is still under investigation (Cephalon, 2008).  Modafinil has been 
marketed under the trade name Provigil in the UK by US company Cephalon for the 
treatment of the rare sleep disorder narcolepsy since 1998 and excessive day- time 
sleepiness (EDS) associated with obstructive sleep apnoea/ hypopnoea syndrome 
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since 2002. Since its emergence in 1998 as a treatment for narcolepsy, various states 
of somnolence have been redefined in (bio)medical terms and subjected to 
pharmaFRORJLFDODQGRUSV\FKLDWULFWUHDWPHQW0RGDILQLO¶VOLFHQVHKDVEHHQH[WHQGHG
to cover excessive daytime sleepiness (EDS) associated with a wide range of 
conditions including chronic fatigue syndrome, cancer, and other sleep disorders such 
as restless legs syndrome (RLS). In 2004 the license was extended to include the 
treatment of the disruption in circadian rhythms resulting from shift work, in both the 
US and the UK.  
 
The effects of modafinil reportedly include a variety of other cognitive benefits, such as 
improving alertness, concentration, and memory (Turner et al., 2003). In a recent 
study the cognition enhancing effects of modafinil were investigated using healthy 
subjects. Modafinil was found to significantly enhance performance on a variety of 
neuropsychological tests including those testing visual memory, spatial planning and 
reaction time. In addition to this, subjects reported feeling more alert, attentive and 
energetic whilst on the drug. It was not found to have any significant side effects or 
addictive qualities (Turner et al, 2003). There have been reports of other studies with 
similar findings of increased alertness and wakefulness whilst testing the drug on 
pilots (Walz, 2003).  
 
It is argued that modafinil is a drug that that could potentially be taken by the general 
population to promote alert wakefulness and reduce the need for sleep. It has 
captured public and professional imagination alike and been the subject of radical 
articles in both the scientific and popular press. Modafinil has also been one of the 
focal points of the bioethical discussion on human cognitive enhancement. Over 
recent years this drug has featured in numerous newspaper stories, scientific studies, 
bioethics articles, and even been given the starring role in television documentaries, 
radio talk shows and news bulletins (BBC Television, 2009a; 2009b; BBC Radio 4, 
2007; Channel 4 news, 2009; 2008). 
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$OWKRXJKRIWHQUHIHUUHGWRDVDµVDIH¶GUXJLQWKHQHXURHWKLFVOLWHUDWXUHDQGPHGLD
discourse, modafinil does come with some serious health warnings. The company that 
PDQXIDFWXUHVWKHGUXJZDUQVWKDWXVHUVFRXOGGHYHORSDµVHULRXVRUOLIHWKUHDWHQLQJ
rash, including Steven-Johnsons Syndrome (a rare life threatening condition which 
DIIHFWVWKHVNLQDQGFDXVHVFHOOGHDWK¶WKDW this has been reported in both children 
and adults and that the drug is not approved for use in children for any indication.  
On the patient information leaflet provided with the drug, patients are reminded that 
PROVIGIL (modafinil) is a: 
 
µ«controlled substance because it can be abused or lead to dependence. Keep 
PROVIGIL in a safe place to prevent misuse and abuse. Selling or giving away 
3529,*,/PD\KDUPRWKHUVDQGLVDJDLQVWWKHODZ¶&HSKDORQ 
 
Common side effects reportedly include headache, nausea, rhinitis, diarrhea, back 
pain, insomnia, dizziness, and dyspepsia. Although less frequently reported, use of 
the drug has also been linked to psychiatric symptoms including suicidal ideation, 
psychosis, mania, delusions, hallucinations, aggression, anxiety, nervousness, 
depression, agitation and confusion (Cephalon, 2008). The company also reports that 
modafinil has reinforcing properties, as evidenced by its self-administration in 
monkeys previously trained to self-administer cocaine (Cephalon, 2008).  
 
The idea that the use of neurotechnologies, such as modafinil, to manipulate brain 
function can be understood within multiple frameworks that provoke varied cultural 
commentary and normative reaction provides the starting point for this research. 
Because of its multitude of uses and wide range of prospective users, modafinil can 
be used as a good case study to investigate the reception and uptake of these new 
technologies within popular culture, the role and function of medicine in attempts to 
control sleep, once considered a private corporeal form of existence, and the 
normative implications this might have.  
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Research Aims  
 
The overall aim of this study is to explore the social and ethical issues relevant to the 
pharmaceutical augmentation of human cognitive functioning, in order to determine 
how sociotechnical spaces for µWKHUDS\¶DQG µHQKDQFHPHQW¶DUHEHLQJFRQVWUXFWHGDQG
negotiated in different domains of social life. The core research question this project 
aims to address is: How is the use of the drug modafinil to augment human cognition 
understood within the mass media, by researchers and potential users, and what 
implications does this have for debates about enhancement technologies? 
The overall aim of the study can be broken down into four sub-aims: 
 
1. To establish the ways in which modafinil is represented in the mass media 
and how this impacts upon views of the legitimacy of its use across different 
contexts. 
2.  To describe how the use and users of the technology are framed within 
medical and scientific discourse. 
3.  To analyse the ways in which prospective users of modafinil understand, 
position and negotiate use of the drug in the context of their everyday lives. 
4. To explore the implications of these empirical findings for normative debates 
about the idea of cognitive enhancement and social science debates about 
(bio)medicalisation. 
 
Framework for thesis 
 
Running parallel to bioethical debates, in the sociological literature the prospect of 
human enhancement is discussed in relation to therapy where one finds extensive 
FULWLFDOFRPPHQWDU\DQGDQDO\VLVVXUURXQGLQJWKHµPHGLFDOLVDWLRQ¶DQG
µSKDUPDFHXWLFDOLVDWLRQ¶RIQXPHURXVERGLO\DQGSV\FKRORJLFDOVWDWHVWKDWZHUHRQFH
WKRXJKWRIDVZLWKLQWKHµQRUPDO¶UDQJHRIKXPDQEHKDYLRXUVEXWKDYHQRZFRPe 
under the purview of medicine (Williams et al, 2008a; Williams et al, 2008b; Williams, 
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Gabe & Davis, 2008; Conrad, 2007; Scott, 2006; Singh, 2003).  How the prospect of 
human cognitive enhancement relates to contemporary social theory on medicine, 
society and the body will be discussed in chapter 2.   
 
Informed by previous work in both medical sociology and bioethics, the debate around 
medical/ non-medical or therapy/enhancement uses of this drug will be approached 
from an Science and Technology Studies (STS) perspective. Conceptualising 
modafinil as a sociotechnical object, the analytical framework will focus on the 
interaction between the technology and prospective users (Woolgar, 1991; Akrich, 
1992) to understand how pharmaceuticals with both therapeutic and enhancement 
potential are understood, positioned and negotiated in social context.  Data collection 
and analysis are discussed in chapter 3. 
 
The mass media have been shown to provide a central forum for debates regarding 
issues relating to science, society, lifestyle, and most importantly, health and illness 
(Nerlich, Johnson & Clarke, 2003). It is mainly through the mass media that the 
general public becomes aware of scientific advances, new therapies and the social 
and ethical issues regarding their use and availability. Because the media operate at 
this interface between science and society, reporting on scientific advances and 
technological developments in specific ways, they are likely to play an important role 
in shaping public perceptions of new technologies and their value and applications 
(Nelkin, 2001; Nisbet, 2007; Nisbet, Scheufele et al., 2002). An analysis of the way in 
which the British print media construct and interpret issues surrounding therapy and 
enhancement of brain function and the conceptual links they create between sleep 
and health, and the body and technology will presented in chapter 4. 
 
In addition to media discourses and debates, the linguistic medico-scientific 
representations of medicine, illness, disease and the body are influential in the 
construction of both lay and medical knowledge and experiences (Nisbet & Mooney, 
40 
 
2007; Ettorre, 1999; Nelkin, 2001). How sleep, cognition and modafinil use are framed 
by scientific and medical experts will be discussed in chapter 5.  
 
The importance of the context in which psychopharmaceuticals are prescribed or 
bought and used is acknowledged by some academics involved in neuroethical 
debates (Sahakian & Morein-Zamir, 2007; Racine & Forlini, 2009). Presently, the 
empirical evidence of how, when, why and by whom cognitive enhancers are used is 
limited and the extent to which psychopharmaceuticals are used for purposes of 
enhancement has not been subject to extensive empirical investigation. Therefore, it is 
difficult to evaluate the significance of the benefits or problems raised in neuroethical 
debate to (potential) end users4. Additionally, the ways in which 
psychopharmaceuticals are used within different sections of society and in different 
cultures is likely to be reflective of socio-cultural norms (Chatterjie, 2006; Malacrida, 
2004). Chapters 6 and 7 aim to situate understandings of and attitudes towards 
modafinil use in social context in an attempt to further explore how the visions of 
contemporary/future society presented in the neuroethics literature compare and 
relate to how modafinil as an enhancement drug is understood by prospective users in 
the contexts of their everyday lives. 
 
Chapter 8 draws the empirical findings of the study together to comment on how: 
modafinil is understood in social context in relation to existing practices and cultural 
norms; the role of medical expertise and medical control in the construction of both 
use and user; and the impacts of this type of technology on notions of self-governance 
and identity. It aims to contribute empirically to the emergent body of sociological work 
on medicalisation/pharmaceuticalisation of sleep and also in more general terms, to 
shed new light on the challenges new neurotechnologies pose to upholding a 
distinction between therapy and enhancement in contemporary society. 
                                                          
4
 )RUIXUWKHUHODERUDWLRQRIWKLVSRLQWVHH0DUWLQ	$VKFURIW¶VGLVFXVVLRQRQµ7KHH[SHULHQFHRI
QHXURWHFKQRORJLHV¶S-26).  
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Chapter 2: Literature review 
 
Introduction 
 
As discussed in Chapter 1, the relationship between therapy and enhancement is 
complex. Enhancements are FRQFHSWXDOLVHGRQWKHRQHKDQGDVJRLQJµEH\RQG
KHDOWK¶WKHrefore outside of the remit of medical authority and on the other as forms of 
medicalisation when augmentation of the body (or mind) is understood within a 
biomedical framework and performed through medical procedures or technology. 
Tension exists in demarcating legitimate use of medical resources from unjustified 
social control and in the separation of positive (or enhancing) and negative (or 
harmful) applications of the same substances outside of medical authority. 
 
Numerous states that were once thought RIDVZLWKLQWKHµQRUPDO¶UDQJHRIKXPDQ
behaviours and conditions have been identified that are now thought of, at least 
partially, in terms of illness or disorder. These include shyness [Social Anxiety 
Disorder], height [Idiopathic Short Stature], small breasts [microstatia] and high body 
weight [obesity], to name but a few (Chang & Christakis, 2002; Hall, 2006; Scott, 
2006). When considering traits and behaviours that can be altered via over-the-
counter pharmaceutical products the list expands even further. Medicalisation is the 
WHUPXVHGWRGHVFULEHWKHSURFHVVRIµPDNLQJPHGLFDO¶&RQUDG,QRWKHUZRUGV
a physical, biological or psychological condition or behaviour is said to be 
µPHGLFDOLVHG¶ZKHQLWLVGHVFULEHGZLWKLQDELRPHGLFDOIUDPHZRUN given a medical 
label (as an illness or disorder) or treated with a medical intervention (pharmacologic 
or otherwise). Theories of medicalisation can therefore be used to understand how 
new technologies, such as modafinil, come to be thought of, used for, and accepted 
as legitimate medical treatments. When thinking about non-medical uses of the drug, 
a newer term, pharmaceuticalisation, may be more applicable. Pharmaceuticalisation 
LVXVHGWRGHVFULEHWKHµWUDQVIRUPDWLRQRIKXPDQFRQGLWLRQV¶LQWRµSKDUPDFHutical 
PDWWHUVRIWUHDWPHQWRUHQKDQFHPHQW¶ZKLFKµRYHUODSZLWKEXWH[WHQGIDUEH\RQGWKH
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UHDOPVRIWKHPHGLFDORUWKHPHGLFDOLVHG¶DQGµVHUYHWRIXUWKHUEOXUWKHERXQGDULHV
EHWZHHQWUHDWPHQWDQGHQKDQFHPHQW¶:LOOLDPV et al, 2008a). 
 
There are a plethora of studies within the social sciences that address the issue of 
medicalisation focusing on various types, levels and consequences of the process. 
Whilst pharmaceuticalisation is still a relatively new term, interest in this phenomenon 
is also growing. Due to the vast quantity of medicalisation literature that exists, this 
chapter attempts to provide an overview rather than a review of all of the previous 
work in this area. Particular attention is paid to recent studies and debates 
concentrating on how the concepts of medicalisation and pharmaceuticalisation are 
being used to investigate the relationship between sleep, therapy and enhancement, 
before moving on to discuss the rationale for approaching this topic from an STS 
perspective. 
 
Medicine, pharmaceuticals and society 
 
Modafinil is presently available in the UK as a medicine, prescribed for the medical 
treatment of clinically defined disorders. For this reason, it is important to uncover how 
the various uses of this substance are being legitimated, promoted and restricted 
within the medical and scientific domains. This will contribute towards a greater 
understanding of how spaces for therapy and enhancement are being constructed and 
negotiated in contemporary society. 
 
This section begins with an overview of sociological theory surrounding the role and 
influences of medical professionals and medicine in society. Firstly, the concept of 
medicalisation is introduced and literature discussing the role of the patient as 
consumer of medicine and the relationship between medicine and enhancement are 
presented. Following this, pharmaceuticalisation and the role of pharmaceuticals in 
society is discussed. 
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Medicalisation  
 
According to Conrad (1992) medicalisation is a bi-directional and multi-faceted 
process that can occur on three distinct levels; the conceptual, institutional and 
interactional. It is at the conceptual level where the condition is defined through a 
medical framework as a (bio)medical problem. At the institutional level organisations 
may adopt a medical approach to treating a particular problem. The interactional level 
is where doctors are most involved in the medicalisation process, providing a medical 
diagnosis during a doctor-patient consultation or prescribing a medical treatment for a 
particular problem.  
 
Early works on the medicalisation of everyday life were generally based upon a thesis 
RIµPHGLFDOLPSHULDOLVP¶± µWKHLQFUHDVLQJDQGLOOHJLWLPDWHPHGLFDOLVDWLRQRIWKHVRFLDO
ZRUOG¶6WURQJ7KHPHGLFDOLVDWLRQWKHVLVWKXVHPHUJHGDVDcritique of medical 
dominance and power. Medical professionals (and medical knowledge) were thought 
of as illegitimately extending their power and control into domains of social life outside 
of their competence as social problems came to be viewed through the prism of 
medicine and disease (Zola, 1972; Friedson, 1970; Illich, 1975). Within this 
framework, patients were conceptualised as passive targets of medical control and 
medicalisation was considered to be a negative process whereby the power of the 
medical profession removed autonomy from the patient to make decisions about their 
own healthcare. 
 
How processes of medicalisation are defined and understood varies within the 
sociological literature. For instance, the description of a particular trait or behaviour in 
medical terms, the existence of a medical diagnosis and the availability of a medical 
treatment are not mutually exclusive for a condition to be referred to as medicalised 
(Conrad, 2007). Additionally, any definition of a problem in medical terms, or treatment 
by a medical intervention can be referred to as medicalisation, with or without the 
direct involvement or endorsement of medical professionals. By consequence, 
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medical professionals are no longer viewed as the key to understanding 
medicalisation.   Some argue that any understanding of medicalisation that excludes 
the role played by the medical profession is invalid and highly flawed with such 
analyses loosing rigor and coherence (Davis, 2006). However, Conrad (2000) points 
out that several studies have shown that the medical profession, or even individual 
doctors may only be marginally involved in the medicalisation process and actual 
medical treatments are not a requisite for medicalisation to occur.  
 
In recent years the medicalisation debate has moved on from a focus on medical 
imperialism to take into account the way that socio-cultural processes create a 
demand for medical definitions to make sense of everyday problems (Furedi, 2006).  
Current debates within medical sociology talk about thHµVKLIWLQJHQJLQHV¶RI
medicalisation (Conrad, 2007) and how new drivers of the process include: the 
patient-consumer in search of diagnosis or a technological fix for a variety of self-
diagnosed problems; the pharmaceutical industry aiming to expand their markets in 
order to sell more drugs in the pursuit of higher profits; and cultural influences such as 
the Internet and media which often cast problems and their solutions in the rhetoric of 
medicine, contributing to the process on a conceptual level by encouraging problems 
to be thought about in medical terms. 
 
From patients to consumers of healthcare 
 
Early proponents of the medicalisation thesis claimed that patients were passive 
targets of medical control. The decision of whether to prescribe medication or not is 
W\SLFDOO\XSWRWKHGRFWRUKRZHYHUWKLVFULWLTXHODUJHO\LJQRUHVWKDWLWLVWKHSDWLHQWV¶
choice whether they seek medical advice in the first instance, and if prescribed 
treatment, whether they decide to take it (Strong, 2006). For example, in a review 
paper drawing together several qualitative studies on lay experiences of medicine 
taking, Pound et al. (2005) found that modifications to treatment regimens without 
prior discussions with medical professionals were common, dosages were generally 
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decreased by patients and medicines were often supplemented or replaced with non-
pharmacological treatments.  The study found the existence of widespread caution 
towards taking medicines based upon fears of adverse effects, worries about 
dependency, tolerance, addiction and potential harms of taking medicines in the long 
term. They conclude that the main reason why people do not take medications as 
prescribed is concern about the medicine itself, as opposed to a failing in 
communication, a lack of understanding or problematic doctor-patient relations.  This 
study is interesting because, when thinking about the medical uses of modafinil in 
SDUWLFXODULWDOHUWVWKHDQDO\VWWRWKHDJHQF\RIWKHµSDWLHQW¶7KLVVWDQFHFRQWUDVWV
significantly with the image of the patient presented in the neuroethical discourse 
(Chapter 1), in which, therapeutic uses of drugs such as modafinil are typically 
presented as straightforward and acceptable. Social research into how patients 
actually consume medicines in the context of their daily lives highlights how this too is 
a complex and often problematic practice where the patient has autonomy and agency 
to decide both if and how they use prescription drugs. 
 
0RVWPHGLFDOLVDWLRQVWXGLHVµEUDFNHWRII¶WKHTXHVWLRQDVWRZKHWKHUPedical 
intervention is beneficial for the patient, instead focusing on how and why such 
changes have come about. In taking this approach such studies do not take into 
account many of the normative or positive values associated with medical diagnosis 
and treatment such as recovery from illness, restoration of a socially acceptable health 
status and relief from pain (Furedi, 2006). Today it is often argued that one of the main 
GULYHUVRIWKHWUHQGWRZDUGVPHGLFDOLVDWLRQLVWKHWUDQVIRUPDWLRQRIWKHµSDVVLYHSDWLHQW¶
into a consumer in search of a diagnosis (Tomnes, 2007; Furedi, 2006; Conrad, 
2007). The users of medical technology, whether referred to as patients, consumers or 
some hybrid of the two, have become the focus of many medicalisation studies.  It has 
been argued that it is often patient activists rather than professional bodies that 
campaign for medical labels to describe their conditions. The application of a medical 
label can provide legitimacy for those living with the illness to gain medical treatment 
/HHDQGPD\DOVRKHOSLQGLYLGXDOVPDNHVHQVHRIWKHLUµV\PSWRPV¶)XUHGL
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2006). Biological explanations of mental illness in particular can lead to de-
stigmatisation and hope of new treatments (Lakoff, 2005). A number of studies have 
emerged in the field of science and technology studies (STS) that show how patient 
activists can assert their claims to be regarded as experts on their own illnesses in 
order to play a more active role in health-care decision making (Epstein, 1995). It is 
argued that such patient initiatives have resulted in significant changes in the practice 
of medicine.  
 
Through the lens of the patient-consumer then, the conceptualisation of medicalisation 
as increasing domination and control of the designation of ill and healthy bodies is 
being re-envisioned as a collaborative process between doctors and patients that 
reconfigures the boundaries of acceptable behaviours and bodies (Tomnes, 2006). 
The rise of the active patient or patient-consumer is seen as a positive step in 
removing some authority from the medical profession (Lupton, 1997). However, 
according to Dingwall (2006) the fact that patient groups campaign for medical 
recognition of their conditions is somewhat inconsistent with claims of a decline in 
medical dominanFH+HDUJXHVWKDWµWKHZRXOG-be-sick who want their deviance 
labelled as unmotivated and deserving of social support still need the affirmation of the 
RUJDQLVHGSURIHVVLRQWRVXVWDLQWKLVFODLP¶'LQJZDOO 
 
When one thinks carefully about the choices a patient-consumer has, especially the 
wealthy patient-consumer, in relation to the global healthcare market, to a certain 
extent the dynamics of the traditional doctor-patient relationship can be bypassed as 
individuals have the choice to seek out surgical procedures and therapies from 
practitioners willing to provide them. The patient-as-consumer has the power of 
choice: they are able to choose which service they require and where they go for it. 
For example, if a particular treatment is not available through the NHS (or covered by 
insurance in the USA) the consumer has the option of paying privately to receive it. If 
a condition is not recognised as a medical condition in the part of the world one lives 
or a procedure not available (e.g. penis extension, abortion) or legal in the country 
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they reside (e.g. euthanasia, egg donation), the consumer has the choice to perhaps 
even travel to other parts of the world to undergo medical treatment.  
 
Despite this, as Lupton (1997) suggests, there are also likely to be times when the 
consumerist role is rejected in preference of the more traditional role of patient-as-
recipient of expert knowledge. µPassive¶ patients go to the doctor for information and 
expert advice, with both groups appreciating the asymmetry in knowledge and patients 
do not identify (or perhaps even resist) themselves as consumers in this context. 
However, the same individual can act as both consumer of health care and passive 
patient depending on context (Stevenson, Leontowitsch & Duggan, 2008). The focus 
of these studies on patient-consumers illustrate how users of technology can shape 
the demand for medical treatments for human problems, thus transforming medicine 
LQWRDµYHKLFOHIRUVHOI-LPSURYHPHQW¶&RQUDG 
 
The biomedical era 
 
Contemporary scholars often argue that the social role of medicine is changing from 
an institution that cares for and heals the sick to a tool for self-improvement in a 
society where people can (re)create themselves and their bodies in the fashion they 
choose. The term biomedicalisation is used to describe a recent shift in medicine 
taking place since the 1980s (Clarke, Fishman, Fosket, Mamo & Shim, 2003). In the 
biomedical era, new discourses within science and medicine promote the idea of an 
individualised body. The body is no longer thought of as stable and static but instead 
as flexible, it can be manipulated, reconfigured, moulded, sculpted and transformed 
(Martin, 1994; Rose, 1999). Biomedicalisation is based on the premise that everyone 
is µDWULVN¶RI future ill health and this idea has become institutionalised through the 
medical surveillance of healthy populations where individuals are surveyed, screened, 
measured and tested in relation to medical ideals or pre-conceived standards of what 
is normal (Armstrong, 1995). At the same time, outside of medical encounters and 
institutions there is also thought to have been a shift in medical and political discourse 
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towards giving more responsibility for attaining health to the individual through health 
campaigns and initiatives as it becomes their responsibility to maintain or optimise 
their health through biomedicine.  
 
In his early writings Nikolas Rose (1996GLVFXVVHVKRZWKHVHOIDQGWKHµQRUPVRI
VHOIKRRG¶- autonomy, liberty, choice, and identity-  have become central to the ways in 
ZKLFKµPRGHUQPHQDQGZRPHQKDYHFRPHWRXQGHUVWDQGH[SHULHQFHDQGHYDOXDWH
themselves, their DFWLRQVDQGWKHLUOLYHV¶:1). Biomedicine has therefore opened 
up new possibilities for action on the self, creating new choices, identities and 
possibilities. Natural and artificial are combined as humans continue to transform 
themselves through technology; through this process not only is the body reshaped 
EXWDOVRRXUµVHQVHRIVHOYHV¶*UD\7KHUHLVWKHQDW\SHof biomedical 
governance at work that can act at the level of identity and social relationships altering 
subjectivities, providing us with new ways of understanding ourselves and our 
behaviours and shaping desires for transformed bodies and identities (Clarke et al., 
2003; Rose, 1996; Gray, 2002). Whereas medicalisation describes the transformation 
of social deviance to illness and is centrally concerned with notions of control and 
normalisation, it has been argued that through processes of biomedicalisation bodies 
DQGLGHQWLWLHVERWKLQGLYLGXDOO\DQGFROOHFWLYHO\DUHµFXVWRPL]HGWDLORUHGDQG
IXQGDPHQWDOO\WUDQVIRUPHG¶&ODUNHet al., 2003; 169).  
 
Beyond therapy? 
 
Clarke et al. (2003) argue that the customization5 of bodies through tailor-made 
medicines, technologies and cosmetic surgery in addition to the proliferation of 
µOLIHVW\OHGUXJV¶PDUNWKHPRYHDZD\IURPPHGLFLQH-as-therapy towards medicine-as-
enhancement. Customisation is not only about improvement of bodies and 
                                                          
5
 Other terms, besides customization, that are used in the sociological literature include augmentation, 
modification, remodelling (Wehling, 2005) and optimization (Conrad & 3RWWHUµ2SWLPL]DWLRQ¶ is also at 
the heart of the transhumanist project which projects an image of the body as flawed but perfectible through 
technoscience (Robitaille, 2008).  
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enhancement of bodily functions, but also about health promotion with information 
about susceptibilities, potential illnesses and preventative medicine. It has been 
DUJXHGWKDWWKURXJKELRPHGLFLQHDQGQHZELRPHGLFDOWHFKQLTXHVRILQWHUYHQWLRQµZH
have become responsible for the design of RXUERGLHV¶1HJULQ 
 
As discussed in Chapter 1, the use of medical technologies and procedures for self-
improvement raises concerns about where the limits to medical authority over the 
body lie and the blurring of the boundary between therapy and enhancement (Parens, 
1998). Recently, biomedical enhancement has been conceptualised as operating in 
three distinct ways: in terms of normalisation, bringing the body in line with a cultural 
norm; the repair and restoration of lost functions; or the (il)legitimate improvement of 
performance (Conrad & Potter, 2006). Concerns are raised that the use of biomedical 
technologies for enhancement purposes could increase the medicalisation of human 
problems, as the existence of medicalised solutions to these problems coupled with 
cultural attitudes and social values may contribute to shifts in the boundaries of what is 
FRQVLGHUHGµQRUPDO¶DQGDFFHSWDEOH7KHVRFLDOUROHRIPHGLFLQHLQWKLVFDVHLV
conceptualised as one of amelioration against pain, suffering and discomfort. 
 
However, over the past few decades medical procedures, for example, surgical 
remodelling of the body, have become detached from therapeutic contexts and goals 
of healing or repair, through successful advertising and media promotion. It is now 
commonplace to see invasive surgical procedures being used to alter or transform the 
body for the goals of boosting self-esteem, social recognition and even to advance 
one¶s career (e.g. glamour models and breast enlargements). Wehling (2005) argues 
thaWWKLVGHPRQVWUDWHVWKDWDZLOOLQJQHVVWRµFRQWLQXRXVO\VKDSHDQGFRUUHFWWKHERG\
LVVHWDVDFXOWXUDOQRUP¶/LNHZLVH&RQUDGDUJXHVWKDWµWKHKXJHH[SDQVLRQ
of cosmetic surgery makes it abundantly clear that medicalised solutions to problems 
oIWKHERG\DUHLQFUHDVLQJO\FRPPRQDQGDFFHSWHGLQRXUVRFLHW\¶2WKHUV
echo these sentiments when talking about the mind, arguing that we have already 
entered into an era where psychotropic drugs are used to treat mild symptoms and 
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improve upon cognitive functioning and emotional states that are well within the range 
FXUUHQWO\VHHQDVQRUPDO.UDPHU$FFRUGLQJWR&RQUDGµELRPHGLFDO
enhancements are one of the prime frontiers of consumer-GULYHQPHGLFDOLVDWLRQ¶DQG
he predicts that this area is likely to grow extensively.  
 
Although this suggests that optimisation and shaping of the self through technology is 
a positive process, Wehling (2005) argues that it does not necessarily mean that we 
can escape from cultural stereotypes and discriminations that exist in society. He 
points out that many current cosmetic surgery procedures still serve as means to alter 
or remove socially undesirable physical features that do not align with the current 
social norm (i.e. liposuction, nose augmentaWLRQVXUJHU\WRµZHVWHUQLVH¶H\HV
Therefore, new biomedical knowledge, techniques and practices do not only liberate 
but can also act to constrain behaviours and reinforce existing social or biomedical 
norms (Wehling, 2005). Through an historical analysis of the emergence and 
understanding of human growth hormone as an anti-aging therapy, 0RUULVRQ¶V
work shows how the boundary between therapy and enhancement shifts over time 
and between countries. Similarly, in their analysis of dichotomies between what was 
FRQVLGHUHGDµQDWXUDO¶DQGDQµDUWLILFLDO¶VXEVWDQFHLQHOLWHVSRUWYDQ+LOYRRUGH9RV	
GH:HUWDUJXHWKDWERXQGDULHVEHWZHHQµQDWXUDO¶DQGµHQKDQFHG¶ERGLHVDUHWKH
product of institutional boundary work. Both therapy and enhancement, then, are 
understood in relation to socio-FXOWXUDOFRQFHSWLRQVRIZKDWLVERWKµQRUPDO¶DVGHILQHG
by scientific medicine) and desirable. 
 
As discussed in Chapter 1, problems arise in practice when trying to demarcate 
technological intervention in terms of therapy or enhancement as the same activity 
could be classified as either a therapeutic or a non-therapeutic intervention depending 
XSRQWKHVWDUWLQJSRLQWRIDQLQGLYLGXDOUHODWLYHWRWKHµQRUP¶7KXVERWKGHILQLWLRQVUHVW
on the assumption that a stanGDUGRUµQRUPDO¶OHYHORIIXQFWLRQLQJFDQEHLGHQWLILHG
Importantly, these definitions have been shown to shift over time, shaping and at the 
same time being shaped in response to technological innovations such as new 
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pharmaceutical products (Morrison, 20$Q\GHILQLWLRQRIµQRUPDO¶KHDOWKLVOLNHO\WR
FKDQJHDVQHZWKHUDSLHVEHFRPHDYDLODEOHRUVWDQGDUGVRIOLYLQJFKDQJH3UHVLGHQW¶V
Council on Bioethics, 2002). Additionally, illness is legitimated through definitions of 
normality proffered by the medical profession which differ socio-culturally and 
KLVWRULFDOO\7KHUHIRUHGHILQLWLRQVRIµQRUPDOKHDOWK¶DUHXQOLNHO\WREHXQLYHUVDOO\
applicable considering that socio-cultural values are embedded within definitions of 
µQRUPDOLW\¶ZKLFKDUHFRQVWUXFWHGE\ medicine (Wolpe, 2002; Ettorre, 1999).  
 
The development of new technologies, such as modafinil, that can alter states of 
consciousness can then influence (neuro)scientific and medical understandings of the 
mind and the body. As the medico-scientific gaze penetrates deeper into the mind, 
conceptualisations of normality, pathology, health and illness are subject to change 
(Foucault, 1989). Therefore, social and cultural values and our understandings of 
health and illness as well as bodies, mind and performance are all subject to alteration 
through technological developments. The power of medical knowledge, techniques 
and practices extends far beyond understanding illness to influence expectations of 
how we should look and behave and gives meaning to the way we experience the 
world around us. Conceptually then, it is difficult to demarcate therapy and 
enhancement or health and illness in a binary fashion. Instead these concepts can be 
understood as fluid and contingent, with diverse meanings that are socioculturally, 
historically and institutionally situated (Conrad, 2007). 
 
Through taking account of the heterogeneous processes of medicalisation and the 
varied roles of medical professionals and patients/ consumers, in defining illness and 
creating demand for, enabling or restricting access to treatment, it becomes even 
more apparent how complex the relationship between therapy and enhancement is. 
The distinction between therapy and enhancement is blurred further through 
interventions that are still considered medical or therapeutic but are available outside 
of professional medical jurisdiction, for example, pharmaceuticals and other remedies 
that can be purchased over the counter (OTC), on the Internet or bought illegally 
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(Conrad, 2007; Williams et al., 2008a).   In the next section, literature discussing 
pharmaceuticals more generally will be introduced which is directly relevant to 
understanding the non-medical or extra-medical uses of pharmaceuticals in society. 
 
Pharmaceuticalisation  
 
Although scientific medicine still holds much power and cultural authority to define 
states of normality, health, illness and disease in the early 21st century, it would be 
ignorant to disregard the range of pharmaceutical technologies that are otherwise 
available to the consumer outside of the medical encounter. There are pills and 
potions available to treat a huge array of different everyday problems that one can buy 
OTC in the local pharmacy, from painkillers to decongestants, emergency 
contraceptive pills to weight loss drugs (Stevenson et al., 2008). These products are 
still manufactured by pharmaceutical companies and tested, regulated, labelled and 
packaged via much the same institutional mechanisms as prescription medication. 
However, who has access to these substances and the way in which they use them is 
much less restricted.  In this cultural formation, the reason why someone experiences 
a problem or symptom becomes irrelevant. For instance, the painkiller and anti-
inflammatory drug Aspirin can be used to treat symptoms of mild illness without 
needing a trip to the doctor, to alleviate the effects of an overindulgent lifestyle, as a 
preventative measure to prevent the formation of blood clots on long haul flights, or 
even as a compress to reduce the redness of pimples or insect bites. These examples 
demonstrate how, in the words of Andrew Lakoff (2005:10) psychopharmaceutical 
GUXJVDUHµLQVWUXPHQWVZKRVHIXQFWLRQLVVKDSHGE\WKHIRUPRIUDWLRQDOLW\LQZKLFK
WKH\DUHGHSOR\HGWKH\DUHPHDQVWRYDULRXVSRVVLEOHHQGV¶In relation to modafinil: a 
prescription pill which some argue should be available over OTC; the question arises 
as to what norms are used to decide who should use pharmaceuticals to augment 
cognition. 
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Through the availability of new neurotechnologies, it is not only the body but the brain 
and its various functions that are increasingly thought of as flexible and open to 
manipulation, pharmaceutical control and transformation (Martin, 1994). 
Pharmaceutical drugs are only one part of a larger assortment of medical 
technologies, which include various devices, discourses and talking therapies aimed 
at modulating physical, behavioural, psychological and emotional states. Lakoff (2005) 
GHYLVHGWKHWHUPµSKDUPDFHXWLFDOUHDVRQ¶WRUHIHUWRWKHµXQGHUO\LQJUDWLRQDOHRIdrug 
intervention in the new biomedical psychiatry: that targeted drug treatment will restore 
WKHVXEMHFWWRDQRUPDOFRQGLWLRQRIFRJQLWLRQDIIHFWRUYROLWLRQ¶ 
 
Fox and Ward (2008) argue that over the past decade, instead of developing 
pharmaceuticals as medicines for disease and disorder, there has been a new 
emphasis on lifestyle in the production, marketing and consumption of pharmaceutical 
products. Their analysis draws attention to two processes at work: firstly, the 
domestication of pharmaceutical use, which they link to the availability of drugs via 
home computers and secondly; the marketing of pharmaceuticals as solutions to 
resolve a range of problems occurring in the private life of citizens. Two broad 
FDWHJRULHVRIµOLIHVW\OHGUXJV¶have been defined. Firstly, drugs that are designed to 
treat a condition which falls on the boundary between health and illness and has a 
direct lifestyle element (e.g. contraceptive pills; weight loss drugs); secondly, drugs 
that have been developed to treat a medical disorder but have secondary lifestyle 
uses (e.g. Statins) (Lexchin, 2001; Flower, 2004; Fox & Ward, 2008). It has been 
argued that the rise in profile and availability of so-FDOOHGµOLIHVW\OHGUXJV¶LVFRQWULEXWLQJ
to the pharmaceuticalisation of daily life as consumers come to see such substances 
DVµPDJLFEXOOHWV¶WRUHVROYHWKHLUHYHU\GD\SUREOHms (Fox & Ward, 2008; Williams et 
al, 2008c). Like medicalisation, pharmaceuticalisation is a complex and multi-faceted 
process that  involves many overlapping features including the biological impacts of 
the substance; the legitimacy of the target condition as a disease; the adoption of the 
drug by consumers as a solution to their specific problem in their everyday lives; and 
corporate interests.  
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Although pharmaceutical technologies that have been developed as medicines have a 
legitimate medical primary disease indication and are accessed via medical 
professionals, their usage can extend far beyond the treatment of disease or disorder 
to become ways of enhancing aspects of social life (Williams et al, 2008a).  For 
example, drawing on empirical data, Fox and Ward (2008) illustrate how 
pharmaceutical products are not only consumed for medical reasons, but choices are 
made by consumers based on lifestyle. They refer to the weight loss drug Xenical, 
designed for the treatment of obese patients, that has allegedly found controversial 
uses as a method of sustaining a low body weight within pro-anorexia groups6. Viagra 
is probably the most iconic lifestyle drug, with several commentators arguing that the 
promotion of this substance was a test case, paving the way for pharmaceutical 
FRPSDQLHVWRPDQXIDFWXUHSURGXFWVDLPHGDWµOLIHVW\OH¶SUREOHPV (Flower, 2004; 
Gilbert ,Walley & New, 2000; Lexchin, 2006; Moynihan, Heath & Henry, 2002).  
 
Recent studies have shown that the location of sale of a drug (e.g. whether it has 
been prescribed for the treatment of a specific problem during a clinical encounter and 
is accessed via a pharmacist or is available as a consumer product on the 
supermarket shelves) has the potential to affect the way it is understood by the 
consumer (Harding & Taylor, 1997; Stevenson et al, 2008). In a 2001 study Bissell, 
Ward and Noyce examined consumer¶s abilities to self-manage several minor 
conditions using over-the-counter (OTC) pharmaceutical products, finding that the vast 
majority of their respondents held the belief that the availability of medicines OTC 
meant that they must be safe for consumption. 
 
Despite the availability of many pharmaceutical products OTC, the most potent of 
these drugs are often highly regulated and tightly controlled, only being made 
available to the individual on the discretion of a medical professional (Fishman, 2004).  
$VWXG\E\)R[:DUGDQG2¶5RXUNH(2005) investigated consumer experiences and 
                                                          
6
 Supporters RIµ3UR-$QD¶JURXSVconceptualise anorexia nervosa as a lifestyle choice rejecting current 
medical understanding of the condition as a mental illness. 
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attitudes towards the consumption of pharmaceutical products through participation 
and interviews with users of an online forum. They found that despite many of the 
substances being mandated via prescription, consumers were still able to access the 
GUXJVYLDRQRQOLQHFRQVXOWDWLRQVXVLQJWKHLUKRPHFRPSXWHULQDVHQVHµUHORFDWLQJ
FRQVXPSWLRQZLWKLQWKHKRPH¶)R[	:DUG7KHLUDQDO\VLVLOOXVWUDWHVWKH
importance of the local context in which pharmaceuticals are actually consumed and 
for what reason. They argue that even when prescribed in a clinical setting, 
pharmaceuticals are often consumed in the home as a way of treating private or 
embarrassing conditions that impact upon the daily lives of patients (they provide 
examples such as obesity, impotence and hair loss). They also acknowledge how 
such substances are rarely used in isolation, for example, information on diet and fat 
consumption is given to consumers alongside the weight loss drug Xenical (Fox & 
Ward, 2008).  Their study highlights that the way in which pharmaceutical products are 
actually used in relation to other substances, artefacts and alongside various 
behaviours in social context can make a significant contribution to how pharmaceutical 
use is understood and whether this use is accepted, resisted, challenged or modified 
by the user. 
 
Furthermore, in order to get new pharmaceutical products authorised, in both the UK 
and USA, regulators require a primary disease indication. For new drugs to be proved 
efficacious in clinical trials according to biomedical criteria, they have to target a 
clearly definable illness or disorder to measure improvements against (Lakoff, 2005; 
Fishman, 2004).  By consequence, new diseases or disorders may be defined in order 
to legitimate new medical treatments and interventions. In these instances, 
medicalisation of a problem may in fact be a requirement for a particular drug to gain 
approval in the first instance (Clarke et al, 2003) if medical professionals act as 
µJDWHNHHSHUV¶IRULWVGHOLYHU\&RQUDG7KLVOHDGVVRPHWRVSHFXODWHWKDWZHOLYH
LQDVRFLHW\ZKHUHWKHUHLVDQµLOOIRUHYHU\SLOO¶DVSKDUPDFHXWLFDOFRPSDQLHVDWWHPSWWR
increase the markets for their products and legitimate consumption (Busfield, 2010). 
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Disease mongering 
 
There has been much interest in recent years in the activities of the pharmaceutical 
and biotechnology industries, and the role they play in the redefinition of behaviours 
DQGVWDWHVIURPµZLWKLQWKHQRUPDOUDQJH¶LQWRµPHGLFDOSUREOHPV¶What warrant 
SKDUPDFHXWLFDOWUHDWPHQW3KDUPDFHXWLFDOFRPSDQLHVDUHRIWHQDFFXVHGRIµGLVHDVH
PRQJHULQJ¶µWKHVHOOLQJRIVLFNQHVVWKDWZLGHQVWKHERXQGDULHVRILOOQHVVDQGJURZV
WKHPDUNHWVIRUWKRVHZKRVHOODQGGHOLYHUWUHDWPHQWV¶0R\QLKDQ et al, 2002).  Direct-
to-consumer advertising in the US, and to a lesser extent, newspaper stories of 
µZRQGHUGUXJV¶LQWKH8.PDUNHWGUXJVGLUHFWO\WRFLWL]HQVZKRDUHHQFRXUDJHGWR
HQJDJHLQµKHDOWKFDUHFRQVXPHULVP¶5RVH) and act as informed consumers 
participating in decisions about their healthcare by asking their doctor for a particular 
product for their self-diagnosis. The marketing of both drugs and their µGLVHDVH 
LQGLFDWLRQV¶LVLQFUHDVLQJO\FRQVLGHUHGWREHDQLPSRUWDQWFRQWULEXWLQJIDFWRULQWKH
medicalisation of specific conditions (Conrad, 2007).  It is therefore, important to 
consider such corporate activities and interests in the extension of patient populations, 
namely increasing awareness of a particular disorder, that are likely to increase the 
number of individuals that present to the healthcare system.  
 
Modern medicine is increasingly a technological medicine. Medical technologies are 
used to diagnose, detect, classify, treat and prevent disease (Waldby, 2000).  In many 
cases the medicalisation of a problem is strongly linked to the availability and 
profitability of a chemical treatment for it. For example, the development of synthetic 
Human Growth Hormone (HGH) in the 1980s, a low-cost, high yield, safer alternative 
to cadaver extracted HGH, coupled with its successful marketing to medical 
professionals is considered to be one of the most important, if not the central factor, in 
GULYLQJIRUZDUGWKHPHGLFDOLVDWLRQRIµVKRUWVWDWXUH¶ZKLFKQRZKDVWKHPHGLFDO
diagnosis Idiopathic Short Stature (ISS) and a medical treatment (Conrad, 2007; Hall, 
2005; Morrison, 2008). 
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The official approval of pharmaceuticals to treat problems with a lifestyle component 
consequently legitimates both the problem and the pharmaceutical solution for it 
(Fishman, 2004; Clarke et al, 2003). Therefore the drug not only has a biological effect 
but also interacts with social and cultural forces that define a condition as problematic 
in the first instance (Fox & Ward, 2008).  However, despite the efforts of the 
pharmaceutical industry in widening awareness of their products and expanding the 
therapeutic perimeter of their application (Lexchin, 2006; Moynihan et al, 2002), 
PHGLFDOSURIHVVLRQDOVVWLOODFWDVµJDWHNHHSHUV¶IRUthe prescription of most drugs, 
assessing whether the individual is in fact ill and in need of therapy (Dingwall, 2006). 
In contrast to medical imperialism, this might be indicative of how medical 
SURIHVVLRQDOVFDQDFWXDOO\SURYLGHUHVLVWDQFHWRWKHµSDWKRORJLVDWLRQRIHYHU\WKLQJ¶
(Conrad, 2007).    
 
To summarise the literature presented thus far, the relationship between therapy and 
enhancement is complex, especially in relation to pharmaceutical technologies which 
can be accessed outside of the medical encounter, but still used to treat some type of 
perceiveGSUREOHPRUGHILFLW:ROSH$OWKRXJKWKHYHU\ZRUGµHQKDQFHPHQW¶
suggests that technological optimisation and shaping of the self is a positive process 
that allows the individual to free themselves from the constraints of their biology and 
transform their identity, there is still a form of biomedical governance at work shaping 
desires for how bodies, brains and identities should be transformed (Clarke et al, 
2003; Wehling, 2005). The medicalisation and pharmaceuticalisation of daily life 
alongside the domestication of pharmaceutical consumption affects the ways in which 
elements of everyday life are understood and problematised. 
 
Modafinil, sleep and society 
 
This section provides a brief overview of the medicalisation/ pharmaceuticalisation 
literature directly relevant to the wake-promoting drug modafinil. As discussed in 
Chapter 1, the drug modafinil is being used as case study to provide a focus for this 
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research.  Modafinil first came to the market as a pharmaceutical treatment for the 
rare sleep disorder narcolepsy in 1998. Since then it has reportedly been prescribed 
off-ODEHOWRµLPSURYHZDNHIXOQHVV¶LQDUDQJHRILOOQHVVHVDQGFRQGLWLRQVWKDWLQYROYH
fatigue, excessive sleepiness and cognitive impairment. Studies have also shown that 
its use can induce a variety of cognitive benefits in those without illness (Turner et al, 
2003; Pigeau et al, 1995; Müller et al, 2004), although the efficacy of using the drug 
for this purpose has also been questioned (Randall et al, 2002). It is repeatedly 
claimed by bioethicists that this drug could potentially be taken by the general 
population to enhance cognition and reduce the need for sleep. However, a closer 
look at the prescribing information provided with the drug to patients and practitioners 
reveals that the drug is associated with a number of adverse side-effects, some of 
which are serious and life threatening, and the drug is considered to be open to abuse 
and misuse (Cephalon, 2008).  
 
The potential for stimulants such as caffeine to promote wakefulness has been studied 
by scientists for decades. Some argue that the introduction of pharmaceuticals to 
replace caffeine as the wakefulness agent of choice is just the next step in an already 
established practice (Lawton, 2006). There is historical evidence to suggest that the 
development of technologies, such as the electric light bulb, have already caused one 
µUHYROXWLRQ¶LQQDWXUDOVOHHSSDWWHUQV(NULFK&ODLPVDUHEHLQJPDGHLQWKH
ethics literature and in the media alike that we are on the verge of another revolution, 
as a result of novel pharmaceuticals such as modafinil that can promote wakefulness 
and reduce the need for sleep. Recent examples of headlines encapsulating visions of 
DFRJQLWLYHO\HQKDQFHGIXWXUHZRUOGZLWKRXWVOHHSLQFOXGH³*HWUeady for 24-hour 
OLYLQJ´1HZ6FLHQWLVWth )HEDQG³6D\JRRGE\HWRVOHHS´7KH6XQGD\7LPHV
12th March 2006).  
 
Because of the multitude of uses for the drug and the wide range of prospective users 
that are imagined across various social domains, modafinil can be used as case study 
to investigate the reception and uptake of these technologies within popular culture, 
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the role and function of medicine and pharmaceuticals in attempts to control sleep and 
enhance cognition and the normative implications this might have. 
 
Medicalisation of sleep 
 
Studies in the sociology of sleep (Taylor, 1993)- an emerging field of research ± have 
investigated the commodification and commercialisation of sleep in modern consumer 
VRFLHW\:LOOLDPV	%RGHQWKHµGRLQJRIVOHHS¶LQDSUDJPDWLFVHQVH:LOOLDPV
2007a; 2007b; 2005); and the experiential embodiment of sleep (Meadows, Arber, 
Venn & Hislop, 2008) thus illustrate KRZVOHHSLVEHLQJµFRORQLVHG¶E\µYDULRXVIRUPVRI
H[SHUWLVHZLWKDQGEH\RQGPHGLFLQH¶:LOliams, 2002; 195). It is important, therefore, 
to bear in mind that studies that focus on the (prospective) medicalisation/ 
pharmaceuticalisation of sleep are only looking at one part of a much larger picture. 
However, many of the recent studies in this area have focused their attention on the 
medicalisation of sleep (Williams & Boden, 2004; Williams, 2004; Williams, 2002) 
DVNLQJµ,VVOHHSDQRWKHUFKDSWHULQWKHPHGLFDOLVDWLRQVWRU\"¶:LOOLDPV 
 
Culturally many behaviours associated with sleep are becoming less and less socially 
acceptable with the most somnolent bodies being redefined in (bio)medical terms and 
VXEMHFWWRSKDUPDFRORJLFDODQGRUSV\FKLDWULFWUHDWPHQW7KLVµPHGLFDOLVDWLRQ¶RIVOHHS
has been investigated sociologically at different levels and across different sites: at the 
organisational level with the creation of specialised sleep clinics (Moreira, 2006); the 
interactional level in for example, the context of the doctor-patient relationship (Hislop 
& Arber, 2003); and at a conceptual level through media discourses and debates 
about sleep problems (Kroll-Smith, 2003; Woloshin & Schwartz, 2006; Williams et al. 
2008a). 
 
Concerns have been raised within the sleep science community regarding the lack of 
attention given to sleep issues by the medical profession (Dement & Vaughan, 2000) 
and the disparity between the volume of popular texts and clinical attention to sleep 
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problems (Kroll-Smith, 2003). In addition, studies have found that information about 
sleepiness and sleep disorders found in popular texts, on the Internet and in the media 
is often cast in the rhetoric of medicine (Kroll-Smith, 2003).  The media, then, come to 
the fore as an important site in which to investigate the medicalisation of sleepiness 
outside of the medical encounter. Investigating the roles of the media in the 
medicalisation of sleep has attracted some sociological attention. Recent research has 
LQYHVWLJDWHGWKHZD\WKHPHGLDUHSRUWRQGLVHDVHVDQGLWVUROHLQµGLVHDVHPRQJHULQJ¶
(Woloshin & Schwartz, 2006); the rhetorical authority presented in the media and its 
role in shaping perceptions of disease (Kroll-Smith, 2003); and the social construction 
of sleep disorders in the media (Seale, Boden, Williams, Lowe & Steinberg, 2007; 
Williams et al, 2008b) and their treatments (Williams et al, 2008a). 
 
In a recent study, Kroll-6PLWK	*XQWHUIRFXVWKHLUDWWHQWLRQRQµWKHHPHUJHQFH
RIDQHZWUXWKDERXWVOHHSLQHVV¶LQDVRFLHW\WKH\GHHPWREHLQFUHDVLQJO\RUJDQLVHG
around expertise and its representation in visual and print media. They argue that 
somnolence, once considered a benign state of being and a naturally occurring 
corporeal precursor to sleep, is increasingly being represented as a potentially 
hazardous and morally reproachable problem of public concern. They found that this 
new representation of sleepiness was emerging in society from several, seemingly 
unrelated sources including scientific studies, social movement literatures, magazines, 
newspapers and websites.  Williams (2002) analysis shows that sleep in general is 
increasingly associated with issues of health and wellbeing, while specifically the 
diagnosis and treatment of many sleep problems is falling under the jurisdiction of 
medicine.  
 
In his analysis of the relationship between sleep and health, Moreira (2006) explores 
the emergence of the sleep disorder Obstructive Sleep Apnoea Syndrome (OSAS) 
and the social shaping of a medical treatment for this condition, continuous positive 
airway pressure (CPAP). He suggests that as disordered breathing during sleep 
coupled with loud snoring and excessive daytime sleepiness in a typically obese body 
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came under the purview of scientific medicine, these behaviours were defined as 
symptoms of upper airway respiratory problems during sleep. The study of these 
problems focused on apnoeas- periods where the individual stops breathing- and a 
new disorder called OSAS was defined. Viewed through the lens of medicine, the 
body of the once slothful, overweight and antisocial sleeper was reconfigured in terms 
of disorder, defined as ill and in need of treatment. Rather than assigning culpability to 
DQLQGLYLGXDO¶VZHLJKWREHVLW\FDPHWREHXQGHUVWRRGDVDULVNIDFWRUIRUWKHGLVRUGHU 
 
The medicalisation of sleep in the case of OSAS is apparent conceptually with the 
emergence of a medical definition to describe particular sleep behaviours; at an 
interactional level with OSAS being diagnosed and CPAP prescribed by medical 
professionals; and institutionally with the training of clinicians to recognise the 
disorder, the creation of respiratory sleep clinics and research and development into 
novel treatments. In fact, the medical definition of OSAS has been referred to as the 
µRIILFLDOELUWKGD\RIWKHFOLQLFDOVFLHQWLILFGLVFLSOLQHRIVOHHSGLVRUGHUVPHGLFLQH¶
(Dement & Vaughan, 2000). However, Moreira (2006) argues that using the concept 
of medicalisation alone is not sufficient to understand the complex set of relations 
EHWZHHQUHVHDUFKHUVFOLQLFLDQVDQGSDWLHQWVDQGKRZWKH\µLQWHUDFWLYHO\GHSOR\WKH
knowledge, techniques and technologies through which different sleep problems are 
XQGHUVWRRGDQGPDQDJHG¶+HJRHVRQWRDUJXHWKDWDQ676SHUVSHFWLYH
that takes into account the social shaping of scientific knowledge and technological 
development and the way they in turn shape social, economic and political 
RUJDQLVDWLRQFDQEHXVHGWRDLGLQXQGHUVWDQGLQJWKHµFRPSOH[SURFHVVHVRI
contestation and heterogeneity that are recognisably at the heart of the medicalisation 
SURFHVV¶ The value of STS approaches to studying the medicalisation of 
sleep as related to modafinil use will be returned to and discussed further later. 
 
,QWKHLUVWXG\RQZRPHQ¶VPDQDJHPHQWRIVOHHSSUREOHPV+LVORS	$UEHUDOVR
DWWHPSWWRJRµEH\RQGPHGLFDOLVDWLRQ¶WRKLJKOLJKWWKHLPSRUWDQFHRIµSHUVRQDOLVHG
VWUDWHJLHV¶IRUPDQDJLQJVOHHS7KH\DUJXHWKDWVXFKVWUDWHJLHVH[LVWRXWVLGHRI
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µPHGLFDOLVHG¶RUµKHDOWKLFLVHG¶VWUDWHJLHVWKDWDUHSURPRWHGLQSRSXODUFXOWXUHDQGPD\ 
even indicate the demedicalisation of particular aspects of sleep. However, through a 
study of the social construction of sleep in the UK media, Seale et al (2007) provide 
some evidence that many constituents of even so- FDOOHGµSHUVRQDOLVHGVWUDWHJLHV¶IRU
dealing with sleep problems can be traced back to narratives found in popular culture. 
:LOOLDPVDUJXHVWKDWZKLOVW+LVORSDQG$UEHU¶VVWXG\LVLOOXPLQDWLQJWKH\
conflate the different levels of medicalisation in their analysis and that further detailed 
sociological analysis is required before any conclusions can be reached regarding the 
demedicalisation of sleep problems. 
 
Pharmaceuticalisation of alertness 
 
Previous sociological research has investigated the medicalisation/ 
pharmaceuticalisation of alertness also using modafinil as a case study. Williams et al 
(2008a) locate their study of modafinil in the British print media within recent 
sociological work on the role of the media in relation to pharmaceuticals. They focus 
their study on investigating the role of the media in the medicalisation or 
pharmaceuticalisation of alertness and the governance of sleepy bodies in 
contemporary culture. Their analysis focuses on four main themes that emerged from 
the data, the first being the use of modafinil to treat medical conditions. They describe 
how the voices of sleep experts and doctors were frequently used in the media sample 
WRFRQVWUXFWPRGDILQLODVDµZRQGHUGUXJ¶IRUPHGLFDOFRQGLWLRQVVXFKDVQDUFROHSV\
and show in their analysis that new clinical uses of modafinil, such as its use for the 
treatment of SWSD, are legitimised through medical rhetoric. The second theme 
µOLIHVW\OHFKRLFHVDQGSDUW\SHRSOH¶IRFXVHVRQFRQFHUQVUDLVHGLQWKHSUHVVRYHUWKH
potential for modafinil to blur the boundaries between treatment of legitimate medical 
conditions and fRUµXVHVDQGDEXVHVDVDOLIHVW\OHGUXJRIFKRLFH¶E7KH
third theme focuses on the use of modafinil in military operations including the way 
VOHHSLVIUDPHGLQWKHPHGLDLQWHUPVRIDµFRPPRGLW\RIZDU¶,QWKHILQDOWKHPH
HQWLWOHGµ8QIDLUFRPSHWLWLRQ"7KHUDFHWRJHWDKHDG¶:LOOLDPVet al (2008a:12) discuss 
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DPRQJRWKHUWKLQJVKRZµERJXVDSSHDOV¶DUHPDGHWRPHGLFDOFRQGLWLRQVE\DWKOHWHV
as (il)legitimate grounds for using this drug. 
 
They argue that the media is a key way µLIQRWWKHNH\ZD\¶RI mediating a 
pharmaceutical to the public in the UK where direct-to-consumer advertising is 
SURKLELWHG+RZHYHUWKH\TXHVWLRQWKHH[WHQWWRZKLFKWKLVFDQEHYLHZHGDVµH[WUD-
LQVWLWXWLRQDO¶GUDZLQJUHIHUHQFHWRWKHIUHTXHQF\WKDWVOHHSH[SHUWVDQGGoctors are 
referred to and indeed the traditional doctor-patient relationship is used in the media 
DVDIUDPLQJGHYLFHIRUWKHVHVWRULHV,QWKHLUFRQFOXVLRQWKHDXWKRUVDOHUWXVWRµWKH
limits of a solely or strictly medicalised interpretation of these isVXHV¶,QVWHDGWKH\
interpret the way media debates and discourses are organised around non-medical 
XVHVDQGDEXVHVRIWKHGUXJDVµDUWLFXODWLRQRUDPSOLILFDWLRQRIDVHULHVRIFXOWXUDO
anxieties about the pharmaceuticalisation rather than the medicalisation of alertness, 
sleepiness DQGHYHU\GD\QLJKWOLIH¶; 13, emphasis in original).  
 
Although not specifically related to the pharmaceuticalisation of alertness, some other 
studies have taken a sociological perspective to investigate the use of 
pharmaceuticals to alter cognitive states. Of most significance here is the work of Ilina 
Singh on the use of Ritalin (methylphenidate) to treat children with ADHD. Despite 
much debate in the bioethics literature (outlined in Chapter 1) about the over-use of 
mediFDWLRQVVXFKDV5LWDOLQLQFKLOGUHQWRDFKLHYHVRFLDOJRDOV6LQJK¶V
work on boys who were prescribed Ritalin as a treatment for ADHD  is one of the few 
studies which investigates the experiences of those taking the drug. Singh interviewed 
parents whose children were prescribed Ritalin and studied their justifications for 
giving their child the drug. She found that parental discourse surrounding the decision 
of whether to give their child Ritalin had a strong moral dimension relating to ideas of 
authenticity and personal freedom.  Whilst many mothers saw the drugs effect as 
WUHDWLQJDSUREOHPORFDWHGLQWKHEUDLQDQGWKXVDOORZLQJWKHLUVRQV¶µWUXHVHOI¶WR
appear, others described how they would give their child breaks from the medication 
on tKHZHHNHQGVIRUH[DPSOHVRWKHµUHDO¶RUDXWKHQWLFFKLOGFRXOGVSHQGWLPHZLWKWKH
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family (Singh, 2005). In these cases, drug use was thought of as creating a false or 
modified self for their sons. Singh argues that therapeutic decisions are guided by 
moral conceptions of authenticity and personal freedom whilst also being embedded in 
cultural ideology, in this case related to ideas about parenthood, masculinity, self-
actualization and success. 6LQJK¶VDQDO\VLVGHPRQVWUDWHVDVVKDOOEHGLVFXVVHG
further in the next section, how technologies are not neutral artefacts, but are 
designed, developed and promoted for specific reasons and therefore embody social, 
cultural and political values. It also highlights how people can construct ethical 
concepts (in this case, the concept of authenticity) in several different ways. It can 
therefore be argued that this raises questions about their validity as transcendental 
moral categories and highlights the need to ground ethical debates about the uses of 
pharmaceuticals such as modafinil and Ritalin, in their social contexts (Martin and 
Ashcroft 2005; Singh, 2004). 
 
To summarise, using the concept of (bio)medicalisation to analyse the emergence of 
new sleep disorders and therapeutics enables one to build an understanding of how 
the realm of sleep (and sleepiness), once considered a private corporeal form of 
existence, has begun to fall under the jurisdiction of medical authority. Although 
ILQGLQJWKLVFRQFHSWXVHIXOPDQ\VFKRODUVDWWHPSWWRJRµEH\RQGPHGLFDOLVDWLRQ¶LQ
various ways to take account of other practices and processes that may aid in 
explanations.  
 
Williams et al (2008a) argue that the media coverage of modafinil is best interpreted in 
WHUPVRIµSKDUPDFHXWLFDOLVDWLRQ¶UDWKHUWKDQµPHGLFDOLVDWLRQ¶DVWKHQRQ-medical use of 
modafinil for enhancement purposes goes beyond the medicalisation debate. 
However, as discussed above, the relationship between therapy and enhancement is 
not straightforward, and enhancement uses are not always conceptualised as being 
incompatible with medical supervision of the technology (e.g. cosmetic surgery). To 
separate out pharmaceuticalisation and medicalisation may be appropriate in certain 
circumstances. However, this research is interested in uncovering different 
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representations of sleep, modafinil and the body that act to frame pharmaceutical use 
in specific ways. It will take into account how these different frames act to include or 
exclude medicalised narratives with the aim of examining the role played by medical 
authority in the legitimation of uses of the drug use across different social contexts. 
Although questions regarding the pharmaceutical regulation of sleepiness may well 
WDNHXVµEH\RQGWKHUHDOPVRIWKHVWULFWO\PHGLFDORUPHGLFDOLVHG¶DWWHQWLRQWRKRZ
medical authority is deployed, how pharmaceutical use is constructed across different 
social contexts and the role of this in further medicalisation of sleep is important and 
cannot easily be dismissed. 
 
Others, such as Moreira (2006) argue that an STS approach that takes into account 
the social shaping of scientific knowledge and technological development and the way 
they in turn shape social, economic and political organisation can be used to aid in 
understanding the complexities of the medicalisation process. An STS approach is 
also adopted in this research to analyse the phenomenon of cognitive enhancement 
and the specific case of modafinil. The rationale behind this analytical choice is 
discussed in the following section. 
 
Science, technology and society 
 
In the above sections discussing the concepts of medicalisation and 
pharmaceuticalisation it was argued that pharmaceutical technologies do not act in a 
vacuum, they are developed and used by people in the context of their everyday lives 
and therefore can be understood in different ways and used for different purposes 
(Lakoff, 2005). In this section STS literature will be introduced to argue that even 
though this might be the case, technologies are not neutral artefacts.  They are 
designed and developed for specific uses with a specific group of users in mind. 
7KHUHIRUHWKHGLVWLQFWLRQEHWZHHQZKDWLVµVRFLDO¶DQGZKDWLVµWHFKQLFDO¶LVRIWHQ
difficult to make. 
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Co-production of science, technology and society  
 
The field of STS views science and technology as actively constructed through 
interaction with society. According to Law (1987) the builders of technology have to 
simultaneously build their artefacts and the environments in which they function. This 
idea forms the basis of theories of the social construction of technology: that there is 
no intrinsic logic to technology and that the working of technology is only partly 
explained by technical functioning and must also be explained by social factors. 
5HVHDUFKHUVLQ676IRUPHGWKHFRQFHSWRIµWHFKQRVFLHQFH¶WRHQFRPSDss the 
simultaneously social, technical and cultural nature of all artefacts (Sismondo, 2004).  
This concept is built upon theories of the µco-production¶ of science and society 
(Jasanoff, 2004) that challenge both natural and social determinism, arguing that we 
gain explanatory power in thinking about natural and social orders being produced 
together. According to Jasanoff (2004), knowledge simultaneously embeds and is 
embedded in the social. She argues that co-production is symmetrical as it draws 
attention to both the social dimensions of knowledge production and the cognitive and 
material connections to social arrangements. 
 
New reproductive technologies can be used to illustrate the co-production and mutual 
shaping of science, technology and society.  These technologies enable infertile or 
same-sex couples to have children through the processes of egg donation or 
surrogacy, whilst pre-natal genetic screening technologies make it possible for parents 
to choose the sex of their future child before becoming pregnant. Although the 
technology exists, some of these practices and procedures remain controversial. The 
social implications of such applications are strong and far-reaching, for example, 
encouraging the redefinition of the traditional family unit. These technologies are being 
GHYHORSHGWRµIL[¶VRFLDO problems (e.g. of infertility); however, some scholars argue 
that their existence puts increasing pressure on women to try to fulfil their social role in 
becoming mothers, reinforcing the need for the technology and its continued 
development (Bauchspies, Croissant & Restivo, 2005). This example demonstrates 
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how technologies are developed within a social, cultural and political context where 
particular social norms and values frame how certain aspects of human life or 
behaviours are understood. The way in which a problem is framed influences the 
range of solutions thought of as possible and influences the development of 
technological fixes for these problems. The existence of a technological solution for a 
particular problem then feeds back into the system and can reinforce the values and 
norms that lead to the conceptualisation of the particular phenomenon or behaviour as 
being problematic in the first instance. 
 
Successful technologies depend on the mobilisation of both social and material 
networks. As such, when adopting an STS perspective, technologies are studied in 
their context of use to take into account how they are embedded in a complex web of 
sociotechnical artefacts and relationships with diverse cultural meanings. An STS 
analysis can therefore be used to take into account not only the technical artefact but 
also the social and cultural factors that shape technological development. 
 
Technologies and their scripts for use 
 
Winner argues (1980; 1993) that technologies are not neutral: values and politics are 
incorporated into the design process so that technologies embody the interests of their 
designers. Therefore, technologies come with social scripts for how they should be 
used. Bauchspies, Croissant & Restivo (2005) discuss the neutrality of technology 
XVLQJWKHZHOONQRZQSKUDVH³*XQVGRQ¶WNLOOSHRSOHSHRSOHNLOOSHRSOH´7KH\DUJXH
that intentions are designed into technological systems and that guns are designed to 
kill, therefore social values are reflected in technological design and there is cultural 
meaning attached to technology.  
 
Pinch and Bijker (1987) developed ideas about the social construction of technology 
(SCOT) arguing that both users and manufacturers play a part in how a technology is 
constructed. They introduced the notion of interpretative flexibility. Put simply, this 
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suggests that different groups of actors or individuals can construct alternative 
meanings for a technology. Many early studies using the SCOT approach looked at 
technologies during the developmental stages and focused on understanding how 
such flexibility was closed down to reach a stable interpretation of the technology 
(Pinch and Bijker, 1987). Later studies took a more symmetrical approach taking into 
account the co-construction or mutual shaping of both technologies and users 
(Oudshoon and Pinch, 2005). From STS perspectives, users of technology are not 
passive consumers, but actively engaged in shaping how technology is positioned, 
negotiated and understood in social context. Many studies in the field of STS place 
great importance on the relationship between technology and prospective users in 
attempts to situate technology within its social and cultural contexts. It is through the 
user then that possible connections between the social and technical are 
demonstrated.  
 
A focus on users of technology 
 
,QDQRZFODVVLFSDSHUHQWLWOHGµFRQILJXULQJWKHXVHU¶6WHYH:RROJDUH[SODLQV
the relationship between a technology, its creators and prospective users through the 
PHWDSKRURIµPDFKLQHDVWH[W¶+HXVHVWKLVPHWDSKRUWRH[SODLQKRZWHFKQRORJLFDO
artefacts are designed and created (or written) to be used (or read) by particular users 
in a specific way.  He proposes that the relationship between innovators and users of 
technology is then mediated by the machine and what it can do. He argues that a 
technology is organised in such a way that its intended use is apparent to the user. 
And further to this, that in the design process it is not only the machine that is 
constructed but also the prospective user as other design activities attempt to define 
WKHXVHUWKHLUOLNHO\IXWXUHUHTXLUHPHQWVDQGVHWSDUDPHWHUVRQWKHXVHUV¶DFWLRQV 
 
According to Woolgar (1991) neither configuration of user nor machine is settled or 
established; interaction invites assessment as to whether the user is acting as an 
DSSURSULDWHXVHUDQGWKHPDFKLQHDVDµUHDO¶PDFKLQH+RZHYHU:RROJDU1) does 
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acknowledge that in the process of reading of a technology it is opened up to flexible 
interpretations and users might find novel or unexpected uses for the artefact. In the 
context of his case study of the development of a new microcomputer, he argues that 
not all interpretations of technology are equally valid, with unexpected uses of 
technology considered bizarre and these users as violating the configured 
relationships they have entered in to. 
 
Continuing with the textual metaphor, Akrich (1992) discusses the idea that 
technologies come with scripts for use. She proposes that during the design phase 
manufacturers envisage who the users of the artefact will be, imagining their 
motivations for using the technology and even their specific tastes, competencies and 
political prejudices. She argues that this vision of the world becomes inscribed into the 
technical object through its design features, in a sense building or scripting into the 
artefact how it should be used. Drawing on Actor Network Theory (ANT) to avoid 
giving determining agency to either technological or social actors, Akrich argues that 
users take their place within a cast of roles designated by the producers of technology 
that prescribe how a technology should be used. However, she argues that through 
alternative use of technology users can re-write these scripts. Mallard (2005) refers to 
this disjuncture between how prospective users for a technology are imagined and the 
ways in which the artefact is eventually used DVµXVHUVGULIW¶ 
 
Both Woolgar and Akrich focus on analysing representations of the user by designers 
of technology during the early stages of the innovation process. More recent studies 
view users as much more active in the construction of their identity and particular 
relationship with the technology. For instance, in a study examining the continued use 
of outdated computing equipment (the TRS-80, which was rendered obsolete by most 
users in the 1970s) within a small community of users, Lindsay (2005) analyses how 
different representations of the user interact within different social groups. She argues 
that images of the user and technology are dynamically co-constructed by different 
groups throughout the whole life history of a technology (so not just in the innovation 
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or introductory stages) and demonstrates how user-technology relationships are (to 
some extent at least) mediated by such images of the user.  
 
In a recent paper Wilkie & Michael (2009) discuss the figure of the future user in policy 
discourse surrounding new communications technology.  Bringing together STS 
literature on both users and futures (e.g. Brown & Michael, 2003) they argue that the 
figure of the future user is performative. In their analysis they explore how future users 
of an emerging technology are constructed in various ways, arguing that how the 
future user is imagined both embodies and delimits a range of future possibilities, in 
the case of their study this was different policy options.  They conclude that specific 
configurations of the future user depicted as inhabiting particular sociotechnical 
futures can then directly influence the present through the direction of policies and 
therefore contribute to shaping the future.  Similarly, Borup, Brown, Konrad and van 
Lente (2006) argue that expectations of future users are literally and materially 
scripted into technologies and socio-technical systems. How the prospective user is 
imagined is therefore of relevance to all studies of new and emerging technologies.  
 
Understanding non-use is also an important area of research that often has strong 
political motivations, especially in the health arena where uptake of medical 
technologies (e.g. vaccinations) and other services may be lower than anticipated or 
desired among particular social groups. Often in policy and ethical discussion non-use 
of technology is associated with inequality and deprivation. Non-users emerge in 
debates around access to new technologies with two groups proposed- WKHµKDYHV¶
DQGµKDYHQRWV¶- and it is often assumed that all non-users want to become users 
(Wyatt, 2005). The idea of non-use is explored further in a recent paper by Wyatt 
(2005) where she looks more closely at the so-FDOOHGµGLJLWDOGLYLGH¶EHWZHHQXVHUV
and non-users of the internet. In her analysis she identifies four different types of non-
use: resistance (prospective user is against prescribed use of the technology); 
rejection (prospective user chooses not to use technology in favour of other 
alternatives); exclusion (non-users who do not have access to the technology); and 
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expulsion (users who are no longer able to use the technology for a variety of 
reasons). She believes that whilst focusing on users is important, without taking into 
account the various forms of non-use  one risks following the dominant actors and 
argues that non-users and former users should be taken seriously as relevant social 
groups as they too can shape technology and society. 
 
Medical technologies 
 
STS perspectives acknowledge that medical technologies do not exist in isolation or a 
social vacuum. They are manufactured, sanctioned and deployed within various 
networks of social actors; including hospitals, surgeries, patients, insurers, 
laboratories, governments, regulatory agencies, funders and so on. The acceptance or 
rejection of technology is then reliant upon not only if it works in a technical sense, but 
also how compatible it is or if it can be shaped to suit the requirements of the different 
parties involved. An example here comes from Locke (2001) and her study of organ 
transplantation technology in Japan where until relatively recently transplant 
technology was not being utilised. 
 
,Q-DSDQ¶V2UJDQ7UDQVSODQWDWLRQ/DZZDVSDVVHGSHUPLWWLQJSHRSOHWRFKRRVH
between brain death and traditional death by writing their preference on a donor card 
(Trends in Japan, 1999). This meant that organs could be removed from coma 
patientVZKRKDGSUHYLRXVO\FRQVHQWHGZKRZHUHFODVVLILHGDVµEUDLQGHDG¶DQGXVHG
for transplant. Despite this, relatively few organs were either donated or transplanted 
in the years following. According to Locke (2001), in traditional Japanese culture, 
death is a socially determined process not just a biological event. The concept of 
reciprocity is strong within Japanese culture so notions of charity and anonymous 
donation of a human organ breaks through a strong cultural tradition. This example 
illustrates that the existence of a technology alone is not sufficient for its acceptance in 
society. The technology may work in a technical sense but be rejected on a cultural 
basis.  
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In modern scientific medicine normality and abnormality are measured and defined 
through technologies which are used to visualise the body and the mind in a specific 
way.  These technologies are not passive; they are created and designed for a 
specific purpose, for use within a particular social context and to meet a particular goal 
(Mackenzie and Wacjman, 1999). However, medical technologies are complex 
entities; the way they are interpreted is not static as they are shaped by and in turn 
VKDSHPHGLFDONQRZOHGJH$QLQWHUHVWLQJH[DPSOHFRPHVIURP5DFKHO0DLQHV¶
(2001) study of the history of the vibrator, which describes the development of this 
technology as a medical treatment for hysteria in the 19th century. As the diagnostic 
category went out of favour in the early 20th century, Maines documents how the 
vibrator shifted from being positioned as a medical therapeutic under professional 
authority used to treat a medical disorder in the clinic to a non-medical device used to 
enhance sexual pleasure in the private lives of ordinary citizens. Maines (2001) 
research shows how technology can be interpreted in relation to contemporary 
theories and knowledge claims and clearly illustrates the importance of social and 
cultural processes in the (de)medicalisation of human conditions and the legitimacy of 
technological interventions. Further than this, though, it illustrates that how medical 
technologies are understood, positioned and used can shift over time in accordance 
with contemporary knowledge claims, social values and cultural norms.  
 
A more contemporary case is that of contraceptive pills which, once only available on 
discretion of a doctor for use by women to prevent unwanted pregnancy (which is itself 
a medicalised social problem)  are on now on their way to becoming an OTC product 
available to all. Presently, this technology does remain under institutional expertise (of 
nurses and pharmacists) and has a literal script for use written down by manufacturers 
DQGLQFOXGHGLQLWVSDFNDJLQJ+RZHYHUµXVHUVGULIW¶(Mallard, 2005) is well 
documented as women of all ages use the pills in unanticipated ways for example, to 
prevent outbreaks of acne or delay menstruation until a socially desirable time. This 
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perhaps contributes to a conceptual transformation of these pills from medicine to 
consumer product in popular consciousness.  
 
Modafinil as a medical technology 
 
7KLQNLQJEDFNWR/DNRII¶VSRVLWLRQWKDWSKDUPDFHXWLFDOWHFKQRORJLHVDUHPHDQV
to various possible ends, from an STS perspective this becomes more problematic to 
accept at face value. Technologies do not exist in isolation, they have been designed, 
developed, tested, manufactured and are sold, bought and consumed within socio-
technical networks that give meaning to their use and non-use. A modafinil pill is not 
simply an amalgamation of its active ingredients. It is a medical technology that exists 
within complex social-technical systems that include chemical laboratories, guidelines 
and approval, companies, culture, law, doctors, patients, journalists and so on. 
Medical technologies embody various social and cultural understandings of the kinds 
of bodies they are interacting with, the disease, illness or trait being targeted, and 
what is normal or desirable (Nichter and Vockovitch, 1994). They form a link between 
the actions of individuals and how they understand their bodies and functioning and 
how disease and disorders are formed through scientific medicine (Morrison, 2008). 
 
Pharmaceutical technologies are not neutral; they are coded with ideologies about the 
social lives, relationships, self image and characteristics of their consumers (Rose, 
2007; Lakoff, 2005, Kramer, 1997). For instance, it has been argued that in its 
privileging of penetrative sex, Viagra is a technology that is coded with specific images 
of sexuality and masculinity (Potts et al, 2003). Rose (2007) points out that the effects 
RIDGUXJµDUHQRWVLPSO\JLYHQLQWKHGUXJWKH\DUHHPEHGGHGLQFRPSOH[VLWXDWLRQV
DQGWKHDIIHFWVWKH\JHQHUDWHUHTXLUHDOOPDQQHURIVRFLDODQGFRQWH[WXDOVXSSRUWV¶ 
 
Although modafinil could be flexibly interpreted and used in different ways for different 
ends, not all interpretations of technology will be equally valid and unexpected uses of 
the technology could be considered bizarre or these users as violating the configured 
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relationships they have entered in to (Woolgar, 1991). MoQDJKDQ¶VUHVHDUFKH[SORUHV
one such violation of a technology-user relationship in relation to pharmaceuticals: the 
XVHRIVWHURLGVE\ERG\EXLOGHUV¶IRUWKHSXUSRVHVRIEXLOGLQJPXVFOHPDVV7KURXJK
interviews with Bodybuilders he found that although acknoZOHGJHGDV¶ULVN\¶VWHURLG
use within this group was rationalised in several different ways by actual users as 
being a legitimate means to achieve an end goal. Studies such as this one 
demonstrate how it is imperative to explore not only the official discourses of 
KHDOWKFDUHSURIHVVLRQDOVDQGµH[SHUWV¶EXWDOVRWKHVRFLDOPHDQLQJVZKLFKXVHUV
themselves attach to their drug taking practices in order to appreciate and understand 
why people behave as they do (Monaghan, 2002).  
 
To summarise, medical technologies come with scripts for how and why they should 
be used: to relieve pain and suffering, to attempt to restore normality with the goal of 
achieving health or preventing illness. There may be one dominant use of a 
technology, one that is configured, scripted or prescribed by its manufacturers. 
However, STS studies that focus on how users actually use, modify, domesticate or 
resist technologies clearly demonstrate that a single fundamental use cannot be 
deduced from the artefact itself (Oudshoon and Pinch, 2005). The studies discussed 
above demonstrate how the figure of the user, be that actual, prospective, future, 
proscribed or non-user, provide useful analytical foci through which to understand the 
acceptance or rejection of new technologies in their context of use.  
 
Conclusion  
 
Medicalisation and pharmaceuticalisation are complex and multi-faceted processes 
which can occur in various ways, at a range of sites and have diverse implications for 
different groups. Over recent years there has been a shift from medicalisation as a 
critique of medical imperialism to focus on the interplay of a variety of social actors in 
driving the process forward and indeed, in reverse. However, in most instances 
PHGLFDOSURIHVVLRQDOVVWLOOUHWDLQWKHLUUROHDVµJDWHNHHSHUV¶ to expert knowledge 
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regarding health and illness and can sometimes be seen as providing resistance to 
over-medicalisation. Through the process of medicalisation human differences are 
transformed into pathologies, diagnosable disorders and treatable conditions. The 
definition of medical norms through the existence of new scientific knowledge and/or 
new medical treatments may change perceptions of how the human body functions 
and importantly, influence social and cultural expectations of how the body should 
function.  
 
The users of medical technology have become an analytical focus for many 
contemporary medicalisation studies. Patients or consumers of medicine have come 
to be seen as one of the drivers of the medicalisation process searching for diagnosis 
and treatment. Outside of the traditional institutional boundaries of the medical 
profession, studies focus on consumers of pharmaceutical products as these become 
domesticated and available in their everyday life.  
 
As the body and its parts become the objects of commodification and regulation and 
are subjected to technological applications, they are framed in particular ways 
according to current social and cultural trends. Therefore, the interpretation of the 
body can also be said to be socially shaped. Studies in STS have shown that 
technologies are social, that they are shaped by their designers to fit into a social role 
within a broader cultural context. As cultural norms and values change so too do the 
social problems that are faced and the technological fixes that are developed.  To 
understand the impact of technological development on society one must take into 
account not only technical changes but also the social, political, cultural and economic 
factors involved. An STS analysis can provide a critique of technological applications 
and challenge the nature of technology showing that technology is not neutral, but is 
designed and promoted in certain ways for particular effects. It can shed light on why 
controversies around new technologies might arise through the drawing of different 
boundaries which impose different social, ethical and legal constraints onto a situation.  
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Informed by previous work in both medical sociology and bioethics, the debate around 
medical and non-medical uses of modafinil will be approached from an STS 
perspective. The analytical framework will focus on the interaction between technology 
and prospective users to understand how pharmaceuticals with both therapeutic and 
enhancement potential are understood, positioned and negotiated in social context. In 
adopting this approach, this research aims to contribute to the emerging literature on 
the medicalisation and pharmaceuticalisation of sleep and also in more general terms, 
to shed new light on the therapy/enhancement debate. 
 
The core research question this project aims to address is: How is the use of the drug 
modafinil to augment human cognition understood within the mass media, by 
researchers and potential users, and what implications does this have for debates 
about enhancement technologies? 
 
The aims of the study, outlined in Chapter 1, have been operationalised into specific 
research questions. The specific research questions relevant to each of the four data 
chapters are outlined at the beginning of each data chapter and include the following: 
 
x How are sleep, cognition and the body conceptualised in different social 
contexts and by different stakeholder groups? 
x How is modafinil use understood, positioned and negotiated in each of these 
domains? What sociotechnical scripts are associated with modafinil use and 
how is it positioned as a medical or non-medical technology? 
x  According to what norms do different groups believe that augmentation of the 
mind should take place? What role is given to medical authority in deciding if 
particular uses are acceptable? 
x  In the light of these empirical findings does the maintenance of a therapy/ 
enhancement dichotomy remain viable when discussing the various uses of 
cognition enhancing drugs? What are the implications for the idea of 
(bio)medicalisation?
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Chapter 3: Methods 
 
Introduction 
 
The aim of this research project is to explore the issue of cognitive enhancement from 
the perspective of different stakeholders in order to assess the viability of framing the 
debate around medical and non-medical uses of cognition enhancing drugs through a 
therapy/enhancement dichotomy and uncover the implications of this for the idea of 
(bio)medicalisation. The research focuses on one drug, modafinil, as a case study to 
investigate how different uses of neurotechnologies to alter brain functioning are 
understood, positioned and negotiated in social context in contemporary society. 
Through a focus on use and users of technology (as discussed in Chapter 2) the 
approach taken intends to produce an in-depth and critical account of how such uses 
are understood outside of professional bioethical discourse (as outlined in Chapter 1). 
This research approaches the topic for investigation from a perspective rooted in the 
ontology and epistemology of Science and Technology Studies (STS), understanding 
both science and society in terms of co-production. This position will be explained in 
more detail in the next section. The remainder of the chapter will focus on the methods 
used for data collection and analysis. 
 
Philosophical standpoint 
 
The theoretical approach adopted in this study to analyse modafinil as a medical/ non-
medical technology in social context was informed by theories and draws upon 
analytical concepts from the medical sociology and STS literatures. STS perspectives 
could be broadly termed constructivist, viewing science and technology as social and 
active (Hacking, 1999; Sismondo, 2006). STS perspectives adopt a symmetrical 
approach to data analysis. Instead of upholding the traditional dichotomies of nature- 
culture, fact- value and structure- agency, STS approaches favour co-production 
which recognises that all knowledge is socially situated, constituted and constrained 
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(Bijker, 1993). According to this standpoint, no knowledge is ever value-free. 
Epistemologically, the consequence of this position is that the phenomena under 
investigation are considered not to have a static decontextual or uncoverable 
existence. Facts are understood as contingent, the success of a particular science or 
technology is not a given, but entwined with human choices and obligations 
(Sismondo, 2006). 
 
At the level of ontology, truth does not have absolute foundations in the natural world, 
there is no knowledge or truth that is true for all people at all times. Instead truth is 
more dependent upon who articulates that truth, how it is discovered and represented 
and the norms and conditions in the social and historical traditions within which it was 
formed (Rorty, 1999). A problem related to adopting this stance is that all truth must 
then be recognised as being context dependent (Hughes & Sharrock, 1997). Any 
attempts to understand social reality must then be grounded in people¶s experiences 
of that reality (Bryman, 1988). However, this does not mean that ontologically, one 
must then take a relativist stance where all truths are considered to be the product of 
subjective social and cultural process and that any one account of a phenomenon is 
as valid as any other, to a large extent ignoring the materiality of the social world 
(Murphy & Dingwall, 2003). When taking an STS perspective, the physical effects, 
material properties of objects and the conditions and constraints these pose on how 
they are understood (their meanings) are fully acknowledged and taken into account 
(Morrison, 2008; Mackenzie & Wacjman, 1999).  
 
The ontological position this research therefore takes is closer to what has been 
WHUPHGDµFULWLFDOUHDOLVW¶SHUVSHFWLYHZKLFKWDNHVLQWRDFFRXQWWKHPDWHULDOLW\RIWKH
social world whilst acknowledging that multiple meanings and understandings (or 
divergent frames of reference) can co-exist in and between groups and that not all 
accounts will be equally valid (Dingwall & Murphy, 1998). Therefore, in adopting this 
position epistemologically, the analyst attends to both the social dimensions of 
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knowledge production and the cognitive and material connections on which this 
production is based (Jasanoff, 2004).  
 
Research design 
 
Although often set in opposition to one another, the critical realist perspective adopted 
in this study does not view qualitative and quantitative research as belonging to 
opposing paradigms (Silverman, 1997).  When taking this view, according to 
Hammersley (1992: 163): 
 
µ«we are not faced with a choice between words and numbers...our decisions 
about what level of precision is appropriate in relation to any particular claim 
should depend on the nature of what we are trying to describe, on the likely 
accuracy of our descriptions, on our purposes, and on the resources available 
to us; not on ideological commitment to one methodological paradigm or 
DQRWKHU¶ 
 
Qualitative research aims to provide in-depth explorations of the meanings people 
attach to their experiences in a particular social domain and the way in which social 
structures and processes may shape these meanings (Bryman, 1992). Qualitative 
methods are therefore best suited to research questions that ask why and how rather 
than those which seek to establish facts or measure effects, for example addressing 
when or how often a particular phenomenon is occurring. Qualitative methods 
emphasise context and display a commitment to viewing the subject of investigation 
from the perspective of the people being studied (Bryman, 1988). Qualitative methods 
are generally more flexible than quantitative approaches, enabling research 
participants to explore subjects of importance to them, define issues in their own 
vocabularies and generate and pursue topics of interest in their own terms.  
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Following this conception, as this research seeks to describe and explain 
perspectives, understandings and behaviours and how they are influenced by social 
context (and the values and norms operating within that context), a qualitative 
approach to data collection was thought to be most suitable. The emphasis on using 
qualitative methods of data collection and analysis is therefore a deliberate part of the 
research design. 
 
An inductive analytical approach was favoured that focused on the data collected and 
moved towards forming general conclusions rather than starting with a theoretical 
claim or hypothesis to test against empirical data (Bryman, 1992; Dingwall & Murphy, 
1998). Data collection and analysis were not discrete stages of the research design. 
Instead this was a cyclical process and often conducted in tandem so as not to impose 
a pre-defined structure onto the data. Theory was used to provide a general frame of 
reference and guide the initial collection of data. Preliminary analysis of the data 
collected was used to inform and refine subsequent data collection and analysis by 
focusing in on topics of interest, including further exploration of unexpectedly 
important topics. Methods of data collection analysis are discussed further in the 
following section. 
 
The case study 
 
As cognitive enhancement is a relatively broad topic, it was necessary to choose a 
case study to provide a focus for investigation. Case studies involve collecting in-
depth, contextual qualitative data for analysis of a phenomenon in its natural setting 
(Avison, 1997). By carefully scrutinizing the case study, the researcher is in a position 
to obtain information as to what factors might be operating in that particular situation 
and how specific problems may be solved.  
 
Modafinil was chosen as a case study because of several distinguishing features; it 
has received a license for medical use in the UK, it has received significant media 
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attention over recent years; has been involved in wider political and ethical debates 
concerning human enhancement technologies; can be used in multiple ways, and is 
assumed to appeal to a wide range of potential users. Modafinil can therefore be used 
to investigate the reception and uptake of new neurotechnologies within popular 
culture, the role and function of medicine in attempts to pharmaceutically control 
sleep/ alter cognition, once considered a private corporeal form of existence, and the 
normative implications this might have. 
 
A fundamental limitation with using case studies in social research is the plausibility of 
generalising results and extending the findings of the investigation to other similar 
cases. Hammersley (1985) describes three styles of case study research. The first 
style is where the researcher wants to study typical cases, which are representative of 
a larger whole. The second is where the researcher uses case studies to test 
theoretical assertions. The third is where the researcher is not concerned with the 
case study being representative, the uniqueness of each case is acknowledged and 
interest lies in the how the workings of particular processes are explained by single 
cases.  
 
Other studies have successfully adopted a case study approach when investigating 
the emergence of new pharmaceutical technologies. For example, in a study looking 
at the role of the pharmaceutical industry in potential medicalisation and disease 
mongering relating to various conditions, Moynihan et al (2002) used case studies to 
present a wide variety of controversial material to provoke further debate and research 
in an understudied area.  
 
In the case of this research, the use of a single case study to explore the wider 
phenomenon of human cognitive HQKDQFHPHQWIDOOVFORVHUWR+DPPHUVOH\¶VWKLUGVW\OH
of case study research. This means that the results obtained will not be representative 
of all cognition enhancers. However, it will be possible to gain an understanding of 
how decisions are made and how these positions are negotiated by stakeholders 
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across different social contexts and to comment on how social and cultural 
representations of science and technology can influence the perceived 
appropriateness and acceptability of the uses of a new technology. According to 
Morse (1999), in this sense, qualitative research can be considered to be 
generalisable, not because it can claim to be representative of a wider population but 
because the sample has been purposefully selected for the contribution it can make 
toward the emerging theory. She argues that the theory developed is applicable 
beyond the demographic group or specific case studied because it gives details of the 
process by which a phenomenon occurs. This can then be applied to similar 
situations, problems, questions and so on.  
 
There are three main methods of finding out about how people think and act in the 
social world. Put simply, these are direct observation; asking questions and reading 
documents (Dingwall, 1997). The use of a case study to explore the research 
questions required a combination of qualitative methods drawing on both documentary 
data and interviews with a selection of different stakeholders.  Each method of data 
collection and analysis used will be discussed in the following section. 
 
Data collection and analysis 
 
Empirical data were collected and analysed in two stages using two different 
techniques- media analysis and semi-structured interviews. The methods were chosen 
pragmatically for their suitability to best address the specific research questions being 
addressed in each case. Firstly, media data were collected and analysed to uncover 
the wider cultural framing of sleep, cognition and modafinil use in contemporary 
society. Secondly, interview data were obtained to uncover in-depth understandings 
of, and perspectives relating to, the medical and non-medical uses of modafinil by 
those outside of professional bioethics. Conducting the media analysis prior to 
collecting the interview data allowed inferences from the first analysis to be followed 
up in the second. The results of the media analysis, alongside reading secondary 
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literature on the topic of cognitive enhancement, provided a framework which was 
used to both guide the second stage of data collection and to interpret subsequent 
results.  
 
The analysis of popular and interview accounts of modafinil use enabled the 
investigation of how expectations of pharmaceutical enhancement are changing social 
perceptions of normality and of behaviours in need of medical treatment/ lifestyle 
intervention, and how this influences the acceptability of cognitive enhancement in 
different social settings at two different levels; the cultural and the individual. 
The following section will discuss the practical, methodological and ethical issues 
arising during each stage of data collection and analysis. 
 
Collection of media data 
 
Documents can be studied to understand culture, or the process and array of objects, 
symbols and meanings that make up a social reality shared by members of society 
(Altheide, 1999). The UK media were chosen as a site of investigation because the 
media have been shown to provide a central forum for debates regarding issues 
relating to science, society, lifestyle, and most importantly, health and illness (Nerlich 
et al, 2003). It is mainly through the media that the general public becomes aware of 
scientific advances, new therapies- especially in the UK where direct-to-consumer 
advertising is not permitted (Williams et al, 2008a)- and the social and ethical issues 
regarding their use and availability. Because the media operate at this interface 
between science and society, reporting on scientific advances and technological 
developments in specific ways, they are likely to play an important role in shaping 
public perceptions of new technologies and their value and applications (Turney, 
1998; Nesbit, 2006). 
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Access, selection and sampling 
 
There is no standard method of conducting a media analysis. According to Altheide 
LWLVWKHUHVHDUFKHU¶VLQWHUHVWSHUFHLYHGUHOHYDQFHSOXVWKHUHWULHYDEOH
characteristic that produces a research document. When conducting any type of 
documentary analysis sampling is a salient issue as the decision of which material to 
focus upon is down to the discretion of the researcher (Kroll-Smith, 2003). The 
UHVHDUFKHU¶VTXHVWLRQVSHUVSHFWLYHDQGDSSURDFKDUHDOOUHIOHFWHGLQKRZDGRFXPHQW
is transformed into data. Choosing which sources, publications and time periods to 
study is an important issue and must be considered carefully as this could act to 
distort the results.  
 
For the purposes of this study, the focus of interest was on stories appearing in the 
British media about modafinil from the year the drug was developed (1989) to the 
present date (December 2006). Newspapers were chosen as data sources as 
newspaper archives are easily accessible and their textual form makes them primary 
sources of data. More visually orientated media would be more difficult to analyse 
using the approach taken in this study (discussed in the next section). It would also 
have been impossible to compare these data with those collected in the interviews.  
 
A wide sampling frame was used in the first instance to find all UK newspaper 
coverage of the drug. Nexis7, an online media database, was searched to locate 
relevant news articles. News articles published on the web and accessible through the 
BBC News and Sport online archive were also included in the study as recent 
research shows that the internet is an important site through which people access 
current news stories and information about science and health (Fox & Rainie, 2000). 
Two alternative names for the drug, modafinil and Provigil, were used as search terms 
using the OR operator. This search produced a corpus of 203 UK news articles in 
which the drug was mentioned. Newspaper coverage was plotted by year of 
                                                          
7
 Formerly called LexisNexis Professional 
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publication (Figure 1) and the graph analysed for trends in coverage, for example any 
obvious peaks8.  Sample size is important; however, the corpus obtained for study 
was relatively small.  In cases where there are a lot more articles available for 
analysis, the researcher could devise a sampling frame to obtain a particular sub-set 
of articles to analyse using this approach, for example, by randomly selecting a 
number of articles from the peak periods of publication. This step was not undertaken 
in this study.   
 
Figure 1. UK media coverage of modafinil/ Provigil 1989-2006 
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The newspaper and online articles were downloaded in rich text format into Microsoft 
Word and then subsequently uploaded into the qualitative analysis software tool 
NVivo. The articles were read and re-read. There was some degree of overlap in the 
newspaper coverage of modafinil between publications. This was particularly the case 
when comparing tabloid and broadsheet coverage of modafinil, where there were 
                                                          
8
 Peaks in publication were found to roughly correspond to specific events:  
1998 The UK approval of modafinil for the treatment of narcolepsy 
2002 Modafinil UK license extension to cover EDS associated with Obstructive Sleep Apnoea 
2003 Athletics scandal as several Olympic athletes test positive for modafinil 
2004 Modafinil UK license extension to cover EDS associated with Shift Work Sleep Disorder 
2005 Drug Futures 2025? Report published by The Office of Science & Technology 
([KLELWLRQFDOOHGµ1LJKW&UHDWXUHV¶KHOGDWWKH/RQGRQ6FLHQFH0XVHXP¶V'DQD&HQWUH 
2006 &RQIHUHQFHKHOGRQ³7RPRUURZ¶V3HRSOH´DW2[IRUG8QLYHUVLW\  
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numerous instances of a shorter version of the same article appearing in the tabloids 
after a longer article had been published in a broadsheet publication.  The decision 
was taken to focus the study on broadsheet publications and exclude tabloid stories 
about the drug. This step was also taken for pragmatic reasons, making the corpus 
size smaller, thus more manageable and adaptable to an in-depth qualitative analysis. 
At this stage duplicate articles were eliminated as well as articles in which modafinil 
was not central to the story. The remaining corpus consisted of 53 British newspaper 
articles and 24 BBC news stories.  
 
Analysis of media data 
 
The aim of this part of the study was to empirically investigate discourses surrounding 
the new sleep drug, modafinil, in order to examine how modafinil and related drugs 
are represented in popular culture through the media. Thus, providing access to 
information on how positive and negative expectations associated with this 
technological development and associated social and ethical issues are used to frame 
the uses of cognition enhancers across different social domains. Recent analyses of 
the social construction of modafinil in the media have contributed to such an 
understanding (Williams et al., 2008a). However, in order to gain more fine-grained 
insights into how the media portray the various uses of modafinil and its status in 
science and society, it was necessary to apply a method that could give access to 
deeply embedded and sometimes hidden conceptualisations of the phenomena.  
 
Analytical approach 
 
The corpus of media reports were analysed using discourse analytical approaches 
(DA) (Antaki et al, 2003; Hepburn & Potter, 2003) specifically drawing upon and 
combining aspects of frame analysis (Entman, 1993; Nerlich, Hamilton & Rowe, 2002) 
and metaphor analysis (Lakoff & Johnson, 1980; Schmitt, 2005; Kövecses, 2006). 
Congruent with the philosophical standpoint outlined above, DA approaches focus on 
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how social realities and identities are constructed through discourse rather than 
searching for an underlying truth. Language is viewed as a mediating tool that 
represents the world and discourses are viewed as actively constructed and situated 
through the choice of language that is used (Titscher et al, 2000).   
 
Discursive frames act to organize thought and package complex information by 
focusing on certain interpretations over others. Frames organise and impose 
coherence and can be evoked by the use of images, metaphors, clichés, book titles 
and other devices (Goffman, 1974; Turney, 1998). In the media, frames are usually 
derived from shared cultural narratives and myths and resonate with the larger social 
and cultural themes (Schön & Rein, 1994; Eubanks, 2008). The study of frames is 
important as they provide journalists and readers with ways to make sense of complex 
VLWXDWLRQVE\ILOWHULQJSHRSOH¶VSHUFHSWLRQVDQGH[SHFWDWLRQVDQGSURYLGLQJSDUWLFXODU
visions of a problem or a solution to a problem (Tannen, 1979). 
 
How problems are framed can be influenced by the use of particular metaphors which, 
DFFRUGLQJWR6FK|QµJHQHUDWHSUREOHPVHWWLQJDQGVHWWKHGLUHFWLRQRISUREOHP
VROYLQJ¶0HWDSKRUVDUHPXFKPRUHWKDQUKetorical devices used poetically 
or as linguistic aids to explanation. They are often underlying framing devices that are 
used to draw parallels between two seemingly unrelated concepts, transferring their 
image structure from a familiar or straightforward experience to a novel or complex 
one (Kövecses, 2006).  Metaphor is pervasive in everyday life, shaping both how we 
think about and understand the world on an epistemological level and how we see and 
act in the world on an ontological level (Lakoff & Johnson, 1980). They also structure 
our attitudes about public and scientific issues (Nelkin, 2001). For example, media 
coverage of medicines and other health products are often framed E\µVWRFNVWRULHV¶
(Seale, 2003) in part generated though metaphor. In such stories the metaphorical 
systems used to describe illness, disease and the body are important linguistic 
choices which can reveal deep social anxieties about the control of health and the 
control of society. According to Lupton (2003µUHSUHVHQWDWLRQs of the ill body are 
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inherently political, seeking to categorise and control deviancy, valorise normality and 
promote medicine as wondrous and ever-SURJUHVVLYH¶ 
 
The way metaphors are used in the media to draw parallels between seemingly 
unrelated concepts and to make the novel or unfamiliar appear familiar is therefore an 
important aspect of analysing media data. Metaphor analysis combined with frame 
analysis has been used successfully in media studies and STS in recent years to 
reveal hidden agendas, ideologies and beliefs about emerging technologies, policy 
controversies and issues of health and illness (Wallis & Nerlich, 2005; Nerlich, Clarke 
& Dingwall, 2000; Nerlich & Hellsten, 2004; Nerlich et al., 2003; Gwyn, 2002). 
 
Analytical process 
 
In order to investigate how the uses and users of modafinil were portrayed in the UK 
media, a version of metaphor analysis combined with frame analysis (or metaphorical 
frame analysis) was used. An iterative analysis process was undertaken, re-reading 
and coding the corpus of articles and generating themes. Thematically related parts of 
the embedded analysis in each data source were grouped together. The coding of 
articles was discussed with BN and PM9, ensuring a degree of inter-researcher 
reliability was built into the interpretation of data and enhancing analysis. The articles 
were first categorised according to their main theme(s). Four main themes emerged, 
UHODWHGWRIRXUµGLVFRXUVHV¶LQZKLFKPRGDILQLOXVHZDVGLVFXVVHGSDWLHQWGLVFRXUVH
(focus on treating a sleep disorder); sports discourse (focus on the use of modafinil by 
athletes); occupational discourse (focus on military, shift workers, students); 
recreational discourse (focus on leisure or general use). 
 
During the next stage of analysis articles were read and re-read to isolate sub-themes 
and central metaphorical concepts in order to reveal emerging frames and their 
distinctive features (Entman, 1993). This involved the systematic isolation of sections 
                                                          
9Thanks to Brigitte Nerlich and Paul Martin for agreeing to take on this role and all of their help during this 
stage of data analysis. 
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of text containing conceptual metaphors from each article. Through discussion 
between researchers thematically related expressions were then grouped together as 
µQRGHV¶LQ19LYRWRHQDEOHDGHWDLOHGVWXG\RIWKHLUOLQJXLVWLFIHatures and implicit value 
judgements (refining methods proposed by Lakoff & Johnson, 1980; Schmitt, 2005; 
Kövecses, 2006). The extent to which each metaphorical frame was found in each of 
the four sleep discourses (these are introduced and discussed fully in Chapter 4) was 
quantified to gain an overall picture of the way such metaphoric expressions framed 
the media discourses. Many different types of metaphorical expressions were 
identified. However, the analysis was focused on the use of the three most prevalent 
metaphorical frames which were used to varying degrees across the four discourses.   
 
Metaphorical frames were not based solely upon salient metaphors, but around 
particular and sometimes inconspicuous metaphoric expressions that enabled 
discourse to be articulated in a specific way. Wider framing devices that were 
consistent witKWKHFHQWUDOPHWDSKRULFDOFRQFHSWVXFKDVUHIHUHQFHWRµVWRFN
FKDUDFWHUV¶HJ)UDQNHQVWHLQUHIHUHQFHWRVWDQGDUGZRUNVRIOLWHUDWXUHHJ%UDYH
New World), historical references (e.g. Eugenics) and argumentative clichés (e.g. 
µRSHQLQJ3DQGRUD¶VER[¶ RUµJRLQJGRZQDVOLSSHU\VORSH¶ZKLFKSURYLGHDVKRUWKDQG
link to complex ethical arguments and debates, were also included in the analysis. 
Each article contained some, but rarely all components of one or more metaphorical 
frames. The approach used, however, was based upon an analysis of how the 
metaphorical frames were built up and used to structure discourse across the media 
sample as a whole rather than in individual articles. 
 
The evaluative orientation of each sleep discourse was determined by counting how 
often a metaphorical expression was used in a positive or negative way. These data 
are illustrated in percentage form (Chapter 4). To give numbers in a more formulaic 
way would be less accurate, as the data do not support this degree of refinement 
(Bryman, 1988). Therefore, the quantitative data were used as a descriptive tool to 
guide the analysts gaze, enabling focus to be centred on the most prevalent 
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metaphors and frames used in the first instance. In the second instance, it enabled the 
value-orientation of particular frames to be quantified and thus differences between 
them opened up for deeper qualitative analysis.  Importantly, this also allowed the 
analysis to take into account that all frames and perspectives present in media 
debates do not carry equal weight or value. This enabled an assessment to be made 
of the extent to which modafinil use was portrayed as legitimate or illicit in each 
context of use. Results and analysis of media data are discussed further in Chapter 4. 
 
Qualitative interviewing 
 
In-depth qualitative interviewing is a powerful research tool that can be used to reveal 
the details of how people think and act in everyday life (Haimes, 2002). It gives the 
opportunity to explore how the informants themselves define the experiences and 
practices that are the object of research (Murphy & Dingwall, 2003). Interview data 
FDQEHWUHDWHGDVJLYLQJDQDXWKHQWLFLQVLJKWLQWRSHRSOH¶VH[SHULHQFHV$FFRUGLQJWR
Silverman (1993), the best way to obtain this type of data is through qualitative open-
HQGHGLQWHUYLHZVZKLFKIRFXVRQDQLQIRUPDQW¶VRZQGHILQLWLRQRIDSKHQRPHQRQ+H
argues that this allows a penetration of public accounts and a reorientation of the 
research to the perspective of the community being researched.  
 
Others argue that no data are ever free of contamination and a researcher may never 
be sure that what a respondent says in an interview is a true representation of what 
they really think (Dingwall, 1997; Hammersley & Atkinson, 1983; Murphy & Dingwall, 
2003). It must also be remembered that an interview situation is a social encounter 
that is deliberately created to talk about a specific topic of interest as defined by the 
researcher. It follows a specific pattern of interaction, usually a turn-taking system 
where the interviewer proposes topics for discussion and the respondent attempts to 
SURYLGHDFFHSWDEOHDQVZHUV'LQJZDOOKDVOLNHQHGLQWHUYLHZVWRDµGDQFHRI
H[SHFWDWLRQV¶LQZKLFKLQGLYLGXDOVDUHUHTXLUHGWRGHPRQVWUDWHWKHLUFRPSHWHQFHLQWKH
role in which the interview places them. He explains that: 
91 
 
 
µ,SURGXFHP\DFWLRQVLQWKHH[SHFWDWLRQWKDW\RXZLOOXQGHUVWDQGWKHPLQD
particular way. Your understanding reflects your expectations of what would be 
a proper action for me in these particular circumstances which, in turn, becomes 
the basis of your response which, itself, reflects your expectations of how I will 
UHVSRQG¶S 
 
As a result, the respondent will attempt to present themselves as a sane, competent 
and moral member of a particular community (Goffman, 1974). Drawing on the work of 
Cicourel (1964), Dingwall (1997) describes this is an unavoidable constraint of face-to-
face interaction. The consequence of this is that the data produced during interviews 
are social constructs, created by self-presentation of the respondent and the signs of 
acceptability from the interviewer that they receive. From this perspective, interview 
responses are not taken as true or false. Instead interviews are considered to be 
occasions for giving and receiving accounts of a particular phenomenon that are 
treated as legitimate in a particular setting and should be treated as displays of 
perspectives and moral forms (Silverman, 1993; Dingwall, 1997; Hammersley & 
Atkinson, 1983). 
 
The semi-structured interview 
 
Semi-structured interviews were used in this study rather than open-ended interviews, 
as the way the different groups talked about specific phenomena was of importance. 
Using an open-ended interview design may have led to entire topics of significance 
being omitted. Semi-structured interviews are based upon a pre-compiled interview 
guide that can allow for the interactive flow of information between the interviewer and 
interviewee within certain limits (Hannock, 2002). Semi-structured interviews work well 
when the researcher has already identified specific topics they want to address, as the 
researcher can decide in advance what to cover while maintaining a degree of 
flexibility to receive any unexpected information the respondent may offer. This flexible 
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approach allows interviewees to discuss information that they think is relevant that 
could have otherwise been neglected (Green et al, 2002). The inclusion of such 
information is of importance for this research, as the associations different actors 
make and the contexts they link with cognitive enhancement are necessary in 
obtaining a complete picture of how modafinil use was understood and positioned in 
social context. Therefore, this characteristic of the semi-structured interview is an 
essential part of the research design. 
 
Semi-structured interviews were therefore used as a tool to explore and discover how 
each group talked about sleep and modafinil use in their own terms, which cultural 
narratives and frames they appealed to and how they negotiated social and ethical 
issues that arise from human enhancement technologies in the context of their 
everyday lives. Large scale opinion questionnaires have been carried out in this area 
before (Nature, 2009) and could have been devised to collect data from a larger 
sample. However, qualitative interviewing was selected as the method of inquiry as it 
would allow the participants to reflect upon modafinil and its prospective uses in depth, 
providing both a rich description and also an understanding of the significance of 
events in relation to their own experiences (Biddle, 2003). 
 
Collection of interview data 
 
Mapping the domain of research began with a reading of the neuroethics literature 
which revealed a broad range of potential stakeholder groups in the development of 
cognition enhancing pharmaceuticals (Chapter 1). All of these would be likely to have 
different interests and views on how the drug ought to be used and would be highly 
informative to study. From the results of the media analysis it was decided that the 
second stage of data collection would focus on ambiguous spaces the technology 
occupies and how social, ethical and future orientated discourse is used to construct 
the technology as medicine, enhancement tool or otherwise in these spaces. It was 
necessary to limit both the amount and the breadth of material collected to allow for a 
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complete and comprehensive in-depth analysis of the data to be carried out 
(Silverman, 1993). Two such spaces were identified, the workplace and university. 
Therefore, shift-workers and students were selected alongside scientists and clinicians 
as groups to target for interview (as opposed to patients or athletes for example).  
Issues of access, selection and sampling will be discussed in relation to each of these 
three groups in turn before attending to the practical, methodological and ethical 
considerations impacting on the collection and analysis of interview data more 
generally. 
 
Scientists and clinicians  
 
Scientists and clinicians who were involved in the study of modafinil and its uses in the 
WZRERXQGDU\FDVHVRUWKRVHZLWKµH[SHUW¶NQRZOHGJHLQUHODWHGILHOGVHJ
neuroscientists, circadian biologists and other sleep researchers) were targeted for 
interview. Interviews with this stakeholder group aimed to investigate how sleep, 
cognition and modafinil use were framed by scientific and medical experts. Although 
this information could have been gathered by examination of the extensive scientific 
and medical literatures that are available there is much to be gained by carrying out 
interviews in this area. For example, perspectives that conflict with dominant ideas 
and theories10, unrecorded information, new theories, personal opinions and 
experiences of these individuals could be obtained (De Chadarevian, 1997). The 
findings of this strand of the research are discussed in Chapter 5. 
 
Access and sampling 
 
Random sampling was not an appropriate or desirable strategy for the selection and 
recruitment of scientists and clinicians.  The aim was to interview individuals with 
interests and expert knowledge in specific areas of research, not to obtain a large or 
                                                          
10
 For example, scientists often told me during the interviews that modafinil was probably not as efficacious 
LQµKHDOWK\¶SRSXODWLRQVDVLWDSSHDUHGWREHLQWKHOLWHUDWXUHEHFDXVHLWZDVPXFKKDUGHUIRUVFLHQWLVWVWRJHW
research published that showed a negative finding as opposed to a positive one.  
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representative sample. The sampling frame that was developed and used had two 
components. Firstly, media data were used to: extrapolate key voices from the sleep 
science and medicine communities; identify sleep clinics and research institutes based 
in the UK; and sleep scientists or clinicians involved in dissemination of sleep research 
or medicine information via the media. Drawing on these sources, a list of scientists 
and clinicians with an active interest in sleep, sleep disorders and/ or modafinil was 
complied and further leads identified to follow up. A benefit of including the online 
news stories in the first part of the study was the network of links related to each story 
that was available alongside the main news article. This was used to provide 
information about key actors in the sleep field. Using the media data in this way (as a 
component of the sampling frame) meant that some important sources may have been 
missed. However, this provided access to the organisations and opinions that 
dominate the public domain.  
 
A second component of the sampling frame involved identifying individuals for 
interview through their participation at one of the most prominent academic 
conferences in this area, WorldSleep, which is held every four years and brings 
together professionals from all around the world who have an interest in sleep science 
and medicine. Through attendance at the 5-day conference in September 2007 in 
Cairns, Australia (attended by an estimated 3,000 delegates, making it one of the 
largest international meetings for sleep medicine), observation of various talks, 
interaction with delegates and collection of different types of documentary data (e.g. 
conference notes, paper abstracts, sleep science and medicine journals, flyers, 
promotional material from pharmaceutical companies), individuals with world-leading 
expert knowledge in the sleep field were identified. There was also an element of 
µVQRZEDOO¶RURSSRUWXQLVWLFVDPSOLQg as some of the respondents passed on details of 
the study to their colleagues or provided details of individuals whom they thought 
would be interested in taking part in the research. 
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Interview population 
 
Virtually every lead available was followed up and over 50 individuals/institutions were 
contacted via email for interview. Of these, 20 individuals replied and expressed their 
interest to take part in the research11. Between July 2007 and June 2008 interviews 
ZHUHDUUDQJHGDQGFRQGXFWHGZLWKµVOHHSH[SHUWV¶HLJKWZHUHPDOHDQGVL[IHPDOH
Interviews were conducted until redundancy in information was reached, at which 
point further sampling was terminated (Lincoln & Guba, 1985)12.  
 
Ten respondents were based in UK clinics or research institutions at the time of 
interview. The remaining five respondents were based in clinics or institutions outside 
of the UK. These individuals were included in the study due to their world-leading 
expertise in the area of this research. Scientists and scholars and their knowledge or 
theory tend to move between institutes and countries and cross-continental 
collaborations are very common. It was therefore thought desirable to include the 
accounts of highly influential scholars working outside of the UK in the study to obtain 
a more rounded and complete picture of current scientific and medical sleep 
discourses13.  
 
5HVSRQGHQWVZHUHFDWHJRUL]HGDVHLWKHUµVOHHSVFLHQWLVW¶RUµVOHHSFOLQLFLDQ¶EDVHG
upon their experience and activities. Overall, the interview population consisted of nine 
sleep scientists based across three sleep research centres in the UK or at one North 
American research institute. This group included neuroscientists, geneticists, circadian 
biologists, clinical psychologists, and psychologists whose primary conduct in the 
sleep field was academic research of a biological (3), psychological (4) or 
                                                          
11Interviews were not conducted with all of these individuals for various reasons. For example, difficulties in 
arranging a convenient time for interview or after initial expression of interest the individual failed to respond 
to further contact.  
12
 As discussed previously, data collection and analysis were not discrete stages of the research. 
Preliminary analysis of the interview data was used to guide and focus the collection of further interview 
data. After each set of 5 interviews codes were reviewed and compared and the interview guide modified to 
take account of theoretical leads arising in the data. 
13
 The UK/ non-UK distinction was not clear cut. For example, one of the scientists, currently based in North 
America, had spent most of his career in the UK. Another was working in a North American institute for 
purposes of collaboration with a European Sleep research centre, and due to return to this European 
institution after two years.  
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biopsychosocial (2) nature. Six respondents were categorised as sleep clinicians. 
These individuals worked in two private UK-based sleep clinics or were based across 
three different North American sleep clinics. This group included practitioners of 
medicine (2), clinical psychology (3) and psychotherapy (1) whose work involved the 
direct assessment and treatment of patients in a clinical setting14. Further details of the 
interview population and how they are identified in the data presented can be found in 
Appendix III. 
 
Interviewing elites 
 
In an interesting and informative discussion of his own experiences of fieldwork, 
sociologist, bioethicist and ethnographer Charles Bosk (2001) states that gathering 
GDWD>DVDQHWKQRJUDSKHU@µUHTXLUHVDFHUWDLQVNLOODWSOD\LQJGXPE¶
Although interviewing is somewhat different from the all-encompassing immersion into 
DILHOGH[SHULHQFHGE\HWKQRJUDSKHUV%RVN¶VDFFRXQWLs relevant and recognisable to 
PDQ\TXDOLWDWLYHUHVHDUFKHUVZKHUHDQHOHPHQWRISOD\LQJGRZQWKHH[WHQWRIRQH¶V
own prior knowledge of the field is crucial to the research strategy adopted. Prior to 
interviewing those with expert knowledge in a particular field it is often necessary for 
the researcher to become familiar with literature, principles, practices, theories and 
even values and norms operating in a particular sphere in order to delineate which 
information is relevant and define the focus for their research. This was the case in 
this research where, by the time of interviewing the majority of respondents, familiarity 
had been achieved with some of the sleep science and medicine literature, current 
theories and practices. Areas of contestation had been identified through attendance 
and observation at a sleep science and medicine conference and other interviews had 
been conducted. Although a level of competence in the area was displayed, it is 
doubtful whether the same lengthy and detailed accounts that were given by sleep 
scientists and clinicians during the interview process would have been solicited had I 
                                                          
14
 The researcher/ clinician divide was also not clear cut, as most of the clinicians also had an interest in 
clinical research and teaching with three holding university teaching posts.  Three of the respondents 
FODVVLILHGDVµVFLHQWLVWV¶GLGDOVRRFFDVLRQDOO\VHHDQGWUHDWSDWLHQWV 
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revealed the full extent of my knowledge prior to the interview. Instead, I assumed the 
role of student and let the interviewee assume the role of teacher. This proved to be a 
XVHIXOZD\RIµUHVHDUFKLQJXS¶DQGRIHOLFLWLQJIXOODQGGHWDLOHGDFFRXQWVIURPWKH
interviewees15. It enabled the conversation to flow naturally and for questions probing 
for more information to be asked without feeling intrusive or inappropriate. Upon 
reflection, this was more of a natural occurrence at first, roles which both I and the 
respondents seemed comfortable with rather than a conscious decision16. Scientists 
and clinicians were interviewed at a place of their choosing. This ranged from coffee 
shops, restaurants and hotel lobbies to university based offices. 
 
Shift workers 
 
Shift workers were targeted for interview with the aim of situating understandings of 
psychopharmaceutical use in one specific social context in order to further explore the 
emerging social and ethical issues surrounding the use of modafinil as defined by 
potential users. As discussed in Chapter 1, several specific occupational roles are 
repeatedly referred to by bioethicists when discussing the potential use of cognition 
enhancing substances among the workforce. Typically, these include the drowsy 
doctor or surgeon on night call; airline pilots on transcontinental flights; air-traffic 
controllers who have to operate in a high stress environment; long-distance lorry 
drivers who drive through the night; nurses working long shifts; and ambitious 
professionals trying to pack more work into a day (e.g. Greely et al, 2008; Sahakian & 
Morein- Zamir, 2007; Glannon, 2008; Synofzik, 2009; Wolpe, 2002; Farah, 2002).   
Because of the wide-range and mix of professions and type of person the drug is 
assumed to appeal to, the decision was made to include shift workers in the study 
from a range of occupational roles and types of job.  Rather than just focusing in on 
one particular occupational context which could have significantly biased the data 
                                                          
15
 Several of those interviewed also got in touch with me after the interview to provide copies of papers that 
were not yet published and which they thought might be relevant to me and to provide details of papers and 
books that I might find useful. 
16For example, the first interview conducted was with a Professor over coffee in his university based office 
and I had already identified myself as a postgraduate research student. 
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collected, it was hoped that this type of sample could offer more general and varied 
data.  
 
Access and sampling 
 
The decision to recruit respondents across professional boundaries did impose 
constraints on the research. In relation to access to research participants, a common 
or organised space was not identified where people who work shifts, regardless of 
their profession or occupational role, gather to form a collective idenWLW\DVµVKLIW
ZRUNHUV¶7KHUHIRUHWKHGHFLVLRQZDVWDNHQWRFUHDWHVXFKDVSDFHVSHFLILFDOO\WR
recruit shift workers to take part in the study. A virtual space was set up online via a 
VRFLDOQHWZRUNLQJZHEVLWHZLWKWKHJURXSQDPHµ8.6KLIW:RUNHUV¶ZKLFh was used to 
invite people who were resident in the UK and currently working shifts to take part in a 
short interview. Information about what to expect during the interview was also 
included on the website'HWDLOVRIWKHJURXSZHUHDGYHUWLVHGYLDWKHµQHZVIHHG¶DQG
µJURXSV¶VHFWLRQRIWKHZHEVLWHDQGVHQWRXWWRSHUVRQDOFRQWDFWVNQRZQWRZRUNVKLIWV
A form of snowball sampling was also implemented. The message on the webpage 
urged others to pass on the group details or my contact details to anyone they thought 
might be interested in taking part in the study. The group was left open for 3 weeks 
during October 2008 in which time it accumulated 20 members. 
 
The internet is increasingly becoming a site where social research takes place. Large 
scale online surveys are relatively common and many qualitative methods have been 
transferred to the Internet, for example, there are forms of online and email 
interviewing, participant observation and virtual ethnography (Murthy, 2008). It has 
been argued that using the Internet as a tool enables the researcher to reach people 
and groups of people who would have otherwise been difficult or impossible to reach 
(Flick, 2009).  
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The creation of an artificial research group such as the one described above has both 
advantages and limitations. Individuals who joined the group did this on a voluntary 
basis and self-identified as shift workers. The consequence of this was that they were 
interviewed on a personal level as a member of the group rather than as a member of 
their professional organisation. The main benefit of this was that it allowed individuals 
from different professions living in any area of the UK to be included in the study and 
accessed with relative ease. Other benefits were the efficiency (in terms of time and 
research costs) and interactivity afforded to the recruitment process. The virtual nature 
of the group meant that participants could express their interest in the study 
immediately by clicking on a tab to join the group. Anyone that was interested or had 
further questions could contact the researcher informally through the website without 
giving their personal contact details. The group was also free to set up and enabled 
details of the study to be advertised to any shift worker in any profession nationwide 
relatively quickly at no cost.  
 
A major disadvantage that can be applied to Internet research in general is that those 
without access to the technology are excluded from the study in the first instance 
(Murthy, 2008). Specifically in this case, the consequences of using a particular social 
networking site meant that only those who were already members of that particular 
site were able to be reached during the initial stages of recruitment.  However, the 
snowball element to the sampling strategy went some way to remedying this, as 
members of the site and the group were encouraged to pass on the contact details to 
anyone they thought might be interested in taking part. In three cases individuals that 
joined the group did so on behalf of a friend or family member and acted as a go-
between passing on contact details between parties. Two other disadvantages of 
recruiting participants online that have been identified are the lack of personal or 
demographic information that is available to the researcher (often only an email 
address or screen name is made available) and how the demographic information 
given by participants can be verified. Not having complete information about a 
participant can lead to difficulties in evaluating whether the individual is who they say 
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they are (Flick, 2009). However, the partial demographic profile of potential 
participants was not considered to be problematic in this study as further relevant 
details could be gathered and others verified if necessary during the interview 
process.  
 
Interview population 
 
All 20 individuals who joined the group were contacted separately and invited to take 
part in an interview. Some members of the group did not respond to the request17. 
Individuals were contacted and interviews were conducted until the available leads 
were exhausted (Lincoln & Guba, 1985).  In total, 11 shift workers were interviewed for 
the study. Respondents ranged in age from 21 to 53. Seven identified as male and 
four as female18. As evidenced in the eventual interview population, the lDEHORIµVKLIW
ZRUNHU¶GRHVQRWUHIHUWRDKRPRJHQRXVJURXSRILQGLYLGXDOVQRUZRUNLQJSDWWHUQV7KH
shifts these individuals worked varied from full time night shift to part time rotating day 
shift work. The length of time each person had worked shifts also varied from just 7 
months to over 11 years.   
 
One respondent was a permanent night shift worker in an airport. Six respondents 
were rotating shift workers. Four of these individuals were hospital-based medical 
professionals: two doctors, two nurses. One respondent was a police officer and 
another worked as a telephone operative in a call centre. One respondent worked on 
a part-time basis in two different jobs and had done so for two years. Her main job 
was in mental health care and her second job was in a shop as a retail assistant. The 
final three respondents in this group were a retail staff trainer, a machine operator in a 
factory and a postal worker who all worked fixed early shifts19. On aggregate, the 
                                                          
17
 ,KDYHWHUPHGWKHVHµVLOHQWPHPEHUV¶- individuals who join causes or groups online to show their support 
but do not play an active role in contributing to the group agenda or activities. 
18The relatively low number of shift workers interviewed was not considered problematic as there was some 
overlap between the shift worker group and student group. Three of the students interviewed also worked 
shifts and one of the shift workers was also a student. Data from each of these respondents was therefore 
included in the analysis of both shift workers and students discourse where appropriate. 
19
 Further details of each of the respondents and how they are identified in the text can be found in the 
appendices. 
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working hours of those interviewed spanned the full twenty-four hours of the day, 
seven days a week at all times of the year.  
 
Interview strategy 
 
:KHQLQWHUYLHZLQJVKLIWZRUNHUVWKHUHVHDUFKVWUDWHJ\GLVFXVVHGDERYHRIµSOD\LQJ
GXPE¶%RVNZDVDOVRVRPHZKDWDSSURSULDWH%\WKLVVWDJHRIWKHILHld work a 
great deal of knowledge and familiarity with medical and scientific discourse about 
shift work and its effects on sleep, cognition and lifestyle had been accumulated. 
µ3OD\LQJGXPE¶ZDVWKHQDXVHIXOVWUDWHJ\WRDGRSWWRDYRLGPDNLQJDVVXPSWLRQV 
being prescriptive or imposing scientific or medical discourse onto the data. 
Respondents were interviewed in their own homes or a place of their choosing. 
Interviews were informal and conversational with the interviewee given the freedom to 
describe their experiences and opinions in their own terms using their own words20.  
 
Students 
 
In both the neuroethics and media discourses analysed, university students were 
depicted as existing users (and imagined as future users) of cognition enhancing 
drugs for distinctly non-medical purposes, to enable them to study longer, perform all-
night study sessions, boost alertness in lectures, and improve exam grades (Nature, 
2009). Claims are frequently made that an ever-increasing percentage of students are 
obtaining neuropharmaceuticals either illegally or by false diagnosis and using these 
substances to improve their academic performance (Volkow & Swanson, 2007; Chan 
& Harris, 2006; Greely et al, 2008; Farah, 2004; Schermer et al, 2009; Forlini & 
Racine, 2009). Students were interviewed with the aim of situating the pharmaceutical 
augmentation of cognition by this group of prospective users in social context. The 
way in which students talked about and understood modafinil use in relation to their 
                                                          
20I wore casual clothes and identified myself as a student- one without a job- curious to find out about the 
world they work in.  
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everyday lives as university students was analysed (Chapter 7) to explore the different 
ways in which modafinil use can be configured in social context and how this 
influences its perceived acceptability in this social domain.  
 
Access and sampling 
 
This research was conducted at the University of Nottingham. For pragmatic reasons 
(e.g. cost, efficiency and ease of access) the students interviewed for the study were 
recruited from the University of Nottingham undergraduate population. An email 
advertising for undergraduate students to participate in the study was sent out to 
undergraduaWHVWXGHQWVYLDWKH8QLYHUVLW\¶V internal email system21. In October 2008, 
over 1000 undergraduate students were randomly selected and invited to take part in 
an interview. The email contained information about the study, what to expect during 
the interview and asked respondents to specify a preferred time for interview chosen 
from a selection of time slots offered by the researcher22. As interviews were 
scheduled to take place in the last two weeks of term when many deadlines were 
looming, students were informed that they would be compensated for their time as an 
extra incentive to participate23.Eighty students replied to the initial email and 
expressed their interest in taking part in the study. Around three quarters of the 
students who replied to the initial email were female. Forty of these students were 
chosen at random and contacted with a date and time for interview. Fourteen students 
actually turned up at the specified time and place and were interviewed. The hit rate 
was therefore much lower for this group than in either of the other two stakeholder 
groups interviewed.  
 
 
 
                                                          
21
 The email system allowed emails to be sent to all students in a particular year group who were registered 
for each course in a school. There are hundreds of courses run by each school and over 60 schools across 
5 faculties. For this reason, 30 schools were chosen to contact at random, and emails sent to students who 
were registered for the most popular course run by that school.  
22
 A copy of the email sent to students can be found in appendix II. 
23
 Students were given a £5 gift voucher. 
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Interview population 
 
Fourteen students from seven schools across four faculties were interviewed for the 
study. Nine of the respondents were in their first year of study, one was a second year 
undergraduate student and the remaining four were in their third year of study.  Ten of 
the students interviewed were female and four were male. Although gender is not a 
primary concern in this study, the gender bias is worth noting as it could potentially 
influence and act to distort the results. Although coming from a variety of disciplinary 
backgrounds, the students interviewed are not representative of the student 
population at the University of Nottingham as a whole nor the wider student population 
in the UK more generally. Therefore, the data collected is not considered to be broadly 
generalisable to other student groups.  
 
Interview strategy 
 
When interviewing students, it was not so eDV\WRµSOD\GXPE¶WRVROLFLWLQIRUPDWLRQ,Q
fact, this group were the most difficult to interview and required the most prompts and 
encouragement to expand upon their answers. All interviews were conducted at the 
University of Nottingham, either in my office or one of the seminar rooms in the 
Department of Sociology and Social Policy. I identified myselIDVµIHOORZVWXGHQW¶DQG
wore casual clothes to put interviewees at ease. In retrospect, it was perhaps for these 
reasons that students did not provide detailed descriptions of their views and activities 
without much prompting. Perhaps, they felt that I already knew where they were 
coming from, being µone of them¶.  Or perhaps it was because they were the group 
furthest from the technological innovation, in the sense that most of them could not 
see any use for the technology in their lives. Analysis of the data collection from 
student interviews is discussed in Chapter 7. The next section of this chapter 
discusses the methodological and ethical considerations arising during the interview 
process more generally and details how they were addressed in this study. 
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The interview process 
 
As described above, virtually every lead available was followed up and interviews 
conducted until redundancy of information was reached or leads were exhausted 
(Lincoln & Gruba, 1985). I travelled up to five hours each way to conduct face-to-face 
interviews, where possible (n=33). In the case of shift workers most interviews were 
conducted on Sundays or in the evenings when the individual was not at work. Where 
face-to-face interviews were not possible, due to the availability or preference of the 
respondent and the large geographical area covered, interviews were carried out via 
the telephone (n=7). This was the case for two clinicians and one sleep scientist, who 
indicated they would prefer a telephone appointment, and for four of the shift workers 
who worked nights and did not live in the locality of the researcher.  They were each 
telephoned at a time that they specified as suitable to them24. Interviews lasted 
between 3 hours and 20 minutes, with an average of around an hour. All respondents 
consented to their interviews being recorded using a digital voice recorder. The first 
couple of interviews with members of each stakeholder group tended to be the longest 
and more exploratory in nature. Overall, interviews were on average longest with the 
scientists and clinicians, who were used to talking about sleep and most familiar with 
modafinil, and shortest in the student group.  
 
Telephone interviews 
 
Several limitations have been identified with using telephone rather than face-to-face 
techniques for interviewing. Some argue that conducting an interview over the 
telephone can make it difficult for the researcher to build a rapport with the 
respondent, that it could cause interactional problems when addressing sensitive 
issues (for example trouble in assessing the reaction of those being interviewed to the 
topics raised in the absence of non-verbal cues and expressions) and may lead to the 
premature ending of the interaction (Opdenakker, 2006). Despite this, many 
                                                          
24
 Telephone interviews were conducted between 8am and 10pm.  
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researchers have successfully used this technique in a variety of studies investigating 
a wide range of issues (e.g. McDonald et al, 2010; Thomas et al, 2004; Adams et al, 
2006).  
 
Respondents were only interviewed over the telephone if they identified this as more 
desirable to them than taking part in a face-to-face interview. Telephone interviews did 
tend to be shorter on average than face-to-face interviews but there was no noticeable 
lack of rapport compared to face-to-face interviews. The main benefit of using 
telephone interviews for this study was that people from all areas of the UK could be 
reached and interviewed at no extra cost to the project.  
 
The interview guide 
 
Interviews were conducted using a semi-structured topic guide which encouraged 
respondents to narrate their own accounts and focus on those areas of importance or 
interest to them (Murphy & Dingwall, 2003; Silverman, 1993). The use of an interview 
guide allowed the interviewer to elicit WKHUHVSRQGHQWV¶RZQXQGHUVWDQGLQJVRIWKH
phenomenon in question while still addressing topics identified beforehand as being of 
interest to the study and providing direction for the study to follow (Hannock, 2002). 
The interview guide was developed prior to data collection informed by reading the 
neuroethics and scientific literatures and by the results of the media analysis. It was 
refined and adapted throughout the data collection process. It consisted of four broad 
headings which related to themes to be covered and a series of prompt questions 
which may or may not have been asked depending upon the answers already given. 
These main themes carried across each of the stakeholder groups interviewed but 
wording differed slightly between each group as appropriate25.  
 
Firstly, respondents were asked to provide some background information about 
themselves and their lifestyle (addressing issues of education, employment, recreation 
                                                          
25
 A sample interview guide can be found in the appendix IV. 
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and so on). This section of the interview also acted as a way to put the interviewee at 
ease and for rapport building. Secondly, they were asked some general questions 
about sleep and health (sleeping patterns, perceived relationship between sleep and 
health etc.). The third section of the interview focused on modafinil and its potential 
uses (exploring medical/ non-medical uses of the drug in different user groups)26. In 
the final section of the interview the respondent was asked about their personal views 
and opinions (specifically in relation to the perceived social impact cognition 
enhancing drugs could have on society, whom they thought modafinil should be 
available to now and in the future and who they thought the drug would be used by). 
Directive questioning was used in the later stages of the interview to ensure that all 
areas were covered and to follow up on theoretical leads from both previous 
interviews and the literature27.The interview ended with an opportunity for the 
respondent to add any additional information or comment.  
 
Analysis of interview data 
 
The methods literature indicates many ways in which interview data can be 
analysed (Coffey & Atkinson, 1996). Some researchers consider interview data 
to reveal what people treat as self-HYLGHQWRUWKHµULJKW¶WKLQJVD\DQGXVHWKLV
data to find the cultural and moral discourse surrounding a particular topic 
(Green et al, 2002; Silverman, 1997). The use of interview data in this way is 
relevant to the aims of this study; however it will be necessary to bear in mind 
that although it may yield important information, interview data must be treated 
as socially and contextually constrained (Dingwall & Murphy, 2003).  As 
discussed above, iQWHUYLHZGDWDPXVWEHUHFRJQLVHGDVDFFRXQWVRISHRSOH¶V
actions, feelings and opinions and how these are shaped by social context, 
                                                          
26
 In some cases respondents expressed concern that they might not be knowledgeable enough about 
modafinil to be helpful. This was true of respondents from all groups, including sleep scientists.  
27
 6RPH UHVSRQGHQWV EHJDQ E\ UHSHDWLQJ µRIILFLDO¶ ELRPHGLFDO GLVFRXUVHV ZKHQ DVNHG WR WDON DERXWVOHHS
and health. For example, one respondent (a sleep scientist) simply recounted the presentation he had given 
of his work at the conference the day before. Questions that were designed to probe beyond this type of 
data were asked in the later stages of the interview which encouraged accounts that were more personal 
and emotional.  
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including the interview context itself (Hammersley & Atkinson, 1983). How 
questions are asked and information presented to respondents during an 
interview by the interviewer can therefore influence the type of answers elicited 
as respondents attempt to provide acceptable answers and demonstrate their 
competence as a sane and moral member of their community (Goffman, 1974; 
Dingwall, 1997; Dingwall & Murphy, 2003). This is especially relevant to 
consider when discussing concepts and technologies that the respondent may 
not be familiar with or used to talking about before the interview. When 
analysing interview data of this sort it is therefore important to take into account 
that there are not always stable meanings attached to an event or experience, 
that people can hold conflicting sentiments at any one time (Dingwall & Murphy, 
2003). Therefore, the opinions expressed during an interview may, in a sense, 
reflect the questions that were asked by the interviewer, the information that 
was given to the respondent and how this was framed.  
 
Taking this into account, details about modafinil were given to respondents in 
an attempt to accurately reflect information about modafinil that is currently 
available in the public domain rather than the interviewers own opinions on the 
subject. This included a description of its current status as a prescription drug 
used to treat sleep disorders, a summary of its potential cognition enhancing 
effects and an outline of recorded adverse effects.  A typical example of how 
this information was given to respondents, how they were asked to imagine 
uses for the drug and potential future impacts, and how they responded to this 
is illustrated in the interview extract below: 
 
Interviewer:   Have you ever heard of the wake promoting drug Modafinil? 
S1, Mike:   Nope. 
Interviewer:   Well, it is a wake promoting drug that is used to treat sleep 
disorders such as Narcolepsy - you know the one where people fall asleep all 
the time? 
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S1, Mike:   Yeah. 
Interviewer:   And it has been tested by the military and also different groups of 
scientists since about 1991 and it has been found that it can keep healthy 
people awake for up to 72 hours. It also is said to have these other cognition 
enhancing properties such as making people think clearer, concentrate better, 
improving memory, problem solving and planning skills and things like that.  The 
kind of adverse effects - it is marketed as a safe drug, but there are obviously 
problems, like some people with hypertension it might increase their heart rate 
so not be good for them, it has been linked to severe headaches in some 
people and severe skin rashes, but overall it is generally known to be quite safe. 
Do you think that this type of tablet should be kind of available to everybody, 
sold in the Supermarkets like caffeine tablets or be a medicine prescribed by 
doctors? 
S1, Mike:   7KDW¶VDJRRGTXHVWLRQ,WKLQNLWZRXOGKDYHWREHSUHVFULEHG
because you would then have probably people abusing it to stay awake for 
longer - or trying to exceed the dose to stay awake for longer than 72 hours.  I 
would have to see the research to actually sort of have an informed opinion 
about it I think. 
Interviewer:   So thinking quite generally then - what impacts could the 
widespread availability of these kind of drugs have on society do you think? 
S1, Mike:   Positively if you took say a medical sense, you could have doctors 
making less mistakes due to tiredness.  Potentially you could reduce work place 
accidents with people being more alert and that sort of thing.  I suppose there 
are possible negative effects if people become dependent on it to be able to 
actually function properly, in which case I think it is going to be like any other 
sort of drug addiction, in which case you will have to be weaned off it and that 
sort of thing.  I think possibly if you were of an addictive personality as well, you 
PLJKWJHWKRRNHGRQLWDQGHYHQLILWLVQ¶WSK\VLFDOO\PHDQLQJWKH\FDQ¶WIXQFWLRQ
- it might be psychosomatic that they feel they have to have it to function 
properly - VR,VXSSRVHWKDW¶VDSRVVLEOHQHJDWLYHHIIHFWRILWDVZHOO 
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Interviewer:   And do you think it would be something that would appeal to a lot 
of students then, this kind of -? 
S1: Mike:    I would imagine it would probably appeal to quite few people 
GHILQLWHO\,GRQ¶WNQRZLI,ZRXOGOLNHWRVD\PDMRULW\RUQRWEXW,FDQLPDJLQH
quite a few people probably would take it, especially during exam times and at 
the end of - sort of lot of the third years we have got a big project and probably 
taking towards the end of that to be able to get it all done and get all sorted in 
time. 
 
Interview data of this sort can therefore be used to explore and to uncover the cultural 
resources, norms and values that are drawn upon in order to evaluate the 
acceptability of new and emerging technologies.  The analysis of this type of data 
should then, also be sensitive to the interactional and political contexts in which the 
data was generated (Murphy & Dingwall, 2003).   
 
Transcription, coding and interpretation of interview data 
 
The first stage of data analysis was the transcription of data from verbal into written 
form. At this stage choices were made about the level of detail to include and the data 
was µcleaned¶ to an extent. The first two interviews of each set were transcribed by the 
researcher in order to gain a greater familiarity with the data. The remaining interviews 
were transcribed by a professional transcriber. Upon receipt of the transcripts the 
recorded interviews were listened to and the transcripts checked for accuracy.  
The results of the media analysis were used to develop a coding frame for the 
interview data in the first instance. After carefully reading and re-reading the interview 
transcripts with the results of the media analysis in mind, it became apparent that the 
metaphorical frames that were most prevalent and structured media discourses about 
modafinil were largely absent in the talk of those interviewed. In fact, although 
metaphors were present in various forms in the talk of those interviewed, they were 
not used as dominant framing devices as was the case in the media data. The 
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decision was made at this stage to analyse interview data using a similar approach to 
that used to analyse media data (based on discourse analytic techniques and drawing 
upon elements of frame analysis) to ensure that the data was analyzed in a systematic 
and coherent fashion, but without the central focus on metaphors. Instead the 
analytical framework was developed based on concepts drawn from the medical 
sociology and STS literatures on medical/ non-medical uses of technology and how 
prospective uses and users were imagined by the respondents (Chapter 2).  
Interview transcripts were uploaded into NVivo for coding. As with the first stages of 
the media analysis, the analytical approach taken to analyse the interview data used a 
DA approach (Antaki et al, 2003; Hepburn & Potter, 2003) which drew heavily on 
grounded theory (Glasner and Strauss, 1967; Strauss and Cobin, 1990; Charmaz, 
2003). Grounded theory approaches are based on the premise that: 
 
 µ«WKHEHVWWKHRU\LVGHYHORSHGIURPFORVHHQJDJHPHQWZLWKWKHGDWD,W
involves an elaborate process of coding, or identifying recurrent patterns, 
relationships, or processes found in the data, and the generation of conceptual 
categories and their properties from the evidence using the constant 
FRPSDUDWLYHPHWKRG¶%HHVRQ	 Doksum, 2001: 162).  
 
The quantitative approach used to guide the qualitative analysis of media data was not 
appropriate for the interview data. Looking for phrases or words used most would not 
allow access to revealing common themes and ideas that were expressed in different 
ways or to contrasting or unique cases. A more qualitative, but nontheless systematic, 
approach to coding and uncovering themes was thought more appropriate. The 
interview data were analyzed using NVivo to systematically sort and code each 
section of data (Charmaz, 2003; Bryman, 2001). Topics were indexed, collated and 
cross-referenced in order to organise emerging themes (Coffey & Atkinson, 1996; 
Dingwall & Murphy, 1998; Morse, 1994). The inclusion of negative cases or data that 
do not fit any category is also crucial to grounded theory approaches (Strauss & 
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Cobin, 1990). The systematic and consistent categorisation of themes and codes in 
the data is one way to achieve reliability (Kirk & Miller, 1986).  
 
Emerging themes were named, data included in each of the themes were re-read, 
refined and the specific details of each theme organised to ensure that themes were 
internally coherent and distinct from one another (Braun & Clarke, 2006). The 
interview populations were not large or representative samples. It was therefore not 
appropriate to use any type of statistical analysis. Instead, interpretation of the data 
began with the establishment of ordered relationships between codes and theoretical 
concepts (Coffey & Atkinson, 1996). The analysis of interview data is presented in 
Chapters 5-7. 
 
Ethical issues 
 
A University of Nottingham Research Ethics Review was successfully completed for 
this project in 2007. The research was designed with reference to the ethical 
guidelines published by the British Sociological Association (2002) and as such 
relevant ethical issues were adhered to in the conduct of empirical work. These are 
outlined below.  
 
Data collection and storage: Interview data were collected via face to face 
interviews and telephone interviews. Interviews were recorded using a digital voice 
recorder with the permission of those interviewed and data are securely stored both 
physically and electronically in locked files. In accordance with current research code 
of conduct guidelines data will be held for 7 years before being destroyed. 
 
Informed consent: Informed consent is a problematic notion. The amount of 
information that is disclosed to participants has to be weighed up carefully to make 
sure that respondents are informed of the purpose of their participation in the 
research, what is required of them and how the information they provide might be 
112 
 
used, but without soliciting particular responses. Information about the study, including 
some basic background material, ethical considerations and what their participation 
would involve was provided in both the initial recruitment email and outlined verbally 
before each interview took place. Participants were encouraged to contact the 
researcher if anything was unclear to them or if they required further information about 
the study. They were also informed of the intended use of the data collected (i.e. 
quotations to be taken from their answers and reproduced in this thesis, oral 
presentations and any subsequent papers derived from this thesis). Verbal consent 
was obtained prior to conducting the interview and respondents were also asked for 
their permission for their interview to be recorded.  
 
Anonymity, confidentiality and privacy: Participants were ensured that their 
responses would be kept confidential and their identities private. Any potential 
identifying information was removed from the data prior to use and all names and 
places were anonymised. Respondents were assigned pseudonyms and referred to 
by reference to their occupational role in general terms (i.e. sleep scientist, nurse, 
student etc). Gender was also assigned randomly to each participant. These 
categorizations serve the purpose of protecting the anonymity of research participants. 
 
Right to withdraw and ownership: Participants were informed of their right to 
withdraw from the study at any time and informed that upon this request their interview 
data would be destroyed. They were informed of their right to request a full transcript 
of the interview following transcription and their right to retract any part of it prior to the 
data being used. Several participants did request and were sent a full transcript of 
their interview. No information was retracted and to date, no participants have 
withdrawn from the study. There were two incidences where during the interview, the 
respondent requested that the recorder was switched off and that their disclosures 
about a specific topic were not included in the study. Their wishes have been 
respected and those parts of the interviews were not included in the present study. 
However, the extent to which any comment is really ever completely off-the-record is 
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debatable. It undoubtedly contributes towards the researcher¶s understandings and 
evaluation of events discussed and also could influence the ways in which similar data 
are interpreted and understood.  
 
Limitations and implications of research design 
 
A general pitfall when dealing with media data is the issue that it is impossible to know 
who is reading or accessing media information. Because a message has been printed 
or published in newspapers or on the Internet does not necessarily mean it has been 
widely disseminated in society as a whole. Some forms of media analysis take a more 
quantitative approach than the one used this in study. Quantitative media analysis is 
based upon assumptions of a passive audience; therefore the study of the frequency 
and pattern of messages is equated to the audienFH¶VSHUFHSWLRQV$OWKHLGH
Although this research does take the frequency and pattern of media coverage into 
account, this information was used as part of the sampling frame (Kroll-Smith, 2003). 
A more in-depth analysis of the material was also conducted to take account of the 
DXGLHQFHDVµDFWLYH¶DQGDEOHWRLQWHUSUHWPHVVDJHVZLWKLQGLIIHUHQWIUDPHZRUNV2I
interest in this study were the messages, behavioural directives and bodily narratives 
that were being made available in the media rather than how this information was 
received or understood by an audience. 
 
As with all qualitative studies, issues of validity and reliability arise when conducting a 
media analysis in the way outlined above. Relevant questions here include the extent 
to which the data collected are representative, whether other unreported data sources 
might contradict the findings and the extent to which the findings reflect the interests of 
the researcher. Although all qualitative research essentially involves a high degree of 
flexibility and choice in the direction of analysis on the part of the researcher, attempts 
were made in the present study to go some way towards addressing these issues.  A 
stringent sampling frame was devised and a quantitative element to the study 
incorporated to aid in the selection and filtering of relevant data sources. Additionally, 
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the coding frames used were developed independently and tested through 
discussions between three researchers to identify potential areas of ambiguity, errors 
and inconsistency. However, it is acknowledged that despite the analysis being 
empirically grounded and systematic, the conclusions derived from this type of study 
of a small corpus of media reports will certainly not be incontrovertible scientific truths; 
alternative accounts and readings of this body of data are possible. 
 
The main implications of the sampling strategies adopted to recruit people to take part 
in interviews and the focus on qualitative methods of data collection and analysis are 
that the interview populations are not large or representative. Therefore, it would be 
inappropriate to make statistical generalisations from the data. Instead, the study aims 
to investigate competing narratives that are present, understand a range of concerns, 
compare groups, illuminate general patterns and processes and to identify key 
elements of social contexts that are linked to particular responses to the uses of 
cognition enhancing drugs. Adopting the analytical approach taken does involve 
researcher bias regarding what themes to focus on and to interpret how they relate to 
one another so it cannot claim to be objective. However, the knowledge of the 
processes by which people understood, positioned and negotiated the use of modafinil 
will, in a sense, be broadly generalisable to other similar cases (Morse, 1999). 
 
In an attempt to demonstrate reliability and validity of the analysis, data extracts are 
included in the reporting of findings enabling the reader to determine that the claims 
being made are present in the data. Care has been taken in the research report to 
present data that are representative of the data collected as a whole rather than a 
reliance on extreme cases which could be used to back up preconceived ideas 
(Silverman, 2000; Charmaz, 2003).  
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Summary 
 
The in-depth analysis of the language used to describe and the conceptual metaphors 
employed to articulate the multiple uses of modafinil revealed three central 
metaphorical frames that were each built up around a central metaphorical concept 
framing the use of modafinil within a culturally available narrative. This analysis 
provided an understanding of how a single medical technology can be understood in 
different ways and through the use of different metaphors and their entailments and 
the normative impacts this might have. This type of analysis can be useful for the in-
depth qualitative analysis of small samples of textual data. The value of this approach 
lies in the rich and detailed descriptions of phenomena it can uncover. In analysing the 
conceptual structure underpinning discourse surrounding a phenomenon it is possible 
to map a societal conversation about one aspect of science. One can go some way to 
providing an explanation as to why the phenomenon in question may be understood 
differently in different domains of social life and how this has come about. Results of 
the media analysis are presented and discussed further in Chapter 4. 
 
Interviews were conducted with forty individuals belonging to three stakeholder 
groups: scientists and clinicians, shift workers and students. The semi-structured 
interview was chosen as a research tool because it enabled focus to centre on specific 
topics of interest that had already been identified while maintaining a degree of 
flexibility and allowing for an interactive flow of information between interviewer and 
interviewee (Green et al, 2002; Hannock, 2002). The sampling strategies used to 
select and recruit individuals to take part in the study varied between each stakeholder 
group. Where scientists and clinicians were purposefully targeted due to their 
expertise in a particular area, students were contacted at random to take part in the 
study. For shift workers, the sampling strategy was again different due to access 
difficulties. Therefore, a virtual space was artificially created specifically for recruiting 
these individuals to take part in the study. It has been argued that using the Internet as 
a tool enables the researcher to reach people and groups of people who would have 
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otherwise been difficult or impossible to reach (Flick, 2009). In the case of this 
research it was particularly useful in enabling access to a hard to reach group without 
a collective identity. Interview data is presented in Chapters 5-7.
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Chapter 4: Modafinil in the media: metaphors, medicalisation & 
human enhancement 
 
Introduction 
 
This chapter focuses on newspaper articles to explore discourses surrounding the 
new sleep drug, modafinil. The mass media have been shown to provide a central 
forum for debates regarding issues relating to science, society, lifestyle, and most 
importantly, health and illness (Nerlich et al, 2003). It is mainly through the mass 
media that the general public becomes aware of scientific advances, new therapies- 
especially in the UK where direct-to-consumer advertising is not permitted (Williams et 
al., 2008a )- and the social and ethical issues regarding their use and availability. 
Because the mass media operate at this interface between science and society, 
reporting on scientific advances and technological developments in specific ways, they 
are likely to play an important role in shaping public perceptions of new technologies 
and their value and applications (Nelkin, 2001; Nisbet, 2007; Nisbet et al., 2002). 
 
Previous work has examined the social construction of modafinil in the British print 
media using a thematic and interpretative analysis to reveal how modafinil is 
constructed in terms of its various µuses and abuses¶ (Williams et al., 2008a). In 
applying metaphor analysis combined with frame analysis to this area, this chapter 
aims to go beyond previous research to empirically investigate the discursive 
FRQVWUXFWLRQRIWKHVHµXVHVDQGDEXVHV¶LQWKHPHGLD 
 
Metaphors used in the communication of scientific and technical information can 
connect public, scientific and policy discourses, facilitate understandings and acting to 
FUHDWHFRPPRQJURXQGIRUWUDQVSRUWLQJPHDQLQJDFURVVWKHµERXQGDU\¶RIVFLHQFHDQG
society (Nerlich, Hamilton & Rowe 2002; Massen & Weingart, 2000). According to 
Nerlich et al. (2002), metaphors can act to directly shape public policy by tapping into 
cultural imagination and through the reinforcement of cultural stereotypes (discussed 
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more fully in Chapter 3). The analysis presented in this chapter focuses on the 
metaphorical frames used in media discourses and the conceptual links they create 
between sleep and health, and the body and technology. 
 
Sleep is a corporeal state, a lived and embodied experience (Meadows, 2005). An 
analysis of modafinil, a technology that can be used to correct, alter or interfere with 
the functioning of the body must also consider cultural representations and 
conceptualisations of the body it is being taken into. In their analysis of newspaper 
coverage of modafinil in the military, Williams et al (2008a) briefly discuss concerns 
raised in media discourse over how understandings of the body may be reconfigured 
through modafinil use. The following discussion pays more attention to this point, 
giving the framing of the body a greater role in the analysis and arguing that 
understanding the kind of bodies technology is working on or taken into plays an 
important role in elucidating how the technology in question is itself understood 
7KDFNHU,QWKLVFRQWH[WLWLVLPSRUWDQWWRXQGHUVWDQGZKDWW\SHRIµERGLHV¶DUH
implied by the various discourses around modafinil. 
 
Using metaphorical frame analysis as an analytical tool, this chapter explores under 
what circumstances modafinil is constructed as a necessary medical treatment or a 
(il)legitimate performance enhancement and, how in this process, various images of 
the body are (re)constructed. This will enable an assessment of the extent sleep is 
conceptualised in medical terms in different domains, the normative assumptions that 
are embedded in discourse on modafinil and to comment on the relationship between 
medicine, enhancement and cultural understandings of the body. Specific research 
questions addressed include: How are sleep, cognition and the body conceptualised in 
different social contexts? How are uses of modafinil discursively constructed in the 
British print media? What role is given to medical authority in deciding if particular 
uses are acceptable? To what extent do media discourses surrounding modafinil use 
JRµEH\RQGPHGLFDOLVDWLRQ¶"  What does this tell us more generally about cultural 
attitudes towards human enhancement?  
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Metaphors and frames 
 
As outlined in chapter 3, media reports on modafinil were categorised into four 
domains of discourse: patient, sports, occupational, and recreational. This section 
describes the three distinct metaphorical frames that were used to structure media 
discourse on modafinil and analyse how they enable the body, corporeal states and 
the use of drugs to be constructed in specific ways. It shows how metaphorical frames 
are built up around a central metaphorical concept that frames the use of modafinil 
within a culturally available narrative. Metaphorical frames are not based solely upon 
salient metaphors, but around particular and sometimes inconspicuous metaphoric 
expressions that enable discourse on pharmaceutical use to be articulated in a 
specific way. Each article contained some, but rarely all components of one or more 
metaphorical frames. The analytical approach used, however, is based upon an 
analysis of how the metaphorical frames are built up and used to structure discourse 
across the media sample as a whole rather than in individual articles (refer to Chapter 
3 for more detail on the analytical process). In the next section, how the metaphorical 
frames were differentially employed in each of the four sleep discourses will be 
analysed.  
 
War frames: fighting sleep 
 
The war frame was based around the use of military metaphors that constructed the 
µERG\DVDEDWWOHJURXQG¶LQZKLFKPRGDILQLOZDVODXQFKHGWRµFRPEDW¶µDWWDFNV¶RIVOHHp. 
An analysis of the components of the war frame revealed that four concepts of war 
were drawn upon by the media: that of an enemy or injustice; the strategic war plan 
and events of the battle; personification of victims and heroes; and purpose or 
desirabOHRXWFRPH6OHHSZDVGHVFULEHGDVDµNLOOHU¶DGDQJHURXVµHQHP\¶WKDWFRXOG
µDWWDFN¶RUµVWULNH¶DWDQ\WLPH3HRSOHZLWKVOHHSSUREOHPVZHUHSRUWUD\HGDVWKH
µYLFWLPV¶RIWKLVPHWDSKRULFDOZDUOLYLQJWKURXJKDFRQVWDQWµEDWWOH¶VWUXJJOLQJWRµILJKW¶
ofIµVOHHSDWWDFNV¶0RGDILQLOZDVIUDPHGLQKHURLFWHUPVEHLQJFRQVWUXFWHGDV
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VRPHWKLQJWKDWFRXOGEHµODXQFKHG¶WRERWKµFRPEDW¶VOHHSDQGDOVRDVDW\SHRI
DUPRXUWKDWFRXOGSUHYHQWIXUWKHUµDWWDFNV¶7KURXJKWKLVIUDPLQJWKHVWRU\HQGVZLWK
modafinil giving those with sleep problems control back over their body, in a sense to 
win the battle and achieve victory over their illness. 
 
Military metaphors used in this way allowed excessive sleepiness to be framed as 
dangerous, and in the majority of cases, modafinil was constructed as a safe and 
effective treatment for this condition. By enabling individuals to stay awake during the 
day and sleep at night, pharmaceutical use was represented as restoring normal sleep 
patterns and thus providing the means through which one could lead a normal life. 
War frames are popular in many discourses on health and disease. They provide a 
VWURQJIRFXVDQGDPRUDOLPSHUDWLYHWRXVHWKHPHDQVDYDLODEOHWRµKHOS¶WKH
individuals in question. The war frame allowed for medical and non-medical uses of 
PRGDILQLOWREHGHPDUFDWHGWKURXJKWKHFRQFHSWRIµDEQRUPDOLW\LQIXQFWLRQLQJ¶,Q
discourse structured through this frame, the diseased, injured or abnormal body was 
WUDQVIRUPHGYLDWKHDFWRIWDNLQJPRGDILQLOLQWRDµQRUPDO¶ERG\0odafinil use was 
constructed as a positive action to restore impaired bodily functions, whether they 
arose as result of biological lesions or social factors. In both cases, medicine was 
given authority over the sleep± wake cycle. 
 
When modafinil was perceiYHGWREHHQWHULQJDµQRUPDO¶ERG\LQZKLFKWKHUHZDVQR
battle to be fought (i.e. in individuals without sleep problems), its usage was framed as 
DW\SHRIµHQKDQFHPHQW¶IDOOLQJRXWVLGHWKHUHPLWRIPHGLFLQH,QVXFKLQVWDQFHVZDU
frames were used to argXHDJDLQVWWKHXVHRISKDUPDFHXWLFDOVWRµILJKW¶VOHHSLQHVV
Individuals taking modafinil outside of medical authority became the villains of the 
SLHFHDEXVLQJWKLVPHGLFLQHIRUµOLIHVW\OH¶SXUSRVHV&RQFHUQHGµVFLHQWLVWV¶WKHQHZ
heroes, were used to voice fears of the dangers posed by unmonitored or uncontrolled 
use of this medical technology that might find its way into the wrong hands and the 
µZURQJ¶ERGLHV 
 
121 
 
The data extract presented below provides an example of how the war frame was 
typically used in media reports. In a story detailing the daily life of an individual with 
narcolepsy the journalist writes:  
 
µ7KRVHZKRVXIIHUIURPQDUFROHSV\DUHGRRPHGWRORVHWKHILJKWWRNHHSWKHLU
eyes open, and the battle is lost more rapidly if they are already WLUHGRUERUHG¶
(The Times, 8th September 2003) 
 
Here the use of war metaphors conveys a sense of how serious sleepiness is, and 
how hopeless the fight to stay awake for those with narcolepsy can be. The way a 
problem is framed often includes what range of solutions is seen as possible (Conrad, 
2001). In this case, war metaphors were typically used to frame sleep in such a way 
as to make pharmaceutical intervention seem a desirable and necessary solution to 
the problem of sleepiness. Using modafinil was depicted as a way to win the µbattle¶ 
against sleepiness, thus, enabling the user to µseize WKHGD\WLPH¶The Times, 27th July 
2004). 
 
Commodity frames: trading sleep 
 
The commodity frame was built up around mechanical and economic metaphors to 
include seveUDODVSHFWVRIDµFRPPRGLW\¶WKDWLWKDVDSK\VLFDOSUHVHQFHFDQEH
renewed, replenished, diminished or depleted; and has an extrinsic value, so may be 
bought or sold. Within this frame the body was constructed as a machine, a set of 
parts, workings and systems. As illustrated in the data extract below, sleep was often 
IUDPHGDVDµIXHOVRXUFH¶UHTXLUHGIRUµSRZHULQJ¶RQHVPHWDSKRULFDOHQJLQHV
,QGLYLGXDOVZHUHGHVFULEHGDVQHHGLQJWRµILOOXS¶WKHLUERGLHVZLWKHQRXJKVOHHSLQ
RUGHUIRUWKHPWRUHPDLQµSURGXFWLYH¶DQGµHIILFLHQW¶DQGµIXQFWLRQ¶QRUPDOO\+RZHYHU
µILOOLQJXSZLWKVOHHS¶ZDVRIWHQIUDPHGDVWLPHFRQVXPLQJRUµDZDVWHRIWLPH¶DQG
WKHUHIRUHDµOX[XU\¶WKDWPDQ\SHRSOHFRXOGQRWµDIIRUG¶OHDYLQJWKHPµUXQQLQJRQ
HPSW\¶ 
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"We want to treat [sleep] like fuel - how much do people have, how long will it 
last them, and when do we need to fill them up again" (Greg Belenky of The 
Walter Reed Army Institute of Research quoted in The Guardian, 29th July 
2004, p.4) 
 
Modafinil enters the story, again LQDKHURLFIRUPDZD\WRµNHHSJRLQJ¶µD
SKDUPDFHXWLFDOPLUDFOH¶WKDWFRXOGµFKDQJHPRGHUQOLIH¶RUPRUHPRGHVWO\KHOSXV
VOHHSµPRUHHIILFLHQWO\¶ZKHQWLPHLVDWDSUHPLXP7DNLQJPRGDILQLOZDVWKHUHIRUH
constructed as an alternative to sleep, allowiQJSHRSOHWRµUHPDLQIXQFWLRQDO¶ERWK
SK\VLFDOO\DQGPHQWDOO\7KHGUXJZDVGHSLFWHGDVEHLQJDEOHWRµNHHSWKHXVHUDZDNH¶
RUµNHHSWKHPJRLQJ¶µUHGXFHWLUHGQHVV¶E\µWXUQLQJRII¶RUµFXWWLQJRXW¶DSHUVRQ¶VQHHG
to sleep; an alternative method of providLQJµSRZHU¶E\DOORZLQJVOHHSWREHµWUDGHG¶IRU
more time, and enabling individuals to adjust to the demands of a living in a 24/7 
culture. Visions of a future world were imagined by journalists constructing modafinil 
as a chemical replacement for sleep, a way in which sleep could be traded for more 
time awake: 
 
³0RGDILQLOEHORQJVWRDQHZFODVVRIDZDNHQLQJGUXJVNQRZQDVHXJHURLFV
which are unravelling the mechanisms of sleepiness. Once you've done that 
you will end up in a world where the need to sleep is optional. I would say that 
will happen within the next quarter of a century." (The Sunday Telegraph, 4th 
January 2004) 
 
The SLEEP IS FUEL conceptual metaphor links to wider commodification narratives 
relating more generally to sleep and wakefulness. Situating stories about modafinil 
within a commodity framework links the novel and unfamiliar to pre-existing narratives 
UHJXODUO\IRXQGLQWKHPHGLDZKLFKSUHVHQWµVOHHS¶RUDµJRRGQLJKW¶VVOHHS¶DVD
consumer good (Williams, 2005; Williams & Boden, 2004). A plethora of different 
SURGXFWVVHOOLQJµVOHHS¶DUHFXUUHQWO\DYDLODEOHUDQJLQJIURPEHGVDQGSLOORZVWRKHUEDO
remedies and pharmaceutical products. Alternatively, products and strategies for 
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maximizing alertness and energy are also widely available. According to Williams 
µLQWKHVRFLHW\FDSLWDOLVPFDVKHVLQDVERWKDGLVUXSWRUDQGD
JXDUDQWRURIVOHHS¶ 
  
In discourse structured through a commodity framework, modafinil is constructed as a 
tool rather than a therapy, a way to technologically optimise the body/machine so it 
can function efficiently. The commodity frame was generally used to argue for 
pharmaceutical intervention in the sleep±wake cycle, constructing modafinil as an 
acceptable solution to social problems that have been translated into sleep-related 
matters (Williams, 2005). 
 
Commodity frames were mostly located within discourses of modafinil use in 
occupational and recreational contexts and often used in conjunction with competition 
frames (Fig. 2). The use of commodity frames provided an alternative way to articulate 
moral arguments for taking modafinil without necessarily having to demarcate the 
medical and non-medical uses of the drug. Through commodity frames wider societal 
FRQFHUQVDERXWWKHGDQJHUVRIµQRUPDO¶VOHHSLQHss are brought into the discussion, 
allowing moral arguments for individual performance augmentation to be made on the 
grounds of both individual and public safety. 
 
Competition frames: beating sleepiness 
 
The competition metaphorical frame was found across all four discourses and 
competition metaphors were the most abundant in the corpus by far. The competition 
metaphorical frame was configured from several components of the competition 
source domain, including that of: competitors; rules of the game; speed and distance; 
and that of a prize or goal. The competition frame was based around a metaphorical 
competition taking place between an individual and their body/bodily functions. Within 
WKLVIUDPHWKHERG\ZDVYLHZHGDVPDOOHDEOHRUµSODVWLF¶DQGWKHUHIRUH open to 
biomedical augmentation, enhancement, improvement and design. Modafinil was 
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FRQVWUXFWHGDVDZD\WRµEHDW¶VOHHSDQHQKDQFHPHQWWRROUDWKHUWKDQDWKHUDSHXWLF
WKDWRQHFRXOGXVHWRµHOLPLQDWHWKHQHHG¶IRUVOHHSDOWRJHWKHU 
 
³6OHHSGUXJEHDWV06)DWLJXH´BBC News, 20th January 2002) 
 
Through the use of competition frames modafinil was often located within a 
µVXSHUKHUR¶VWRU\OLQH,QWKLVZHOO-known narrative, taking a drug (or other substance) 
transforms the individual in some way thus enabling performance beyond the norm. In 
this vein, the use of the technology was depicted as enabling an individual to 
µHQKDQFH¶µLQFUHDVH¶µLPSURYH¶µERRVW¶RUµEHWWHU¶WKHLUSHUIRUPDQFHDQGFDSDELOLWLHV
RXWVLGHRIDµQRUPDO¶UDQJHWKHOLWHUDORXWFRPHVRIZLnning a metaphorical competition 
against the need to sleep. 
 
Competition frames were used with almost equal prevalence to argue both for and 
against pharmaceutical intervention in the sleep±wake cycle, and were found across 
all four discourses (Fig. 2). The competition frame was often situated within articles 
discussing literal competitions where individuals would be depicted as not only 
competing internally against sleep, but also engaged in actual competitions on the 
sports field, in the workplace or during exams. This rhetorical strategy allowed 
parallels to be drawn between the two situations and similar moral judgements to be 
PDGH8VLQJDGUXJWRµEHDWVOHHS¶ZDVRIWHQHTXDWHGWRFKHDWLQJLQWKHOLWHUDO
competition through the provision of an unnatural advantage that was condemned as 
illegal or unfair.  
 
Where a link to literal competition was more tenuous, metaphoric and other linguistic 
expressions were often used to compare modafinil to drugs such as caffeine, a 
substance already in widespread usage DURXQGWKHZRUOGWRµEHDWVOHHSLQHVV¶7KLV
rhetorical strategy sought to justify the use of modafinil in society through a context in 
which such a goal is conceptualised as a normal or everyday occurrence. The 
competition frame enabled strong social values relating to competition and fairness to 
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be articulated. The debate was focused at the level of the individual, with arguments 
based around freedom and autonomy and to what extent one should be allowed to 
FKRRVHZKDWRQHGRHVWRRQH¶VRZQERG\:KHQH[SUHssed through this frame, the 
outcomes of taking modafinil were constructed as either individual improvement or 
individual detriment. 
 
Overall, the three metaphorical frames were used to different extents across the four 
discourses in which modafinil use was discussed in the media (Fig. 2). Uncovering the 
underlying structure of media discourses through metaphoric frame analysis enables a 
deeper understanding of how different arguments are expressed and linked to specific 
sets of cultural values with distinct moral implications. War metaphors were related to 
µKHDOLQJ¶FRPPRGLW\PHWDSKRUVWRµHIILFLHQF\¶DQGOLQNHGWRGLVFRXUVHVRIµSXEOLF
VDIHW\¶ZKHUHDVFRPSHWLWLRQPHWDSKRUVZHUHUHODWHGWRµLQGLYLGXDOLPSURYHPHQW¶ 
 
Figure 2: Prevalence of metaphorical frames in each discourse 
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Figure 3:  Evaluative orientation of each discourse 
Metaphorical framing of sleep discourses 
 
This section moves on to assess how the three central metaphorical frames were 
used to structure four types of discourses about the (il)legitimate use of modafinil in 
four domains of social life: the use by patients, for recreation, in the context of work 
and in sport. These discourses broadly relate to and overlap with the four key themes 
RIµPHGLFDOFRQGLWLRQV¶µOLIHVW\OHFKRLFHV¶µPLOLWDU\RSHUDWLRQV¶DQGµVSRUWLQJ
FRPSHWLWLRQ¶WKDWKDYHSUHYLRXVO\EHHQLGHQWLILHGDVRILPSRUWDQFH:LOOLDPVet al., 
2008a). This analysis, by contrast, focuses on how the particular use of frames affects 
the boundary between medical and non-medical constructions of pharmaceutical 
intervention in the sleep±wake cycle in these four contexts. The complex relationship 
between medicine and enhancement is discussed through consideration of the 
functions of the rhetoric of medical authority in the media discourse, the type of bodies 
being (re)constructed and the normative assumptions embedded therein. 
 
Patient discourses: abnormal bodies 
 
Patient discourses were predominantly structured through the war metaphorical frame 
(Fig. 2) and were overwhelmingly in favour of pharmaceutical intervention in the 
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sleep±wake cycle (Fig. 3DVDPHWKRGRIPDLQWDLQLQJRUUHVWRULQJDµQRUPDO¶ERG\
through the tools of medicine. The organisation of discourse around the concept of 
normality has the effect of not only describing how things are, but also inferring how 
they ought WREH+DFNLQJ3DWLHQWERGLHVZHUHGHVLJQDWHGDVµDEQRUPDO¶DQGLQ
need of correction or normalisation (see: Fraser & Greco, 2005: 17) with 
pharmaceutical use constructed as a legitimate medical intervention in all instances. 
By giving the individual control back over their sleep±wake cycle, modafinil was 
framed as a chemical solution to restore the body to a normal level of functioning and 
allow tKHLQGLYLGXDOWREHDEOHWROHDGDPRUHµQRUPDO¶OLIH7KLVrhetoric is evident in 
the data extract below which we are told comes from thirty-year old Henry Nicholls, a 
London-based science writer who is talking about his experiences of taking modafinil 
to treat narcolepsy: 
 
µ%HIRUH,XVHGWRZRUU\WKDW,
GQHYHUEHDEOHWRKROGGRZQDQRUPDOMRE
because when the sleepiness took over there really was nothing I could do. 
Now I am able to function like anyone else. I take a 100mg dose in the morning 
and in the evening I go to sleep like anyone else. Conversely, if I forget to take 
it, the symptoms come back almost immediately." (The Sunday Telegraph, 4th 
January 2004) 
 
The metaphorical war frame was used to justify pharmaceutical intervention at both 
the individual and societal level, with the rare sleep disorder narcolepsy often the main 
point of reference through which moral reasoning about pharmaceutical intervention in 
the sleep±wake cycle was articulated. Interviews with narcoleptics frequently 
appeared in this discourse adding a human-interest dimension to the disorder and its 
WUHDWPHQW1DUFROHSV\ZDVGHVFULEHGDVµDGLVDEOLQJFRQGLWLRQZKLFKLQWHUUXSWV
VWXGLHVPDNHVZRUNLPSRVVLEOHDQGGHVWUR\VUHODWLRQVKLSV¶The Independent, 4th 
March 1998). The treatment of narcolepsy with modafinil was constructed as a 
positive action, enabling the narcoleptic to overcome their disability and restoring the 
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individual to a regular pattern of wakefulness during the day and sleep at night, as 
illustrated in the data extract above and in the following example: 
 
 µµ,DPILJKWLQJDFRQVWDQWEDWWOHWRVWD\DZDNH,NQRZZKHQ,JHWWLUHGVR,WDNH
DWDEOHWDWWKRVHWLPHVWRSUHYHQWWKDWWLUHGQHVV¶¶The Daily Telegraph, 1st 
October 2002). 
 
This resonates with a substantial body of social research into the use of metaphors in 
discourses relating to many different areas of medicine and disease (Riesfield & 
Wilson, 2004). Research in this area claims that metaphors can have a powerful 
influence on the practice of medicine and the experience of illness. The war metaphor 
is often prevalent in such discourses. According to Riesfield and Wilson (2004: 4025) 
µZDUKDVDQH[FHSWLRQDOO\VWURQJIRFXVLQJTXDOLW\DQGLWVLPDJHVRISRZHUDQG
aggression serve as strong counterpoints to the powerlessness and passivity often 
DVVRFLDWHGZLWKVHULRXVLOOQHVV¶ 
 
This type of framing was also observed at a societal level. Wake-promoting drugs 
were often represented as protecting society from the dangers posed by the problem 
of excessively sleepy iQGLYLGXDOVZKLFKPLJKWGLVUXSWRWKHUSHRSOH¶VµQRUPDO¶OLIH2QH
headline in The Independent alerted readers to this problem by announcing that 
SHRSOHZLWKQDUFROHSV\FDQµIDOODVOHHSDWDQ\WLPH- HYHQDWWKHZKHHORIDFDU¶th 
September 2000) and attaFNVRIRYHUZKHOPLQJVOHHSLQHVVZHUHEODPHGIRUµFDXVLQJ
GHDWKRQWKHURDGV¶The Times, 5th March 1998). According to advice offered by The 
7LPHV¶VUHVLGHQWPHGLFDOGRFWRU('6LVDµGDQJHURXVFRQGLWLRQDQGDQ\RQHZLWK
excessive daytime sleepiness should sHHWKHLUGRFWRU¶The Times2, 26th January 
2004).  
 
Here a direct normative stance emerges: people who have sleep problems should see 
their doctor and ought to take medication to regain normal functioning of their body so 
as to not endanger themselves or others. Therefore, in patient discourse, medical 
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authority was strongly linked to behavioural directives articulating a strong normative 
SRVLWLRQµQRUPDO¶ERGLHVDUHGHVLUDEOHDQGFDQEHSURGXFHGWKURXJKPHGLFLQH7KHUH
were very few exceptions to this overwhelmingly positive representation in the corpus 
where the benefits of taking modafinil were questioned.  One example comes from  a 
2004 article titled µ,QVHDUFKRIWKHPLUDFOHSLOO¶The Sunday Times, 14th November 
2004) in which the journalist questions the efficacy of drugs taken for treatment 
purposes, VXJJHVWLQJWKDWWKHHIIHFWRIPRGDILQLORQWKRVHZLWKVOHHSGLVRUGHUVµ«PD\
QRWEHDVPDUNHGDVWKHSDWLHQWH[SHFWV¶ 
 
Sports discourses: natural vs. unnatural bodies 
 
Sport discourses were dominated by metaphors of competition (Fig. 2) which were 
used to frame arguments against modafinil use and articulate concerns about fairness 
and legality. In direct opposition to patient discourse these were almost exclusively 
negatively orientated (Fig. 3). In the context of sport, medical language was not used 
to describe modafinil use by athletes with modafinil clearly differentiated as an 
enhancement technology. The use of modafinil by sportspersons was framed as 
deviant behaviour, whereby the power and tools of the medical profession were being 
used outside of medical authority by individuals to enable them to overcome their 
QDWXUDOOLPLWDWLRQVDQGJDLQDQµXQIDLUDGYDQWDJH¶RYHURWKHUV0odafinil was described 
as stimulant drug that can boost performance and was often grouped with other drugs 
that have been reportedly used as performance enhancers in sport such as steroids 
and Human Growth Hormone.  
 
³>7KHVSULQWHUV¶@VXSUHPHSHrformances in the 100 metres and 200 metres are 
utterly devalued by a positive test foU0RGDILQLO´The Times, 3rd September 
2003) 
 
As illustrated above, the sport discourse was characterised by strong moral 
judgements about modafinil use in this context. Taking modafinil in sport was 
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UHSUHVHQWHGDVµFKHDWLQJ¶DVGHYDOXLQJWKHDWKOHWHV¶Serformance and as ruining their 
reputation. Competition frames constructed the act of taking modafinil in a sporting 
context as inducing an abnormal bodily state of prolonged wakefulness. Here the 
QDWXUDOERG\ZDVYDORULVHGZLWKµQDWXUDOQHVV¶HTXDWHGWRFXltural conceptions of the 
normal, typical and regular (Fraser & Greco, 2005). It was argued that athletes should 
EHµFOHDQ¶µQDWXUDO¶DQGWUDLQKDUGDVWKLVLVWKHRQO\µIDLU¶DQGOHJLWLPDWHZD\WR
compete and to win. An example illustrating several elements of the competition frame 
and its normative implications can be found in the following data extract, in which an 
2O\PSLFDWKOHWHFRQGHPQVDIHOORZDWKOHWH¶VXVHRIPRGDILQLOWKLVDWKOHWHODWHU
admitted taking modafinil and other banned substances as performance enhancers 
and testified before the Committee on Oversight and Government Reform): 
 
µ3HRSOHPLJKWZRQGHUKRZVKHKDGWKHQHUYHWRJRLQIURQWRIWKHZRUOG¶VPHGLD
and offer an excuse like a sleeping disorder, but her nerve existed long before 
that. It went back to the first time she took drugs and lined up on the track, 
claiming to be clean and trying to win medals off people who have legitimately 
WUDLQHGKDUG¶The Daily Telegraph, 3rd June 2004) 
 
The framing of modafinil through the competition frame as a way of overriding normal 
sleep was associated with strong negative normative values and acted to exclude 
medical narratives to describe sleepiness in this context. Therefore medicine was not 
given (or not claiming to have) any cultural authority over the sleep±wake cycle in this 
domain. However, the use of modafinil by professional athletes could also be 
considered as an occupational use of the drug. In addition, susceptibility to circadian 
rhythm disorders would almost certainly apply to this group whose working conditions 
involve travelling and competing across different time zones. Despite this, in the sport 
GLVFRXUVHPRGDILQLOZDVSRUWUD\HGDVDµVOHHSGLVRUGHUGUXJ¶WKDWKDGIRXQGLOOLFLWXVH
in this context as an enhancement tool. This is interesting, given that the same drug is 
being taken to the same effect in each domain; the only difference being the context of 
use. Medicine was however still given rhetorical authority over the technology in 
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question by the media, despite the fact it has found uses beyond the limits of medical 
control. In the data extract below modafinil is described as a medication that when 
used out of its intended context, as a treatment for sleep disorders, becomes a 
performance enhancing drug. 
 
³7KH,$$)ZLOOORRNDWthe fact that she did not apply for exemption by declaring 
Modafinil on any list of medications taken before the race, and then at the 
information freely available that identifies it as a performance-enhancing 
banned drug." (The Times, 3rd September 2003) 
 
There were only two instances where commentators argued for the use of modafinil in 
VSRUW%RWKRIWKHVHDSSHDOHGWRWKHFRQFHSWRIµUXOHVRIWKHJDPH¶DQGFRQVLVWHGRI
quotations from professional athletes, both of whom tested positive for modafinil and 
GHIHQGHGWKHLUXVHRIWKHGUXJDUJXLQJWKDWLWZDVQRWLGHQWLILHGRQWKHµEDQQHG
VXEVWDQFHOLVW¶28DQGWKHUHZDVQRHYLGHQFHWKDWLWZRXOGKDYHDµSHUIRUPDQFH
HQKDQFLQJ¶HIIHFWLQVSRUW7KLVUKHWRULFDOVWUDWHJ\ZDVXVHGWRLPSO\WKDWWKHUHIRUHWKH
athletes in question had not done anything wrong or punishable29.  
 
µ,NQRZ,WKDW,GLGQRWKLQJZURQJDQGVRXJKWQRDGYDQWDJHRYHUP\
FRPSHWLWRUV«,DPFRQILGHQWWKDWWKLQJVZLOOZRUNRXWLQWKHHQG7KHPHUHIDFW
of this allegation is personally harmful and hurtful. I have never taken any 
substance to enhance my performance." (Professional athlete quoted in BBC 
News, 11th September 2003) 
 
The controversy and ensuing media debate in 2003 around several athletes testing 
positive for modafinil led to public condemnation of the drug in this domain. It was 
depicted as a way to gain an unfair advantage over one¶s competitors through the 
                                                          
28 0RGDILQLOZDVDGGHGWRWKHµEDQQHGVXEVWDQFHVOLVW¶ in 2004. 
29 Interestingly, one article in the corpus written in 2005 reports that caffeine has been put back on the 
EDQQHGOLVWLQ$XVWUDOLDDIWHUDOOHJHGO\EHHQXVHGDVDµSHUIRUPDQFHHQKDQFLQJ¶VXEVWDQFH7KH*XDUGLDQ
May 19th 2005 ) suggesting that the use of any substance that alters states of wakefulness and alertness is 
not acceptable in sport again illustrating the blurry lines between medicine, enhancement, performance and 
pleasure.  
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chemical enhancement of performance. Taking a drug to achieve this goal was 
damned even by those who tested positive for modafinil use, thus demonstrating the 
strong social and moral values (some expressed in terms of bodily cleanliness or 
purity) that are attached to competitive sport in the UK. Again, a relatively clear 
normative stance emerged: when there is no abnormality or impairment in functioning 
medical intervention ought not to take place as in these normal bodies this would not 
OHDGWRKHDOLQJWKHLQGLYLGXDODQGLQDGGLWLRQLWZRXOGOHDGWRµXQIDLUQHVV¶ZLWKUHJDUG
to others in society.  
 
Occupational discourses: the body as a trading place 
 
Through the combined use of commodity and competition frames, in occupational 
discourses the body was represented as a trading place in which modafinil provided 
an alternative to sleep, and sleep could be traded for time. Individual bodies could be 
WHFKQRORJLFDOO\RSWLPLVHGDQGDGMXVWHGWRµVWD\DOHUW¶RUµVWD\DZDNHORQJHU¶DQG
µIXQFWLRQPRUHHIILFLHQWO\¶LQWKHPRGHUQZRUNSODFHPDNLQJWKHPPRUHSURGXFWLYH 
 
³Studies in the US have found that helicopter pilots who had been kept awake 
for 40 hours functioned far better on Provigil, especially between the hours of 
DPDQGDPZKHQWLUHGQHVVUHDFKHVLWVSHDN´The Guardian,  July 
30, 2004) 
 
Within the occupational discourse there was a debate over the extent to which 
medicine has authority over the bodies of sleepy workers. Conflicting standpoints were 
evident: sleep problems resulting from working conditions were viewed as either a 
µQRUPDO¶SDUWRIZRUNLQJOLIHDQGPRGDILQLOWKHUHIRUHDVRFLDOLQWHUYHQWLRQRU
alternatively working condLWLRQVZHUHVHHQDVFDXVLQJVRPHGHJUHHRIµDEQRUPDO
IXQFWLRQLQJ¶PDNLQJLWSRVVLEOHWRMXVWLI\PRGDILQLODVDPHGLFDOWUHDWPHQW'HVSLWH
such inconsistencies, the way in which this discourse was framed through commodity 
and competition metaphors enabled justification for the drug to be sought through 
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alerting readers to the dangers posed by a tired workforce (to both the individual and 
social body), rather than through a normative association with normal bodies. 
 
³3URYLJLO did bring about a modest improvement in the night-shift workers' 
problems: they were more alert when working and their accident rate on the 
ZD\KRPHZDVVLJQLILFDQWO\UHGXFHG´The Times, August 15, 2005) 
 
Work-related sleepiness was often constructed as an abnormal physiological and 
psychological state and compared to the extreme sleepiness consequent of sleep 
disorders and resulting in similar impairment of functions. In this context modafinil 
was represented as an alternative to sleep, allowing individuals to adjust to 
disrupted patterns of sleep and wakefulness resulting from working conditions. 
 
³7KH86DUP\DHURPHGLFDOUHVHDUFKODELQ$ODEDPDKDVEHHQWHVWLQJWKHGUXJ
for possible use on helicopter pilots. They discovered that after 40 hours without 
sleep, 400mg of the new drug restored alertness to the patient's predeprivation 
OHYHOV´(The Sunday Times, July 9 2000)  
 
In the above quotation the journalist is describing tests carried out by the US military 
at a medical research facility. In this statement the helicopter pilots are referred to as 
µSDWLHQWV¶ZLWKSUHFLVHDPRXQWVRIWKHGUXJDEOHWRµUHVWRUH¶IXQFWLRQVWKH\KDYHORVW
through working conditions. The use of medical language such as referring to 
PRGDILQLODVDµSUHVFULSWLRQGUXJ¶DQGGUDZLQJUHIHUHQFHWRFOLQLFDOWULDOVRUscientific 
studies published in medical journals on pilots, troops and shift-workers contribute to 
the framing of the use of modafinil amongst these groups as a medical intervention. 
The two statements in this group with more negative connotations relating to 
pharmaceutical intervention in the sleep-wake cycle by members of the workforce both 
related to fears of spread of usage to other groups or the potential for research into 
wake-SURPRWLQJGUXJVWRH[WHQGWRµUHPRYLQJ¶WKHQHHGIRUVOHHSDOWRJHWKHU 
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Arguments in support of modafinil use in the workplace constituted three quarters of 
occupational discourse (Fig. 30DQ\RIWKHVHDUJXPHQWVZHUHVLWXDWHGZLWKLQµKRUURU
VWRULHV¶GHWDLOLQJWKHGHYDVWDWLQJFRQVHTXHQFHVH[FHVVLYHVOHHSLQHVVFRXOGKDYHLQ
the workplace. The backdrop to many of the articles in the corpus included 
GHVFULSWLRQVRIWKHGDQJHUVRIEHLQJWLUHGDWZRUNLQFOXGLQJµIULHQGO\ILUH¶LQZDU]RQHV
and major disasters such ship wrecks and train crashes that were attributed to a tired 
workforce. As illustrated below, modafinil was positioned within these arguments as a 
W\SHRIµVDYLRXU¶WKDWFRXOGEHXVHGQRWRQO\WRVXVWDLQWKHFDSDELOLW\RIWKHZRUNIRUFH
but keep people alive and prevent accidents:  
 
µµ&DOOHG0RGDILQLOLWKDVDOUHDG\EHHQLQvestigated by military organisations in 
France, the US, and Britain, where keeping weary soldiers alert can prolong 
WKHLUOLYHV¶¶The Independent, 10th July 1997) 
 
This rhetorical strategy brings wider social and environmental costs of a tired 
workforce into consideration, often on a global scale. Pharmaceutical intervention in 
the sleep-wake cycle is therefore constructed as the moral and socially desirable 
action to take to counter the effects of work-related sleepiness. The boundary between 
medical and social uses of modafinil was not clearly demarcated within work-related 
discourse. Although work-related tiredness was sometimes articulated within a 
medical framework as impairment or abnormal functioning, so eligible for medical 
treatment, it was also often described as a normal consequence of lifestyle choices 
with sleepiness a natural, but often unproductive or unnecessary occurrence. In these 
situations pharmaceutical wake-promoting drugs were equated with non-medical 
LQWHUYHQWLRQVWRµH[WHQG¶SHULRGV of wakefulness or overcome work-related tiredness 
which positions their usage closer to a form of enhancement.  
 
As illustrated in the data extract below, a second rhetorical strategy found in the 
occupational discourse to argue for the social use of modafinil was based upon 
normalising the idea of taking a performance enhancing substance at work:  
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µµ$PHULFDQXVHUVGHVFULEHLQHQWKXVLDVWLFWHUPVKRZWKHSLOOKDVHQDEOHGWKHP
to stay awake without the jitteriness and anxiety brought about by large 
amounts RIFDIIHLQH¶¶The Sunday Times, 4th July 2004). 
 
Modafinil was compared to other drugs used in the workplace (e.g. caffeine) with 
FODLPVPDGHWKDWPRGDILQLOµLVDOUHDG\EHLQJXVHG¶LQWKLVFRQWH[WDVDQµHQKDQFHPHQW¶
UDWKHUWKDQDVDµWKHUDS\¶,QFUHDVLQJ sales of the drug were attributed to shift workers 
WDNLQJPRGDILQLOµRII-OLFHQVH¶WRµUHPDLQIXQFWLRQDODIWHUDEXV\QLJKW¶The Times, 2nd 
July 2005). In a military context, modafinil was more clearly demarcated as an 
HQKDQFHPHQWWHFKQRORJ\ZLWKWKHµVROdier±PRGDILQLOFRPSOH[¶UHSUHVHQWHGDVD
µF\ERUJIXVLRQ¶+DUDZD\EOXUULQJWKHERXQGDULHVEHWZHHQERG\DQG
technology (see Williams et al., 2008a). Soldiers on modafinil were constructed as 
being able to adapt to their environment and perform with maximum efficiency. Here, 
FRPSHWLWLRQPHWDSKRUVZHUHXVHGWRIUDPHWKHGUXJDVDZD\RIJDLQLQJDµPLOLWDU\
DGYDQWDJH¶The Independent, 28th 6HSWHPEHUSURYLGLQJWURRSVZLWKDQµH[WUD
HGJH¶BBC News, 26th 2FWREHUDQGDOORZLQJWKHPWRµIHHOPRUHDOHUW¶DQG
IXQFWLRQµEHWWHU¶The Guardian, 30th July 2004) without needing to sleep. It was 
VXJJHVWHGWKDWPRGDILQLOZDVDµEHWWHU¶RSWLRQWKDQH[LVWLQJGUXJVVDLGWREHDOUHDG\
XVHGE\WKHPLOLWDU\VXFKDVDPSKHWDPLQHVDVLWZRUNVµORQJHU¶LVµPRUH HIIHFWLYH¶
DQGKDVµIHZHU¶VLGHHIIHFWV 
 
Around twenty-five percent of occupational discourse presented arguments against 
pharmaceutical intervention in the sleep±wake cycle (Fig. 3). These often drew upon 
potential detriments to health, including abuse and addiction, therefore demonstrating 
the moral judgements attached to taking drugs outside of medical authority in British 
culture. Opposition to modafinil use by the workforce was often justified at the level of 
individual safety and liberty, invoking fears of coercion and harms to individual health 
WKURXJKWKHXQFRQWUROOHGXVHRIWKHµWRROVRIPHGLFLQH¶ 
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,QRQHLQVWDQFHWKHFRPPRGLW\IUDPHZDVXVHGWRGHVFULEHVROGLHUV¶ERGLHVDVEHLQJ
µZLUHGDZDNH¶The Guardian, July 29th 2004) through modafinil, as if they were being 
coerced into prolonged wakefulness and forced to survive with little sleep. The word 
µFRQWURYHUVLDO¶ZDVXVHGWRGHVFULEHWKHPLOLWDU\XVHRIPRGDILQLORQIRXURFFDVLRQV
ZLWKWKH0R'UHSRUWHGO\µGHQ\LQJ¶PLOLWDU\XVHRIWKHGUXJWKXVKighlighting a degree 
of disagreement about the use of this drug in work-related circumstances. The voices 
of concerned doctors and scientists were used to criticise the non-medical use of 
modafinil, blaming overwork or stress for excessive sleepiness at work. Using 
PRGDILQLOWRSUHYHQWVOHHSLQHVVZDVYLHZHGDVDOORZLQJSHRSOHWRµZRUNKDUGHUDQG
SOD\KDUGHU¶GUDZLQJRQIHDUVRISRWHQWLDOGHWULPHQWVWRKHDOWKZLWKUHVWUDWKHUWKDQ
pharmaceutical intervention put forward as a solution. Within the competition frame 
many of the arguments against the use of modafinil in a work-related context related 
WRWKHµUXOHVRIWKHJDPH¶FRPSRQHQWRIWKHIUDPHUHVXOWLQJLQWKHQRUPDWLYHDUJXPHQWV
bearing great similarity to those evoked in the sport discourse. Furthermore, at a 
societal level questions were raised over the value of using drugs to improve 
performance. The costs of enhancement on a wider scale were evident here and 
included fears based on increasing competition in all areas of life and homogenising 
individuals into a norm influenced by current social and cultural standards. 
 
To summarise, despite a high prevalence of medical rhetoric, justifications for the 
legitimate use of modafinil in this social context were generally sought through 
appeals to individual and public safety where the technology was framed in terms of 
its ability to protect society (the social body) from harm and danger. Normative 
TXHVWLRQVHPHUJHGWKHQDURXQGPRGDILQLOXVHRQWKHERXQGDU\EHWZHHQµZRUN¶DQG
µOLIHVW\OH¶ 
 
Recreational discourseVWKHµSODVWLF¶ERG\ 
 
Recreational discourses were structured through both competition and commodity 
frames (Fig. 2). Whereas societal issues dominated normative reflections in 
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occupational discourses, the focus shifted to individuals and their lifestyle choices 
when modafinil use was discussed in a recreational context. Within this discourse the 
ERG\ZDVFRQFHSWXDOLVHGDVµSODVWLF¶LQWKHVHQVHWKDWLWFRXOGEHDOWHUHGFKDQJHG
moulded, and designed. It was constructed as a site for optimisation and 
improvement, a commodity through which one could construct oneself. This 
understanding of the body fits into a paradigm of consumer culture that is based on an 
ideology of our ability to create and transform, in which one can choose both who one 
wants to be and how one wants to be. In this context, arguments for and against 
pharmaceutical intervention in the sleep±wake cycle were given almost equal attention 
(Fig. 3). Within recreational discourses opposing viewpoints clashed over whether 
modafinil use should bHYLHZHGDVDZD\RIµWUDGLQJVOHHSIRUPRUHWLPH¶DQG
µLPSURYLQJRXUVHOYHV¶E\RYHUFRPLQJRXUHYROXWLRQDU\FRQVWUDLQWVRULQGXFLQJDQ
µXQQDWXUDO¶DQGµDEQRUPDO¶VWDWHWKDWFRXOGEHGHWULPHQWDOWRKHDOWKDQGOHDGWR
widespread psychological addiction and drug abuse. 
 
³$QREYLRXVWDUJHWZKHQWU\LQJWRFODZEDFNmore time is sleep, that big chunk 
of the stuff that squats apparently unproductively in the middle of every 24 
KRXUV´The Times, 2nd July 2004) 
 
A natural/unnatural dichotomy was often used to frame arguments against the 
recreational use of modafinil and raise concerns over potential harms to health that 
could result from using pharmaceuticals to achieve a state of prolonged wakefulness. 
One article in The Guardian (25th April 2006) used this dichotomy to criticise the whole 
idea of human enhancement, arguing that human enhancement is based upon the 
assumption that we are naturally inadequate. Other articles in the sample expressed 
IHDUVWKDWLWPD\EHGLIILFXOWWRµVWD\QDWXUDO¶The Guardian, 30th January 2006) if drugs 
such as modafinil become readily available due to improved performance and 
increased competition, and ethical questions were raised about the use of drugs to 
gain advantages over others (BBC News, 13th July 2005). 
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The majority of this discourse positioned the recreational use of modafinil as a social 
use of the drug. Pharmaceutical use was represented as away to reduce time spent 
VOHHSLQJDPHWKRGRISRWHQWLDOO\µHOLPLQDWLQJVOHHS¶DOWRJHWKHUDQGDWRROWRHQKDQFH
one¶s cognitive abiOLWLHV0RGDILQLOZDVWLSSHGDVWKHQH[WµZRQGHUGUXJ¶WRKLWWKH8.
ZLWKFODLPVPDGHWKDWLWFRXOGEHFRPHWKHµSKDUPDFHXWLFDOHTXLYDOHQWRIWKHHOHFWULF
OLJKWEXOE¶E\µH[WHQGLQJWKHZDNLQJGD\¶The Independent, 4th March 1998). However, 
and perhaps surprisingly, in around one third of recreational discourses, the use of 
PRGDILQLOIRUµVHOI-LPSURYHPHQW¶ZDVIUDPHGWKURXJKWKHUKHWRULFRIPHGLFLQH7KH
competition frame allowed for the legitimate limits of medical authority to be debated 
within the media and the tensions between medical and non-medical uses of 
technology to improve oneself to be expressed. An important aspect to this debate 
was the kind of bodies medical intervention was thought of as producing and whether 
this was a legitimate role for medicine to play in society. For example, one article in 
The Guardian DVNVµ:HLPSURYHRXUVHOYHVYLDFRVPHWLFVXUJHU\ZK\QRWDOVR
LPSURYHRXUEUDLQV"¶¶th January 2006).  
 
Such comparisons between modafinil (as a cognitive enhancer) with cosmetic surgery 
(a medicalised form of physical enhancement) were drawn to argue that medicine is 
already an institution through which we alter and enhance our normal bodies. Other 
arguments positioned such enhancement uses of modafinil outside of medical control 
referriQJWRWKHPDVµOLIHVW\OHDEXVHV¶RIµVOHHSGLVRUGHUGUXJV¶ 
 
³3URYLJLO is increasingly being used as a lifestyle drug by people who do not 
have sleep problems. Suggestions that it could also help boost weight loss and 
mood have made it even more popular. Clubbers are using it to keep partying 
through the night, while businessman are buying it to help them through long 
days in the office, and students are taking it to keep revising. Doctors have 
warned that the drug can be psychologically addictive and can induce 
KHDGDFKHVDQGQDXVHD´The Independent, April 18, 2006) 
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The framing of modafinil use in this way resulted in the normative debate within 
recreational discourse being positioned at the individual level, with questions emerging 
about whether we should be allowed to alter ourselves using this technology. Fears 
and concerns surrounding potential consequences of individual augmentation were 
however often aimed at the social body. Often visions of the future were imagined in 
which the availability of such neurotechnologies were depicted as having detrimental 
effects on society. )RUH[DPSOHLQDVWRU\WLWOHGµ3OHDVXUHSLOOVWRSHUNXVXSDQGERRVW
WKHEUDLQ¶UHSRUWLQJRQWKHSXEOLFDWLRQRIJRYHUQPHQWUHSRUW'UXJV)XWXUHV"WKH
journalist writes: 
 
 ³.the pharmaceutical industry might change its focus from drugs that treat 
mental health to cognitive enhancers, "mental cosmetics" and treatments for 
DGGLFWLRQ>DQG@PD\QRWPDNHQHZPHGLFLQHVIRUPHQWDOKHDOWKFRQGLWLRQV´The 
Daily Telegraph, July 14, 2005) 
 
With no impairment of functioning it appears more difficult to justify modafinil use 
without the moral imperative of restoring health. However, around one third of 
recreational discourses did construct modafinil use through the rhetoric of medicine. 
Interesting questions arise here regarding the role of medicine in self improvement 
and the conceptual relationship between medicine and enhancement. 
 
Summary and conclusions  
 
This chapter explored representations of the wake-promoting drug modafinil in a 
corpus of UK media reports. Media reports on modafinil were categorised into four 
domains of discourse: patient, sports, occupational, and recreational, broadly relating 
WRµNH\WKHPHV¶WKDWKDYHSUHYLRXVO\VKRZQWREHRILPSRUWDQFH:LOOLDPVet al, 
2008a). Each discourse was built up around the specific deployment of the 
PHWDSKRULFDOIUDPHVµZDU¶µFRPPRGLW\¶DQGµFRPSHWLWLRQ¶WKDWDFWHGWRFRQVWUXFWWKH
biological body in a particular way. How the body was framed in each discourse 
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impacted upon how modafinil use was portrayed in terms of therapy or enhancement 
and the level of engagement with a medical rhetoric. This had distinct normative 
implications strongly influencing the legitimacy afforded to modafinil use in each 
domain. 
 
Both the patient and sports discourses were organised around the valorisation of 
µQRUPDO¶RUµQDWXUDO¶ERGLHVLQZKLFKUHODWLYHO\FOHDUQRUPDWLYHGLUHFWLYHVHPHUJHG
abnormal bodies and bodily functions (attributed to both biological and social factors) 
should be fixed through medical technology, whereas this technology should not be 
XVHGLQµQRUPDO¶ERGLHVZKLFKGRQRWQHHGµKHDOLQJ¶7KLVOHIWURRPLQWKHPLGGOHIRU
debates regarding the legitimate role of medicine in society and the kind of bodies 
over which medicine is perceived to have authority.  
 
Work-related discourses were centrally concerned with notions of repair of lost 
functions or the prevention of harm- conceptually, an area medicine is increasingly 
moving towards with preventative medicine initiatives and health campaigns. 
Interestingly, in discussions of shift work, this was represented as not only a risk factor 
for other health problems, but one of the causal factors for a disorder in its own right, 
SWSD. At present only a small group of individuals with EDS are thought to have 
SWSD. Through this small study it is not possible to reach a definitive conclusion as to 
whether the media are promoting the medicalisation of work-related EDS through the 
expansion/extension of the disease boundaries for SWSD. 
 
Although there ZDVVRPHHYLGHQFHRIVXFKµGLVHDVHPRQJHULQJ¶:RORVKLQ	
Schwartz, 2006) in the occupational discourse, the majority of articles in this domain 
bypassed the medical/non-medical debate altogether. The potential consequences of 
abnormal functioning (excessive sleepiness and cognitive impairment) were framed in 
such a way that the normative positions emerging in the discourse did not rely on the 
concept of normality nor the distinction between medical and social uses of the drug. 
Instead justification was sought through appeals to wider non-medical narratives 
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relating to both individual and public safety. However, medical rhetoric was prevalent 
in more critical aspects of this discourse attending to potential negative consequences 
of using drugs outside of medical control. Despite the availability of a drug that can 
treat work-related sleepiness and associated cognitive impairments and the 
construction of a medical disorder (SWSD) to explain it (in its extreme form at least) a 
fully medicalised account was not presented in this domain.  
 
&XOWXUDOFRQFHSWLRQVRIµQRUPDOLW\¶ZHUHDOVRFHQWUDOLQWKHUHFUHDWLRQDOGLVFRXUVH
where debates were situated around the use of modafinil for enhancement or 
LPSURYHPHQWRIµQRUPDOERGLHV¶7KHIUDPHDQDO\VLVFRQGXFWHGUHYHDOHG that 
discourses concerning individual augmentation were often saturated with competition 
PHWDSKRUVIUDPLQJPRGDILQLODVDQLOOLFLWµSHUIRUPDQFHHQKDQFHPHQW¶,QWKHVHFDVHV
the rhetoric of medicine was often used to argue against the application of modafinil in 
these situations, framing its usage as outside of medical control and therefore 
unauthorised. In other instances individual augmentation via modafinil was 
constructed as a medicalised form of self-improvement. Questions were raised 
regarding whether modafinil should be used for enhancement purposes, and if this 
would be an abuse of medicine leading to the production of abnormal or unnatural 
bodies.  
 
$UJXDEO\PHGLDFRQVWUXFWLRQVRIPRGDILQLODVDPHGLFDOLVHGµHQKDQFHPHQW¶LQWKH
context of the commodification of medicine in a global healthcare market coupled with 
the rise of the patients-as-consumer, could shape the demand for medical treatments 
to alter states of alertness, thus contributing to the transformation of medicine into a 
µYHKLFOHIRUVHlf-LPSURYHPHQW¶&RQUDG+RZHYHULQVLWXDWLRQVZKHUHQR
impairment or threat to society was identified in the media data, there was a lack of 
PRUDOLPSHUDWLYHVWRMXVWLI\WKHHQKDQFHPHQWRIµQRUPDO¶ERGLHVWKURXJKPHGLFDO
intervention. Instead, medical rhetoric was coupled with the moral obligation to restore 
health and normality, suggesting culturally at least, the Parsonian sick role prevails 
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(Parsons, 1957). This could however be due to the production of media texts where 
stories tend to be bXLOWXSDURXQGWKHRSLQLRQVRIFHUWLILHGµH[SHUWLVH¶ 
 
Using a new method and data set this study confirms to an extent Williams et al. 
(2008bILQGLQJVWKDWDWWKHFRQFHSWXDOOHYHODWOHDVWµVOHHSLVLQGHHGDQRWKHUFKDSWHU
LQWKHPHGLFDOLVDWLRQVWRU\¶However, media coverage of modafinil is complex, with 
medicalised discourses deployed in some contexts more than others. The use of 
cognitive enhancers was contested in work-related contexts where new disorders are 
being defined and in academic contexts where cognitive enhancement drugs are 
purportedly being used for the improvement or extension of abilities to increase 
performance and productivity beyond the norm. In both of these contexts the 
technology was not framed in either exclusively medical or social terms, instead 
modafinil use straddled the boundary between therapy and enhancement, and 
normative reaction was also mixed. Discussions of modafinil for self-improvement 
revealed cultural anxieties about the future role of medicine in a culture of 
consumerism, and the kind of bodies medical technology should be used to alter. 
These findings were used to inform the second stage of empirical work which focuses 
on further exploration of these µboundary¶ cases (explored further in chapters 5-7).  
 
When thinkLQJDERXWµXVHVDQGDEXVHV¶RISKDUPDFHXWLFDOVLQWHUPVRIWKHUDS\DQG
HQKDQFHPHQWLWLVDFWXDOO\YHU\GLIILFXOWWRJRµEH\RQGPHGLFDOLVDWLRQ¶DV:LOOLDPV et al 
(2008aSURSRVHDVLVVXHVRIµSKDUPDFHXWLFDOLVDWLRQ¶DUHXQGRXEWHGO\ERXQGXSLQ
processes of medicalisation and their normative connotations. Through the analysis of 
media data it became apparent that there is a strong qualitative difference in the social 
and ethical issues raised in each domain of discourse. There are clearly different 
forms of enhancement, so how and where the technology was used became more 
LPSRUWDQWWKDQLWVµELRORJLFDOFRPSRVLWLRQ¶&RQUDG$WSUHVHQWLWDSSHDUV
difficult to justify using medical technology for enhancement without the moral 
imperative of restoring health. In the case of new medical technologies such as 
modafinil that are approved for the treatment of specific conditions but can be used as 
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enhancements for other capacities, medicalisation may in fact be a requirement in the 
legitimation of technological/pharmaceutical intervention whilst medical professionals 
DFWDVµJDWHNHHSHUV¶&RQUDGIRUWKHLUGHOLYHU\0HGLFDOQRUPVSOD\DUROHLQ
setting social norms through the labelling of the abnormal. As such, further 
medicalisation of sleep at the conceptual level may lead to the expansion of medical 
social control through the creation of new expectations for bodies, behaviour and 
health. This will be explored in greater depth in Chapter 5: the scientific and medical 
constructions of sleep, cognition and modafinil use. 
 
As this analysis shows, through consideration of the normative issues allied to medical 
authority, medical authority acts to legitimise enhancement for repair, restoration and 
relief of suffering, whilst being deployed to criticise enhancement in bodies already 
perceived as functioning normally. This therefore leads to the conclusion that 
FRQFHSWXDOO\WKHDFFHSWDELOLW\RIµHQKDQFHPHQW¶LVVWURQJO\WLHGWRFRQWH[WDQG
intricately related to medical social control.  
 
The era in which we can pharmaceutically manipulate sleep and alertness it seems is 
upon us. Pharmaceutical companies are reportedly working on new technologies to 
alter sleep thus creating further medicalised solutions to augment individuals to 
perform in line with cultural expectations and ideals rather than prompting a change in 
the way we live our modern lives and the social conditions that have contributed 
towards the conceptualisation of sleepiness as a problem in the first place. However, if 
the chemical enhancement of normal bodies continues to be normatively constrained, 
a world in which one is free to technologically alter their cognitive functioning and need 
to sleep will remain a cultural biofantasy. 
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Chapter 5:  Scientific constructions of sleep, modafinil and human 
enhancement 
 
Introduction 
 
As discussed in Chapter 2, expert constructions of sleep, cognition and society are 
important to uncover because scientific medicine defines states of normality, health 
and illness and issues guidelines, advice and recommendations on how people should 
live their lives (Armstrong, 1995). As the medico-scientific gaze penetrates deeper into 
the mind, conceptualisations of normality, pathology, health and illness are subject to 
change (Foucault, 2001). The linguistic medico-scientific representations of medicine, 
illness, disease and the body are therefore influential in the construction of both 
medical knowledge and lay understandings and experiences (Ettorre, 1999; Nelkin; 
2001; Nesbit & Mooney, 2007; Nisbet & Scheufele, 2007).  The development of new 
technologies that can be used to alter states of consciousness, can influence 
neuroscientific and medical understandings of the mind and the body. Through the 
availability of new neurotechnologies, such as modafinil, the brain and its various 
functions are then increasingly thought of as flexible, open to manipulation, 
pharmaceutical control and transformation (Martin, 1994; Wehling, 2005). As sleep 
increasingly comes under the purview of scientific medicine it is important to uncover 
how scientific and medical knowledge are providing us with new ways of 
understanding ourselves and our behaviours and shaping desires for transformed 
bodies and identities (Clarke et al., 2003; Rose, 1994; Gray, 2002).  
 
The aim of this chapter is to describe how the use and users of modafinil are framed 
within medical and scientific discourse. Specific research questions addressed 
LQFOXGH+RZDUHVOHHSFRJQLWLRQDQGWKHERG\FRQFHSWXDOLVHGE\µVOHHSH[SHUWV¶"
How is modafinil use understood in this domain? What sociotechnical scripts are 
associated with modafinil use and how is it positioned as a medical or non-medical 
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technology? What role is given to medical authority in deciding if particular uses are 
acceptable?  
 
Firstly, scientific constructions of sleep, cognition and society are described to 
understand the framework within which modafinil use is understood by sleep experts 
and investigate which methods of sleep regulation are deemed to be appropriate or 
acceptable. The second section of this chapter explores scientific configurations of 
modafinil use by different groups of users and how these are being legitimated and 
contested within the sleep science and medicine communities. Finally, 
conceptualisations of modafinil as a cognitive enhancer for use in µhealthy¶ populations 
are considered.  
 
Sleep, cognition and society 
 
This section provides some background as to how sleep experts spoke about sleep on 
a biological and social level and how they understood the relationship between sleep 
and human cognitive functioning. Firstly, representations of sleep as a biological 
process and as a social activity are considered. Following this, the ways in which 
sleep problems were conceptualised is explained and the social impacts of these 
problems explored. 
 
The mechanics of sleep 
 
Respondents talked about sleep using multiple and overlapping frames of reference 
that encompassed biological mechanisms and processes, behavioural characteristics, 
social and cultural contexts and meanings. However, first and foremost, respondents 
described sleep in biological terms as a brain- based process that is under biological 
FRQWURO6OHHSZDVWKRXJKWRIDVEHLQJµessential to life¶, a vital part of human 
existence, much like air, food and water with sleepiness compared to feeling hungry or 
thirsty. Through the use of biomedical language and terminology the biological body 
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was framed by sleep experts as a machine that has been designed to operate in a 
specific way. Mechanical and informatics metaphors were used to refer to the brain as 
tKHERG\¶Vcentral processing unit and the eyes as µsensors¶ detecting signals from the 
HQYLURQPHQWDQGWUDQVPLWWLQJWKHVHWRWKHERG\¶Vµinternal clock¶. As illustrated in the 
data extract below, within this frame of reference, sleep and wakefulness were 
conceptualised as being on a continuum, as mechanical processes of rhythms, cycles, 
SDWWHUQVDQGVWDJHVRIHOHFWULFDODFWLYLW\JHQHUDWHGDQGUHJXODWHGE\LQWHUQDOµFRQWURO
VWUXFWXUHV¶ORFDWHGLQWKHEUDLQ 
 
³«WKHZD\ZHGHILQHVOHHSLQRXURZQVSHFLHVLVRn the basis of electrical 
DFWLYLW\LQWKHEUDLQ´$GULDQ6OHHSVFLHQWLVW 
 
Respondents described two brain-based systems that act in oscillation to control the 
sleep-ZDNHF\FOHWKHµKRPHRVWDWLFGULYH¶DQGWKHµFLUFDGLDQV\VWHP¶7KHIRUPHULV
thought to induce sleep and the latter to promote wakefulness. Respondents regularly 
asserted that because of the way these two systems operate, humans simply cannot 
go without sleep. In this biological view the brain is thought to be programmed to take 
sleep despite any efforts of the individual to stay awake; the body will eventually shut 
down5HVSRQGHQWVDUJXHGWKDWWKHKXPDQEUDLQLVµSURJUDPPHGWRstay awake for 16 
KRXUV¶'DQ, Clinician) followed by around eight hours of sleep in each 24 hour cycle. 
However, individual differences were thought to be considerable and many 
respondents felt uncomfortable in offering average numbers. All agreed that less than 
six hours sleep per night would be sub-optimal and less than four hours sleep per 
cycle was identified as extreme sleep restriction. 
 
Physiological and genetic explanations were frequently given to explain why different 
people prefer to sleep at different times. As explained by Jane, each individual has a 
brain-based internal body clock that µticks¶ according to its own endogenous 
periodicity. TKHOHQJWKRIDSHUVRQ¶V internal body clock is thought to be determined by 
their biological make-up, which has a direct influence on the time they sleep. People 
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who prefer to get up later in the morning and stay awake later into the night were 
UHIHUUHGWRDVµRZOV¶3HRSOHZKRSUHIHUWKHRSSRVLWHZHUHUHIHUUHGWRDVµODUNV¶7KLV
seemingly personal preference of when someone decides to go to bed was explained 
(in part) by the length of their internal biological clock at a genetic level. 
 
³ZHDOOKDYHWKHVHLQWHUQDOFORFNVWKDWSHUVLVWLQWKHDEVHQFHRIWLPH
cues...The later your internal clock period, the later you are likely to live on a 
normal day. Owls get up late and go to bed late. Owls have longer internal 
clocks. Larks have shorter internal clocks and get up DQGJRWREHGHDUOLHU´
(Jane, Sleep scientist) 
 
Despite giving accounts of sleep and wakefulness as being under biological control, 
respondents did not take a deterministic view by attributing sleep timing and duration 
solely to biological mechanisms and genetic influences. Respondents acknowledged 
that despite the biological mechanisms that exist within us to control sleep there is 
also a degree of flexibility where, to some extent, individuals can choose to change 
their sleep patterns and trade in sleep for social opportunities. On a social and cultural 
level, sleep was described as something we learn to do appropriately, an activity that 
is riddled with rituals, routines and habits we develop throughout our lives and strongly 
influenced by the social and cultural norms that operate within a particular society. 
Respondents spoke about the day/night divide as one of the central features around 
which our lives are organised. On a socio-cultural level, sleep was described as taking 
place in a particular space, whilst one is wearing specific clothes and in the presence 
of certain people and not others. Above and beyond biological survival, sleep was 
attributed to an essential part of care and nurturing that has emotional significance 
conveying comfort, security and belonging, affecting relationships between couples 
and within families.  
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Sleep in modern society 
 
Across the scientific discourse modern society was constructed as a highly stressful 
place to live where people are increasingly busy, short of time and trying to cram more 
and more activities into their waking day by cutting back on sleep. Respondents 
acknowledged that people can and do use available technologies- ranging from 
artificial lights to alarm clocks- to get up earlier and stay awake longer than their 
biology dictates. A wide variety of other environmental, psychological and lifestyle 
factors which might disturb sleep were also discussed. These included light exposure, 
noise, sleeping with a partner, diet, pain, working hours, family demands (e.g. having 
a baby to feed during the night), stress and rumination (being XQDEOHWRµVZLWFKRII¶DW
night). Several respondents described contemporary western societies as chronically 
sleep deprived estimating that up to 60% of the population do not get sufficient sleep.  
 
³Modern VRFLHWLHVDWWHPSWWRFKHDWELRORJ\«ZHKDYHFUHDWHG environments in 
which the biology that we come naturally by collides with the environment and it 
collides with the culture...´%HUQDUd, Sleep scientist) 
 
Visions of modern society were paralleled with romanticised notions of the past. 
Respondents described a time when people used to have a biomodal sleep pattern, 
their sleep periods encompassing a full twelve hours during the night in which they 
would have a first sleep, followed by a dip and then a second sleep. Research was 
also referenced which pointed towards a third period of sleepiness, occurring just after 
lunchtime, as providing evidence of human sleep being polyphasic in nature. By 
reference to these studies, sleep experts argued that humans used to sleep according 
to day length like animals do, but that this has changed due to a change in lifestyles 
and particularly since the advent of electric lights.  
 
Experts feared that sleep is not understood properly and not taken seriously in the 
modern world and is becoming reOHJDWHGLQSHRSOHV¶ order of priorities. They explained 
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KRZRXUELRORJ\µFROOLGHV¶ZLWKWKHFXOWXUDOHQYLURQPHQWVZHKDYHFUHDWHG, as people 
increasingly attempt to µRYHUULGH¶their biological processes in order stay awake for 
longer periods and achieve social goals. Although acknowledging how behavioural, 
psychological and lifestyle factors can affect the quality and quantity of sleep, all 
respondents agreed that they would not alter the basic rhythm of sleep that is under 
biological control and were adamant that it is not possible to go without sleep 
altogether.  As shown in the data extract below, fears were often raised that interfering 
with the biology of sleep can have serious consequences for health.  
 
 ³«sleep is important and at our peril we mess around with human circadian 
IXQFWLRQV«WKHUH¶VFHUWDLQWKLQJV\RXFDQGREXWWKHUHDUHOLPLWVWRZKDW\RXFDQ
GRDQGWKHUH¶VFHUWDLQFRVWV RIGRLQJZKDW\RXGR´+DUU\ Clinician) 
 
Sleep deprivation and cognition 
 
Many of the respondents interviewed were involved in undertaking scientific research 
to understand the risks of disturbed or shortened sleep, both physiologically and 
behaviourally30. On a functional level, what sleep does is still largely unknown within 
the sleep science community, although there are numerous theories that drift in and 
out of favour. However, the effects of going without sleep, or sleep deprivation are 
fairly well characterised.  
 
The physical effects of sleep deprivation described by respondents were vast and 
often severe, thus reinforcing the importance of sleep to human health and cognitive 
performance. The sleep deprived individual was described as feeling very sleepy or 
WLUHGµKRUULEOH¶RUµXQZHOO¶WKHLUµguts would churn¶ and appetite be affected. Sleep 
deprivation was associated with the onset of a range of serious health conditions 
including obesity, heart disease, cardiac arrest, stroke, diabetes, high blood pressure, 
cancer and metabolic syndrome. In addition to these physical effects, psychological, 
                                                          
30
 The notion that we are a sleep deprived society is contested by some prominent members of the sleep 
science community who argue that short sleep does not harm health (See: Horne, 2007). 
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cognitive and emotional impacts were also discussed. Sleep was described as crucial 
for emotional regulation, mental health and cognitive performance. The impacts of 
sleep deprivation at an individual level that were described included: feelings of mental 
µIX]]LQHVV¶ODSVHVLQDWWHQWLRQPHPRU\SUREOHPVLQDELOLW\WRIRFXVWURXEOHZLWK
complex decision-making, feelings of frustration and low mood, anxiety and 
depression. Sleep was said to LQIOXHQFHDSHUVRQV¶ sense of humour, sociability and 
ability to think innovatively. Sleep deprivation was also considered to drastically affect 
cognitive performance. However, many respondents discussed that even though an 
individual might be severely impaired through sleep deprivation, they would be likely to 
be unaware of just how impacted they are. As shown in the data extract below, one 
respondent went as far to say that sleep makes us who we are as people: it is part of 
what makes us human beings.   
 
³«VOHHSDOORZVXVWREHWKHVRUWRISHRSOHZH¶GOLNHWREH, relaxed, intelligent, 
social animals coming up with new and excitiQJFRQFHSWVDQGLGHDV´$GULDQ, 
Sleep scientist) 
 
Sleep deprivation was perceived to be of enormous importance because of its 
association with major disease but also due to indirect harm caused by individual 
performance deficits on a wider societal level. A reduction in sleep was frequently 
linked to an increase in the likelihood of accidents and mistakes that could cause harm 
to othHUV7KHGDQJHUVDVVRFLDWHGZLWKµGURZV\GULYLQJ¶DQGULVNRIµIDOODVOHHSYHKLFOH
craVKHV¶ZHUHFRPPRQO\GLVFXVVHGZKHUHWhe level of injury and death was often 
compared to that of alcohol-related crashes. The comparison of driving whilst under 
the influence of alcohol and driving when sleep deprived added a normative dimension 
to the discourse, inferring a degree of culpability to the individual for their cognitive 
state. 
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Importantly, the effects of sleep deprivation were said to be subject to great variability 
across the population; it was argued that there was evidence that this too may be a 
heritable trait determined by biological make-up.  
 
³«P\ODEKDVVKRZQWKDWWKHGLIIHUHQFHs among people in response to sleep 
deprivation are stable and trait-like. That means that maybe there is a genetic 
EDVLVWRWKLV´%HUQDUG6leep scientist) 
 
Although it was argued that people are predisposed to react differently to sleep loss, 
as illustrated in the data extract below, how sleep deprivation impacts on an individual 
was also thought to be dependent upon the demands of their lifestyle. 
 
³/RWVRISHRSOHORVHVOHHSEXWGRQ¶WUHDOO\VXIIHUWKHFRQVHTXHQFHVEHFDXVH
WKH\GRQ¶WKDYHWKHGHPDQGVDQGWKHQLW¶VQRWUHDOO\DSUREOHP«)RUVRFLHW\LW¶V
a different matter, it depends on when they start making mistakes that put other 
people in jeopardy or cause loss of productivity, or when they get health 
problems that becoPHDEXUGHQWRVRFLHW\´)D\6leep scientist) 
 
To summarise, sleep was understood as a brain-based biological process that is 
primarily under biological control but also open to a degree of manipulation through 
various socio-cultural, psychological and environment factors that can have an 
influence on sleep timing, duration and efficiency.  Contemporary Western society was 
depicted as busy and hectic. Sleep experts frequently asserted that people do not give 
enough importance on sleep or recognition that it is fundamental to their physical and 
mental health, cognitive and emotive performance. Sleep deprivation was discussed in 
terms of both the medical and social problems it can lead to and lack of sleep was 
thought of as leading to real costs for the individual and society. In the next section, 
how modafinil fits into this understanding of sleep and vision of modern society as a 
medical treatment for the problem of sleepiness will be discussed. 
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Modafinil as a medicine: treating sleepiness 
 
All of those interviewed had heard of modafinil prior to the interview, although some 
were much more familiar with the drug than others. Many of the respondents had 
worked with the drug in a research setting or prescribed the drug to patients in a 
clinical setting. In addition, two of the respondents (both US-based) had personal 
experience of using the drug as a treatment for jet lag. In general, the way in which 
modafinil was configured was not flexibly interpreted in this domain.  
Modafinil was presented as a relatively safe and effective wake-promoting medication 
that could be used to treat excessive or problem sleepiness that is of clinical 
significance. Excessive sleepiness was conceptualised as a symptom of various 
PHGLFDOGLVRUGHUV7KHGUXJZDVUHIHUUHGWRDVµUHPDUNDEOH¶RUµWHUULILF¶GXHWRLWV
apparent lack of side effects when compared with other amphetamine-based 
treatments for sleepiness. All respondents agreed that modafinil should remain a 
prescription drug with its usage monitored by medical professionals. Some drew on 
the safety of the drug, pointing to how it is still relatively new and that its mechanism of 
action is not known, to argue that it should be kept under medical supervision, at least 
until the drug is proven to be relatively benign, and shown to have low potential for 
abuse .Often respondents spoke about the potential side effects of modafinil and the 
strength of its effects. They argued that there is not enough known about the drug for 
it to be made freely available, raising fears of side effects, drug-drug interactions, 
interactions with lifestyle, social addiction, and misuse. Although presented in media 
and neuroethical debates as a relatively safe drug, this claim was treated with caution 
by sleep scientists.  
 
³«WKHUH>LV@ information about the psychological effects of modafinil such as an 
increased rate of depression«WKHUHLVDERG\RIWKRXJKWthat says it should be 
used for sleepiness per se«,DPDELWZHDU\RIWKDWSDUWLFXODUVFKRRORIWKRXJKW
WKDWHQFRXUDJHVPHGLFDWLRQXVHZLWKRXWDFOLQLFDOLQGLFDWLRQ«P\YLHZLVWKDW
primarily these need to be used fRUFOLQLFDOLQGLFDWLRQV´0DV&OLQLFLDQ) 
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There was a generally cautious attitude towards using drugs as a panacea for all the 
problems associated with sleepiness and sleep deprivation. Drugs were not seen as 
the whole answer; rather respondents thought that they should be seen as part of the 
µDUVHQDO¶DQGthey all agreed that relatively safe medications such as modafinil should 
be available for those who really need them. Drawing parallels with the media 
discourse, war metaphors were occasionally present in the talk of scientists and 
clinicians, although to a much lesser extent than in media stories, describing drugs in 
terms of weapons in the fight against sleepiness. Again, modafinil was conceptualised 
as a way to control sleepiness. 
 
Legitimate users 
 
Examples of legitimate patient groups and the appropriateness of pharmaceutical 
treatment varied somewhat between respondents dependent on their own area of 
expertise. Overall, examples of potential treatment sites given by sleep experts 
included recognised sleep disorders such as narcolepsy, sleep apnoea, insomnia, 
restless legs syndrome, hypersomnias, jet lag sleep disorder, SWSD (in some 
instances) and other physical and mental health disorders that may involve some 
degree of sleep disruption including ADHD,  depression, anxiety, schizophrenia, 
dementia and cancer. 
 
Whether respondents thought that modafinil should be used as a first line treatment 
IRUWKHµV\PSWRP¶RIVOHHSLQHVV was generally dependent upon the disorder in 
question and the professional affiliation of the respondent, with psychologists usually 
drawn towards non-pharmacologic or behavioural therapies in the first instance. Using 
modafinil as a primary treatment for the excessive sleepiness associated with 
narcolepsy was generally considered to be acceptable, although some respondents 
did also speak about benefits that lifestyle and dietary changes and scheduled 
napping, in addition to pharmaceutical therapy, could have for narcolepsy patients. 
Some respondents spoke about using modafinil in combination with other approaches 
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to treating sleepiness, such as with cognitive behavioural therapy (CBT) in insomnia 
patients and the mechanical continuous-positive-airway-pressure device (C-PAP) 
used to treat sleep apnoea patients. 
 
Sleep disorders were conceptualised as being comprised of many different elements 
and typically referred to as irreducibly biological, psychological and social in nature.  
Although biomedical frameworks were used to describe why a sleep disorder might 
occur at the biological level and explanations included information about genes, 
hormone levels and brain-based structures, respondents also spoke in great detail 
about environmental factors such as light, noise, temperature, psychological 
predispositions and lifestyle factors such as diet, exercise, family situation, and 
working patterns as contributory factors. As explained in the data extract below, for 
this reason sleep disorders do not easily fit into a traditional medical model where 
diagnosis of a disorder automatically leads to medical treatment.  
 
³WKH\¶UHQRWMust biological problems that can be corrected by an imbalance of 
this or that togethHU«for most of these disorders, the treatment that people get 
LVQRWDFXUDWLYHWUHDWPHQW,W¶VDPDQDJHPHQWVWUDWHJ\VRWKHUHIRUH
[pharmaceuticals] should be one of the tools, not the only tool that [is used«] it 
has to be seen LQDEURDGHUFRQWH[W´+DUU\&OLQLFLDQ) 
 
Although modafinil was understood as providing the pharmacological means to control 
sleepiness by those that use the drug, context of use was seen as incredibly 
important. The underlying cause of the sleep problem, patient choice and the 
availability or success of other non-pharmacologic interventions were often raised as 
important factors in deciding how to treat sleepiness. Several respondents discussed 
that often, patients who they had come into contact with, preferred non-
pharmacological treatments for sleep problems. Medical professionals were thought to 
be equipped with the skills to decide, along with patient preference, whether modafinil 
was an appropriate treatment for that particular patient and their specific problem. 
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Within the psycho-bio-social framework used to explain sleep problems, that was 
adopted by many of the respondents, modafinil was clearly defined as a prescription 
medication that should be used when clinically appropriate as a medical treatment 
under medical supervision as a result of a clinical encounter.  
 
Some respondents spoke about how drugs, including modafinil, are already 
prescribed off-label and the ways in which this is beneficial to society. They argued 
that although the prescription process has a degree of flexibility in-built into the 
system, there is still some sort of clinical judgement involved that protects society 
against potential negative impacts that widespread (ab)use of the drug could lead to. 
However, fears that there still might be social problems associated with the drug, even 
if it does remain under medical supervision, were also raised. 
 
³«if you use sleeping pills as an example, where there still seems to be an 
DEXVHHYHQWKRXJKWKH\¶UHFRQWUROOHGWKURXJKWKHSUHVFULSWLRQSDGWKH
expectation is, LI\RX¶YHJRWVRPHWKLQJOLNHPRGDILQLORXWWKHUHWKDW\RX¶OOHQGXS
with the same run of problems, people will get addicted to the compounds and 
VRRQ´2UOD6leep scientist). 
 
Themes of performance enhancement and recreational use of modafinil by those 
without clinical disorders will be returned to in greater depth later on. The following 
section focuses on one area in which the application of modafinil straddled the 
boundary between legitimate medical treatment and abuse of prescription medication.  
 
Shift workers: a contested user group 
 
In this section, the various ways in which use of modafinil was positioned, argued 
against and legitimated in the context of one specific users group will be discussed. 
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Shift workers as patients: Shift work sleep disorder 
 
Throughout the interview data, shift work31 was portrayed as a lifestyle that comes 
with consequences impacting at various levels. Shift workers were positioned DVµDW
LQFUHDVHGULVN¶RIGHYHORSLQJVOHHSGLVRUGHUVDVZHOODVYDULRXVRWKHUELRORJLFDODQG
psychological problems in the short term. 6KLIWZRUNZDVFRQVWUXFWHGDVDµSDWKRORJLF¶
environment through discussion of the heightened longer term risks of developing 
other serious health problems such as cardiovascular disease (CVD), type II diabetes, 
and cancer. Sleep loss and sleep deprivation were attributed to working in an 
environment that iVQRWV\QFKURQLVHGZLWKDSHUVRQV¶ body or internal biological 
processes, which in turn puts them at risk of developing health problems. 
 
³«VKLIWZRUNHUV«KDYHDQLQFUHDVHGULVNRIKHDUWGLVHDVe [and] metabolic 
syndrome«\RX¶UHWU\LQJWRZRUNRXWRIV\QFKURQ\ZLWK\RXULQWHUQDO
FORFN«ZKLFKLVDVVRFLDWHGZLWKVOHHSGHSULYDWLRn during the day and a four-fold 
increaVHLQKHDOWKULVNV´Jane, Sleep scientist) 
 
Analysis of the interview data revealed different attitudes towards the clinical 
significance of sleep problems experienced by shift workers. It was commonly 
acknowledged that all shift workers could potentially experience problems with sleep 
and cognitive performance when biological rhythms become disrupted.  
 
³«SHRSOHZKRDUHRQVKLIWZRUNDUHIDUPRUHOLNHO\WRGHYHORSSUREOHPVZLWK
sleep because obviously it makes sense«WKH\¶YHQRWJRWWKHDELOLW\WRUHJXODWH
WKHLUSDWWHUQ«WKHLUERG\FORFNLVDOORYHUWKHSODFH«´Lin, Clinician)  
 
It was also generally accepted that some individuals will be affected more severely 
than others when immersed in a shift work environment. On a biological level, this 
                                                          
31
 Examples of shift work discussed by respondents encompassed a range of occupations falling into a 
variety of socio-economic groupings and included both males and females and young and elderly workers. 
Different types of shift work were discussed including night, day, early morning and rotating shift work with 
the latter group being described as the most at risk or vulnerable to developing health problems. 
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phenomenon was frequently explained through geneticised accounts. There was said 
WREHDµJHQHWLFFRPSRQHQW¶LQWKHµJHQHVLVRIVOHHSGLVRUGHUV¶WKXVH[SODLQLQJZK\
VRPHLQGLYLGXDOVDUHµSUHGLVSRVHG¶WRGHYHORSLQJVOHHSSUREOHPV when they are living 
µRXWRIV\QFZLWKWKHLUELRORJ\¶ (Bernard, Sleep scientist). Through this lens, the body 
ZDVUHGXFHGWRDVHWRIZRUNLQJSDUWVZLWKVOHHSSUREOHPVH[SODLQHGDVµLQWHUQDO
G\VIXQFWLRQ¶6OHHSSUREOHPVDQGFRJQLWLYHLPSDLUPHQWVDVVRFLDWHd with shift work 
were then, given a physiological basis and located inside the individual: inside the 
brain and body. As in data extract below, individual shift workers that developed sleep 
and performance problems were said to carry a genetic intolerance to shift work32. 
 
³«RQHSDUWLFXODUFORFNJHQHZKLFKLVUHODWHGWRVOHHSDQGSHUIRUPDQFH
SUREOHPVLQVKLIWZRUN«LVFDOOHGper3 DQGLWKDVOHQJWKSRO\PRUSKLVPV«LW
seems that there is a real genetic component to tolerDQFHWRVKLIWZRUN´Jane, 
Sleep scientist) 
 
SWSD is defined in the International classification of sleep disorders- version 2 (ICSD-
2) as a circadian rhythm sleep disorder characterised by a primary complaint of 
insomnia and/or excessive sleepiness that persists for the duration of at least one 
month. This complaint must be associated with a work period occurring in the habitual 
sleep phase and other sleep disturbances must first be ruled out before diagnosis.  It 
has duration criteria of acute, sub-acute or chronic and may be mild, moderate or 
severe (Fahey & Zee, 2008). 
  
SWSD was flexibly interpreted by those interviewed and emerged as a contested 
disease category. Some respondents gave fully medicalised accounts of shift work 
                                                          
32
 'HVSLWHWKHULFKDQGGHWDLOHGGHVFULSWLRQVRIWKHµJHQHWLFEDVLV¶WRVOHHSGHSULYDWLRQ¶RUµWROHUDQFHWRVKLIW
ZRUN¶DQGWKHIUHTXHQWDFFRXQWVRIµFORFNJHQHV¶DQGµJHQHWLFPHFKDQLVPV¶LQYROYHGLQVOHHSUHJXODWLRQ
there was a notablHDEVHQFHRIµWKHJHQH¶DWWKHEuropean Sleep Research Society (ESRS) 08 conference. 
,REVHUYHGRYHUWDONVRQVKLIWZRUNDQGRUVKLIWZRUN>VOHHS@GLVRUGHUGXULQJZKLFKµJHQHWLFV¶ZDVRQO\
GLVFXVVHGRQFH$IWHUJLYLQJDWDONHQWLWOHGµclinical consideration and factors influencing tolerance to early 
morning shifts¶WKHVSHDNHUZDVDVNHGµZKDWDERXWJHQHWLFV¶"7RZKLFKKHDQVZHUHGµVRPHSHRSOHUHVSRQG
EHWWHUWRVOHHSORVVWKDQRWKHUV7KLVLVDQHZDVSHFWWKDWZHKDYHWRDQDO\VH,WLVLPSRUWDQW¶6RDOthough 
the majority of sleep experts interviewed for this study did discuss the genetic basis of sleep disorders, it is 
important to acknowledge in the sleep field overall genetic discourse may not be as dominant.  
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sleep problems, accepting SWSD as a legitimate medical disorder based upon its 
inclusion in the DSMIV or the ICSD-2. In such accounts, biomedical discourses were 
predominantly used to frame some individuals as genetically predisposed to react 
more severely than others to shift work with the disorder resulting from a gene-
environment interaction. In the data extract below SWSD is framed in terms of a 
legitimate occupational disorder and compared other such conditions.  The 
conceptualisation of SWSD, as a legitimate medical condition with a genetic or 
physiological basis, allowed for treatment via medical intervention to be proposed and 
shift workers to be configured in the role of patient. Here, similar rhetoric to other 
µSDWLHQWXVHV¶ZDVIRXQGWKURXJKZKLFKPRGDILQLOZDVFRQILJXUHGDVDPHGLFDWion for 
treating sleepiness. 
 
³7KHquestion of shift work disorder is fairly straightforward, it is in the 
noVRORJ\«DQGWKHUHLVDWOHDVWRQHPHGLFDWLRQLQGLFDWHGIRUWUHDWLQJLW«,VLW
UHDVRQDEOHWRKDYHDQRFFXSDWLRQDOEDVHGGLVRUGHU",GRQ¶WNQRZH[FHSWWKDW
there is a whole field called occupational medicine where people have lots of 
RFFXSDWLRQDOGLVRUGHUV«We are talking about medications for the brain to help 
XVVWD\DZDNH«LI\RXGRQ¶WWUHDWQLJKWVKLIWZRUNHUVZHDOUHDG\NQRZWKHLU
cancer rates are higher than other people, their heart attack rates are higher ± 
sRLWLVQRWOLNHWKH\DUHOLYLQJKDSS\KHDOWK\OLYHV«´%HUQDUG6leep scientist) 
 
Although biomedical discourses were dominant in the interview data overall, they were 
rarely used in isolation. Empirically, most respondents took biological, psychological, 
socio-cultural and environmental factors into account when discussing sleep and 
health in the shift work population. Pickersgill (2009) discusses similar findings in a 
study investigating the ontology of psychopathy in contemporary neuroscience. 
Whereas biomedical frameworks were used by respondents to explain why some 
individuals might respond differently to shift work, psychosocial discourses functioned 
to locate the effects of WKLVµinternal dysynchronisation¶ in a social context. This is 
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illustrated in the extract below. Firstly, the respondent describes why shift workers 
may lose sleep and experience excessive sleepiness from a biological perspective: 
 
³«\RXDUHORVLQJVOHHSEHFDXVH\RX¶UHWU\LQJWRZRUNDWWLPHVZKHQ\RX¶UH
VXSSRVHGWREHDVOHHSDQGWU\LQJWRVOHHSDWWLPHVZKHQ\RX¶UHVXSSRVHGWREH
DZDNHZKLFK\RXUELRORJ\GRHVQ¶WFRSHZHOOZLWK)URPZKLFKVOHHSLQHVV
UHVXOWV«´ 
 
She then goes on to discuss how the deficits incurred from shift work become a social 
problem: 
 
³«WKDWLVRIVXFKDPDJQLWXGHWKDWLWEHFRPHVLPSRVVLEOHWRGRWKH
requirements of work and normal life, and then subsequently leads to other 
problems of family, prREOHPVRIPRRGDQGVRRQ´)D\6leep scientist) 
 
Other respondents questioned the physiological basis of shift work sleep disorder, 
regarding the condition as largely imposed and resulting from lifestyle and behaviour. 
Despite this, shift work was still understood as a lifestyle that comes with health 
consequences and shift workers were still considered as legitimate patients if their 
health was impacted by this lifestyle. The most important consideration for these 
respondents appeared to be whether the patient was suffering and how best they 
could be helped. This is evident in the data extract below where a clinical psychologist 
is talking about SWSD. He explains how shift workers who are biologically 
predisposed to react severely to working in a shift work environment may be 
diagnosed with SWSD, but because their biology is not able to fit in with socio-cultural 
working patterns, rather than there being something inherently wrong with carrying 
these particular genetic polymorphisms. 
 
³,WKLQNLQWKH8.«LW¶VQRW«VHHQDVDGLVRUGHU«\RXMXVWZHQWRQDVKLIWVR\RX
KDYHQ¶WFUHDWHGDGLVHase proFHVV«7KHUHDUHLQGLYLGXDOVZKRGRQ¶WDGMXVWDWDOO
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to shift patterns and so for them it becomes an issue, these are the relatively 
small numbers of people who would be medicalised through occupational 
health, referral routes and so on «PRUHVREHFDXVHWKH\¶UHVHHQDVQRWEHLQJ
able to fit into the system- WKHLUELRORJ\MXVWGRHVQ¶WILWZLWKWKDWOLIHVW\OHVR they 
FDQ¶WGRLW´+DUU\&OLQLFLDQ) 
 
In some instances respondents were more overtly sceptical of the disease construct 
and referred explicitly to the processes of co-construction that might be occurring, 
namely, that SWSD as a disease category was created after the effects of modafinil 
were discovered so that the drug could be indicated to treat a new group of patients. 
 
³«LWVHHPVWRPHWKDWWhey have created an entirely new disease just so that it 
FDQEHWUHDWHGE\PRGDILQLODQGLW¶VFDOOHGVKLIWZRUNVOHHSGLVRUGHU´-DQH
Sleep scientist) 
 
Resistance within the sleep field to the medicalisation of shift work was frequently 
acknowledged. This tension between the availability of an effective treatment and the 
resistance towards medicalisation of shift work can be seen in the data extract below: 
 
³7KHUHKDVEHHQWKLs issue in the sleep fieldWKH\GRQ¶WZDQWWRWXUQVKLIWZRUN
into a medical conGLWLRQ«\RX¶YHJRWDUHDOGLVRUGHUDQGZH¶UHJRLQJWRWUHDW
you. I mean, it is a real disorder, EXWZH¶UHJRLQJWRWUHDW\RXSKDUPDFHXWLFDOO\´
(Dan, Clinician) 
 
Others pointed to the general competence of doctors to argue that they make these 
kinds of clinical decision all the time, and that in consultation with the patient, if both 
parties felt as though pharmacological medication could help, then the shift worker 
should be prescribed the drug. All respondents agreed that modafinil should be under 
medical supervision, prescribed by medical professionals who would assess each 
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individual on a case-by-case basis prescribing medications to only those who really 
needed them.  
 
³,WLVWKDWGRFWRUV¶FKRLFHZKHWKHr they are going to prescribe [modafinil] or 
QRW«,WIalls with the individual practitioner to make a clinical decision at the 
WLPH«´0DV&OLQLFLDQ) 
 
0RGDILQLODVDWUHDWPHQWRIµODVWUHVRUW¶ 
 
The choice, or lack of choice, a shift worker has over their working patterns featured 
heavily in respondents¶ accounts. A few respondents discussed how some shift 
workers choose to do shift work because it suits them, financially, socially or 
otherwise. 
 
³,WKLQNDORWRISHRSOHJHWFDXJKWXSLQZDQWLQJWKHERQXVHVQHHGLQJWKLV
QHHGLQJWKDW«,WKLQNWKDWSHRSOHLn an ideal world, need to kind of re-think the 
SULRULWLHVLQWKHLUOLYHV´*LWD&OLQLFLDQ) 
 
However, in the main, most respondents thought that shift workers had little -if any- 
choice over the shifts they worked and therefore did not position them as morally 
culpable for the health or performance problems they might experience. This position 
is evident in the account below where the respondent is discussing her thoughts on 
the prescription of modafinil for shift workers. Again, she casts modafinil in the role of 
treatment and shift workers in the role of patient despite believing that sleepiness is a 
normal consequence of shift work. She reasons that if the individual in question is 
unable to change their job, and that scientific knowledge regarding the optimal 
scheduling of shifts to avoid excessive sleepiness is still lacking, that taking modafinil 
could help the individual in some situations, implying that the risks associated with 
shift work could be avoided with modafinil treatment. In this case, the respondent sees 
modafinil as one temporary solution to some of problems associated with shift work. 
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³«I think a normal person working [shifts] will be alwayVVOHHS\,¶PQRWDJDLQVW
drugs«LI>PRGDILQLO@LVDKHOS,FDQOLYHZLWKWKDW«6RXQWLO\RXKDYH a perfect 
way to organise [shift rotations] and people have to be sleepy [and] driving, if 
WKHUH¶VVRPHWKLQJWKDWFDQKHOSRUFDQDYRid risks, yeah, why not?´ (Gemma, 
Sleep scientist) 
 
The majority of respondents thought that pharmaceuticals should be used as DµODVW
OLQHRIGHIHQFH¶RUµODVWUHVRUW¶LIWKH\ZHUHWKHmost effective option available; the 
individual was unable to change their lifestyle; other non-pharmacologic measures had 
failed to produce sufficient changes in their behaviour. Some of the non-
SKDUPDFRORJLFWUHDWPHQWVDQGPHDVXUHVGLVFXVVHGLQFOXGHGµEULJKWOLJKWWKHUDS\¶RU
µRSWLPDOVFKHGXOLQJ¶WRKHOSVKLIWZRUNHUVµDGMXVWWRVKLIWSDWWHUQV¶DQGIXQFWLRQ
efficiently. It was often proposed that pharmaceuticals should be used in conjunction 
with some type of psychological or behavioural treatment that was advised or even 
µSUHVFULEHG¶E\PHGLFDORURWKHUSURIHVVLRQDOV7KHVHLQYROYHGVOHHSUH-retraining 
programmes, courses of behavioural sleep medicine, psychotherapy, and life 
coaching to help the individual adapt to their work schedule and sleep more efficiently.  
 
³,KDYHORWVRIGLIIHUHQWVWUDWHJLHVWKDW,FDQXVH- meds, napping, bright light, 
melatonin, relaxation, meditation techniques«LQP\FOLQLFI would look at the 
specific context of that specific individual and figure out what is the best mix of 
all of these things to help you sleep when you want to sleep and help you be 
awake whHQ\RXZDQWWREHDZDNH´&KDUOLH&OLQLFLDQ) 
 
In the data extract below the importance of medicalisation in the legitimation of 
modafinil use by shift workers at the conceptual level is evident.  
 
³«ZKDWFDQZHGREHVWWRPDNHRXUVKLIWZRUNHUVZRUNPRVWRSWLPDOO\WR
promote their safety and the safety of others? And does that include drugs?  
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And when you put it that way it sounds bad.  Does that include medical attention 
for those thaWDUHLQGLVWUHVV"<HV´(GZDUG&OLQLFLDQ) 
 
Hence, the overriding message was that modafinil use should be acute; with 
behavioural measures providing longer-term benefits for the individual. Clinically, it 
was acknowledged that the definition of SWSD needed further clarification and more 
research was called for to determine when the symptoms of excessive sleepiness 
and/or insomnia related to shift work become clinically significant.  
 
Modafinil as a safety tool: the case of acute use 
 
Occasionally, respondents drew on potential societal impacts of sleep deprived 
workers to argue that in some situations although drug use might not be the answer 
ideologically, practically speaking it would be acceptable if it was providing a level of 
safety or preventing accidents. Cognitive impairments associated with sleep 
deprivation were framed as a significant problem in the shift work population, posing a 
danger to the physical, mental and emotional wellbeing of the individuals and also 
impacting on wider society through an increase in workplace accidents and mistakes. 
Some respondents referred to specific situations where acute use of the modafinil 
might be beneficial for workers. Examples of people who might benefit from a dose of 
the drug included: fire fighters and other emergency services, astronauts, military 
personnel in combat situations, hospital workers and police officers on vital operations 
during the night. In situations such as this, modafinil was conceptualised as a safety 
tool rather than a medical treatment for a sleep disorder. 
 
³«there could be certain acute situations where it would be a good thing to do. I 
have no problems with somebody taking [modafinil] acutely, ZHNQRZLW¶VQRW 
going to do them a lot of harm, you know, lLNHLQDILUHVLWXDWLRQ´'DQ&OLQLFLDQ)  
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Other respondents spoke about the shift work population more generally. At the 
societal level the dangers of sleep deprived workers were expressed in terms of 
accidents related to sleepiness such as car crashes. Indirect harm to society was 
discussed in the form of errors and mistakes due to for example, medical staff or 
policemen not getting enough sleep so not being able to react appropriately during the 
night shift due to tiredness and impaired concentration. Examples of major disasters, 
such as the Selby rail crash, the Challenger space shuttle disaster and the 3 mile 
Island disaster, were all attributed to impaired performance due to sleep deprivation 
and used to illustrate the societal impacts of sleepy workers on a wider scale.  
 
³«policemen, firemen, soldiers, VXUJHRQV\RX¶YHJRWORWVDQGORWVRISHRSOH
out there who are having to function at a very high level despite the fact that 
WKH\KDYHQ¶WKDGDVXIILFLHQWDmount of sleep to allow them to function at a high 
OHYHODQGWKDW¶VZKHQVRFLHW\JHWVLQWURXEOHDQGWKDW¶VZKHQZHVWDUWWRKDYHD
lot of accidents UHODWHGWRVOHHSLQHVV´&KDUOLH&OLQLFLDQ) 
 
The reality that, as a society, we do rely on individuals that operate around the clock 
and we do have a huge population of shift workers was often used to justify the 
treatment of these individuals on grounds of safety.  Some considered it idealistic to 
suggest that we could somehow turn back the clock and change how the working 
SUDFWLFHVLQPRGHUQVRFLHW\RSHUDWH7KHFRQVHQVXVYLHZZDVWKDWµZHDUHDKRXU
ZRUOG¶DQGWKDWWKHSKHQRPHQRQRIVKLIWZRUNLVKHUHWRVWD\+RZHYHUUHVSRQGHQWV
talked about existing technological means for supporting those whose cognitive 
functioning might be impaired by shift work, stressing that in some occupations wake-
promoting drugs would be more necessary than in others. 
 
³6RPHWLPHVLWPD\QRWEHDSUREOHP, like in pilots where so much of the 
cognition is supported by technology«7KHLQGLYLGXDOGULYLQJDIRUN-lift truck at 4 
R¶FORFNLQWKHPRUQLQJLVQRWVRWKHFDSDFLW\IRUWKHPWRKXUWWKHPVHOYHVRU
anybod\HOVHLVKLJK´$GULDQ6OHHSscientist) 
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Often this type of acute use was suggested with caution. Respondents, considering 
the potential side effects of the drug, returned to the rhetoric that these drugs do not 
µPLPLFELRORJLFDOVOHHS¶$GULDQVOHHSVFLHQWLVWDQGthat the scientific community is 
still not certain what all the functions of sleep are and therefore cannot predict the long 
term consequences of using wake-promoting drugs.  
 
³«WKHUHDUHVRPHYHU\XQSOHDVDQWVLGHHIIHFWVRIPRGDILQLOWKDW\RX¶YHJRWWR
ZRUU\DERXW«WKHVLWXDWLRQZKHUHPRGDILQil is probably the most useful [is] a 
VLQJOHQLJKW«´-DQH6leep scientist) 
 
Two respondents took a more conservative view towards acute use of modafinil 
arguing that it is down to the individual to take responsibility for their own health and 
behaviour. In the data extract below, the respondent imagines the future user and 
envisions how the drug could be taken in the workplace as a replacement for sleep or 
to increase productivity. The concern she raises, about acute use in one situation 
potentially leading to other non-clinical uses of the drug, is used to justify her stance 
that wake-promoting drugs should not be used acutely.  
 
³,WKLQNZHKDYHWRWDNHUHVSRQVLELOLW\IRURXUVHOYHV«,GRQ¶WWKLQNLW¶VDJRRG
LGHDWRVD\µ,¶PIHHOLQJDELWWLUHGVR,¶OOWDNHRQHRIWKHVHDQGWKHQ,¶OOEHILQHWR
GRWKDWRSHQKHDUWVXUJHU\WKDW,¶YHJRWSODQQHG¶,WKLQNWKDW¶VDUHDOO\EDG
LGHD«EHFDXVHZKHUHGRHVWKDWHQGWKHQ"IIVRPHERG\FRPHVLQDQGWKH\¶YH
ZRNHQDWILYHLQVWHDGRIHLJKWVRWKH\¶UHDELWWLUHGµRK,¶OOMXVWKDYHRQHRIWKHVH
DQG,¶OOEHDELWPRUHSURGXFWLYHWRGD\¶DSRSXOation of people who are all 
mediating themselves is something that should really be discouraged DQGWKDW¶V
ZKHUHWKDWZRXOGHQGXS´/LQ&OLQLFLDQ)  
 
Several respondents discussed how they were personally involved in research 
developing countermeasures to prevent accidents, mistakes and other stresses in the 
workplace, whether disturbed sleep or shortened sleep arises due to a medical 
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condition, a work/rest schedule or some other lifestyle variable. Such technical 
solutions to workplace sleepiness and impaired cognitive performance could 
eventually eliminate a need for the drug in the first instance. A number of these 
VWUDWHJLHVLQYROYHGµKXPDQ-PDFKLQHLQWHUIDFHV¶, with visions of how workplace 
performance might be technologically optimised in the future, to ease the demands 
placed on individuals without a need for medication.   
 
³There are other interventions that we can think about to make people safer 
ZKHQWKH\¶UHVOHHSGHSULYHG«7KHUH¶VKXPDQPDFKLQHLQWHUIDFHLVVXHVLIZH
better understand the way that GHFLVLRQVFKDQJHZKHQZH¶UHVOHHSGHSULYHG«
the next step would be to work with these interfaces, in order to help us make 
EHWWHUGHFLVLRQV´&KDUOLH&OLQLFLDQ) 
 
To summarise, there was a general resistance to medicalise sleep in the shift work 
context. The variety of interpretations of, or reactions to, SWSD reveals a contested 
disease category which is not universally accepted in the sleep science/medicine 
community. Many respondents considered sleep and performance problems to arise 
due to gene-environment interactions in susceptible individuals. Social or lifestyle 
factors were implicated in the origin of the problem as much as biological factors and 
6:6'SODFHGXQGHUWKHUXEULFRIµRFFXSDWLRQDOGLVRUGHUV¶ There were five main 
µVROXWLRQV¶RUµFRXQWHUPHDVXUHV¶WRPDQDJHVKLIWZRUNVOHHSSUREOHPVGLVFXVVHGE\
respondents: prescription medications; behavioural sleep medicine programmes; 
education; behavioural changes; changes to the shift work environment. 
 
On the most part, modafinil was clearly understood within a medical framework as a 
treatment for the relief of suffering, regardless of how the disease definition was 
interpreted. An overwhelming majority of respondents agreed that treatment via 
prescription medication would be necessary or beneficial for at least some shift 
workers, or in combination with other non-pharmacological measures, in light of the 
current shift work context and information presently available. Overall, regulation of 
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sleep and cognitive performance in the shift work population was conceptualised as 
under responsibility of the medical profession, if the individual shift worker finds that 
they cannot cope with working shifts and are unable to successfully implement lifestyle 
changes. Pharmaceutical use by shift workers was, in the main, controversial within 
WKHVOHHSILHOGDQGVHHQSXEOLFO\DVDµODVWUHVRUW¶RUWHPSRUDU\PHDVXUHXQWLOPRUH
scientific knowledge and technological aids are available to optimise the health of the 
modern workplace environment.  
 
Illegitimate uses and imagined users 
 
Although the dominant configuration of modafinil led to it being understood as a 
medical treatment and positioned as such within society, respondents did 
acknowledge alternative ways in which the drug could be used. However, these 
readings of the technology were generally positioned as illegitimate uses of the drug 
and referred to as µabuse¶ or µmisuse¶ of prescription medication. In this section the 
focus is on how, through scientific understandings of sleep, cognition and society, 
modafinil was constructed as a medicine, not a food, a recreational drug or a 
performance enhancer.  
 
Modafinil is not a food 
 
Respondents reasoned that if a drug is shown to be non-toxic and it is not considered 
harmful in any way, then there is no reason why it should not be available on the 
supermarket shelves, much like other foodstuffs or health products. However, 
modafinil was not configured in this way. It was understood to be a powerful and 
potent medicinal drug with clinical applications demonstrated through scientific 
research and clinical trials. Respondents argued that modafinil is not a food: it is a 
medicine and so should be regulated and treated as such. In the account below this 
technological script is revealed. The respondent describes how modafinil is not a food 
because it was designed and developed as a medicine. Furthermore, the respondent 
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argues that modafinil should remain a controlled medicinal product due to the potential 
that its use could have serious side effects. 
 
³«LW¶VQRWDQDSSOHLW¶V something we developed for this purpose that has the 
potential to have serious side-HIIHFWV«6RDEVROXWHO\PRGDILQLODQGOLNH
substances should be prescription...the function of having prescriptions is when 
ZH¶UHFRQFHUQHGDERXWVXEVWDQFHVLQWHUDFWLQJWRSroduce bad health, that 
WKHUH¶VDV\VWHPLQSODFHWRZDWFK$QGWKDW¶VRND\DQGPRGDILQLOVKRXOGULJKWO\
EHXQGHUWKDWUXEULF«´(GZDUG&OLQLFLDQ) 
 
When considering how modafinil might be used outside of the clinical encounter, 
respondents regularly compared modafinil to caffeine. Often the wake-promoting and 
performance enhancing effects of modafinil were likened to drinking coffee or the 
consumption of other caffeinated products. Respondents also voiced fears over the 
dangers of caffeine consumption and referred to this too as a drug that is no more 
natural than modafinil, a drug which has strong physiologic effects and is both 
addictive and widely abused in many cultures. It was argued that if modafinil was to be 
available in the same capacity as caffeine, it would indiscriminately promote the idea 
of performance enhancement and it too would be abused. In the data extract below, 
the respondent differentiates between medicinal use of modafinil, in this case to treat 
children with ADHD and use of the drug by both adults and children without disorders 
for the purposes of performance enhancement. Whilst medical use of the drug is 
viewed as acceptable, its use to sustain wakefulness in a non-medical context is 
framed as abhorrent. 
 
³6KRXOGDQ\ERG\Zho wants to stay up take it? That seems a little extreme and 
\HWWKDW¶VZKDWSHRSOHGRLI\RXPDNHDQ\WKLQJDYDLODEOH/RRNKRZZHDEXVH
caffeine, it is the most heavily abused drug in the world.  Well it is a food so we 
WKLQNµRKWKDW¶VMXVWFXWHWKDW¶VILQH¶,t is not cute, it is not fine, we have got 
children on the damn druJLQKXJHTXDQWLWLHV«I do not think we should be using 
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ZDNHSURPRWLQJGUXJVIRUFKLOGUHQ«,DPQRWWHOOLQJ\RXDERXW$'+',DPMXVW
talking about lifestyle, but I could show you newspaper ads in America that 
make a positive point about waking up a pre-pubescent girl at 3.45am to 
practice ice-skating so she can be an Olympic champion.  I consider that an 
DERPLQDWLRQ´%HUQDUG6leep scientist) 
 
Some respondents questioned why it is legal and socially acceptable to sustain 
performance under conditions of sleep deprivation through caffeine, conceptualising 
this as µperformance enhancement¶ and as a practice that can have serious health 
impacts. Respondents also regularly defended the availability of caffeine due to the 
fact that it is has been available for so long and its use is embedded in cultures all 
over the world. By comparison modafinil was considered a novel technology with 
many unknowns associated with it usage both in the short term and over longer 
periods. All thought that modafinil should not be available over the counter like 
caffeine is because it is too strong a drug, it has been shown to have medicinal 
properties, and although it might not be biologically addictive it could be socially 
addictive, lead to major societal changes and could easily be misused. Essentially, 
respondents thought that modafinil should be regulated and controlled due to fears 
that people will abuse the drug which could negatively impact on individual and 
population health. 
 
³>PRGDILQLO@LVDUHODWLYHO\QHZGUXJFDIIHLQHKDVEHHQDURXQGVLQFHWKH\HDU
dot± probably if it was introduced now it would have the same kind of 
classification system as [modafinil],WKLQNWKHMXU\¶VVWLOORXWRQ>PRGDILQLO@VR
my fHHOLQJZRXOGEHWKDWLW¶VSUREDEO\EHVWDYRLGHGXQWLOZHNQRZDEVROXWHO\
PXFKPRUHDERXWLWDQG,WKLQNLW¶VXVHVKRXOGEHYHU\FRQWUROOHG´/LQ&OLQLFLDQ) 
 
One respondent considered the idea of pharmacologically manipulating sleep to be a 
uniquely Western desire. Again, comparing the use of modafinil to promote 
wakefulness with the use of caffeine for the same purpose, she gives a slightly 
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different appraisal of the drug to most, reasoning that the availability of another such 
substance will probably not have too much impact on society.  
 
³,I\RX¶UHWDONLQJDERXW:HVWHUQVRFLHW\LQVRPHVHFWLRQVRIVRFLHW\\RX¶OOVHH
that people will start to use more and more to get ahead in life and that creates 
DSUHVVXUHIRURWKHUSHRSOHWRGRWKHVDPHWKLQJ«%XWWKHUH will be other 
VRFLHWLHVZKHUHWKLVZLOOQRWOLNHO\KDSSHQ«ZHDUHDOUHDG\GRLQJVRPDQ\
things to get the maximum amount of wakefulness out of the day that a drug 
H[WUDKHUHDQGWKHUHWRPDNHWKDWSRVVLEOHLVQ¶WJRLQJWRPDNHDOOthat much of 
an impact, beFDXVHZH¶UHDOUHDG\GRLQJWKDWZLWKFDIIHLQHDQGVLPLODU
VXEVWDQFHVDQ\ZD\6R,¶PQRWWRRZRUULHGWKDWWKHLPSDFWZLOOEHSURIRXQGEXW 
LWZLOOEHQRWLFHDEOH´)D\6leep scientist) 
 
Modafinil is not a recreational drug 
 
Often respondents imagined scenarios where modafinil might be used as a substitute 
for other substances, both legal and illegal, that are used recreationally for 
performance enhancement or pleasure. Despite fears over the potential for modafinil 
to be abused and misused, respondents often spoke about how modafinil is not a 
recreational drug. Comparisons were drawn with illegal substances such as 
amphetamines, cocaine and ecstasy as well as other legal recreational drugs 
including alcohol and nicotine. Each of these drugs were differentiated from modafinil 
on the grounds that modafinil does not give the user any kind of high, and biologically 
speaking, addiction potential has not been demonstrated thus far.   
 
³,WKLQNZKDWVFDres people is the high\RXGRQ¶WJHWWKDWZLWKPRGDILQLO«´
(Edward, Clinician) 
 
Respondents maintained that modafinil should be used only when it is needed, often 
struggling to think of situations in which a recreational dose of modafinil might be 
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justified instead of a change in behaviours. Comparisons were drawn with other drugs, 
such as sleeping tablets and Aspirin, that are readily available over the counter to 
argue that people might end up taking wake-promoting drugs for granted and using 
them as a substitute for sleep. Ethically, the issue of autonomy was raised with 
respondents questioning whether individuals should be allowed the freedom to choose 
whether they take a recreational dose of modafinil. All respondents thought that 
modafinil should not be available recreationally on the grounds of population health 
and the wider impacts this drug could have on individuals, families and society more 
generally. Mandate via medical prescription was again positioned as a good way to 
ensure that only those who need the drug have access to it while at the same time 
reducing the risk of it being abused. 
 
³,¶PDVXSSRUter of drugs when you do need them but I think thHUH¶VWRRPDQ\
people taking them IRUJUDQWHG«\RXPLJKWKDYHDQKHDGDFKHDQGSHRSOHMXVW
WDNHDQ$VSLULQHYHU\VLQJOHGD\VRWKDW¶VJRLQJWRLQFUHDVHWKLVKDELWRI people 
recovering with a drug instead±maybe to mandate it on prescription would be 
EHWWHUWRDYRLGWKHSLOOZKHQ\RXGRQ¶WQHHGLW,¶GQHHGWREHFRQYLQFHG\RX
QHHGLWLILW¶VMXVWWRJRFOXEELQJDQG\RX¶UHVOHHS\\RXFDQjust come back 
HDUOLHU´*HPPD, Sleep scientist) 
 
Respondents found it difficult to predict what the impact of modafinil on society would 
be. Some imagined that perhaps it would come to be used like alcohol and caffeine 
and on the most part be managed by society. Drawing on past experiences and 
through reference to how other substances are used to similar effect, fears were 
raised that widespread availability would lead to abuse of the substance and related 
problems. Potential impacts of uncontrolled availability of modafinil were imagined, 
and fears raised about the unknown health implications that cutting back on sleep 
could have in the long term. Others voiced concerns about the addiction potential of 
the drug, this time on a social or psychological level.  
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³«JLYHQZKDW,VDLGHDUOLHUDERXWWKHIXQFWLRQRIVOHHS\RX¶OOSD\for that 
HYHQWXDOO\,WKLQN«these patients will present to the healthcare system but with 
othHUIRUPV«whether you call it burnout, whether you call it problems with the 
heart, exhaustion, fatigue, whatever it would be, I think this will surface again in 
DQRWKHUIRUP´/LQ&OLQLFLDQ) 
 
Despite concerns over health impacts and social changes, most respondents thought 
that recreational abuse of modafinil was bound to happen with increasing prevalence. 
Occasionally, respondents told stories of the ways in which modafinil is already being 
used outside of medical control to promote alertness and improve cognitive 
functioning.  
 
³«SHRSOH>WDNLQJVRPHWKLQJ@WU\LQJWRFXWEDFNLQWKHLUVOHHSEHFDXVHRIWKH
SUHVVXUHVRIOLIH«WKDW¶VZKDW¶VJRLQJWRKDSSHQ7KHUH¶VQRTXHVWLRQ7KH\WHOO
\RXWKDWLQWKH86WKHUH¶VWKHVHPRUQLQJVKRZVRQWHOHYLVLRQDQGDSSDUHQWO\
WKH\DOOWDNHPRGDILQLOEHFDXVHWKH\¶UHJHWWLQJXSDWDPDQGWKH\KDYHWREH
functioning by 6 and they feel like crap so they take modafinil and they function 
and the\JHWWKURXJKWKHVKRZ´'DQ&OLQLFLDQ) 
 
One respondent was more cautious about referring to non-medical use of modafinil as 
µDEXVH¶RIWKHWHFKQRORJ\,QVWHDGKHSUHIHUUHGWRWKLQNRIWKLVLQWHUPVRIPLVuse- 
however, it was still considered a use of the technology by the wrong people for the 
wrong reasons. 
 
³«ZHKDYHJUDGXDWHVWXGHQWVDQGPHGLFDOVWXGHQWVZKRDEXVHPRGDILQLOVR
that they can basically squeeze more hours out of a day of study and work«,
think some people would argue with the word abused because that has a very 
medical, physiological kind of implication and many people would argue that 
PRGDILQLOLVQ¶WDEXVDEOH\RXGRQ¶WEHFRPHDGGLFWHGWRLW\RXGRQ¶WJHW
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tolerance and withdrawal effects and things like that.  But I think it is easily 
misuabOHLIWKDWPDNHVVHQVH"´&KDUOLH&OLQLFLDQ) 
 
In addition to fears surrounding how widespread recreational use of the technology 
could be detrimental to both the individual and society, some respondents spoke 
about the promise and hope embodied in this drug. Essentially, the allure of wake-
promoting drugs lies in their potential to offer the user more time in consciousness.  
 
³«LIZHFRXOGGHYHORSDSLOOWKDWGRHVZKDWHYHUVOHHSGRHVVRQRZ\RXFRXOG
ruQKRXUVDQGWKHUH¶VDEVROXWHO\QRHYLGHQFHWKDWLQWKHORQJ-run it promotes 
GLVHDVHZRXOGQ¶WWKHWHPSWDWLRQEHRYHUZKHOPLQJWRGRLW"«,ZDQWWROLYHDV
long as possible and being uncRQVFLRXVLVQRWOLYLQJ´(GZDUG&OLQLFLDQ) 
 
However, respondents warned that it has not been demonstrated that prolonged or 
regular use of modafinil is not harmful; pointing out that the drug does not give the 
user everything that sleep does. More research into the functions of sleep was thought 
to be essential before unrestricted access to the technology could even be 
contemplated. There was a general scepticism that a drug that could mimic sleep 
would ever be developed and that in the future there would be a safe and effective 
pharmacological substitute for sleep. 
 
³«WKHUH¶VORWVRIWKLQJVWKDWZHZRXOGEHGHQ\LQJRXUVHOYHVLIZHGHQLHG
RXUVHOYHVVOHHSDQGWKDW¶VNLQGRIWKHH[WUHPHKRUURUVWRU\RIHYHU\RQHLQWKH
whole world now deciding that they can go two or three weeks at a time before 
they have to sleep, cos they can all get through with drugs.  I think that would 
KDYHYHU\VHULRXVSUREOHPV«,ILQGLWYHU\KDUGWREHOLHYHWKDWZHFRXOGKDYHD
GUXJWKDWZRXOGIDLWKIXOO\PLPLFDOORIWKDWWKDWJRHVRQZKHQZHVOHHS«,¶PQRW
sure whether we would ever be able to replace sOHHS´&KDUOLH6leep scientist) 
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Again, looking into the future respondents imagined what might happen if scientific 
research finds that taking a pill to promote wakefulness is not harmful in the long term. 
This would effectively eliminate many of the scientific and medical reasons given for 
controlling wake-promoting technology. Although this scenario was thought 
improbable in light of present scientific understandings of sleep respondents did not 
exclude the possibility that this could change at some point in the future. If the 
extension of wakefulness and shortening of sleep is demonstrated to be benign in the 
long term, the availability of this type of technology could provides us with a choice to 
chemically control when we are awake and when we sleep. 
 
³,WKLQNLWZLOOEHLQWHUHVWLQJWRVHHLIDQRWKHUFKRLFHEHFRPHV>DYDLODEOH@LIZH
can actually chemically choose when to be awake and when to sleep «´
(Karen, Sleep scientist) 
 
Modafinil is not a performance enhancer 
 
Respondents were familiar with claims that modafinil could be used as a performance 
enhancing drug. Whilst acknowledging the enhancement potential of the drug, several 
respondents also raised doubts about the utility of the drug as a cognition enhancer. 
6OHHSZDVUHIHUUHGWRDVµWKHXOWLPDWHSHUIRUPDQFHHQKDQFHU¶DQGE\PHDQVRI
comparison the efficacy of drugs such as modafinil was brought into question. 
 
³:KDWZHGRQ¶WNQRZLVH[DFWO\LQZKDWFLUFXPVWDQFHV>PRGDILQLO@GRHVKHOS
cognitive function.  One of the great hopes for modafinil was that we would be 
DEOHWRWDNHLWZKHQZH¶UHVOHHSGHSULYHG«RXUDELOLW\WRFRJQLWLYHO\IXQFWLRQ
would be completely intact and would have no effect of sleep loss.  And 
modafinil while very promising in that area, it LVQ¶WTXLWHWKHJROGHQQXJJHWWKDW,
think DORWRIXVKRSHGWKDWLWPLJKWEH«,¶YHGRQHresearch studies myself 
where we give modafinil to people and it has aOPRVWQRHIIHFWDWDOO´&KDUOLH
Sleep scientist) 
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It was regularly assumed that the demand for effective cognitive enhancers would be 
high. Students were one particular group that were often imagined as potential users 
of cognition enhancing drugs. Through their own experience of student life, some 
respondents compared modafinil use to the use of amphetamines as performance 
enhancers around exam times2WKHUVVSRNHDERXWWKHXVHRIFDIIHLQHSLOOVE\WRGD\¶V
students to argue that the student population already purse means of performance 
enhancement through pills and to some extent, always have done. 
 
³«ZKHQZHZHUHFROOHJHVWXGHQWVSHRSOHXVHG to take things called purple 
hearts about two months before exams, they were amphetamines. How does 
modafinil compare with amphetamines- is it used E\WKHVWXGHQWSRSXODWLRQ"´
(Jane, Sleep scientist) 
 
A minority of respondents thought that, in the future, acute non-medical use of drugs 
such as modafinil could become acceptable in the student context, if they were proved 
safe enough to be made freely available without prescription. Through the availability 
of wake-promoting technology normal sleepiness was turned into a potential target for 
pharmaceutical intervention (Williams, 2008a). This type of use was compared to the 
use of painkillers such as Aspirin or Paracetamol to get rid of headaches or overcome 
the effects of excessive alcohol consumption.  
 
³«LI,KDYHDQH[DPWRVLWDQGWKHUHLVOLPLWHGWLPHDQG,WKLQNWKDWIRUPHLW¶V
LPSRUWDQWWRVOHHSYHU\OLWWOHEXWVWLOOEHIXQFWLRQLQJ\HV,PLJKWWKLQNµRNLQWKLV
FDVHLW¶VULJKW¶ZK\QRWXVHLWLIWKHUH¶VQRSUREOHPV? BXW,GRQ¶WWKLQNLW¶VULJKt on 
DUHJXODUEDVLV«,W¶VOLNHVD\LQJµ,GULQNDOFRKROHYHU\QLJKWDQGWKHQLQWKHGD\,
WDNHSDUDFHWHPROWRQRWWRKDYHDKDQJRYHU¶2QHQLJKWLVRNEXWLI\RXGRLW
HYHU\GD\,GRQ¶W WKLQNLWUHDOO\KHOSV´,VREHO6OHHSVFLHQWLVW) 
 
Fears were raised around how the unrestricted use of modafinil to curtail sleep and 
enhance performance might impact on society, for instance, that it could potentially 
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lead to longer working hours becoming the norm because people can function for 
longer periods of time. However, there was still a degree of scepticism the drug would 
be proved safe enough for OTC use and its future use in the student context only 
agreed to provided that more was known about the drug in respect of its safety, and 
other effects of sleep loss. As illustrated in the data extract below, respondents were 
often very clear to point out that modafinil is not a performance enhancing drug, it is a 
medication that does have adverse side effects. 
 
³«PRGDILQLOLWVHOILVQRt a performance enhancer. It is a wake-promoting agent 
DQGLW¶VQRQ-addictive. Almost 20% of people report headaches after taking the 
drug and there is more data coming out about its longer term psychological 
effects. So, one should be very cautious about using medication for lifestyle 
LVVXHV´0Ds, Clinician) 
 
Despite this, when thinking about modafinil use by professional athletes; modafinil was 
typically labelled as a µSHUIRUPDQFHHQKDQFLQJGUXJ¶$OWKRXJKVRPHUHVSRQGHQWVGLG
convey a degree of sadness that the drug could be used for the purposHRIµGRSLQJ¶
the majority of respondents expressed a lack of interest or knowledge in how the drug 
could be used or was being used by athletes. The use of the drug by athletes in the 
context of sport was clearly differentiated as outside of the boundaries of their 
professional expertise and many were reluctant to speak about it.  
 
³7KHVHDUHLVVXHVWKDWQHHGWREHQHJRWLDWHGEXWWRPH,GRQ¶W count those as 
relevant«ZKDWSURIHVVLRQDOVLQVSRUWDUHGRLQJ>LV@DELWRIDSHULSKHUDOLVVXHIRU
PH,GRQ¶WUHDOO\FDUHVRPXFKLW¶VQRWP\MREWRMXGJHWKHVHSHRSOHRUsay 
ZKDWWKH\VKRXOGGR«´)D\6leep scientist) 
 
Overall, most respondents were cautious of the use of modafinil and like substances 
for performance enhancement. Typically, this type of use was UHIHUUHGWRDVµDEXVH¶
due to perceived potential for adverse health consequences. The potential for abuse 
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or negative impacts of drug use to the individual and for society, in both the short term 
and longer term, were thought to outweigh the potential benefits of allowing modafinil 
to be available to all in society at present, thus reinforcing the need for it to remain 
under control and supervision.  
 
In the main, the use of modafinil to pharmacologically enhance cognition by those 
without clinical disorders was constructed as improper use of the technology. 
Respondents were sceptical that modafinil would be an effective performance 
enhancing technology despite often acknowledging that the production of drugs that 
will act to further control sleep and enhance cognition is a goal shared by many in the 
pharmaceutical industry. 
 
 ³«DOOWKHVHFRPSDQLHVDUHDIWHUFRJQLWLYHHQKDQFHPHQWDQG,DPQRWWDONLQJ
DERXWMXVWVHYHUDORIWKHP,PHDQDOORIWKHPDQGWKDW¶VDOOLQWKLVLQGXVWU\«´
(Bernard, Sleep scientist) 
 
To summarise, demand and desire for non-medical use of modafinil was assumed to 
exist across all sections of society. In comparisons with caffeine and other food stuffs 
respondents explained how modafinil is different: it is not a food and therefore should 
not be openly available to all on the supermarket shelves. Drawing attention to other 
legal and illegal substances that are currently used recreationally, for performance or 
pleasure, modafinil was again differentiated. Although it could well find a role in 
society as a recreational drug to promote wakefulness and control sleep, scientists 
struggled to endorse this type of use on the grounds of potential health impacts. 
Again, the technology was understood as a potent medicinal drug that can be used to 
treat sleepiness- but not to stop or replace sleep. Scientists and clinicians often made 
it clear that non-medical use of the drug for purposes other than treatment was outside 
of their professional expertise and they were uncomfortable talking about these uses. 
The potential for modafinil to be used as a cognitive enhancer was acknowledged. 
However, drawing on scientific research, many of those interviewed were personally 
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involved in, the efficacy of the drug for this purpose was openly questioned. 
Respondents spoke about the allure of cognitive enhancement but were highly 
sceptical that we would ever be able to pharmacologically mimic sleep and reproduce 
its effects on cognition.  
 
Summary and conclusions 
 
In the scientific and medical discourse sleep and other cognition functions were 
conceptualised as brain-based processes. Despite giving accounts of sleep and 
wakefulness as being under biological control, respondents did not take a reductionist 
or biologically deterministic view.  Empirically, biological, psychological, socio-cultural 
and environmental factors were taken into account when discussing the relationship 
between sleep, cognitive performance and health. Respondents acknowledged the 
importance of social and cultural factors in the origin of sleep problems arguing that 
WKHZD\ZHOLYHRXUOLYHVLQWRGD\¶VZRUOGPD\FRQWULEXWHWRWKHRQVHWRIVRPHRIWKHVH
problems and the conceptualisation of them as problems in the first instance. 
Respondents spoke about sleep disorders as being comprised of many different 
elements, often referring to them as irreducibly biological, psychological and social in 
nature.  Therefore, sleep disorders do not easily fit into a traditional medical model 
where diagnosis of a disorder necessarily leads to medical (or pharmacological) 
treatment. 
 
However, sleep deprivation was constructed as a social problem that can have huge 
impacts at both the individual and social level. It was argued that sleep disorders, 
sleep deprivation and impaired cognitive performance become significant when they 
impact upon the ability of an individual to negotiate the demands of their everyday life; 
in the home and in the workplace or if impaired performance impacts on the wellbeing 
of others. However, such problems only become clinical problems when the individual 
complains of a problem and seeks medical help. 
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Much of the data presented focuses on the case of SWSD, a relatively new construct 
that is still somewhat under debate within the sleep science and medicine community. 
Through this case in particular, the complex bio-psycho-social framework used to 
explain sleep disorders in the scientific discourse was most evident. It was proposed 
that biological factors may predispose an individual to react negatively when 
immersed in a shift work environment. Sleep problems and cognitive impairments 
associated with shift work were, in this sense, given a physiological basis and located 
inside the individual; inside the brain and body. However, scientists and clinicians 
explained that an individual would be diagnosed with SWSD because of an 
incompatibility between their biological make-up, socio-cultural working patterns and 
psychological disposition without labelling their biological make-up DVµDEQRUPDO¶
deviant or pathogenic.  
 
It was apparent in the data that, to some extent at least, sleep is being medicalised 
with the emergence of SWSD. However, it was also clear that such medicalisation is 
controversial within the expert community. The variety of interpretations of and 
reactions to SWSD in the data reveals a contested disease category which is not 
universally accepted. Resistance towards the medicalisation of shift work was also 
evident in various forms throughout the data. Some respondents gave partially 
medicalised accounts of SWSD and others non-medical accounts, whereas in some 
cases the tension around this issue was discussed outright. In this sense, the sleep 
science/ medicine communities could be seen as providing a form of resistance or 
obstacle for the further medicalisation of sleep, rather driving the process forward 
(Dingwall, 2006). 
 
Despite this area of contestation, all respondents agreed that shift work is a lifestyle 
that comes with health consequences, that impact at various levels. Shift work was 
FRQVWUXFWHGDVDµSDWKRORJLF¶HQYLURQPHQW through discussion of the heightened longer 
term risks of developing serious health problems. Cognitive impairments associated 
with sleep deprivation were framed as a significant problem in the shift work 
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population, posing a danger to the physical, mental and emotional wellbeing of the 
individuals and also impacting on wider society through an increase in workplace 
accidents and mistakes.  
 
The conceptualisation of SWSD as a legitimate medical condition with a genetic or 
physiological basis allowed for treatment via medical intervention to be proposed and 
shift workers to be configured in the role of patient. Here, similar rhetoric to other 
µSDWLHQWXVHV¶ZDVIRXQGWKURXJKZKLFKPRGDILQLOZDVFRQILJXUHGDVDPHGLFDWLRQIRU
treating sleepiness, a way to relieve suffering and help those in distress. 
Pharmaceuticals were viewed as valuable short-term measures to treat the symptoms 
of SWSD. Resistance to the pharmacological treatment of at least some shift workers 
was scarce in the data. Only two respondents thought that under no circumstances 
should shift workers be treated pharmacologically. Their reasons for this stance drew 
on future-orientated discourse, raising fears surrounding a proliferation in the use of 
medication to promote alertness which could lead to adverse health consequences in 
the future. All respondents agreed that modafinil should be a controlled substance, 
used under the supervision of medical professionals who would assess each 
individual on a case-by-case basis prescribing medications to only those who really 
needed them.  
 
As an aside to this, it is worth noting that future-orientated discourses describing a 
technological revolution in the workplace featured strongly in the data and in a sense 
made the debate about whether shift workers should be treated for sleepiness (or not) 
seem almost irrelevant. If the visions of technological solutions (e.g. human-machine 
interfaces) to ensure a happy, healthy and alert workforce are soon to be realised, the 
discussion about whether or not to medicate shift workers will be rendered obsolete.   
 
Overall then, modafinil was configured as one of several pharmacologic and non-
pharmacologic treatments for the symptom of sleepiness associated with numerous 
clinically defined disorders, be they to do with sleep, other medical disorders, lifestyle 
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or behaviour. Modafinil was positioned alongside other medical technologies 
(mechanical devices and other pharmacologic substances), behavioural therapies and 
lifestyle changes as one of the many means currently available to help individuals 
suffering from excessive sleepiness/ impaired alertness. The underlying cause of the 
problem, patient choice and the availability or success of other lifestyle interventions 
were often raised as important factors in deciding how to treat sleepiness.  
 
7KHPDMRULW\RIUHVSRQGHQWVVLWXDWHGSKDUPDFHXWLFDOWHFKQRORJ\DVDµODVWOLQHRI
GHIHQFH¶RUµODVWUHVRUW¶WREHXVHGZKHQFRQVLGHUHGWREHWKHPRVWHIIHFWLYHRSWLRQ
available, if the individual was unable to change their lifestyle or if other non-
pharmacologic measures had failed to produce sufficient changes. The most important 
LVVXHZDVQRWZKHWKHUWKHUHZDVDµUHDO¶GLVRUGHUORFDWHGLQVLGHWKHERG\EXWKRZ
HIIHFWLYHDQGDSSURSULDWHDQLQWHUYHQWLRQZRXOGEHWRGHDOZLWKWKHµFRPSODLQW¶7KLVLV
decided between medical professionals and patients in the context of their daily lives 
and personal preferences (Tomnes, 2007). Therefore, it appears that medicalisation at 
a definitional level does not necessarily lead to justification for pharmaceutical therapy 
in the scientific domain as was observed in the media discourse.  
 
Occasionally, however, the role of modafinil was configured not as medical treatment 
but as safety tool for those without clinical disorder, as described in the case of acute 
use in extreme situations which require alertness and high levels of cognitive 
performance. This type of use was debated by sleep experts; some justified such 
applications based upon potential societal benefits whereas others discounted the 
idea. However, in the scientific discourse medicine did maintain rhetorical authority 
over the drug, even in absence of clinically defined illness, as the drug was still 
understood and positioned as a medical technology that should be under medical 
control, prescribed on the discretion and under the supervision of a medical 
professional. Fears were raised in relation to the potential harms that could be induced 
at a biological level by using a drug in the absence of illness to go without sleep. On a 
wider social level concerns were raised about the possible proliferation of non-clinical 
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use of the drug which could lead to social dependency, health problems and an over-
medicated population. 
 
Acute use of the drug in emergency situations for safety reasons cannot be clearly 
defined as therapy or enhancement, instead straddling the boundaries between the 
two. It can be considered therapeutic from the medico-scientific perspective on the 
basis that it is a medicine that is prescribed by medical professions to correct or 
prevent cognitive impairments due to reduced sleep in order to promote individual 
health and safety and the health and safety of others. On the other hand, it can be 
considered an enhancement on the grounds that the drug would be consumed in the 
absence of clinically defined disorder to counter a normal and natural human state, 
and thus would boost individual performance beyond a normal level. Interesting 
questions arise here regarding the social role of medicine. For if health is held as the 
ultimate goal for human existence, is the protection from harm or ill health a goal of 
the medical enterprise? And if so, does the acute use of psychopharmaceutical drugs 
such as modafinil fall under the jurisdiction of medicine or go beyond? Further to this, 
does drug use go µbeyond therapy¶ if the substance is prescribed and controlled by 
medical professionals but used for non-clinical applications? These questions will be 
considered in light of the analysis of prospective users views (Chapters 6 and 7) and 
returned to in Chapter 8. 
 
In the scientific discourse overall, modafinil was clearly defined as a medicine. 
Reading the technological script of modafinil in this way acted to exclude other 
possibilities of use outside of the medical encounter. It was made clear that modafinil 
is not a food; so should not be freely available to everyone on the supermarket 
shelves. It is not a safe and effective cognition enhancer, or a substitute for sleep and 
taking the drug is not risk free. It was argued that modafinil should only be used as a 
medicine when it has been prescribed to those that really need it, in a controlled and 
supervised way via the mechanism of prescription. Through the configuration of 
modafinil as a prescription medication the identity of the user was also constructed. In 
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scientific discourse users take their place within this cast of roles as patients (Akrich, 
1992). Further to this, parameters are set which attempt to define and delimit the 
XVHUV¶possible actions (Woolgar, 1991) where only certain forms of use are 
encouraged. In this case modafinil should only be used as a medicine when it has 
been prescribed as such during a clinical encounter by a medical professional. 
 
Although the dominant configuration of modafinil led to it being understood as a 
medical treatment and positioned as such within society, alternative technological 
scripts for use were readily imagined. Demand and desire for non-medical use of 
modafinil was assumed across all sections of society. Students, athletes, recreational 
drug users, children and various professionals were all imagined as future users of 
modafinil in their attempts to control sleep and enhance performance in everyday life. 
However, sleep scientists and clinicians readily defended their reading of modafinil-as-
medicine and were highly sceptical that the drug would work as a cognitive enhancer 
or that it would be safe for consumption without medical guidance. The data therefore 
illustrates the strong cultural power of medical authority in defining and delimiting 
legitimate spaces for drug use in modern society. 
 
Visions of the past and of the future regularly guided responses in this domain. Some 
respondents drew on stories of drugs that were once thought to be safe but later 
turned out to have adverse consequences to argue that modafinil use by those without 
illness should be approached with caution. Others projected into the future, 
envisioning how the drug could be abused, misused and lead to population health 
problems upstream. Scientists and clinicians alike referred back to the science of 
sleep and reasoned that, at present, the scientific community does not have the 
evidence available to say what the effects of extended wakefulness over a long period 
of time might be. On these grounds respondents found it difficult to endorse non-
medical uses of the drug. 
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Only when science understands more about what sleep is for, how drugs such as 
modafinil actually work, and what the long-term of effects of prolonged wakefulness 
could be, might the use of a technology to pharmacologically control sleep and 
enhance cognition among otherwise healthy individuals be endorsed by the scientific 
community.  For now, modafinil is understood a medical treatment, that is strong, 
largely safe and effective for use in clinical applications. 
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Chapter 6: Imagined uses of modafinil in the workplace 
 
Introduction 
 
As discussed in Chapter 1, the importance of the context in which 
psychopharmaceuticals are prescribed or bought and used is acknowledged by some 
academics involved in neuroethical debates (Sahakian & Morein-Zamir, 2007; Racine 
& Forlini, 2009). However, to date there is a lack of empirical evidence on this front 
with most debates referring to limited survey data (see: Nature, Jan 2008) or drawing 
on anecdotal evidence to discuss whether we µRXJKW¶WRHQKDQFHRXUFRJQLWLYH
functioning (e.g. Farah, 2004; Tannsjo, 2009). Alongside neuroethical debates, there 
are arguments in the sociological literature relating to the medicalisation (Conrad, 
2007) and pharmaceuticalisation (Williams, Gabe & Davis, 2009) of everyday life; the 
increasing tendency for aspects of selfhood and normality to be understood through 
biological and medical discourses and augmented using pharmaceuticals. This leads 
some to claim that new neurotechnologies not only cure illness or enhance health, but 
reconfigure the processes of life itself changing what it means to be a biological 
RUJDQLVP$FFRUGLQJWR1LNRODV5RVHµRXUYHU\ELRORJLFDOOLIHKDVHQWHUHG
WKHGRPDLQRIFKRLFH¶ 
 
The aim of this chapter is to analyse the ways in which prospective users of modafinil 
understand, position and negotiate use of the drug in the context of their everyday 
lives. It focuses on uses of the drug in one specific social context, the workplace, by 
one prospective user group, shift workers. Specific research questions addressed 
include: How are sleep, cognition and the body conceptualised by shift workers? How 
is modafinil use understood, positioned and negotiated within this social domain? 
What sociotechnical scripts are associated with modafinil use and how is it positioned 
as a medical or non-medical technology? According to what norms do shift workers 
believe that augmentation of the mind should take place? What role is given to 
medical authority in deciding if particular uses are acceptable?   
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Drawing on interview data, the chapter begins by providing a detailed description of 
the context of shift work from the perspective of shift workers, focusing on the 
problematisation of sleep and wakefulness in relation to the biological body. In doing 
this it attempts to expose the social and political bias in some key assumptions made 
about this (far from homogenous) group of people in the neuroethical and media 
debates, after which, the different interpretations and configurations of modafinil use 
and users are further explored in this social context. The analysis takes into account: 
the society and network of artefacts within which the technology would be embedded; 
how potential users/ non-XVHUVµUHDG¶WKHWHFKQRORJ\DQGLWVFRQILJXUDWLRQs; and how 
putative users/ non-users and the future impact of their likely actions are configured in 
the process (Woolgar, 1991; Akrich, 1992; Wilkie & Michael, 2009).  
 
The shift work context 
 
As discussed in Chapter 1, it is often assumed that in some professions at least, there 
is both need and desire for cognitive enhancement (Greely et al, 2008; Glannon, 
)DUDK7KHµQHHG¶IRUFRJQLWLYHHQKDQFHPHQWLVMXVWLILHGLQWHUPVRI
dangers posed by cognitively impaired or sleep deprived workers to others in the 
workplace and desire is framed in terms of increased productivity and performance at 
the individual level. Additionally, shift work is commonly associated with a move 
towards 24-hour living, flexibility and choice in when and how one conducts RQH¶VOLIH 
(Boden et al, 2008; Moore Ede, 1993). Psychopharmaceuticals fit into this vision as a 
way to remove corporeal restraints by augmentation of the biological body; a way of 
recreating ourselves in our everyday lives (Rose, 2007).  
 
In the following section these assumptions are questioned through an exploration of: 
the conception of shift work as a lifestyle choice; the perceived impacts of shift work 
on sleep and wakefulness; the problematisation of workplace sleepiness; the existing 
technologies, rituals and routines shift workers use to control sleep and enhance 
cognitive functioning in their daily lives. In the following two sections how modafinil use 
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was understood and positioned by shift workers in relation to these findings will be 
detailed. 
 
Shift work as a lifestyle choice? 
 
Over the past two decades there has been a noticeable move towards the vision of 24 
hour living in the UK (Moore-Ede, 2003). A huge array of services and facilities are 
now available on demand around the clock, from licensed premises to libraries. A 
result of the move towards 24 hour living is that more people are required to work 
shifts outside of the traditional 9-5 working day. It is tempting to assume that shift work 
FRQWULEXWHVWRZDUGVµIOH[LEOHOLYLQJ¶SURYLGLQJQRW only consumers but workers with 
more choice in how and when they conduct their life. In this vision of the world, drugs 
such as modafinil are afforded the role of technological enhancements that allow an 
individual to overcome the constraints of their biology and choose when to be awake 
and when to sleep.   
 
Extending the working week beyond the traditional 9am to 5pm working day Monday 
to Friday may provide greater flexibility for the consumer, however, it appears not to 
deliver this promise to many shift workers. Each of the shift workers interviewed 
reported no or very little control over the shifts that they worked, with only two of those 
interviewed voicing a preference for shift work. In general shift work was 
conceptualised as a difficult and inflexible lifestyle. As captured in the account below, 
most respondents would not choose to work shifts if they were not required to in their 
profession due to the negative impact it was perceived to have on their work-life 
balance and individual well-being.  
 
³,ZRXOGQ¶WVD\,GR>HQMR\ZRUNLQJVKLIWV@,GR>VHHEHQHILWV@EXW,WKLQNWKH\¶UH
IDURXWZHLJKHGE\WKHFRVWIRUPH«WKHHIIHFWRQIDPLO\OLIHVRFLDOOLIHQRWEHLQJ
DEOHWRGRWKLQJVWKDW,HQMR\GRLQJH[KDXVWLRQDVZHOO´+DPLVK0HGLFDO
doctor) 
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Theoretically, modafinil could pose a technological solution to these problems of work-
life balance by providing the user with more time awake and alert outside of the 
workplace for social engagements. However, this would require shift workers to 
forsake sleep for prolonged wakefulness. The desirability of this will be returned to 
later. 
 
Constructing sleep and wakefulness 
 
The social phenomenon of shift work has a direct influence on when, where, and how 
people sleep (Ekrich, 2001). In this section the ways in which sleep and wakefulness 
were talked about by shift workers will be explored with emphasis on how such 
representations act to construct shift workers bodies in relation to cultural conceptions 
of what they consider to be normal.  All respondents thought that sleep was important, 
although most admitted that they had not really thought much about why we sleep and 
what sleep does before the interview.  Although not at the forefront of their minds, 
sleep was constructed as an essential part of everyday life, a period of time for the 
body and brain to rest. As illustrated in the data extract below, it was valued highly and 
thought to be essential, good for and needed by the body, providing the energy 
required for physical and mental functioning during wakefulness.  
 
³,WKLQNLW¶VYHU\LPSRUWDQW\RXQHHGVOHHSVR\RXFDQJHWWKURXJKWKHGD\LW¶V
ZKDWWKHERG\QHHGVLW¶VJRWWRKDYHVOHHS«,WKLQNLW¶VYHU\JRRGIRU\RX´0R
Postal worker) 
 
Sleep and wakefulness were understood as two discrete states of consciousness. In 
WKLVYLHZZKHQDVOHHSWKHLQGLYLGXDOZRXOGEHWHPSRUDULO\µJRQH¶3DXO)DFWRU\
worker) until they awoke. Functionally the role of sleep was understood through 
personal experiences of the effects of sleep deprivation in respondents waking lives. 
Lack of sleep was perceived as impacting on the body, psychology and performance 
in various ways. The physical impacts of sleep deprivation on the body were described 
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DVµWHUULEOH¶7RE\$LUSRUWZRUNHURUDµQLJKWPDUH¶.LP1XUVH5HVSRQGHQWVOLQked 
lack of sleep to health problems both now and in later life, reporting that sleep 
deprivation lead to them feeling ill, shaky, tired all the time and exhausted. This was 
SHUFHLYHGE\RQHUHVSRQGHQWDVWKHERG\¶VZD\RIWHOOLQJWKHPLWFDQQRWJRRQZLWKout 
sleep (Hannah, Support worker).  
 
In the main, the psychological and emotional impacts of lack of sleep were 
emphasised in shift workers accounts. Respondents reported lack of sleep making 
them feel mentally tired, slow, groggy and fuzzy; snappy, cranky, irksome and irritable; 
overly emotional and being down or low in mood. Respondents saw these 
psychological and emotional impacts of sleep loss as transforming their personality. 
6RPHZHQWDVIDUDVWRVD\WKDWZLWKRXWHQRXJKVOHHSWKH\DUHQRWWKHLUµQRUPDOVHOI¶
+DQQDK6XSSRUWZRUNHULQVRPHFDVHVWXUQLQJLQWRµQRWDYHU\QLFHSHUVRQ¶3DXO
Factory worker). Additionally, the physical and emotional effects of lack of sleep were 
thought to negatively affect interpersonal relationships; lead to errors and mistakes in 
the workplace; diminished performance at work; and accidents on the roads.  
 
It was thought that when one works shifts their sleep pattern is disrupted and becomes 
XQVWDEOHDQGWKLVZDVVHHQDVµWKHQRUP¶IRUPDQ\SHRSOH7KLVGLVUXSWLRQZas 
GHVFULEHGDVµKDUG¶µKRUULEOH¶DµVKRFN¶DµNLOOHU¶DQGµQRWYHU\JRRG¶IRUWKHLQGLYLGXDO 
(Toby; Kim; Mo; Karolina)5HVSRQGHQWVUHSRUWHGµIRUFLQJ¶'DYLG0HGLFDOGRFWRU
themselves to sleep in the day or staying awake for up to forty-eight hours at a time 
EHIRUHµFUDVKLQJ¶+DPLVK0DWW2WKHUVVDLGWKDWXQGHUVSHFLILFFLUFXPVWDQFHVZKHQ
changing from day shift to night shift for example) over a twenty-four hour period they 
would probably get very little if any sleep. The effects of shift work on sleep patterns 
were typically described through biological understandings of the body. For example, 
UHVSRQGHQWVRIWHQGLVFXVVHGKRZWKHLUERG\FORFNZDVµRXWRIV\QF¶ZLWKWKHLUVKLIW
pattern. This was especially the case in accounts given by rotating shift workers (see 
data extract below) who thought that the constant change in the timings of their shifts 
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PDGHLWGLIILFXOWWRJHWLQWRDµSURSHUSDWWHUQ¶RIVOHHSDQGZDNHIXOQHVVPDNLQJWKHP
IHHOµWLUHGDOOWKHWLPH¶ 
 
³,GRQ¶WVOHHSYHU\ZHOOLQWKHGD\and when I am back on a day shift a day later 
DQG,IHHOUHDOO\WLUHGEHFDXVH,KDYHQRWJRWEDFNLQWRDSURSHUSDWWHUQ´
(Karolina, Nurse) 
 
In the absence of normative advice or cultural cues relating to sleep timing (for 
example, notions of bedtime, it being late or early) for this population some shift 
workers felt unsure about when they were supposed to go to sleep after a shift. This 
confusion is evident in the data extract below where an airport worker is talking about 
when he sleeps after working a night shift: 
 
³,I\RXFRPHKRPHIURPZRUNLQWKHPRUQLQJDWDPGR\RXJRWREHG
straightaway or do you stay up and then go to bed?  And when you do go to 
EHGVWUDLJKWDZD\\RXZDNHXSIDLUO\HDUO\DQGWKHQLW¶VOLNH\RXKDYHQ¶WVOHSW,I
you go to bed later, you wake up later, but you still feel as though you want to 
JREDFNWREHG´7RE\$LUSRUWZRUNHU 
 
Most respondents perceived themselves to have little control over how long they slept 
for. Several respondents said they would like to get eight hours sleep per night but 
usually got somewhere between five and seven. Eight hours sleep was commonly 
UHIHUUHGWRDVWKHµUHFRPPHQGHG¶µULJKW¶RUµIXOO¶DPRXQWRIVOHHSWKHERG\QHHGV
However, most thought that five to six hours was enough sleep for them on a regular 
EDVLVVOHHSLQJORQJHURQGD\VRIIDQGWDNLQJQDSVWRµFDWFKXS¶RUJHWVRPHµH[WUD¶
sleep. It was regularly stated that shift workers do not sleep well although this seemed 
WREHWDNHQIRUJUDQWHG&RQFHSWXDOLVLQJQRUPDOVOHHSDVDµVROLG¶SHULRG of time, shift 
ZRUNZDVWKRXJKWWRUHVXOWLQµEURNHQ¶VOHHS7KLVµEURNHQVOHHS¶ZDVWKRXJKWWRKDYH
more of a negative impact on the way the individual felt rather than changes to sleep 
duration or timing. 
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 ³,ZRXOGUDWKHUKDYH- 5 hours good sleep than I would 8 hours broken, 
EHFDXVH,ILQGWKDWLILWLVEURNHQVOHHSLWGRHVQ¶WPDWWHUKRZORQJ,KDYH,VWLOO
IHHODVWLUHG6RDOZD\VFRXQWP\VHOIDVDJRRGQLJKW¶VVOHHSLV- 5 solid 
KRXUV«´.DUROLQD1XUVH 
 
Implicitly, through the normative aspects of shift workers accounts we uncover the 
message that normal sleep should be an unbroken period of time, ideally seven to 
eight hours in length, during the night. One should wake up after this time and stay 
awake all day, until the same time the following night when it is time to go back to 
sleep. This stable pattern of uninterrupted sleep and wakefulness is how we should 
behave and how our bodies are designed to function. Shift work disrupts sleep at all of 
these levels. Shift workers (especially of the rotating type) cannot follow a set pattern 
of sleep and wakefulness. They cannot sleep for the recommended duration and are 
confused as to when it is the right time for them to sleep. Shift work results in broken 
sleep which affects the body, emotions, personality and performance. This is 
somewhat at odds with the scientific discourse, which points towards an 
understanding of sleep and wakefulness as on a continuum rather than discrete states 
and sleep timing, duration and efficiency as individual, influenced by social, 
psychological and biological factors. The importance placed on sleep by shift workers 
and their perception of sleep as a biological need brings into question the desirability 
of the technological extension of a wakeful state. This point will be returned to in 
greater detail later on. 
 
Problematising workplace sleepiness 
 
In a recent study Kroll-Smith & Gunter (2005) argue that somnolence, once 
considered a benign state of being and a naturally occurring corporeal precursor to 
sleep, is increasingly being represented as a potentially hazardous and morally 
reproachable problem of public concern. Workplace somnolence was something 
which all of those interviewed had experienced at one time or another. However, the 
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way in which this behaviour was constructed differed between respondents and was 
related to their occupational role.  
 
,QGRFWRUV¶DFFRXQWVZRUNSODFHVOHHSLQHVVZDVQRWSUREOHPDWLVHGRUVHHQDVPRUDOO\
reproachable. Instead this behaviour was thought of as to be expected and controlled 
through formal institutional mechanisms and practices. Neither of the two doctors 
interviewed disclosed that they had unintentionally fallen asleep in the workplace. 
7KH\UHSRUWHGVRPHWLPHVIHHOLQJµRXWRILW¶RUµDOORYHUWKHSODFH¶+DPLVK0HGLFDO
doctor), getting tired, struggling and finding it difficult to stay awake, their motivation 
waning when working nights or nearing the end of long days. In these instances, if it 
was not busy they would go to a specific space in the hospital designated for their use 
in these situations. They would be able to lie down on a bed in a darkened and quiet 
room, put their head down, and close their eyes. During this time they would be able 
WRUHVWDQGVOHHSUHIHUULQJWRWKLVDVWDNLQJDµSRZHUQDS¶+DPLVK'DYLG7KH\
reSRUWHGFDUU\LQJDQHOHFWURQLFSDJHUZKLFKZRXOGµEOHHS¶DQGZDNHWKHPXSLIWKH\
were needed back on the ward. The consequences of falling asleep unintentionally 
ZKLOVWZRUNLQJZHUHFRQFHSWXDOLVHGDVSRWHQWLDOO\µGLVDVWURXV¶RUµFDWDVWURSKLF¶'DYLG
Medical doctor) in terms of posing a danger to patients¶ lives. Both thought this would 
be unlikely to happen due to institutional practices and technologies that are in place 
such as alarms and other people around who would wake them up, which act as 
µVDIHJXDUGV¶'DYLG0HGLFDOGRFWRU 
 
Both the retail staff member and call centre operative reported that they had not fallen 
asleep at work but had felt very tired and sleepy, especially after a late night or when it 
was warm and not busy. Both had witnessed colleagues falling asleep at work and 
thought that if they were to fall asleep at work for a short period of time it would not be 
µD ELJGHDO¶$ODQ5HWDLOVWDII), that their colleagues would probably find it amusing and 
JLYHWKHPµDVKDNH¶WRZDNHWKHPXS(Edie, Call centre operative). One respondent 
UHDVRQHGWKDWZRUNSODFHVOHHSLQHVVLVXQGHUVWRRGDVµHYHU\RQHLVLQWKHVDPHERDW¶
and when it is not busy in the workplace one does not have to stay alert as there is not 
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as much work to do. In these occupations shift workers are not directly responsible for 
the safety of others and falling asleep at the desk does not pose the same dangers as 
falling asleep at the wheel of a car or in the operating theatre. Workplace sleepiness 
was not problematised by these respondents. 
 
Like the doctors interviewed, the two nurses interviewed reported taking time out to 
VOHHSGXULQJQLJKWVKLIWV,QVWDUNFRQWUDVWWRWKHGRFWRUV¶DFFRXQWVZRUNSODFH
sleepiness was identified as an extremely problematic and morally questionable 
EHKDYLRXULQQXUVHV¶DFFRXQWV,QSDUWLFXODUWKHGLIILFXOW\WKDWQXUVHVIDFHLQVWD\LQJ
awake during the night shift was discussed. In the accounts they gave it was 
acknowledged that even though officially nurses are not supposed to sleep at work 
during µZDNLQJQLJKWV¶, this is an ideal that in reality, is often not achievable. Both 
respondents reported that nurses working a waking night would often be allowed by 
their ward manger to take a nap on their break; or for a longer period if the ward was 
quiet to give them a rest. They would lie down on one of the empty beds used by 
patients or in the staff room by putting two chairs together. Other nurses would be 
around and often the environment would be light and noisy. The informal practice of 
taking time out to sleep was justified through appeals to the biological body and the 
µERG\FORFN¶ZLWKUHVSRQGHQWVDUJXLQJWKDWDOWKRXJKQXUVHVGRµVWUXJJOH¶.LP1XUVH
to stay awake, those who GRQRWZRUNSHUPDQHQWQLJKWVDUHµQRWRQDQLJKWVKLIWERG\
FORFN¶.DUROina, Nurse) so cannot keep themselves awake during breaks. Informal 
institutional mechanisms (e.g. other nurses would monitor time asleep and wake the 
individual up after their break) were also in place to ensure that the individual woke up 
as soon as they were needed. However, this practice was seen as strictly off-the-
record and not following official policy. Sleeping during working hours, even if one was 
on their break, was understood as illicit behaviour that was breaking the rules of the 
profession and it was feared that if they got caught sleeping at work that they would be 
disciplined.  
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Five respondents, a postman, a mental health support worker, a police officer, an 
airport worker and a machine operator in a factory, reported that they had felt 
excessively sleepy in the workplace but had not fallen asleep at work. They reported 
IHHOLQJµWLUHG¶µGR]LQJ¶µORRVLQJFRQFHQWUDWLRQ¶µVKXWWLQJRII¶JRLQJRQWRµDXWRSLORW¶
ILQGLQJLWµKDUG¶RUµDJRQLVLQJ¶WRVWD\DZDNHDIWHUDORQJGD\RUGXULQJWKHQLJKW. One 
respondent reported regularly falling asleep on the bus on the way to and from work 
(Toby, Airport worker). For these respondents, the consequences of falling asleep at 
ZRUNZHUHFRQFHSWXDOLVHGDVµGDQJHURXV¶ERWKIRUWKHPSURIHVVLRQDOO\E\OHDGLQJWo 
them losing their jobs; but also posing a danger to others by putting their lives at risk 
through negligence or causing accidents. Several told scare stories of colleagues who 
KDGIDOOHQDVOHHSDWZRUNEHHQµFDXJKW¶DQGKDGORVWWKHLUMREV 
 
³,WLVSUHWW\GDQJHURXVDQG,DPVXUH,FRXOGORVHP\MRELI,JRWFDXJKW«,NQRZ
DFRXSOHDWZRUNWKDWKDYHIHOODVOHHSEHIRUH«RQHZDVZRNHXSE\DWHDP
OHDGHUVRKHZDVVDFNHG´3DXO)DFWRU\ZRUNHU 
 
In one account, going to sleep during work hours was thought of in terms of deception. 
In the account below a postal worker is talking about how he thinks some colleagues 
take time out to sleep arriving back at work to make it look like they have done a full 
GD\¶VZRUNZKHQWKH\KDYHQRW7KHZRUNHULVSDLGWRZRUNIor a specific time period 
and when asleep one is not working. 
 
³,WKLQNVRPHSHRSOHGR>JRIRUDNLS@LQWKHYDQVRQFHWKH\¶YHGHOLYHUHGWKH
bags and boxes for the postmen...about 8, 9am, then go back to work later on 
VRREYLRXVO\ORRNVOLNHWKH\¶YHGRQH DIXOOGD\DQGWKH\KDYHQ¶W´0R3RVWDO
worker) 
 
Others imagined what might happen to those whose wellbeing they were responsible 
for if they were to fall asleep and used this to argue that in some professions, where 
one is responsible for the safety of others one simply cannot fall asleep at work.  
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³3UREDEO\JHWWKHVDFN«EHFDXVH\RX¶UHZRUNLQJZLWKYXOQHUDEOHDGXOWVDQG
\RX¶YHJRWWRGRPLQXWHREVHUYDWLRQVVR\RX¶UHUHVSRQVLEOHLIWKH\NLOOHG
WKHPVHOYHVDQG\RXZHUHQ¶WZDWFKLQJDWVSHFLILFWLPHVWhen ±\HDKVRFDQ¶WIDOO
DVOHHS´+DQQDK6XSSRUWZRUNHU 
 
The ways in which shift workers manage this disruption to sleep/alertness is discussed 
in the next section. 
 
Technologies, rituals and routines 
 
Despite much information being available in the public domain33, none of the shift 
workers interviewed had formally been given any information about how to manage 
sleepiness/alertness in their occupational role. Neither had any of them had sought 
out this type of information from their employers or other official sources. As illustrated 
EHORZLWZDVJHQHUDOO\DFFHSWHGWKDWPRVWVKLIWZRUNHUVGRQRWJHWµSURSHUVOHHS¶RU
µHQRXJKVOHHS¶EXWWKLVLVµSDUWRIWKHMRE¶DQG\RXDUHH[SHFWHGWRGHDOZLWKLW\RXUVHOI 
 
³«,GRQ¶WWKLQNSHRSOHUHDOO\FRQVLGHULW,think that, if you do have a problem, in 
UHJDUGVRI\RX¶UHQRWJHWWLQJHQRXJKVOHHSRUZKDWHYHUWKH\¶GMXVWWKLQNZHOO
you knew this is what the job entailed before you came on board, so you have 
WRMXVWGHDOZLWKLW´.LP1XUVH 
 
Information about how to manage workplace sleepiness and post-shift insomnia was 
often reported to be passed through informal channels, between colleagues and 
friends. In this sense, sleep was seen as a private and personal domain. Respondents 
reasoned that people deal with sleep problems in their own ways and find ways to 
KHOSWKHPVHOYHVJHWLQWRDSDWWHUQVRWKH\FDQVOHHSEHWWHU,QWKHLUVWXG\RQZRPHQ¶V
PDQDJHPHQWRIVOHHSSUREOHPV+LVORS	$UEHUDWWHPSWWRJRµEH\RQG
PHGLFDOLVDWLRQ¶WRKLJKOLJKWWKHLPSRUWDQFHRIµSHUVRQDOLVHGVWUDWHJLHV¶IRUPDQDJLQJ
                                                          
33
 Much information and advice for shift workers about how to manage sleep is available in the public 
domain. For instance, see: http://www.hse.gov.uk/humanfactors/shiftwork/tips.htm 
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sleep. They argue that such strategies exist outside of medicalised strategies that are 
promoted in popular culture and may be indicative of the demedicalisation of particular 
aspects of sleep. As technologies are designed, developed and used in the social 
world, in order to study the prospective uses of modafinil, it is important to first 
uncover the web of other artefacts and activities in which its use will be embedded. In 
this section, the personalised strategies shift workers already use to manage sleep 
and alertness in their daily lives will be described, acknowledging that although 
perceived as private or personal, such strategies may in fact be traceable back to 
narratives found in popular culture (Seale et al, 2007).  
 
Each of the respondents gave accounts of their own personal bedtime routine. 
Typically, this involved various aspects of personal hygiene, putting on specific bed 
clothes, darkening the room and getting into a bed. Some respondents reported self-
medicating, using OTC pharmaceutical products, homeopathic remedies, 
antihistamines and alcohol as sedatives to enable them to sleep when they were 
finding it difficult. One of the nurses interviewed described using an OTC sleep aid to 
help her sleep after DQLJKWVKLIWMXVWLI\LQJWKLVDFWLRQWKURXJKDSSHDOWRWKHµGHVLJQ¶RI
KHUµERG\FORFN¶ 
 
³0\URXWLQHLV,KDYHWRJRVWUDLJKWWREHGDVVRRQDV,JHWLQRIIP\QLJKWVKLIW
Sometimes I might take things like Nytol to help me get to sleep because I find it 
VRPXFKKDUGHUWRVOHHSLQWKHGD\EHFDXVHP\ERG\FORFNLVQ¶WGHVLJQHGWR
VOHHSLQWKHGD\´.DUROLQD1XUVH 
 
In addition, respondents reported reading, having a warm drink or hot bath, doing 
VRPHPLOGH[HUFLVHRUZDWFKLQJWHOHYLVLRQDVDQDLGWRµVZLWFKLQJRII¶2QHUHVSRQGHQW
described how he attempted to prevent developing sleep problems in the first 
instance. Again in his account we can observe echoes of the cultural norms discussed 
earlier: that an unbroken period of sleep during the night and wakefulness during the 
day is normal.  
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³,
PPRUHSUHYHQWLRQUDWKHUWKDQFXUHVR,ZLOOPDNHVXUHWKDW,GRQ¶WJRWREHG
GXULQJWKHGD\LI,NQRZ,¶YHJRWWRWU\DQGJHWP\VHOIEDFNWRDQRUPDOQRFWXUQDO
pattern. I will try and make myself as tired as possible and then wait to go to 
bed until I'm absolutely shattered, so I'm tired and therefore sleep all night 
ORQJ«´'DYLG0HGLFDOGRFWRU 
 
All but two of the respondents reported using an alarm on a daily basis to wake them 
up after a period of sleep. After getting out of bed respondents described various ways 
to help them wake up including: having a hot shower; hot drink; energy drink; 
something to eat; and making their environment light and noisy. Despite such efforts, 
some respondents reported still falling back to sleep.  Overall, respondents perceived 
themselves to have more control over when they awoke (albeit thoroughly mediated 
by technology) than when and how well they slept.  
 
All respondents thought that being busy at work, interacting and talking with people 
and keeping the body and brain active, although tiring, was the most important thing to 
µNHHSWKHPJRLQJ¶DZDNHDQGDOHUWLQWKHZRUNSODFH,WZDVUHJXODUO\DFNQRZOHGJHG
that people do use a variety of substances; both legal and illegal, to help them stay 
awake and alert. Some respondents reported drinking caffeinated drinks, eating 
sugary foods, taking caffeine pills, or smoking cigarettes specifically to promote alert 
wakefulness.  
 
³(DWORWVRIFKRFRODWHWRVWD\DZDNHDQGGULQNORWVRIFRIIHHand sometimes I 
take bottles of Red Bull and Lucozade and just hope that the patients just keep 
SUHVVLQJWKHLUEX]]HUVWRNHHSXVRQWKHEDOO´.LP1XUVH 
 
Other ways of promoting wakefulness included: taking breaks; getting a change of 
scenery; getting some fresh air; splashing cold water into ones face; having a shower; 
browsing the Internet; and watching television. One respondent gave an account of a 
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colleague who used illegal substances to stay awake, but stressed this was not the 
norm in his place of work. 
 
³HYHU\RQH¶VWLUHGEXWUHDOO\WKH\MXVWNHHSJRLQJWKH\¶UHWKHUHIRUWKHPRQH\
DQGWKDW¶VLWWKH\GRQ¶WFDUHVRORQJDVWKH\FDQJHWWKURXJKWKDWVKLIW%\DQ\
PHDQV,VKRXOGLPDJLQH6RPHKDYHSUREDEO\WDNHQVWXII«LW¶VSUREDEO\DUDULW\
ratheUWKDQDFRPPRQWKLQJ«RQHODGZDVVDFNHGODVWZHHN«IRXQGKLPLQWKH
WRLOHWVKLJKDVDNLWH«KHZDVWDNLQJVWLPXODQWV, obviously KHFRXOGQ¶WFRQWURO
them, he disappeared for hours hiding somewhere and eventually they checked 
the toilets, he was in one of the cubicles out of his head, so he got sacked on 
WKHVSRW«´7RE\$LUSRUWZRUNHU 
 
To summarise, the extent to which workplace sleepiness was viewed as a problem 
differed according to occupational role and occupational culture. In some occupations 
(e.g. hospital-based doctors) technologies and other mechanisms are embedded in 
institutional practices which allow for and control sleepy bodies. In other occupations 
(call centre, retail staff) workplace sleepiness was not problematised due to the 
perceived lack of impact this behaviour has on productivity (as it is less busy during 
late or early shifts) and the safety of others. In the other occupational roles discussed, 
workplace sleepiness was problematised in two ways: firstly by posing a danger to the 
securiW\RIRQH¶VMREDVZKHQRQHLVDVOHHSRQHLVQRWZRUNLQJDQGVHFRQGO\E\
putting the safety of both the self others at risk. There is a time and a place to sleep 
and for most shift workers neither of these is in the workplace. Although the body 
might be tired and one might feel sleepy, the shift worker must go against their 
biological clock to stay awake and alert to do their job and earn their pay or face being 
sacked.  
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Shift work sleep disorder: The power of diagnosis and labelling 
 
None of the shift workers interviewed had heard of shift work sleep disorder (SWSD) 
before the interview process. When informed of the symptoms of the disorder as 
defined in the ICSD-234, a few expressed their surprise that this was recognised as a 
medical disorder and disappointment that they had not heard of it before. Despite this, 
all but one of the respondents accepted the medical definition and said they could 
µXQGHUVWDQG¶ZK\6:6'ZRXOGH[LVWZLWKPDQ\UHFRJQLVLQJWKHV\PSWRPVLQ
themselves, family members or colleagues.  
 
Three respondents thought that this disorder explained the way they were affected by 
shift work. This transformation in understanding is captured in the account below. 
Before she was aware of a medical label and explanation for some of the sleep 
problems she had experienced the respondent had not previously linked her sleep 
problems to her job instead, understanding these feelings as normal for and personal 
to her. When informed that a medical disorder existed she became excited as she 
recognised the symptoms in herself. Immediately she reconstructed her own 
experiences through this medical discourse labelling herself with the condition. The 
normalising power of medical discourse is evident here as through the application of a 
medical model the boundaries of acceptable states and behaviours are reconfigured 
transforming the once normal into the pathological. 
 
³«LW¶VVXFKDQRUPWRPHEXWWKLQNLQJDERXWLWQRZWKDWWKHIDFWWKDW,GRKDYH
SUREOHPVVOHHSLQJLVSUREDEO\UHODWHGWRWKHMRE«WKDWZDVWKH last thing I 
WKRXJKWRILWEHLQJDQGWKLQNLQJDERXWLWQRZ,FDQ¶WEHOLHYHLW7KDW¶V
DPD]LQJ2KP\JRVK>ODXJKV@:RDK«,NQHZSHRSOHFDQJHWRYHUWLUHGDQG
KDYHSUREOHPVVKXWWLQJRIIEXW,GLGQ¶WWKLQNLWZDVDQDFWXDOGLVRUGHU«,WKLQN
,¶YHJRWWKDW«,WKLQN,KDYH,KDYH2KP\*RG<HDK,WKLQN,¶YHJRWLW,¶YH
KDGLWIRU\HDUV«´.LP1XUVH 
                                                          
34
 Symptoms have been identified as excessive sleepiness during working hours or in the evening and/or 
insomnia during desired sleep time usually lasting for a period of more than one month (Fahey & Zee, 2008) 
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Similarly, in another account the respondent reconstructed her experiences through 
the medical discourse and used this to explain why she did not cope in a previous job. 
She had found her sleep problems very severe and isolating. She felt that these were 
not taken seriously at her place of work and she ended up leaving her job and 
changing professions altogether. In the medicalisation literature it is argued that the 
application of a medical label can provide legitimacy to those living with the illness to 
gain medical treatment (Lee, 2006) and may also help individuals make sense of their 
µV\PSWRPV¶)XUHGL,QWKHDFFRXQWEHORZWKHVHSRVLWLYHDVSHFts of 
medicalisation are evident as the respondent explains how having a medical label for 
the problems she experienced would have helped her to understand why she was 
having problems, to reassure her she was not alone and give her hope of some 
treatment or help.  
 
³«WKDW¶VSUREDEO\ZK\,ZDVKDYLQJWURXEOHZKHQ,ZDVGRLQJWKHQXUVLQJ%XW,
QHYHUNQHZLWZDVDQ\WKLQJPHGLFDO«LWZRXOGKDYHEHHQQLFHWRNQRZWKDWEDFN
WKHQWKDWWKHUHZDVVRPHWKLQJRXWWKHUHWKDWSHRSOHFRXOGVD\µZHOO,FRXOG
give you soPHWKLQJLWFRXOGEHWKLV¶RUNQRZLQJWKDWRWKHUSHRSOHZHUHKDYLQJ
WKHVDPHSUREOHP«,W¶VMXVWNQRZLQJWKDW\RXDUHQRWDORQHRXWWKHUH«¶(GLH
Call centre operative) 
 
According to Lupton (2003) as individual lives and experiences are increasingly 
understood through the discourses and practices of medicine, power is exercised 
through the persuasion of subjects that certain ways of thinking and behaving are 
appropriate for them. Despite this, although the symptoms of the SWSD were 
recognised by all respondeQWVZLWKPDQ\H[SHULHQFLQJWKHVDPHµV\PSWRPV¶LWZDV
only in those situations where the problem was perceived as being dealt with 
inadequately did the respondents latch onto a medical definition to explain why they 
were feeling the way they were. The remaining respondents reasoned that all shift 
workers experience the effects of shift work and are sleep deprived to some degree 
and that those most severely affected or at the extreme end of the continuum are 
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probably the ones with SWSD disorder. Some thought that if they worked more 
frequent shifts then work-UHODWHGVOHHSSUREOHPVFRXOGEHFRPHµDUHDOSUREOHP¶
(Hamish, Medical doctor) for them too.  
 
$FFRUGLQJWR)DUDKµWKHGLVHDVHPRGHOHPSKDVLVHVWKHGHWHUPLQLVWLFQDWXUH
of behaviours and therefRUHUHGXFHVWKHLUPRUDOVWLJPD¶2WKHUVDUJXHWKDWLQFUHDVHG
awareness of a phenomenon through the process of medicalisation can help popular 
acceptance, boost research into the pathogenesis of the disorder and lead to 
improved pharmacological and psychological management (Stein et al., 2007).  In this 
case, the availability of medical discourse to explain and label experiences as 
symptoms of a disorder transformed the understanding of these experiences from 
personal difficulties for which the individual waVWREODPHLQWRµUHDOSUREOHPV¶WKDWZHUH
seen as legitimate to experience and to an extent outside of individual control and 
responsibility. Once seen as abnormal and biological, at least in part, these 
behaviours become legitimate sites for medical treatment. Nik Rose (2007) suggests 
that: 
 
µDQHXURFKHPLFDOVHQVHRIRXUVHOYHVLVLQFUHDVLQJO\EHLQJOD\HUHGRQWRRWKHU
older sense of the self, and invoked in particular settings and encounters with 
VLJQLILFDQWFRQVHTXHQFHV«WRJUDVSWKHZRUOGLQWKLVZD\LVto imagine the 
disorder as residing within the individual brain and its processes, and to see 
psychiatric drugs as a first line intervention, not merely for symptom relief but for 
ZD\VRIPRGXODWLQJDQGPDQDJLQJWKHVHQHXURFKHPLFDODQRPDOLHV¶-
3).  
 
The next section will explore shift workers attitudes towards the use of modafinil as a 
medical or non-medical intervention to µmodulate and manage¶ their neurochemistry.  
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Modafinil: configurations of technology and users 
 
None of the shift workers interviewed had heard of modafinil prior to the interview. 
They were informed that modafinil is presently available via prescription in the UK as a 
medical treatment for the symptom of excessive sleepiness/ impaired alertness for use 
by those with medical disorders. The role of modafinil in the workplace was flexibly 
interpreted by the shift workers interviewed with use and users (re)configured in many 
different ways. Four main configurations of user and technology dominated shift 
workers accounts: modafinil as a medical treatment for shift workers; modafinil as an 
OTC pharmaceutical product; modafinil as a safety apparatus; and modafinil as a 
cognition enhancer. In this section each of these are discussed in turn and the 
normative aspects to each configuration explored.  
 
Modafinil as a medical treatment 
 
As discussed in Chapter 1, SWSD is often presented in the neuroethics literature and 
media coverage alike, as a legitimate medical target for pharmaceutical intervention. 
Similarly, all of those interviewed DJUHHGWKDWPRGDILQLOXVHE\WKRVHZLWKµPHGLFDO
FRQGLWLRQV¶ZDVDFFHSWDEOHLIµUHFRPPHQGHG¶E\DGRFWRU¶35 Sleep problems 
diagnosed as due to SWSD were not differentiated from other sleep disorders in shift 
workers accounts. The severity of the problem was of primary concern rather than its 
biological or social origin. Medical professionals were thought of as experts 
possessing relevant medical knowledge as to when a problem was severe enough to 
warrant medical treatment. As acknowledged by Greely et al (2008: 704) presently 
medical doctors are the gatekeepers to medications such as modafinil and as such 
µVRFLHW\ORRNVWRWKHPIRUJXLGDQFHRQWKHXVHRIWKHVHPHGLFDWLRQV¶ 
 
                                                          
35
 As all but one of the respondents accepted the medical definition of SWSD, this too was viewed as a 
legitimate site for drug use. Even the one respondent who did question the validity of defining sleep 
problems due to shift work in medical terms agreed that treatment via modafinil would be acceptable if 
recommended by a doctor. 
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The data extract presented below illustrates the way in which respondents configured 
modafinil as a medicine. According to script theory (Akrich, 1992) technological 
objects come with scripts or instructions for use which not only provide a framework of 
action but also define actors and the space in which they are supposed to act. 
Moreover, in their interaction with the technology the prospective user is encouraged 
to find an adequate puzzle for the solution which the machine offers (Woolgar, 1991).  
The script that comes with this reading of the technology includes a serious problem 
that needs help, with actors given the roles of medicine, doctors and patients. 
 
³<HVLWVKRXOGEHDYDLODEOH- on prescription only I think.  If they have got a 
serious case of it and it was affecting their workWKHQZLWKWKHGRFWRU¶V
assistance- they should EHDEOHWRSUHVFULEHLWWRWKHP´$ODQ5HWDLOVWDII 
 
Although a disease-centred framework of understanding was readily applied and 
medical expertise valued in respondents accounts, the application of a pharmaceutical 
solution to sleep problems was not uncritically accepted. The majority of respondents 
positioned modafinil as a medical treatment that they would consider taking under 
PHGLFDODGYLFHDVDµODVWUHVRUW¶LIWKHUHZDVVRPHWKLQJµUHDOO\ZURQJ¶ZLWKWKHPWKDW
ZRXOGµPHULWWDNLQJDWDEOHW¶7KH\DOso provided several caveats: that they had spoken 
to their senior managers about their problem; taking the drug did not negatively affect 
their performance or judgment; there were no health risks; and that they were unable 
to change their shift pattern. All but two of the respondents said they would not want to 
take a drug to keep them awake at work, even as a treatment for a medical disorder, 
and expressed concern about potential health risks it could pose. 
 
It was frequently suggested that other ways of promoting sleep and alert wakefulness 
should EHWULHGEHIRUHµUHVRUWLQJWRGUXJV¶DQGWKHUHZHUHRWKHUWKLQJVLQGLYLGXDOVFRXOG
GRWRWU\DQGµJHWDGHFHQWVOHHS¶WKDWZRXOGEHPRUHµQDWXUDO¶+HUHUHVSRQGHQWV
often referred back to their routines, practices and technologies that they currently use 
to promote sleep/ alertness. For example, having a bath to calm down, relaxing the 
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EUDLQDQGERG\EHIRUHJRLQJWREHGJRLQJWREHGDWWKHµULJKW¶WLPHPDNLQJVXUHWKH
room is darkened and peaceful, or taking herbal remedies. 
 
According to Rose (2007) psychopharmaceuticals36 are promoted not as an external 
control, but as a way to restore the authentic self. He argues that such drugs are 
bound up in certain conceptions of how humans should be and that specific norms, 
values and judgements are internalised into these drugs. At present, when thinking 
about modafinil it is harder to make the same argument as respondents placed more 
YDOXHRQJHWWLQJµDGHFHQWVOHHS¶WKDQRQHQKDQFLQJWKHLUZDNHIXOVWDWH7KLVPD\EH
explained by thinking back to how sleep and wakefulness were understood in shift 
workers accounts. Sleep was constructed as a period of time for rest when the body 
would repair itself and become re-energised. Feeling tired or sleepy at work was seen 
as a conVHTXHQFHRIµEURNHQ¶RULQDGHTXDWHVOHHS:RUNSODFHVOHHSLQHVVZDVQRW
understood as broken wakefulness. In this view, wakefulness is not broken so does 
not need to be fixed, conversely if sleep can be fixed, the body will be re-energised so 
alert the following day and there would be no need to take the drug. Only one 
respondent thought the idea of taking a drug to promote wakefulness was more 
appealing than taking a sedative (Karolina, Nurse). 
 
However, the act of taking the pill was still understood as reVWRULQJDQµDXWKHQWLFVHOI¶
as Rose (2007) suggests. Within this framework of understanding, falling asleep/ 
struggling to stay awake at work was considered to be problematic. Through 
FRQVXOWDWLRQZLWKDGRFWRUVXFKSUREOHPVFDQEHDVVHVVHGYHULILHGDVµUHDO¶RU
µVHULRXV¶DQGZDUUDQWLQJRIPHGLFDODWWHQWLRQ7KHDFWRIWDNLQJPRGDILQLOLVWKHQ
considered to be therapeutic, acting to relieve suffering and help the shift worker feel 
well again. 
 
³LIVRPHRQHZDVVWUXJJOLQJWRVWD\DZDNHRUWKH\ZHUHKDYLQg problems, then 
I think that [modafinil] should be publicised...because it is prescribed by a doctor 
                                                          
36
 Rose is talking about Paxil and Prozac which are used to modulate affect as opposed to cognition. 
205 
 
WKH\KDYHJRWWKHODVWVD\LQLWVRWKH\FDQVHHLISHRSOHQHHGLWRUQRW´(GLH
Call centre operative) 
 
Some questioned whether people who cannot tolerate shift work should be given 
drugs or should change their jobs. However, it was acknowledged that some people 
such as those in medical professions and the emergency services do not have a 
FKRLFHLQWKHVKLIWVWKH\ZRUNDQGWKDWWKHVHLQGLYLGXDOVµKDYHDULJKWWRWUHDWPHQW¶VR
should have the option or choice to take the drug as a medical treatment under 
medical supervision. But, this should be just one of many options available to them 
and they should be fully informed about the both the benefits and risks of drug 
treatment.  
 
³«WKHVHUYLFHVWKDWSHRSOHXVHUHTXLUHSHRSOHWRZRUNVKLIWV6RDOWKRXJK\HV
they have chosen to do that occupation - medical, ambulance - I think there is a 
need to look after these people and if they do need these drugs - yes, it should 
be available for them, because just as anyone else, they have got a right for 
WUHDWPHQW¶0DWW3ROLFHRIILFHU 
 
$OWKRXJKQRWRSSRVHGWRµPHGLFDWLRQ¶RQHUHVSRQGHQWWKRXJKWWKDWWKHUHVKRXOGEH
PXFKPRUHHPSKDVLVSODFHGRQRWKHUZD\VWRµKHOS\RXUVHOI¶EHIRUHµUHVRUWLQJ¶WR
taking a tablet. She hoped people would look for alternatives before XVLQJµPHGLFDWLRQ¶
but accepted WKDWLIVRPHRQHZDVµVWUXJJOLQJ¶DWZRUNDQGVOHHSGHSULYDWLRn was really 
affecting their health and impacting on their work mRGDILQLOµZRXOGFHUWDLQO\EHQHILW
WKHP¶ (Karolina, Nurse). Additionally, the employer was thought to have some 
responsibility or duty of care toward their employees. While all agreed it would be 
unethical for an employer to expect their employees to take any sort of 
pharmacological agent to enhance their performance, they thought employers should 
look for strategies to lessen the problems faced, and provide information about 
medical treatments as one part of that.  
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The technological script was in this case therefore, read as a way of restoring a 
QRUPDORUµDXWKHQWLF¶6LQJKOHYHORIIXQFWLRQLQJZKHUHE\WKURXJKWKHLU
interaction with the technology the user would become themselves again. Despite this, 
as found in the scientific discourse, solutions to the problem of sleep deprived workers 
were not solely conceptualised as medical interventions at the individual level, which it 
has been argued in the medicalisation literature, has become institutionalised as the 
only proper way of dealing with illness (Strong, 2006). Instead, disease and disorder 
were understood as resulting from a combination of biological (those unique to the 
individual e.g. own body clock and common to everyone e.g. design of the body) and 
social factors (both working conditions and other aspects of lifestyle e.g. diet and 
nutrition) and the solutions posed also followed this model.  
 
In the main, the way shift workers perceived the role of medical experts appeared to 
conform to a traditional doctor-patient relationship, whereby the patient would present 
to the medical expert if they considered something to be wrong with them and expect 
medical treatment or advice to return them to health (with conceptions of normality 
understood through medical discourse). However, there was some evidence of the 
FRQFHSWLRQRIPHGLFDOH[SHUWVDVµFRQVXOWDQWV¶WKDWDUHJDWHNHHSHUVWRERWK
information and medication (Chatterjee, 2005). In this view, although the decision of 
whether to prescribe medication ultimately resides with the doctor, it is still the 
patient¶s choice whether they seek medical advice in the first instance, and if 
prescribed treatment, whether they decide to take it (Strong, 2006). The patient (or 
consumer) would use the medical expert as resource to access specialised 
information or medication as desired; or if they thought they could not get this 
elsewhere. For instance, one of the respondents thought that although he might 
consider seeking medical advice about sleep problems LIKHZDVµGHVSHUDWH¶'DYLG
he would not know whom to seek advice about workplace sleepiness from and 
doubted whether his GP would be able to tell him anything he did not already know. 
Another respondent said she would not go to her GP because she would not want to 
resort to prescription sleeping tablets, expecting this would be the only medical advice 
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available. In these instances the individuals chose not to consult a medical 
professional about their sleep problems instead opting to manage by themselves 
using their own lay-expertise and experiential knowledge of what works best for them. 
 
Modafinil as an OTC pharmaceutical product 
 
In a second configuration as an OTC pharmaceutical product, modafinil was still 
understood as a treatment or therapy for impairment or suffering resulting from shift 
work, however, one that shift workers should have access to outside of medical 
authority or without having to go through a clinical encounter. Although this 
interpretation of the technology was present in the data, only two respondents said 
they would consider taking a wake-promoting drug in the workplace outside of medical 
authority. As demonstrated below, respondents raised fears about drug use, relating 
to the possibility of reliance or dependency, leading to respondents reasoning that 
they would not take the drug on a regular basis. 
 
³,ZRXOGQ¶WWDNHLWRQDUHJXODUEDVLVMXVWVR,GLGQ¶WJHWWRRKRRNHGRQLWRU
become too reliant on it, but I would take it, like, if I know that I'm going to be on 
night shifts next week then I would take it to get myself prepared for it and 
SUREDEO\JRRXWDQGEX\LWEHIRUHKDQG´.LP1XUVH 
 
Although some respondents thought that modafinil should be more widely available to 
shift workers, they expressed concern about the amount of drugs that are available 
µRII-the-VKHOI¶.DUROLQD) and on the Internet and built in a level of control into their 
accounts. They feared that in some cases the problems people experience might be 
GXHWRDµKLGGHQPHGLFDOLOOQHVV¶.LPRUVWUHVV, and worried that self-medication 
might not be the right answer. However, they thought that having to go through one¶s 
*3WRDFFHVVWKHGUXJVHHPHGµKDUVK¶DQGWKDWDEHWWHUURXWHPLJKWEHWKURXJKWKH
pharmacist, who could ask questions before giving out the medication rather than 
anyone being able to pick the tablets up off the shop floor.  
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The extent to which pharmacists are seen as separate from the medical institution was 
not investigated in this study. Many GP surgeries work in partnerships with local 
pharmacies (e.g. through the Pharmacy First scheme), with pharmacists providing 
check-ups and supplying appropriate medication for common afflictions and infections. 
Patients also have contact with pharmacists who dispense their prescription 
medication and often offer advice about its consumption. Speculatively, pharmacists 
already operate at the periphery of the medical institution and as such are seen as 
possessing relevant professional knowledge to act as gatekeepers for this medication.    
 
³,WVKRXOGEHVROG\RXNQRZKRZLQWKHFKHPLVWWKH\¶YHJRWWKDWOLWWOHELt where 
\RXFDQJRLQDQGDVN\RXUTXHVWLRQVEHIRUHJLYLQJ\RXDPHGLFDWLRQ,GRQ¶W
think it should be just offhand where people can just walk in and pick it off the 
VKRSIORRU>WKHUH@QHHGWREHDVNHGVRPHTXHVWLRQVILUVW´.LP1XUVH 
 
For most respondents the potential affect the drug could have on alertness was most 
appealing as opposed to its other cognitive enhancing properties. However, most of 
WKHVHUHVSRQGHQWVEHOLHYHGLQµQDWXUDO¶LQWHUYHQWLRQILUVWZLWKVRPHH[SOLFDWLQJWKDW
they were not advocates of drug-taking for the sake of it, but reasoned that when one 
has work, financial and family commitments taking a drug like this could really help 
people cope. It was argued that if someone was having problems and taking the drug 
helped them and made them function better this would be acceptable. As 
demonstrated in the data extract below, this type of use was clearly differentiated from 
µHQKDQFHPHQW¶XVHVRIWKHGUXJDVLWVXVHZDVQRWXQGHUVWRRGDVLQFUHDVLQJ
improving or boosting cognitive performance. Again, the act of taking the drug was 
seen as a way to regain an authentic self, a way to repair a performance deficit and 
regain a normal level of functioning for that individual. 
 
³2QDQLJKWVKLIWZKHQ\RX¶UHUHDOO\WLUHG\RX¶UHQRWTXLWHDVDOHUWDnd attentive 
as you would be, it just helps you to be as you normally would be WKHQWKDW¶V
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GLIIHUHQWWRVD\LQJWKDW\RX¶UHJRLQJWRJLYHWKHPVRPHZRQGHUGUXJWKDW¶VJRLQJ
WRDFWXDOO\LQFUHDVHWKHLUFRJQLWLYHDELOLWLHV´+DPLVK0HGLFDOGRFWRU 
 
Norms change in response to biomedical advances, new therapies and as living 
FRQGLWLRQVFKDQJH3UHVLGHQWV&RXQFLORQ%LRHWKLFV:ROSHDUJXHVWKDWµFOHDUO\
some of the top selling drugs in the world today are being used by patients who fit no 
traditional definition of pathology, yet still see in their own functioning a deficit that 
WKHVHGUXJVDGGUHVV¶,QWKHPRVWSDUWWKLVDSSHDUVWR fit with shift 
workers understandings of modafinil use in the workplace.  
 
Modafinil as a safety tool 
 
In contrast to the configurations of modafinil use and users discussed above, in a third 
configuration modafinil was interpreted as neither therapy nor individual enhancement 
tool, but as a type of safety apparatus. Use of modafinil was constructed as a way to 
prevent accidents and mistakes in the workplace, reducing the risk of harm to self and 
others. Legitimate users were (re) configured as responsible and altruistic adults 
taking the drug for the benefit of others, in some cases even if it was putting their own 
health or safety at risk. Examples of this type of user given by respondents were 
generally individuals whom through their job were in a position of care for the welfare 
and safety of others. These included doctors, nurses, pilots, police officers and other 
emergency services personnel. Within this frame, safety was the most important 
consideration in the legitimation of drug use.  
 
³,ZRXOGORRNDWWKHZKROHVDIHW\DVSHFWLILWVKRZHGWKDWSHRSOHZHUH
functioning better and there was less errors and patients were getting a lot 
EHWWHUFDUHWKHQLWZRXOGQ¶WERWKHUPHDWDOO,ZRXOGMXVWZDQWWRNQRZWKDW
they are safe to work that day and that they are fit for practice that day and that 
VKRXOGEHDOOWKDWPDWWHUHGLQRXUSURIHVVLRQ´.DUROLQD1XUVH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Sahakian and Morein-Zamir (2007: 1158) compare cognitive enhancing drugs to 
FDIIHLQHDQGDVVXPHWKDWµFRJQLWLYHHQKDQFHUVZLWKVPDOORUQRVLGHHIIHFWVEXWZLWK
moderate enhancing effects that alleviate forgetfulness or enable one to focus better 
on the task at hand during a tiring day at work would be unlikely to meet much 
REMHFWLRQ¶7KH\JRRQWRDVNµGRHVLWPDWWHULILWLVGHOLYHUHGLQDSLOORUDGULQN"¶ 
 
Occasionally, some respondents thought that taking a drug was an acceptable route 
WRµNHHSLQJDZDNH¶DWZRUNEHFDXVHSHRSOHDOUHDG\XVHFDIIHLQHDQGHQHUJ\GULQNVIRU
that purpose. Drug use was understood in terms of its effects on the shift worker and 
positioned in line with existing technologies. In some accounts comparisons were 
drawn with high sugar and caffeinated energy drinks, with respondents arguing that 
WKHVHDUHFXUUHQWO\XVHGIRUWKHµVDPHUHDVRQV¶DVWKHGUXJZRXOGEHVROLNHZLVHLW
should be acceptable.  The end goal of being a safe practitioner was viewed as being 
more important than how one achieved their state of alert wakefulness.  
 
However, in the majority of accounts, drugs were clearly demarcated from foodstuffs 
and herbal remedies. In general, these respondents did not oppose other ways of 
intervening in the sleep wake cycle, such as drinking coffee, energy drinks or using 
DOWHUQDWLYHPHGLFLQHVZKLFKZHUHGHVFULEHGDVPRUHµJHQWOH¶RUµQDWXUDO¶WKDQµWDEOHWV¶
In the data presented below, a police officer is describing how on a personal level he 
does not like taking tablets to keep him going, although he thinks he sounds 
hypocritical because he uses energy drinks to promote wakefulness but would not use 
drugs for the same purpose. He justifies his attitude towards drugs through fears of 
dependency and addiction. Addiction in this case is thought of as having a physical 
basis in the body.  
 
³,ZRXOGUDWKHUGHDOZLWKLWWKURXJKGLHWRUZLWKH[HUFLVH«,GRQ¶WZDQWWRHQGXS
being dependent on anything and I hate the idea of my body being addicted to 
DQ\WKLQJ«,MXVWGRQ¶WOLNHWDNLQJWDElets or anything like that to keep me going.  I 
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NQRZWKDW¶VDVOLJKWO\K\SRFULWLFDO- like taking an energy drink - however I do 
WKDWDVVSDULQJO\DV,FDQ´ (Matt, Police officer). 
 
It is interesting that in both academic and media discourses it is often the image of a 
drowsy doctor about to perform life-saving surgery that we are presented with to argue 
that there is a real need for technological augmentation of wakefulness in some 
professions. In these instances, the act of taking psychopharmaceuticals is framed as 
potentially life-saving (e.g. Sahakian & Morein-Zamir, 2007). An argument is often 
made in the philosophical literature and echoes can be found in popular discourses 
which prioritises the 'safety of others'. For example, a doctor working in a hospital in 
an emergency ward needs to be alert and cognitively able for extended periods of time 
so she can do her job properly. Accuracy, concentration and alertness are essential. 
The lives of patients are at stake if the doctors cognitive functioning declines. 
Cognition enhancing drugs are then positioned as a way to prevent decline in 
functioning so lives of others will not be endangered when the doctors has to work 
under pressure for extended periods. The conclusion nearly always drawn is that 
drugs should be allowed in these circumstances. 
 
However, the accounts of the two doctors interviewed reveal techniques and practices 
embedded in their everyday lives, both inside and outside the workplace that in some 
respects centre around the very issue of patient safety. When the enhancement 
technology is placed in context, the relevance of utilitarian philosophical arguments; 
that enhancement is for the 'greater good', are not as convincing. The data presented 
here raises questions as to if there is actually a safety problem posed in the first place 
which casts doubts as to whether the technology is in fact needed. In practice doctors 
are able to take breaks, sleep, have other technological aids such as alarms and 
computers and are surrounded by support staff. The heroic image of the lone surgeon 
struggling against sleep fighting to save innocent lives seems detached from clinical 
reality. Without a 'danger' of impaired doctors and a heightened 'risk' to patient safety, 
212 
 
the technology cannot so easy be enrolled in the socio-technical network operating in 
this workspace. 
 
Modafinil as a cognition enhancing drug  
 
Positive assumptions regarding the demand, social need, impact and desirability of 
cognitive enhancement technologies are in abundance (Chapter 1) and directly 
influence the ethical issues that are prioritised in neuroethical discourse (Martin & 
Williams, 2009). Specifically, talking about its use in the workplace, modafinil is 
assumed to extend workplace productivity through improved cognitive functioning; and 
reduce risk of mistakes and accidents through promotion of alertness, thus being of 
benefit to employers, individuals and wider society alike. Commentators regularly write 
DERXWWKHµJURZLQJGHPDQGIRUFRJQLWLYHHQKDQFHPHQW¶*UHHO\HWDOZLWKsome 
SUHGLFWLQJWKDWµWKHGULYHIRUVHOI-enhancement of cognition is likely to be as strong if 
QRWVWURQJHUWKDQLQWKHUHDOPVRIµHQKDQFHPHQW¶RIEHDXW\DQG VH[XDOIXQFWLRQ¶
(Sahakian & Morein-Zamir, 2007: 1159).  
 
As discussed earlier, for most of the shift workers interviewed an acceptable level of 
performance was considered to be achievable through existing formal and informal 
mechanisms, techniques and technologies meaning that workplace sleepiness was 
not considered problematic. Without a performance deficit, the question then becomes 
about enhancement rather than therapy and how modafinil might fit into existing 
practices, socio-technical networks and spaces as a tool for self-improvement. In this 
section shift worker views about cognitive enhancement in the workplace are 
presented to in order to question the assumptions made about demand and 
desirability to enhance and to explore the social and ethical issues this stakeholder 
group perceive to be of most relevance to them. 
 
Although many respondents did not see a personal need for the drug, in general they 
did not have any problems with the idea of their colleagues using such substances, as 
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long as it was a personal choice they had made. However, efficacy emerged as an 
important consideration. Respondents reasoned that some people perform better than 
RWKHUVLQWKHZRUNSODFHDQ\ZD\VRIRUVRPHZRUNHUVWKLVGUXJFRXOGEHµJRRG¶IRU
them. However, the extent to which the drug improved performance did affect its 
perceived desirability, with one respondent reasoning that although he thinks he is 
good at his job so does not need a drug to improve his performance, if most people at 
work were taking a drug and their performance was markedly improved he would 
consider trying it too (Mo, postal worker). In the account below the respondent 
discusses the issue of efficacy. He draws on the notion that everyone reacts differently 
to different drugs and reasons that even though taking a drug to enhance cognition 
might make some individuals more productive at their job, it could have an adverse 
reaction in other people and make them ill. He thinks that for this reason large 
companies would not promote drug use amongst their employees, as they have a duty 
of care and would not want to be seen as promoting something that could cause harm. 
 
³«LIWKDWDIIHFWVWKHSHUVRQ>SRVLWLYHO\@WKHQPRUHSHRSOHPLJKWZDQWWRWDNHLW
EXW,ZRXOGQ¶WVHHWKHFRPSDQ\SURPRWLQJWKHPEHFDXVHWKHFRPSDQ\KDVD
GXW\RIFDUHIRUWKHHPSOR\HH«HYHQWKRXJKWKHVLGHHIIHFWVPD\EHLQFUHDVHG
productivity, they would also have other side effects - they have always got the 
RWKHUVLGHRILWDQGGLIIHUHQWSHRSOHUHDFWGLIIHUHQWO\WRHYHU\WKLQJ´$ODQ5HWDLO
staff)  
 
:KHQWDONLQJDERXWXVLQJPRGDILQLODVDFRJQLWLYHHQKDQFHUUHVSRQGHQWV¶DFFRXQWV
were generally apprehensive and sceptical that the drug would work and there would 
QRWEHDµSULFHWRSD\¶+DQQDKVXSSRUWZRUNHUHOVHZKHUH:LWKUHIHUHQFHWRRWKHU
drugs and drawing on experiential knowledge they questioned the safety of the drug 
and raised concerns about what other effects it could be having on the body. Their 
reluctance towards taking pharmaceuticals was based upon lack of knowledge about 
what the drug could do to their body; concern about potential side effects; becoming 
dependent or addicted tRVRPHWKLQJDUJXLQJWKDWWKHUHDUHPRUHµQDWXUDO¶ZD\VWRGR
214 
 
WKLQJV$VLOOXVWUDWHGEHORZWKH\VDZWKHGUXJDVµVWRSSLQJ¶VOHHSDQGµIRUFLQJ¶
wakefulness and reasoned that this would probably have negative effects on the body. 
 
³:H¶UHQRWGHVLJQHGWRVWDy awake all that many hours, we need to regenerate, 
VR,WKLQNWREHIRUFHGWRVWD\DZDNH«VWXGLHVKDGVKRZQWKDW\RXGRDFWXDOO\
QHHGDJRRGHLJKWWRQLQHKRXUV¶VOHHSEHIRUHLWVWDUWVKDYLQJDQHIIHFWRQ\RXU
PHPRU\DQG\RXUEUDLQVR,ZRXOGQ¶WWDNHLW´(Hannah, Support worker) 
 
The use of modafinil to enhance cognitive abilities was differentiated from taking it in 
the workplace. In the context of shift work the drug was generally perceived as a 
therapeutic technology:  a way to restore a normal level of cognitive functioning. This 
was viewed as a legitimate use for the drug whereas a technology that could be used 
WRERRVWSHUIRUPDQFHEH\RQGDQRUPDOOHYHOZDVWKRXJKWRILQWHUPVRIDµPLUDFOH¶
0RSRVWDOZRUNHURUDµZRQGHUGUXJ¶DQGZDVWUHDWHGZLWKVcepticism. In the account 
EHORZWKHGLIILFXOW\RIDUJXLQJDJDLQVWDQµHQKDQFHPHQW¶- something that would make 
you perform better is acknowledged.  
 
³:HOO\HDKWKDW¶VDWULFN\RQHEHFDXVHNLQGRIFDQ¶WVD\QRUHDOO\FDQ\RX"
%XWLWMXVWGRHVQ¶WVRXQG ULJKW,WKLQNWKDWZRXOGEHDELWZRUU\LQJWREHKRQHVW´
(Hamish, Medical doctor) 
 
Medicalisation theory can be used to understand how drug use is legitimated in some 
VFHQDULRVWKURXJKWKHLGHDRIµQRUPDOLVDWLRQ¶&RQUDGEXWXVHVWKDWIDOORXWVide 
of this, for the purposes of performance enhancement have more dubious 
connotations. Through an understanding of modafinil as a treatment or safety tool, the 
use of psychopharmaceuticals by healthy individuals was seen as a form of drug 
abuse. In the absence of any deficit or threat to safety, the substance is not being 
used to relieve suffering, to restore normal functioning or to improve safety. Instead its 
use was thought of as an attempt to make the individual better than well, gain an 
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advantage over others or improve oneself above the norm, which was conceptualised 
as an abuse of its intended effects.  
 
³,I\RX¶UHJRLQJWRKDYHDQLJKWRXW,GRQ¶WWKLQN\RXVKRXOGWDNHLWQR,WKLQN
WKDW¶VDELWULGLFXORXV«LW¶VIRUSHRSOHZKRZRUN \RX¶UHQRWJRLng to work when 
\RX¶UHJRLQJRXWGULQNLQJDUH\RX"<RX¶UHMXVWJRLQJRXWWRKDYHDODXJKDQG
VWXII6RQR,GRQ¶WWKLQN\RXVKRXOGWDNHRQHLI\RX¶UHJRLQJRXWGULQNLQJQR
QRZD\´0R3RVWDOZRUNHU 
 
The social use of modafinil, outside of the workplace by those without problems or 
impairments and who were not in a position of responsibility for others was seen as 
illegitimate. Illegitimate users were then, configured as those who choose to stay 
awake longer for their own benefit, thus illustrating how both the context in and 
purpose for which the drug is used is of importance in the perceived acceptability of its 
use. 
 
In shift workers¶ accounts, comparisons were drawn between modafinil and existing 
pharmaceutical technologies such as sedatives, caffeine pills, paracetamol, diet pills 
and laxatives. Discursively such comparisons enabled fears to be raised about the 
pharmaceuticalisation of sleepiness/alertness (Williams et al, 2009) through the 
potential for widespread use and the risks to health this could pose. These fears were 
justified through the fact that modafinil is still a relatively new drug and has lots of 
unknowns attached to it. For example, one respondent described a new sleeping pill 
KHKDGUHDGDERXWZKLFKJDYHXVHUVµEDGQLJKWPDUHV¶ and could lead to dependency 
(Matt, Police officer). Through this comparison he raises his own concerns about the 
negative impact modafinil could have on health and the body. He uses this story to 
argue that if the drug has addictive qualities or can be abused it needs to be 
prescribed so these impacts can be controlled. In fact, most respondents argued that 
controlling access to modafinil through medical prescription would be the best 
mechanism to prevent widespread use and stop potential damage or harms to health 
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this drug could cause. Others questioned the appeal of extending wakefulness and 
were unsure as to whether it would be something they would want to experience (Mo, 
Postal worker). 
 
These findings indicate that perhaps, the demand for cognitive enhancement is not as 
obvious as is assumed in neuroethical and media discourses. Although some potential 
benefits to the drug were recognised, discourse was dominated by fears and concerns 
raised over safety of the drug and potential harms to health it could lead to. Others 
explicitly questioned the appeal of cognitive enhancement. This has been identified 
(Williams & Martin, 2009) by some commentators who recognise that there is little 
empirical evidence that large numbers of people are interested in using cognitive 
enhancers and strong anecdotal evidence for each side of the debate. Williams and 
Martin argue that µif enough positive assumptions are made about these key issues 
[safety, efficacy and demand], then almost any technology can look attractive or 
inevitable¶ (2009: 532).  
 
Although taking modafinil could be seen as fitting in with an array of practices outlined 
in the previous section to control sleep, somnolence and promote alert wakefulness, 
cultural attitudes towards drugs and associated fears of harms to health, abuse, 
addiction and dependency may in fact form a barrier preventing widespread 
acceptability and use of pharmaceutical enhancement technologies.   
 
Some argue that the very existence of technology poses constraints on choice of how 
one lives one¶V life (Cahill, 2004). In the case of modafinil, the existence of a 
technology which allows the possibility of achieving a prolonged wakeful and mentally 
enhanced state both provides and constrains choice. For example, modafinil could 
come to be seen as a way to escape the constraints of the biological body allowing 
one to choose when to sleep and when to work, or equally as likely, the only way to 
effectively manage sleep and work in a 24 hour society. It was the latter view rather 
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than the former that dominated shift workers accounts. Such visions of the future 
expressed by shift workers are outlined in the next section. 
 
Visions of the future and their performativity 
 
Most respondents thought that if drugs like modafinil were to be widely available in the 
future they would have a huge impact on the workplace and the workforce. Around 
half of those interviewed thought that modafinil should be made more widely available 
to shift workers in the future without prescription, provided that it was a µFRPSOHWHO\
IULHQGO\GUXJ¶+DPLVK0HGLFDOGRFWRUWKDWZDVµZHOOUHVHDUFKHG¶'DYLG0HGLFDO
GRFWRUDQGµVKRZQWREHQHILWVKLIWZRUNHUV¶+DPLVK0HGLFDOGRFWRU'HVSLWHWKLV, 
respondents still worried about potential effects on the body of prolonged use, the 
potential to become dependent on the drug and questioned whether taking this drug 
IUHTXHQWO\ZRXOGEHDµJRRGLGHD¶3DXO)DFWRU\ZRUNHU 
 
9LVLRQVRIWKHIXWXUHZRUNSODFHZHUHFRPPRQO\FRQVWUXFWHGLQUHVSRQGHQWV¶DFFRXQWV
In the main, these were characterised by fear, concern, and worry. Modafinil was 
WKRXJKWRIDVDµZRQGHUGUXJ¶WRGHDOZLWKODFNRIVOHHSWKDWZRXOGEHXVHGWRFUHDWHD
new type of worker who was more intelligent, alert, safer and productive. It was 
thought that employers would SXVKWRZDUGWKLVDQGJRGRZQµDGDQJHURXVURDG¶D
µTXLFNIL[URXWH¶WKDWµRSHQVWKHGRRU¶WRDQHQYLURQPHQWRIµPDVVLYHFRPSHWLWLRQ¶
5HVSRQGHQWVIHDUHGWKDWRWKHUGUXJVZLOOEHµVSDZQHG¶WRQRWPDNHSHRSOHKHDOWKLHU
but to make them function better, in part fuelled by the money to be made by drug 
FRPSDQLHV7KLVµSOD\LQJZLWKELRORJ\¶ZDVWKRXJKWRIE\VRPHDVµGHKXPDQLVLQJ¶
µWXUQLQJSHRSOHLQWRURERWV¶VRWKH\FRXOGµUXQDURXQGOLNHPDGPHQ¶MXVWWRGRPRUH
RYHUWLPHUHVXOWLQJLQDQµDUWLILFLDOZRUNIRUFH¶ 
 
³,WZLOOPDNHDQartificial workforce«SHRSOHZLOOHQGXSEHFRPLQJdependent on 
WKHVHWKLQJVEHFDXVHLWZLOOPHDQWKDWWKDW¶VWKHRQO\ZD\WKH\FDQEHEHWWHU- or 
there will just be then a further escalation in developing better drugs which 
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DUHQ¶WUeally in the end for making people healthier, it will be just about making a 
new, more intelligent, more alert workforce, which I think just 
dehumanises«\RXDUHRSHQLQJWKHGRRUZKHUHLWLVMXVWmassive competition 
DQG,WKLQNWKDW¶VTXLWHdangerous«0DWW Police officer) 
 
Hyman (2006) identifies one of the imagined risks of cognitive enhancement as 
inequality; and accounts a vision of the workplace in which medication is required 
either implicitly or explicitly for success. The expectation that improved cognition will 
lead to better, more productive, efficient and successful workers in deeply entrenched 
in the academic literature. In shift workers accounts, fears of coercion sprung from 
ideas of unrestricted access to and legality of the drug. It was feared that in the future 
even if one does not want to take these drugs they might end up taking them because 
WDNLQJGUXJVZLOOEHFRPHWKHRQO\ZD\WRµNHHSJRLQJ¶µEHEHWWHU¶µJHWDKHDG¶DQGµGR
EHWWHU¶$OOLHGWRWKLVZHUHIHDUVRIZLGHVSUHDGXVHOHDGLQJWRdependency, especially 
by those in challenging and pressured jobs. Bearing some similarity to the neuroethics 
and media discourses, shift workers imagine the future workplace as a place filled with 
people that are self-medicating and using taking tablets to do their job, rather than 
people with legitimate knowledge or adequate skills.  
 
³,WZRXOGEHDELWZHLUG,WKLQNLWZLOORSHQXSDGRRUWRORWVRIRWKHUWKLQJV- you 
could have tablets for this, tablets for that so instead of having people who 
actually NQRZZKDWWKH\¶UHGRLQJ\RXPLJKWMXVWKDYHSHRSOHZKRDUHWDNLQJ
WDEOHWV«´+DPLVK0HGLFDOGRFWRU 
 
Others questioned whether it would be fair to allow unrestricted access to a drug 
which could potentially improve performance in the workplace. Respondents imagined 
a future workplace where everyone was taking the drug all the time to perform better 
and it argued that this would somehow devalue their performance (see data extract 
below). Comparisons were drawn with steroid use by athletes to argue that drug 
consumption would give users an unfair advantage over other colleagues who had not 
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taken the drug. One respondent drew on her own experience of taking caffeine pills to 
SURPRWHDOHUWQHVVWRDUJXHWKDWPRGDILQLOZRXOGEHµEHWWHURII¶EHLQJSUHVFULSWLRQRQly 
to prevent it being abused in this way.  
 
³,WDOPRVWPDNHV\RXWKLQNµZHOOLVLWIDLU"¶,FRXOGLPDJLQHWXUQLQJXSWRZRUNDQG
having a few of the lads just taking those constantly and they are getting better 
results at their job and it almost seems a bit fake - like an athlete taking 
steroids. It is on the same level as that.  If everyone was taking it then I think it 
would be a problem, but if only the people who really needed it were, that I 
ZRXOGEHDORWPRUHLQFOLQHGWREHKDSS\IRUWKHP´(GLH&all centre operative) 
 
7KHVHG\VWRSLDQYLVLRQVRIWKHIXWXUHIUDPHGUHVSRQGHQWV¶DWWLWXGHVLQWKHSUHVHQW
The perspectives of all respondents converged on the issues of medical expertise and 
control of the technology. The medical profession were seen as ideally suited to 
control use of the drug, to ensure benefits are there for those who need them whilst 
protecting against potential harms to both the individual and society. Drawing on past 
experiences and situations respondents imagined future uses and users of the 
technology and evaluated the potential implications of these in terms of the present 
situation. They used this strategy to justify action in the present, namely, fears over 
increased competition, illnesses, side effects, addiction, dependency, and reliance on 
substances were used to argue for continued medical supervision of the drug to 
ensure treatment for those in need whilst protecting against detrimental effects .  
 
³RQWKHEDVLVRIZKDWLWFDQJLYH\RXPD\EHLWshould be a prescribed thing«,
would say that it probably would be something that needs to be controlled«D
doctor- someone with some kind of medical knowledge that will have the 
LQWHUHVWRIWKHSHUVRQ¶Vhealth more than the performance RIWKHSHUVRQ´0DWW
Police officer) 
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In summary, it was argued that presently, modafinil should be available to shift 
workers on prescription not as a first line intervention as suggested by Rose (2007) 
EXWDVDµODVWUHVRUW¶LIWKHLQGLYLGXDOZDVµVHULRXVO\¶DIIHFWHGE\VKLIWZRUNDQGµUHDOO\
QHHGHG¶ the drug. Medical professionals were thought to be in a position to assess 
whether someone was in need of the drug and medical supervision of the drug was 
viewed as a way to control access so prevent abuse.  Illegitimate users were 
configured as those who are already functioning normally so do not need treatment. 
 
Summary and conclusions 
 
This chapter takes an empirical approach to explore the complex social context of shift 
work from the perspective of shift workers and argues that the way we live our modern 
lives acts to both create and constrain particular understandings of sleep, wakefulness 
and the body. A contextualised understanding of these phenomena shapes which 
particular social and ethical issues surrounding pharmaceutical augmentation of sleep 
and cognition are deemed relevant by this community to themselves as individuals in 
the conduct of their everyday lives. 
 
Overall, sleep was constructed as an essential part of everyday life, a personal and 
private period of time for the body and brain to rest and repair. Workplace somnolence 
was something which all of those interviewed had experienced at one time or another. 
However, the way in which this behaviour was constructed differed between 
respondents and was related to their occupational role. The information gained from 
the accounts of those interviewed sheds some light on how sleeping behaviours are 
embedded in specific institutional norms and occupational cultures. Where safety of 
others is paramount, from the hospital or clinic to the factory floor, the dangers of 
sleepy bodies are recognised and controlled for through both formal and informal 
practices, at the institutional and individual level. 
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Although periods of sleep and wakefulness were understood as embodied 
experiences partly under bioloJLFDOFRQWUROWKHDFWVRIµJRLQJWRVOHHS¶DQGµZDNLQJXS¶
described were acutely social. Notions of self-governance of and individual 
responsibility for varying states of somnolence were strong in shift workers discourse. 
These behaviours were embedded in existing practices and privatised routines (Hislop 
& Arber, 2004); informed by cultural norms (Seale et al, 2007), experiential knowledge 
(Meadows, 2005) and scientific understandings of the body (Rose, 2007); and 
importantly, thoroughly mediated through numerous technologies. Modafinil then, fits 
into these existing practices in various ways depending upon cultural conceptions of 
normality, values of individuality and the pursuit of health, wealth and happiness in the 
modern workplace.  
 
Neither the configuration of the technology or user was settled or established in shift 
workers accounts, with both subject to flexible interpretations. Legitimate users of the 
drug were configured in two ways. Firstly, as patients who had been diagnosed as ill 
or in need of medical treatment and prescribed the drug by their doctor through a 
clinical encounter. Secondly, those suffering impairments due to their working 
conditions whom, through a process of self-monitoring, might choose to take the drug 
to mediate their own sleepiness/alertness both in and outside of the workplace. Those 
experiencing some sort of deficit saw pharmaceutical treatment as one part of the 
solution for them, regardless of whether the drug was accessed independently or 
administered through a medical consultation. In both instances use of the drug was 
conceptualised as acting to restore impaired functioning and return the individual to an 
authentic or normal level of health. This was partly achieved through medical 
discourse, labelling and defining changes in sleep practices as symptoms of a 
disorder, which in turn, removed some causal responsibility from the individual. The 
medicalisation of sleep was accompanied by powerful images of illness, healing and 
(ab)normality which acted to make drug use appear socially acceptable.   
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The use of modafinil in one¶s daily life without medical control was raised as a possible 
configuration of technology and user. In its configuration an OTC modafinil was often 
accepted, in which individuals could choose to self-medicate if they so wished. 
Although some potential benefits to the drug were recognised, discourse was 
dominated by fears and concerns raised over safety of the drug and potential harms to 
health it could lead to. This type of use was still understood as therapeutic, perhaps 
reflecting the changing nature of patient into consumer, who has their own knowledge, 
expertise and can choose how to treat themselves in consultation with a variety of 
expert knowledges and institutions (Rose, 2007). However, when the technological 
script was read in this way, modafinil did not easily fit into existing practices, 
techniques and technologies used to manage sleepy bodies. Instead it was positioned 
as a last resort, something which one could take outside of their usual routines if they 
perceived something to be wrong with them or had this confirmed by a medical expert. 
 
Alternatively, modafinil use was understood as a safety tool, a way to boost cognitive 
performance, alertness and reduce tiredness. Often, no illness was deemed 
necessary for drug consumption and in some instances OTC availability of such a 
substance thought appropriate. This formation of technology and user was quite 
GLIIHUHQWIURPWKHµPHGLFLQHDVHQKDQFHPHQW¶FRQILJXUDWLRQGLVFXVVHGE\&ODUNHet al 
(2003), as use of the drug was justified on the grounds of public safety rather than 
individual health, prevention of illness or improvement of bodies. 
 
According to Woolgar (1991) the interaction between technology and user invites 
assessment both whether or not the machine is acting like a real machine and 
whether or not the user is acting like a real user. Users take their place within a cast of 
roles, designated by both the producers of technologies and culturally available 
technological scripts that proscribe how a technology should be used. De-scription 
(Akrich, 1992) on the other hand describes the process by which end-users can re-
write these scripts- as evidenced in the case of self-medication and management and 
acute use. However, the extent to which these scripts exist independently from the 
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producers and promoters of the technology is questionable and has not been subject 
to empirical investigation. 
 
When the technological script of modafinil was read as a medicine, the corresponding 
cultural script was one of healing or relief from suffering. In the absence of this, use of 
drug outside of this script was equated to abuse, using the technology in an 
unintended and illegitimate way. The technology was differentiated from foodstuffs 
and other technologies on the grounds that it is a medicine. It is delivered in pill form 
which set it apart from most foodstuffs (with the notable exception of caffeine pills) and 
mechanical technologies (e.g. alarm clock, black out blinds, brain training games) 
used to control sleep and boost cognition. Instead, it was likened to other medicines, 
pills, drugs and tablets that are available in various forms in British society and was 
positioned in line with these cultural scripts. How the substance is regulated, 
controlled and presented to the potential user (as either medicine or consumer 
product) and what this implies in relation to health benefits and the safety of 
consumption come to the fore as important considerations in whether the chemical 
augmentation of cognition was considered to be legitimate or not. 
 
Work-related use of the drug was demarcated from general recreational use.  Overall, 
shift workers accounts were sceptical of proposed benefits of psychopharmaceutical 
enhancement to themselves (in terms of becoming better) and fearful of harms to their 
bodies. There was little evidence of desire to use enhancement technology in the 
µUHPRGHOOLQJRIWKHVHOI¶GHVSLWHthe exploration of existing rituals and routines that 
demonstrated how the acts of going to sleep, waking up and staying awake are 
already thoroughly mediated through various technologies in everyday life. 
 
Around half of respondents thought that modafinil should be more widely available to 
shift workers. The broader social and cultural context of cognitive enhancement was 
given importance through the construction of futures where access to drugs such as 
modafinil would be unrestricted and widespread.  Through the figure of the future user 
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(Wilkie & Michael, 2009) visions of future were often constructed in respRQGHQWV¶
accounts which enabled fears surrounding coercion, safety and efficacy of drug use, 
addiction and dependency to be raised. Socially, concerns over implicit coercion and 
shifting standards of normal workplace performance were discussed. It was feared 
that unrestricted availability of the drug could transform the workplace into a more 
competitive environment in which taking a drug would become the only way to keep 
up and perform optimally. Both the appeal of extending wakefulness and the need for 
cognitive enhancement were questioned by this group of individuals. Medical control 
of the substance via prescription was agreed upon to be the best mechanism to 
ensure benefits to those that need them, whilst protecting other individuals and society 
of potential harms the drug could lead to. Medical professionals were thought of as 
SRVVHVVLQJPHGLFDONQRZOHGJHDQGWREHLQWHUHVWHGWKHSDWLHQWV¶KHDOWKUDWKHUWKDQ
their performance. Therefore they were thought to be in a position to assess whether 
someone was in need of the drug and medical supervision of the drug was viewed as 
a way to control access so prevent abuse.   
 
Situating cognitive enhancement in the context of the workplace allowed some key 
assumptions found in neuroethical debates to be questioned. Firstly, that there is a 
widespread desire to use cognition enhancing drugs to enhance performance (as drug 
use was typically thought of in terms of treatment or protection, not enhancement). 
The expectation that improved cognition will lead to better, more productive, efficient 
and successful workers is deeply entrenched in the academic literature. It was evident 
that in the neuroethics literature cognitive enhancement is too easily equated with 
beneficence at the individual level. Through the notion of modafinil as a safety tool in 
particular, this was questioned with drug use seen as a move towards safety and 
SURYLGLQJEHWWHUFDUHIRURWKHUVZKLOVWSRWHQWLDOO\SXWWLQJWKHLQGLYLGXDO¶VRZQKHDOWKDW
risk from any possible side effects of the substance. In addition, the analysis has 
highlighted the extent to which therapy and enhancement are qualitatively different as 
respondents did not perceive a need for enhancement in the same way those with 
problems have a need for treatment. Whilst medicalisation acted to legitimise use of 
225 
 
the drug under specific circumstances, there was evidence of resistance towards 
pharmaceuticalisation of cognition for those without problems or impairments. 
 
From these findings it is evident that there is still a strong cultural tendency to 
associate drug taking with illness, addiction, dependency and risks to health which 
may provide a barrier to widespread psychopharmaceutical use outside of medical 
control. At present, demand for and desirability of cognitive enhancement may be far 
less abundant than imagined in ethical debates. 
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Chapter 7: Exploring imagined uses of modafinil by students 
 
Introduction 
 
The use of chemical substances to alter mental states, whether for the purpose of 
healing, enhancement or simply for pleasure, is not a new phenomenon. However, 
over the past few years there has been an upsurge in interest both within and outside 
of bioethics regarding the promises and perils of new neurotechnologies, particularly 
psychopharmaceuticals that have the potential to be used as cognitive enhancers. 
Some of those involved in ethical debates recognise, and have raised awareness of, 
how the broader social context of use may shape different paths along which cognitive 
enhancement might develop. Recently, there have been calls for a more realistic 
perspective of the drugs currently available through the empirical investigation of 
concrete cases (Schermer & Bolt, 2009; Forlini & Racine, 2009). 
 
As outlined in Chapter 1, university students are often depicted as both existing and 
imagined future non-medical users of cognition enhancing drugs. As discussed in 
Chapter 2, the relationship between medical and enhancement uses of this technology 
is complex and tensions exist in demarcating legitimate use of medical resources from 
unjustified social control and in the separation of positive and negative applications of 
the same substances outside of medical authority.  
 
The aim of this chapter is to analyse the ways in which prospective users of modafinil 
understand, position and negotiate use of modafinil in the context of their everyday 
lives. It focuses on uses of the drug in one specific social context, the university, by 
one prospective user group, students. Specific research questions addressed include: 
How are sleep and cognition conceptualised by students? How is modafinil use 
understood, positioned and negotiated in this social domain? What sociotechnical 
scripts are associated with modafinil use and how is it positioned as a medical or non-
medical technology? According to what norms do students believe that augmentation 
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of the mind should take place? What role is given to medical authority in deciding if 
particular uses are acceptable?   
 
The data presented in this chapter were drawn from semi-structured interviews with 
fourteen undergraduate students from the University of Nottingham. Firstly, a 
description of student life in 2008/9 from the perspective of these students is provided, 
discussing how these students understood sleep and use existing technologies to 
mediate states of sleepiness/ alertness, after which, the discussion moves on to 
analyse the ways in which modafinil was understood and the different ways its use 
was positioned by this group of prospective users in the contexts of their everyday 
lives. 
 
Sleep, cognition and flexible living 
 
The students that were interviewed all described busy and hectic schedules 
incorporating heavy study workloads, active social lives and most were also in paid 
employment. The flexible and varied nature of university work appealed to most of the 
respondents, giving them independence and allowing them to work when it suited 
them. In their collective accounts the day and night worlds seemed to merge 
somewhat with respondents reporting both study time and social activities that 
spanned the full 24 hours of the day seven days a week. Some identified themselves 
DVEHLQJDµPRUQLQJZRUNHU¶6/RXLVHRUµPRUHRIDQLJKWSHUVRQ¶61LFNODUNV
and owls in the scientific discourse) although this was usually attributed to desirable 
social and environmental conditions rather than biological factors. For instance, 
students felt they could work better at these times dues to less noise and distraction 
with more resources being available (e.g. access to computers and books in the 
library). For some students such working patterns were a regular occurrence, 
however, the majority of respondents said that they only followed this pattern of 
ZRUNLQJZKHQXQGHUSUHVVXUHRUZKHQLWZDVµDQHPHUJHQF\¶6%HOODIRUH[DPSOH
before a deadline or over examination periods.  
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Many of the students recognised the importance of time out from study and work, 
linking their emotional well-being to social networks and social activities. Most of the 
respondents had formed social networks at the university, either through their course, 
recreational activities or living in shared accommodation. Sole focus on study was 
linked to stress, isolation and loneliness whereas, being around people of a similar 
age and situation was said to be both an important and enjoyable part of university 
life. This is illustrated in the extract below where a second year student is talking about 
his work/ social life balance. He says: 
 
³,QWKHVHFRQGVHPHVWHU,MXVWFRPSOHWHO\IRFXVHG«,VDLG,ZDVKDSS\EXW,ZDV
actually getting a bit lonely and more stressed because I wasn't having time 
RXW«,MXVWGLGQ
WVHHDQ\RQH,
GFRPHLQZRUNDQG,FRXOGJRDZKROHZHHNHQG
DQGQRWVHHDQ\RQH´6-DPHV 
 
As demonstrated in the data extract below, although many of the students interviewed 
were uncertain as to exactly what sleep was for, sleep was commonly constructed in 
functional terms as a vital and natural period of time for the body and brain to rest and 
relax, repair, rejuvenate and recharge. When describing the effects of lack of sleep, 
students stressed the importance they placed on getting enough sleep through 
drawing on their own experiential knowledge, which included both their own 
experiences and the experiences of people they know.  They discussed how lack of 
sleep could lead to illness, an impaired immune system, low mood, irritability and 
result in a poor diet, lack of concentration and focus, impaired daytime functioning and 
cognitive performance, ability to learn, and have a negative effect on their 
appearance. 
 
Interviewer:            What do you think sleep does? 
6&KULV,¶YHQRLGHD,¶PSUHVXPLQJZKLOH,¶PDVOHHSP\ERG\¶VJRWD
chance to recharge itself and find a second energy or something, mend 
ZKDWHYHU¶VQRWZRUNLQJSURSHUO\,¶PQRWVXUH 
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To a lesser extent and somewhat overlapping with the first, a second 
conceptualisation of sleep emerged in the data where sleep was understood as a 
waste of time. Respondents said they got up at a particular time in the morning so that 
WKH\ZHUHQRWµZDVWLQJWLPHLQEHG¶6(PPD5educing the sleep period was linked 
to more time to do other things with most respondents saying they would go to bed 
when they got tired or when there was nothing else for them to do. All of the students 
interviewed said they would prioritise social engagements over sleep and most put 
university and paid work before sleep too. 
 
³,GRORYHP\VOHHSLWLVLPSRUWDQWWRPHEHFDXVH,GRIHHO,QHHGLWEXWDWWKH
VDPHWLPH,FXWEDFNRQLWIRURWKHUWKLQJV´6-DPHV 
 
When and for how long one should sleep was open to debate in this domain. Only one 
UHVSRQGHQWOLQNHGVOHHSWLPLQJWRDµELRORJLFDOPHFKDQLVP¶DOWKRXJKDIHZGLGPHQWLRQ
WKHLUµERG\FORFN¶6-RVHSKWKH\GLGQRWVHHWKLVDVGHWHUPLQLQJWKHLUVOHHSWLPLQJ
or duration. In stark contrast to the shift workers accounts, as illustrated in the data 
extract below, most of the students interviewed thought that they were in control of 
sleep.  
 
³,FDQMXVWVWD\XSWLOOZKHQHYHUVR,FDQGRZRUNDQGWKHQVZLWFKRIIZKHQ,IHHO
OLNHLW´6'DQLHO 
 
Respondents reported that they thought they needed between five and ten hours of 
sleep per night depending on how active they were in the day and what they had to do 
the next day. Despite this, most said they usually got between four and seven hours 
sleep a QLJKWµFDWFKLQJXS¶E\VOHHSLQJORQJHURQWKHZHHNHQGVRUWDNLQJQDSVLQWKH
afternoon when they did not have any lectures or work commitments. When asked 
why they thought X number of hours was enough sleep for them, the answers varied. 
Many of the answerVSURYLGHGKDGDVWURQJQRUPDWLYHGLPHQVLRQGHVFULELQJµWKHULJKW
DPRXQW¶RIVOHHSWKDWRQHLVµVXSSRVHGWRJHW¶6'DQLHO6&KULVZKHUHVOHHSLQJ
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WRROLWWOHWRRPXFKRUSDVWDFHUWDLQWLPHLQWKHPRUQLQJZDVUHIHUUHGWRDVEHLQJµEDG¶
RUµOD]\¶S7: Daniel). In the following extract, one student describes how he actively 
tries, and often fails to get the amount of sleep he thinks he is supposed to have, 
based upon popular advice he remembers reading. 
 
³«HLJKWKRXUV",WKLQNWKDW
VZKDWWKH\WHOO\ou to have isn't it? Is it? I don't 
know. I'm sure that's what I've read somewhere you're supposed to have eight 
hours sleep and I think that's why I think it's the right amount to have, but I don't 
NQRZ«,WU\WREXWGRQ
WJHWLWWKDWRIWHQ«´6'DQLHO 
 
Another describes how he disregards information he has read in the media and bases 
his opinion on his own experience. This particular account bears similarity to those 
found in the scientific discourse, that on average that the human brain is programmed 
for 16 hours of wakefulness followed by approximately 8 hours of sleep across the 
diurnal day. 
 
³,
GUHDGLQWKHSDSHUWKDW\RXGRQ
WQHHGWKDWPXFKEXWLQP\RSLQLRQ«\RX
need at least two hours of being awake to one hour being asleep in a day, in 
order to EHDFWLYHDQGWRIXOO\EHDEOHWRFRQFHQWUDWH«´6-RVHSK 
 
Occasionally, advice the respondent had received in the past from parents or in school 
was drawn upon to justify their answer. 
 
³,W¶VEHHQLPSULQWHGLQWRPHWKURXJKP\SDUHQWVWKURXJKVFKRROlearning 
VFLHQFHDQGWKLQJVDERXWWKHERG\,WKLQNLW¶VWKHUHFRPPHQGHGWLPHWRKDYH
EXW,GRQ¶WDFWXDOO\NQRZZKHUHWKDW¶VFRPHIURPLQPHEXWIRUVRPHUHDVRQ
HLJKWKRXUVLVLQPHWKDW¶VZKDW,QHHGWRJHW´6&KULV 
 
Overall, sleep was understood as a period of social withdrawal. Whilst the majority of 
those interviewed attached importance to sleep, understanding it as a time during 
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which the body and brain relax and repair, many also considered sleep to be a waste 
of time, something which, if cut back on, would give them more time to do other things. 
Perceptions of an appropriate amount of and time to sleep were based upon 
experiential knowledge, parental advice, information in the media, and reference to 
science and psychology. Despite acknowledging various forms of normative advice 
DERXWZKDWLVµUHFRPPHQGHG¶µULJKW¶DQGZKDWRQHLVµVXSSRVHG¶WRGRVOHHSWLPLQJ
and duration were considered to be flexible and for the most part under individual 
control.  
 
In ethical and media debates modafinil is positioned as enhancement technology in 
the student domain that will enable students to study for longer periods, stay alert 
during all night study sessions, perform better and be more alert in lectures (e.g. 
Greely et al, 2008; Cahill, 2005; Butcher, 2003; Farah, 2004).  However, going beyond 
this, it was evident in the student data that work-life balance is extremely important to 
student in their successful adjustment to university life and importance is placed upon 
their successful engagement in social and recreational activities as well as academic 
performance. Theoretically, modafinil as an enhancement technology fills this niche 
requirement through the extension of wakefulness, therefore providing more time 
awake and alert to engage in both work related and recreational activities, and the 
enhancement of cognitive functions which could improve academic performance at the 
same time. The viability of such interpretations of modafinil will be returned to in 
greater depth later on. In the next section how students manage sleep and alertness 
in their daily lives is discussed before moving on to consider how uses of modafinil 
were understood in this social context. 
 
Managing sleepiness and alertness 
 
Despite a general overall conceptualisation of sleep timing and duration as somewhat 
flexible and under individual control, all of the respondents reported having 
experienced difficulties in getting to sleep or staying asleep at some point in their lives. 
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All respondents said that they sometimes struggled to stay awake and alert during 
OHFWXUHVDQGKDGH[SHULHQFHGµPLQGEODFN-RXWV¶RUµVZLWFKHGRII¶ILQGLQJLWGLIILFXOWWR
concentrate. Two-thirds of respondents reported that they had unintentionally fallen 
asleep while at university. As shown in the data extract below, some respondents 
blamed themselves for the difficulties they had experienced with sleeping or staying 
awake considering their behaviour to be the causal factor in the development of their 
sleep problems (e.g. inadequate sleep leading to lapses in alertness the following 
day). However, often respondents conceptualised such experiences not as problems 
with sleep per se, but as symptoms of other problems or factors. Examples given 
included: stress; emotional turmoil; lack of interest, activity or stimulation; and 
environmental factors (e.g. the lecture theatre being too warm or too dark). Biological 
factors were not a significant feature of student discourse. Problems with 
sleepiness/alertness were rationalised as a normal part of everyday life, and although 
unpleasant or undesirable behaviours, thought of as things that everyone experiences 
at some time or another.  
 
³,GRWKLQNWKDWLW
VDOOP\RZQIDXOWEHFDXVHRIWKHWKLQJV,GR,I,FKDQJHGP\
patterns of my behaviours and stuff it'd probably change. But I wouldn't think of 
JRLQJWRWKHGRFWRUWREHKRQHVW«,ZRXOGQ
WZDQWWRHQGXSRQVOHHSLQJ
WDEOHWV«´6'DQLHO 
 
,QJHQHUDOVOHHSSUREOHPVZHUHQRWSDWKRORJLVHGRUPHGLFDOLVHGLQVWXGHQWV¶DFFRXQWV
Respondents said that they would only seek medical advice for sleep problems if the 
problem persisted for a prolonged period of time and they could not resolve it in other 
ways. Many respondents were opposed to taking sleeping pills and thought this was 
all medical professionals would be able to offer them. Most said they would attempt to 
PDQDJHRUµFXUH¶WKHLUVOHHSSUREOHPVWKHPVHOYHVILUVWEHIRUHJRLQJWRWKHGRFWRU
They would do this in various ways: by looking on the Internet for advice, trying herbal 
remedies, speaking to a family member or trying to change social or environmental 
factors they thought were causing the problem. Only one respondent had been to see 
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a doctor for advice about sleep problems, but was still cautious of pharmaceutical 
intervention in the sleep wake-cycle (S6: Louise).  
 
Although falling asleep in public was generally thought of in humorous terms by 
students, it was problematised through its social unacceptability, often being referred 
WRDVµVWXSLG¶RUµHPEDUUDVVLQJ¶$IHZVWXGHQWVWROGVFDUHVWRULHVDERXWOHFWXUHUV
embarrassing students who had fallen asleep, saying this provided them with an 
incentive to try to stay awake during lectures. None of the students interviewed 
mentioned a concern that if they did fall asleep during lectures they may miss out on 
information or fall behind in their learning. 
 
The majority of those interviewed said that they would try to stop themselves falling 
asleep in public during the daytime. Many of the students said they used caffeine 
specifically for the purpose of promoting daytime alertness or to help them wake up 
and feel more energetic when they were feeling tired or sleepy. In the data extract 
below the student describes how he uses coffee as a wake-promoting substance 
despite not liking the taste of it. He describes using caffeine to extend wakefulness 
when he feels under pressure, forsaking sleep in order to get his work done. Students 
described consuming caffeine in the form of caffeinated drinks and chocolate, 
although caffeine pills were also used by some students and were prominent features 
of student discourse. 
 
³,GULQNORWVRIFDIIHLQH«DIHZH[WUDFXSVRIWHDRULI,DPIHHOLQJUHDOO\
pressured coffee - HYHQWKRXJK,FDQ¶WVWDQGWKHWDVWHEXWLWNHHSVPHDZDNH
PRUH7KDW¶VXVXDOO\ZKDW,GRDQGMXVWWU\DQGVWD\XSORQJHUHYHQLIit is a 
case of getting not enough sleep - MXVWWRJHW>P\ZRUN@GRQH´60LNH 
 
In addition to caffeine, students discussed various other methods they used to 
µUHIUHVK¶DQGµUH-HQHUJLVH¶WKHPVHOYHVLQRUGHUWRDLGFRQFHQWUDWLRQSURPRWHDOHUWQHVV
and help them focus. These ranged from doing something active such as writing notes 
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and drawing pictures while in lectures to taking a break, and included doing some mild 
exercise or having something to eat or drink (from high-sugar energy drinks to water). 
 
³, try to write down notes to keep me alert - MXVWWRSD\PRUHDWWHQWLRQRQZKDW¶V
going on, whether I find it interesting or not.  If I am free then I will go for a walk 
DQGWKDWXVXDOO\UHIUHVKHVPH$QG,KDYHDORWRIFRIIHHDVZHOO´6.HUU\ 
 
Sleep was also discussed as an alertness promoting strategy. Many respondents 
GLVFXVVHGKDYLQJDµSRZHUQDS¶GXULQJWKHGD\DVDVWUDWHJ\IRUSURPRWLQJDOHUWQHVVRU
catching up on sleep if they felt that they had not had enough sleep the night before. 
Usually, this strategy would be used when the individual was at home rather than in a 
public space. Occasionally, sleeping in the daytime was thought of in negative terms, 
as disappointing and not how adults should behave.  
 
³«ZKHQ,¶YHKDGIRXURUILYHKRXUV¶VOHHS ,¶YHMXVWJRQHWRVOHHSIRUDQKRXULQ
WKHPLGGOHRIWKHGD\EXW,WKLQNWKDW¶VSUHWW\EDGEHFDXVHWKDW¶VZKDWQHZERUQ
EDELHVGR6R,IHHODELWGLVDSSRLQWHG´66XVLH 
 
6WXGHQWV¶DFFRXQWVUHYHDOHGWRZKDWH[WHQWWKHXVHRIDQDODUPFORFNDVDZDNe-
promoting technology or a way of truncating sleep is entrenched in everyday life. 
When asked if they did anything to help them wake up the use of an alarm seemed to 
be taken for granted. As shown in the data extract below most respondents did not 
mention that they used an alarm until specifically asked about it. All respondents 
reported using an alarm, usually one on their mobile phone, to wake them up after a 
period of sleep rather than leaving this to their body clock reasoning that they would 
not wake up at their desired time without using an alarm. Only one respondent spoke 
about his body clock waking him up. However, he still reported using an alarm for 
µHQFRXUDJHPHQW¶6-RVHSK 
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S4: Emma:   I always have a shower first thing in the morning, if I don't then I 
feel like I haven't woken up properly. And breakfast. Never miss breakfast, but 
no nothing more than that really. 
Interviewer:   Do you ever use an alarm clock? 
S4: Emma:   Oh yeah, yeah, alarm clock otherwise I probably wouldn't wake up! 
 
To some extent through the construction of sleep as a waste of time the whole 
concept of sleeping was problematised. Although all students described how they 
would prioritise their waking activities and social engagements above sleep, only a 
small number of respondents expressed the desire to dispense with sleep altogether.  
 
To summarise, all respondents reported having experienced daytime sleepiness to 
some degree, with a large number saying they had actually fallen asleep whilst 
working or studying. Despite this, to a large extent students did not problematise 
daytime sleepiness or impaired alertness in their accounts. Generally, levels of 
sleepiness and alertness were considered to be under individual control and individual 
responsibility. Falling asleep or feeling sleepy in the day was constructed as a normal 
response to boredom, lack of stimulation, lack of sleep the night before or due to 
particular socio-environmental factors. Daytime sleepiness was thought of in 
humorous terms, rather than as a medical problem. Through the construction of sleep 
DVDµZDVWHRIWLPH¶WKHLGHDHPHUJHGWKDWLIVOHHSFRXOGEHGLVSHQVHGZLWKLWZRXOG
enable more time for one to engage in other activities.  
 
Much like in shift workers accounts, sleep was understood by students in functional 
terms as a period of time for the body and brain to rest, repair and rejuvenate. Again, 
the acts of going to sleep and waking up were described as social activities, 
embedded in existing practices and privatised routines (Hislop & Arber, 2004); 
informed by social and cultural norms (Seale et al, 2007); experiential knowledge 
(Meadows, 2005); but perhaps to a lesser extent influenced by scientific 
understandings of the body. The extent to which students rely on existing technologies 
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to wake them up and promote alert wakefulness at personally desirable times was 
particularly striking. Notions of self-governance and individual responsibility for varying 
VWDWHVRIVRPQROHQFHZHUHGRPLQDQWLQVWXGHQWV¶DFFRXQWVZKHUHDVELRORJLFDO
explanations were rarely acknowledged. Although the university might not be 
considered a desirable location to sleep, falling asleep whilst at university was not 
considered an unusual occurrence. Although normatively speaking there might be a 
right time to go to sleep and a recommended amount of sleep to get, in contrast to 
shift workers accounts, students perceived sleep timing and duration to be flexible. 
They choose when they go to sleep and how long they sleep for, prioritising their 
waking life and fitting sleep in around both work related and social activities. In the 
following section the interpretation of modafinil as an enhancement technology in the 
student context will be critically evaluated.  
 
Configurations of modafinil: Students as prospective users 
 
None of the students interviewed had heard of modafinil prior to the interview. They 
were given details about the reported effects of modafinil and informed that it is 
currently licensed to treat various sleep disorders in which excessive sleepiness might 
be a symptom. Modafinil use was positioned in several different ways in student 
discourse. In this section the four most prominent configurations of modafinil will be 
outlined. 
  
Modafinil as a medical treatment  
 
Bearing similarity to the shift workers discourse (Chapter 6), students positioned 
modafinil as a medical technology. Legitimate users were identifiHGDVLQGLYLGXDOVµLQ
QHHG¶ZKR had been designated as patients by medical experts and prescribed the 
drug by their doctor for the treatment of a recognised problem. In the student context, 
respondents tended to speak about students who suffered from concentration 
problems or low levels of alertness that might be holding the student back or 
237 
 
SUHYHQWLQJWKHPIURPµJHWWLQJWKHEHVWRXWRIWKHLUHGXFDWLRQ¶6/RXLVH. Modafinil 
was understood as a treatment for these cognitive impairments or deficits. 
Respondents reasoned that in these instances the student could be prescribed the 
drug by their doctor to regain a normal or authentic level of functioning, thus allowing 
WKHPWRµUHDFKWKHLUIXOOSRWHQWLDO¶6/RXLVH 
 
Use of the drug by individuals who had been designated as ill or in need of treatment 
by the medical profession ZDVUHIHUUHGWRDVµDJRRGWKLQJ¶DQGXQGHUVWRRGDVD
sensible, controlled and careful method of relieving suffering and stopping 
inappropriate bouts of sleepiness. As illustrated in the data extract below, the medical 
profession were thought to be equipped with the necessary skills and expertise to 
identify legitimate patients. 
 
³«DFDUHIXOGRVHRIWKLVGUXJPLJKWKHOSSHRSOH«LILWUHDOO\KHOSHGWKHPLWLVD
good thing, but obviously these kinds of things get abused as well, but doctors 
LGHQWLI\SDWLHQWV«´6.HUU\ 
 
In this instance, passage through a medical encounter and diagnosis of a disorder 
were seen as legitimating use of the drug. Medical professionals were constructed as 
H[SHUWVWKDWµNQRZZKDWWKH\DUHGRLQJ¶VRZRXOGEHDEOHWRUHVWULFWWKHXVHRIWKHGUXJ
to those who really needed it and stop it being used for the wrong reasons by the 
wrong people.  
 
³<RXZRXOGQ¶WEHDEXVLQJLWLI\RXDFWXDOO\ZHQWDQG\RXKDGDGLVRUGHUDQGWKH\
VDLGWKLVLVDUHPHG\IRULW«´66WHSKHQ 
 
Although students commonly referred to the competence of medical professionals to 
decide who should and should not have access to modafinil, many of the students 
LQWHUYLHZHGWKRXJKWWKDWWDNLQJDSLOOIRUWKLVW\SHRISUREOHPVKRXOGEHDµODVWUHVRUW¶WR
be used in times of crises or if the individual was experiencing severe problems or 
238 
 
distress rather than a first line intervention. To these respondents sleep was seen as a 
better way to promote cognitive functioning than taking a tablet, and fears were raised 
WKDWVRPHWKLQJµPLJKWJRZURQJ¶RUWKHWDEOHWPLJKWQRWZRUNHIILFLHQWO\ 
 
³,¶YHQRWJRWWLPHWREHLOO,WKLQNVOHHS¶VDJRRGUHPHG\IRUHYHU\WKLQJ,¶GUDWKHU
GRWKDWWKDQWDNHDGUXJ«,WKLQNRQO\LI,ZDVKDYLQJUHDOEDGSUREOHPV,¶GUHVRUW
WRWKDW«´61LFN 
 
Medical authority and expertise were valued highly by students with the majority 
claiming that they would not consider taking modafinil if it remained a prescription 
medication unless they had been prescribed the drug by their doctor, and that they 
would judge others for doing so. When presented to the user as a medical technology, 
medical control of a drug lead some to think that it was more µVHULRXV¶WKDQ27& 
medications so should not be taken by everyone.  
 
³,I\RXFDQMXVWZDONLQWR%RRWVDQGEX\DSDFNHWWKHQ,¶GWKLQNWKHH[SHUWVKDYH
VDLGWKH\¶UHDOOULJKWVRZK\QRW"%XWQRLIWKH\ZHUHSUHVFULSWLRQRQO\,¶GVHH
WKHPDVPRUHVHULRXVDQGKDUVKDQGQRWIRUHYHU\RQH´6&KULV 
 
However, other respondents thought that if students found out about this drug and 
really wanted it, they would get it regardless of whether it remained prescription-only. 
When modafinil was understood as a medicine, students typically argued against 
modafinil use by those without problems or impairments, drawing heavily on medical 
rhetoric, use of this kind was constructed as abuse of prescription medication. Users 
were reconfigured not as patients; but as cheats or abusers using the technology for 
WKHZURQJUHDVRQV5HVSRQGHQWVUHDVRQHGWKDWSHUVRQVµVKRXOGRQO\WDNHPHGLFDWLRQV
LIWKH\DUHLOO¶6/L]]\RUH[SHULHQFLQJµUHDOSUREOHPV¶6/RXLVHDQGWKDWXVing 
WKHGUXJIRUWKHVHRWKHUPRUHµIULYRORXV¶UHDVRQVZRXOGEHDZDVWHRIYDOXDEOHPHGLFDO
resources.  
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³«SHRSOHZRXOGXVHWKHPIRUWKHVDNHRILWDQGIRUvery wrong reasons. That 
just because say they had a night out and they're really tired...I don't think 
SHRSOHVKRXOGGRWKDW´6'DQLHO 
 
Most respondents thought that modafinil should remain a prescription drug, but 
wanted to evaluate the research themselves or wanted more research to be done to 
inform their opinion. This decision was often based upon fears of side effects later on 
in life, the potential harm the drug could cause both physically and mentally, risk of 
abuse and dependency. Some respondents reasoned that modafinil should be a 
controlled medication as the drug is still relatively new and the long term effects it 
could have on the body are not known. Others worried that even as a prescription 
drug, something might still go wrong or it might not work efficiently so should only be 
used as a last resort by those who really need it.  
 
³3UHVFULbed, EHFDXVHLI\RXVWD\DZDNHIRUKRXUV,DPVXUHWKDW¶VJRLQJWRGR
VRPHWKLQJEDGWR\RXUVHURWRQLQOHYHOV«\RXZRXOGWKHQKDYHSHRSOHWU\LQJWR
H[FHHGWKHGRVHWRVWD\DZDNHIRUORQJHUWKDQKRXUV´60LNH 
 
Overall, students was thought it was µREYLRXV¶WKDWSHRSOHZKRZHUHVXIIHULQJRUKDG
something wrong with them should have access to the drug through their doctor. It 
was feared that if modafinil was available OTC LWZRXOGEHRSHQWRDEXVHRUµRYHUXVH¶
people might exceed the recommended dose, use the drug for µIULYRORXVWKLQJV¶RUµIRU
WKHVDNHRILW¶VXFKDVVWD\LQJXSORQJHUWRZRUNRUJRLQJRXWZLWKIULHQGVZKLFKFRXOG
OHDGWRµGHSHQGHQF\¶or lead to other health problems for the user. Getting more sleep 
ZDVSRVLWLRQHGDVWKHµULJKWWKLQJ WRGR¶HYHQWKRXJKPRVWVWXGHQWVDFNQRZOHGJHGWKDW
they often did not get enough sleep. There are intentions designed into technologies, 
technologies come with scripts for use (Akrich, 1992; Latour, 1980; Woolgar, 1991). 
Because this drug is presently available as a prescription medication, its use to 
enhance wakefulness or cognition by students (without illness) was constructed as 
XVLQJWKHWHFKQRORJ\IRUWKHµZURQJUHDVRQV¶However, where to draw the line 
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between those who should be prescribed the drug and those who should not was 
identified as an ethical question. 
 
Modafinil as a replacement for sleep 
 
Secondly, students discussed the potential for modafinil to be used as a replacement 
for sleep. Two types of prospective user emerged in this frame: the social user and the 
anti-social (ab)user. For the social user, importance was placed on achieving a good 
balance between work and social life and modafinil positioned as a way to provide an 
µH[WUDERRVW¶61LFNZKHQQHHGHG'UDZLQJRQWKHFXOWXUDOLGHa of sleep as a 
waste of time, some respondents thought that potentially anyone could take modafinil 
as a way to extend the time available to them in a given day. Respondents thought 
that this aspect of the drug would appeal to individuals with demanding lifestyles, 
providing them with a release from the pressures of work through the provision of 
more time for social engagements. Some students thought that using modafinil for this 
purpose as a lifestyle choice that should be down to the individual to make, providing 
that safety and efficacy of the technology had been demonstrated through long-term 
studies.  
 
 ³«LWLV quite difficult to juggle a heavy workload and a social life and people 
who work hard should be able to have a good social life, I think, so it would 
XOWLPDWHO\EHXSWRWKHPEXW,WKLQNLW
GEHRN´6/RXLVH 
 
Another respondent goes one step further than this to imagine a purely recreational 
use of the drug.  She imagines how one might use the drug as a way to replace sleep 
to gain more time or get more out of a holiday or short break: 
 
³«\RXZRXOGKDYHWRVDFULILFHVRPHWKLQJLI\RX¶UHZDQWLQJWRVOHHS«LI\RX¶UH
on holiday and you really liked it, if you were visiting a cultural city, it could be 
KDQG\LI\RXWDNHWKRVH´66XVLH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As discussed above, others constructed use of the drug by those without illness or 
impairment as an abuse of prescription medication. Alongside the figure of the social 
user an image of the antisocial user was also evident in the data. 7KHµantisocial user¶
was depicted as an individual who would abuse the drug and misuse the extra time 
DIIRUGHGWRWKHPE\XVLQJWKHLUH[WHQGHGZDNHIXOQHVVWRµFDXVHWURXEOH¶6%HOOD
commit crime (S4: Emma), or consume copious amounts of alcohol and be generally 
disruptive.  
 
Respondents were cautious of both the effects of the drug and the effect that going 
without sleep could have on their health. Modafinil was considered open to abuse 
through the consumption of too many pills which respondents thought would lead to 
overexertion or damage to the body. It was feared that irresponsible users might 
become ill due to lack of sleep and burn themselves out. Although people could be 
informed about possible side effects of enhancement drugs, several respondents 
raised fears that some people would not take notice of health warnings and not care 
what happened to them in the longer term. They used this to argue that modafinil 
should remain a prescription medication and not be available to all as a replacement 
for sleep. As in the account below, some students took a different stance to this and 
argued that there are always going to be people who will abuse substances but 
considered this too as an individual choice. Here the respondent reasons that if people 
do decide to use the substance against expert advice they would be responsible and 
culpable for the consequences of their actions. He did not consider the potential for 
modafinil to be abused as a valid reason to restrict access to the drug. 
 
³,GRQ¶WWKLQN\RXVKRXOGUHVWULFWWKHPDMRULty of people from having a useful 
benefit from it to the minority who are going to abuse it - because it is their 
choice.  If they are informed about it and then they go on to take more than the 
UHFRPPHQGHGDPRXQWDQGKDYHDVLGHHIIHFWIURPWKDWWKDW¶VWheir own fault 
UHDOO\´60LNH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Another respondent reasoned that as adults, individuals are capable of making their 
own choices about their lifestyle and consumption. He argues that most adults would 
be responsible enough to not abuse the drug knowing that it is not normal to stay 
awake for days without sleep (S12: Chris) . Others feared that use of the drug to 
replace sleep could turn out to be addictive or habit-forming, if not biologically then 
socially, reasoning that once someone has got used to not having to sleep it might be 
GLIILFXOWWRJREDFNWRVOHHSLQJDVWKH\ZRXOGIHHOOLNHWKH\KDGµVROLWWOHWLPH¶6
Daniel) . Respondents referred to the importance of sleep for rest and recovery and 
argued that if individuals conducted their lives in an appropriate way (e.g. by sleeping 
at night as opposed to socialising) there would be no need to take this drug.  
 
³«IRUJHQHUDOSHRSOHWKH\VKRXOGQ
WQHHGLWLIWKH\JRDERXWWKHLUOLIHDVWKH\
VKRXOGGR«LIWKH\GRQ
WJRRXWDOOQLJKWWKHQWKH\VKRXOGUHDOly have enough 
HQHUJ\WRVWD\DZDNHDOOGD\´6(PPD 
 
Some respondents thought that it would be interesting to experience a prolonged 
period without sleep and this function of the drug seemed to really appeal to them. 
However, in general, the benefits of chemically extending wakefulness were treated 
with scepticism. Most of the students interviewed treated modafinil with suspicion, 
VD\LQJLWVRXQGHGOLNHDµZRQGHUGUXJ¶6-RVHSKDQGµWRRJRRGWREHWUXH¶6
Susie; S11: Stephen). When configured as a replacement for sleep, modafinil was 
compared to existing recreational drugs, such as cocaine, ecstasy and alcohol, as 
opposed to foodstuffs or other medicinal drugs. As with use of these substances, 
many respondents doubted that the process of extending wakefulness would be 
beneficial to their health.  Drawing on an understanding of sleep as a period of repair 
and restoration, the chemical enhancement of wakefulness was commonly 
approached with caution. Students reasoned that going without sleep would KDYHµD
FRQVHTXHQFHVRPHZKHUH¶66XVLHWKDWWKHUHZHUHµWRRPDQ\XQNQRZQV¶6
Kerry) and that one should be wary of drug use for this purpose. It was argued that all 
drugs have some negative side effects and even if there have not been any major side 
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effects reported to date, something might go wrong or there might problems in later 
life.  
 
³,
PVOLJKWO\VXVSLFLRXVRILWIRUVRPHUHDVRQ«LWVRXQGVWRRJRRGQRWWRKDYH
something bad, like, if someone hits forty and then just want to sleep all the time 
RUEHFRPHVLOO´66XVLH 
 
Arguments against the use modafinil to replace sleep also appealed to ideas about the 
natural body, control over bodily functions, natural rhythms and patterns of sleep. 
$SSHDOVWRWKHµQDWXUDOERG\¶ZHUHXVHGWRDUJXHWKDWthe body needs sleep in order to 
function, and although acknowledging that they often go without adequate sleep, this 
ZDVVHHQDVXQQDWXUDO,QWHUIHULQJLQWKHERG\¶VQDWXUDOµUK\WKPV¶µUROHV¶DQGµURXWLQHV¶
ZDVJHQHUDOO\YLHZHGDVµQRWDJRRGWKLQJ¶0DQy thought that the (ab)use of 
prescription medication by those without illness would ultimately be detrimental to 
health and could lead to dependency which would not be worth it just to have a better 
social life, not be tired or to perform better at work.  
 
³,ZRXOGQ¶WZDQWWRLQWHUIHUHZLWKWKHQDWXUDOUK\WKP«HYHQLIWKH\VDLGµWKLVGUXJ
KDVQ¶WJRWDQ\VLGHHIIHFWV¶,GRQ¶WNQRZZKHWKHULWLVQDWXUDOWRLQWHUIHUHZLWK
WKHVHQDWXUDOSDWWHUQVRIVOHHS´6.HUU\ 
 
It was argued that people should live naturally and if someone has not had adequate 
sleep due to their social life, it is their own fault and they should suffer the 
consequences of their behaviour rather than take a drug to counter its effects. As 
explained by the respondent in the passage below, as a student it is your own fault if 
you are not alert because you have chosen to not get enough sleep.  
 
³«MXVWEHFDXVH\RX¶YHKDGDQLJKWRXWLW¶V\RXURZQIDXOWIRUJRLQJRXWVR
therefore you should suffer ZLWKWKHFRQVHTXHQFHVRIQRWJHWWLQJVOHHS´610: 
Lizzy) 
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The social changes imagined by respondents if modafinil was to be used as a 
replacement for sleep were plentiful. Collectively, respondents accounts depicted a 
strange new world without time cues, extended working hours, higher levels of earning 
and spending, increased engagement in (anti)social activities and higher levels of 
illness. In contrast to visions of the future often found in neuroethics papers, students 
imagined that although less sleep would give people more time, this would give people 
more time for social activities and enable them to have more fun (go shopping, meet 
friends, watch more television) as opposed to more working time. They also thought 
that more time awake would create financial pressure on individuals as they would 
need to eat more often, heat their homes during the night and have more opportunity 
to spend money. Students envisaged that extended wakefulness could have 
detrimental effects on social relationships (too much time together causing strain) and 
that increased noise and activity during the night could cause disruption to those who 
did choose to sleep (S9: James). 
 
³«LISHRSOHZHUHXVLQJLWVROHO\WRVWD\XSORQJHUDQGKDYHmore fun, then that 
PLJKWOHDGWRLWQRWEHLQJDKLJKO\SURGXFWLYHVRFLHW\´6/RXLVH 
 
Far more fears and concerns were raised at every level than potential promises for 
betterment. It was feared that people would take advantage of the drug, so that they 
never needed to sleep. Several respondents clearly thought that using modafinil for 
thLVSXUSRVHZRXOGEHµDEDGWKLQJ¶6%HOODWKDWLWZDVµXQQDWXUDO¶6.HUU\6
Bella; S9: James; S13: Nick) not to sleep and such usage would make those 
LQGLYLGXDOVµQRWQRUPDOIRUDZKLOH¶6/L]]\,QWKHH[WUDFW below, the respondent 
imagines how access to the drug could even encourage students to go without sleep. 
6KHGLVFXVVHVKRZJRLQJZLWKRXWVOHHSDSSHDUVµKDUPOHVV¶EHFDXVHSHRSOHµDOUHDG\
GRLWDQ\ZD\¶DQGIHDUVWKDWWKHDYDLODELOLW\RIZDNH-promoting technology could 
reinforce this view. She thinks that in going without sleep people might be missing out 
on something important.   
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 ³«SHRSOH
GEHPRUHLQFOLQHGWRJRRXW«WKH\
GWKLQNµ,FDQRXWEHFDXVH,NQRZ,
FDQVWD\DZDNHWKHQH[WGD\¶«SHRSOHVD\WKDWGUHDPLQJLVTXLWHLPSRUWDQW«LI
you
UHQRWVOHHSLQJWKHQREYLRXVO\\RX
UHQRWJRLQJWRGUHDPDVPXFK´6
Bella)  
 
She then goes on to say how the availability of this technology could change cultural 
understandings of sleep resulting in sleeping being considered as a negative 
behaviour. Respondents feared that in a world with no set sleeping patterns, sleeping 
would be thought of as unnecessary, as something you do if you are lazy rather than a 
biological need.  
 
³«VOHHSLQJZLOOEHVHHQDVVRPHWKLQJWKDW\RXGRPRUHLI\RXZHUHOD]\UDWKHU 
than a natural thing that you need to do, because you could take [modafinil] and 
VWD\DZDNH´6%HOOD 
 
Others spoke about how degradation of the day/night divide could lead to cultural 
changes fearing loss of cultural rituals and collective identity. They feared that the loss 
of time cues could lead to difficulties in knowing when it is acceptable to engage in 
particular activities or behaviours, such as calling a friend or when to have breakfast, 
as everyone might be sleeping at different times. More people could be coerced into 
working longer or later, thus fuelling an ever increasing cycle of drug use. Some 
respondents said they would not be surprised if this did occur in the future, linking less 
sleep to more time, and more time to more money (S13: Nick).  In the data extract 
below, the respondent is both excited and saddened by the idea of a 24 hour world: 
 
³,WLVDYery exciting idea of the twenty-four hour world, but at the same time I 
think is that going to be a loss of identity and sort of a cultXUDOWKLQJ«LWZRXOGQ
W
EHOLNHµRKZHKDYHWKLVVSHFLDOPHDODWWKLVVSHFLDOWLPH¶EHFDXVHWKDWZRXOG
KDYHJRQH«´6'DYH 
 
246 
 
Many thought that the changes they envisioned occurring would not be instant and 
would probably happen with or without this technology. One respondent compared 
prospective changes to society to the image of 24 hour living in cities such as New 
York to argue that although more people might be awake at night, things could just 
balance themselves out and life might not be that different to the way it is now (S14: 
Susie). Another respondent reasoned that the world is still going on around you when 
you sleep, so being awake for longer would just enable you to engage in what is 
already happening (S5: Joseph). It was frequently pointed out that many businesses 
and big cities are gradually moving towards 24 hour living already. References were 
drawn to the rising global economy to argue that in some respects we are already a 24 
hour world, and that our use of electric lights has already eliminated the traditional 
reason why we went to bed at night.  
 
Overall, on a personal level, the majority of respondents said that they would be 
unwilling to use modafinil as a replacement for sleep. Use of the drug as a 
replacement for sleep was considered recreational as opposed to medical: a way to 
increase time awake and optimise ones work-life balance. However, the acceptability 
of using the substance in this way and for this purpose was strongly debated amongst 
the students interviewed. While some students reasoned, that provided the individual 
had access to all the relevant information, as responsible adults they should be able to 
choose whether to use the drug for this purpose, others were far more cautious of 
using the technology to replace sleep, conceSWXDOLVLQJWKLVDVµDEXVH¶RISUHVFULSWLRQ
medication. Students¶ concerns centred on possible risks to health going without sleep 
might lead to, social addiction to the drug and potential for it to be abused. They were 
sceptical of the proposed benefits of drug use, arguing that the potential health risks 
DUHQRWµZRUWKLW¶DQGLWLVµEHWWHUWRDYRLGGUXJV¶They often proposed that mandate via 
medical prescription would be a good mechanism to prevent abuse, overuse of the 
drug and the detrimental impacts this could have on both an individual and a social 
level. 
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Modafinil as a substitute for caffeine 
 
When discussing the appeal and possible circumstances in which modafinil could be 
used by students, similarities were often drawn with past experiences of using existing 
technologies or strategies to promote alertness and extend wakefulness. Students 
frequently drew analogies between modafinil and caffeine pills, framing modafinil as a 
substitute for caffeine, a drug which, in their accounts, is already widely used by the 
student population to improve cognitive performance and promote a wakeful state. 
Within this understanding, modafinil was positioned as a new and improved version of 
technology that already exists and use of this drug was considered to be just the next 
step in an already established practice of promoting alertness. Furthermore, modafinil 
was considered to be a more appealing substance than existing caffeine-based 
products due to its promise of not only enhancing wakefulness but also improving 
cognitive abilities.  
 
³6RPDQ\SHRSOHXVH>FDIIHLQHSLOOV@WKDW,WKLQNDIWHUDZKLOHWKH\
OOUHDOLVHRK
ZHOO>FDIIHLQHSLOOVDUHQ¶W@GRLQJWKDWPXFKVRZH
OOJRRQWRWKLVQH[WWDEOHWZKLFK
not only'll make me like more active, it'll change my cognitive abilities. So yeah I 
WKLQNWKHUH
OOEHTXLWHDELJGHPDQG´6'DQLHO 
 
Through comparisons of modafinil with foodstuffs such as caffeine, its use was 
generally understood within a framework of consumption and consumerism and 
SRVLWLRQHGDVDµOLIHVW\OHFKRLFH¶WKDWZRXOGEHGRZQWRWKHLQGLYLGXDOFRQVXPHUWR
make. Around half of those interviewed said they would consider using modafinil as a 
substitute for caffeine pills and many others asserted that even though they might 
choose not to take either substance, they would not judge others for doing so.  
It was assumed that students whom already consume caffeinated products and like 
substances to promote wakefulness would probably take modafinil for the same 
reasons and in similar situations. Through reference to the current popularity of 
caffeine tablets and the ready consumption of other OTC pharmaceutical products, 
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such as painkillers and diet pills, most respondents assumed that wake-promoting 
drugs would have a ready market that would gradually expand as the technology 
became more known.  
 
³6RPHRIP\IULHQGVWDNHFDIIHLQHSLOOVDQ\ZD\VRWKH\FRXOGGRDOOWKHLUZRUN
GXULQJWKHZHHNDQGWKHQJRRXWDWWKHZHHNHQGDQGKROGGRZQDMRE«,ZRXOG
think it was an interesting lifestyle choice, but I probably wouldn't judge them for 
LW´6'DYH 
 
The drug was not uncritically accepted though, as illustrated in the data extract below, 
fears were often raised over possible tolerance, dependency, side effects use could 
have and addiction to the drug.  
 
³«,GRQ
WNQRZZKether that drug would have the same effect whether if you 
took a lot of it you'd just start to ignore it. It definitely happens with the people 
>ZKRWDNHFDIIHLQHSLOOV@LWMXVWGRHVQ
WDIIHFWVRPHSHRSOHDQ\PRUH¶6
Emma) 
 
Those who said they would take it provided several caveats: that it was affordable; it 
did not disrupt their sleep patterns later on; that they were fully informed about the 
VLGHHIIHFWVVRFRXOGµZHLJKXSWKHSUR¶VDQGFRQ¶V¶WKH\NQHZZKDWWKHLQJUHGLHQWVRI
the drug were; and that they would not become reliant on it. If these conditions were 
met some imagined themselves taking modafinil under specific circumstances, while 
RWKHUVWKRXJKWWKH\ZRXOGWDNHWKHGUXJµDOORIWKHWLPH¶60LNH'HVSLWHIHDUVEHLQJ
raised over potential side effects or addiction and respondents wanting more 
information about the drug, the use of modafinil as a substitute for caffeine was 
generally WKRXJKWWREHDFFHSWDEOHE\PRVWVWXGHQWVLIµH[SHUWV¶KDGVDQFWLRQHGLWDV
safe for OTC use. 
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Children (or other individuals who are not responsible for their own decisions, e.g. 
dementia patients) were however, depicted as illegitimate users of the drug. The use 
of the drug by children sparked fears that children might not be able to physically or 
mentally cope with extended wakefulness and alertness, thus taking the drug would 
SRVHDULVNRUGDQJHUWRKHDOWKWKHSRWHQWLDOIRUµSXVK\SDUHQWV¶WRIRUFHWKHLUFKLOGWR
stay awake longer to pursue additional educational activities; and also the strain 
extended wakefulness could put on family relations. All respondents agreed that if 
modafinil was to become available OTC, it should only be available to adults.  
 
In this configuration of technology and user, visions of a radically different future world 
were scarce. When modafinil was aligned with caffeine the social impacts of it use 
were rarely discussed. Some respondents reasoned that if modafinil and like 
substances were to be used in future in the same way caffeine products are presently 
used, the availability of this technology would not have much of an impact on society 
(S11: Stephen).  
 
When likened to caffeine, modafinil was understood within a framework of 
consumption and lifestyle choice, as opposed to medicine, therapy or enhancement. 
However, clearly, this form of pharmaceutical consumption could be described as 
cognitive enhancement as the substance is being used with the goal of extending or 
improving mental capacities in the absence of illness, disease or disorder. Interesting 
questions arise here as to why this type of use was not considered to be controversial 
or even a form of human enhancement by prospective users.  
 
Modafinil as a study aid 
 
In the student discourse, discussions of modafinil as a performance enhancing 
substance were much more prominent than in the shift worker data. Modafinil was 
often discussed in relation to its potential to be used as a type of study aid in the 
student domain. Respondents envisaged students using the technology for the 
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purpose of performance enhancement in several situations. These included: during 
exams; when revising or writing an essay; when they were feeling stressed or under 
pressure; on long days; for all-night study sessions; or if they felt their work was going 
badly. Students gave various reasons for why they might use modafinil in these 
situations: to improve concentration or memory; to calm them down and relieve stress; 
or if other people were taking them so not to be disadvantaged or left behind.  
 
The use of modafinil as a study aid was generally thought to be a controversial 
practice by the students interviewed. Most respondents thought use of the drug as a 
study aid would be acute and under these specific circumstances (as shown in the 
extract below). However, a small minority of those interviewed thought they would 
probably end up using this technology all the time in order to improve their academic 
performance. 
 
³«LI\RXKDGDSHULRGZKHUH\RXKDGDORWRIFRXUVHZRUNWRGRRUDQH[DP
SHULRGVRPHWKLQJOLNHWKDWZRXOGEHUHDOO\WHPSWLQJ«\RXSUREDEO\don't need it 
RQDGDLO\EDVLV´6'DYH 
 
Several respondents alluded to the temptation built into enhancement technologies 
arguing that when faced with the choice, most people would prefer to perform better 
as an individual. Positive impacts of this technology were imagined in terms of health, 
wealth and productivity, provided the technology was available at relatively little cost. 
In fact, two thirds of students interviewed said they would be more tempted to take 
modafinil for its prospective performance enhancing effects than as a replacement for 
sleep. Opposition to cognitive enhancement as a concept was fairly weak and instead 
VWXGHQWV¶DFFRXQWVZHUHGRPLQDWHGE\LQWULJXHDQGWHPSWDWLRQDespite this, in 
general, the enhancement potential of the drug was generally treated with scepticism. 
After being informed about the cognitive enhancing properties of modafinil, some 
WKRXJKWWKDWWKHGUXJVRXQGHGµWRRJRRGWREHWUXH¶RUOLNHDµPLUDFOHGUXJ¶DQG
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GRXEWHGZKHWKHULWUHDOO\ZDVWKDWµZRQGHUIXO¶TXHVWLoning safety, efficacy and other 
effects it could have. 
 
³,ZRXOGKDYHWRILQGRXWDERXWWKDWGUXJZKDWLWUHDOO\GRHVEHIRUHKDQG- it 
sounds a bit like a miracle really.  I would have to do a lot of research before 
taking it.  It sounds too good to be trXH´6.HUU\ 
 
Again, some students considered the use of modafinil as a study aid by students to 
enhance cognitive performance was constructed as a personal choice that should be 
down to the individual to make. 
 
³,SUREDEO\ZRXOGFRQVLGHULWas long as I knew the side effects. I know some 
SHRSOHWDNHWDEOHWVLIWKH\
UHJRLQJWRZRUNDOOQLJKW«DVORQJDV,NQHZDQG
weigh up all the pros and cons RILWWKHQ\HDK´6-DPHV 
 
Through making the choice to use a chemical study aid, the individual was thought to 
be responsible for any potential risks to health they might be exposing themselves to 
in the process. 
 
³«LIWKH\WDNHWKHULVNWROLYHZLWKWKHVLGHHIIHFWVWKHQWKDWLVWKHLUEXVLQHVV
UHDOO\´6.HUU\ 
 
Others equated modafinil use as a study aid with cheating, in that using such a drug 
would enhance one¶s cognitive performance, and thus provide the user ZLWKDQµXQIDLU
DGYDQWDJH¶RYHURWKHUVWXGHQWVZKRKDGQRWWDNHQWKHGUXJ2FFDVLRQDOO\WDNLQJ
modafinil as a study aid was compared to professional athletes taking enhancing 
drugs to perform better in competitions and the same judgement made. Measuring 
performance against natural ability, some respondents reasoned that if one performs 
better with the aid of a chemical enhancement than one could without taking the drug, 
this would be cheating.  
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³'HSHQGVLIWKH\
GGRQHEHWWHUWKDQPHRUQRW,IWKH\ZHUHVWLOODWWKHVDPHNLQG
of level then it wouldn't be too bad I suppose, but it would feel like they were 
cheating, because it's not fair natural abiliW\«´6%HOOD 
 
Others argued that if enhancement drugs were widely available to everyone their use 
to aid study would not constitute cheating.  
 
³,ILW
VDYDLODEOHWRHYHU\one then is it cheating? Because, if everybody could go 
down to the chemist and get these drugs, WKHQVXUHO\LW
VMXVWDFKRLFH"´6
Dave) 
 
Efficacy and availability were both important factors in whether using the drug as a 
study aid was considered acceptable or not. Respondents were concerned that if the 
drug worked better in some people than others, or if some individuals suffered an 
adverse reaction to the drug so were not able to take it this could cause disparities 
between those who use the drug and those who do not.  
 
Even if the drug remained prescription only, some students feared that people may 
still try to use this substance as a performance enhancer. In the data extract below the 
respondent describes how students might try to obtain modafinil via deception, 
through faking illness. He reasons that if the drug remained a prescription only 
substance, taking modafinil to enhance cognitive functioning would be providing the 
individual with an unfair advantage over others.  
 
³,IWKH\ZHUHIDNLQJV\PSWRPVWRJHWKROGRIWKHPVRZHUHEHLQJIDOVHO\
prescribed them then I would probDEO\EHDELWPLIIHGDERXWLW´60LNH 
 
Whilst some respondents thought only those students who felt they needed help to get 
their work finished would be the ones drawn to the drug, others were concerned that 
although they personally would not want to use the drug as a study aid, they would 
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feel pressure to take the drug to keep up, especially if their friends were taking it and 
reporting positive effects. Respondents feared that objection to drug use could put 
some students at a disadvantage. Further concerns were raised that drug use could 
become standard for optimal performance and the potential for students to become 
reliant on such a substance, around exam times for example. Respondents feared that 
users might become tolerant to the effects of the drug, and that regular drug use could 
lead to dependency.  
 
³,ISHRSOHEHFRPHGHSHQGHQWRQLWWREHDEOHWRDFWXDOO\IXQFWLRQSURSHUO\LWLV
going to be like any other sort of drug addiction, you might get hooked on it and 
HYHQLILWLVQ¶WSK\VLFDO- it might be that they feel they have to have it to function 
SURSHUO\´60LNH 
 
The risk of side effects, either in the short or longer term, affecting one mentally or 
physically, IHDWXUHGKHDYLO\LQVWXGHQW¶VGHOLEHUDWLRQVDERXWWKHSURVSHFWLYHXVHRI
modafinil as a study aid. All respondents said they would consider the side effects of 
the drug before deciding whether they would take it for this purpose. The case of the 
morning sickness pill thalidomide was used to tell a moral tale about pharmaceuticals 
and illustrate that even if new pharmaceuticals are tested properly and come to 
market, it is never absolutely certain that nothing will go wrong. This moral tale was 
XVHGWRDUJXHWKDWµWKHUHVKRXOGQHYHUEHWKHUHTXLUHPHQWWRWDNHVRPHWKLQJWRPDke 
you better WKDQ\RXDUH¶6 Bella).  
 
/HJDOLW\RIVXEVWDQFHXVHDOVRHPHUJHGDVDQLPSRUWDQWFRQVLGHUDWLRQLQVWXGHQWV¶
accounts. Most respondents said that if modafinil or related substances were available 
OTC, that they would not judge other students for taking them, provided that they were 
legally allowed. As in the interview extract below, most students said they would only 
use the technology as a study aid provided that it was legal and not breaking any 
rules. 
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³$VORQJDVWKHUHZDVQRWKLQJWRVD\WKDW\RXVKRXOGQ
WWKHQ\HDK«LIWKH\
LQYHQWHGDGUXJDQGWKHQLWEHFDPHLOOHJDOWKHQ,ZRXOGQ
WEHWDNLQJWKHP´6
James) 
 
+RZHYHUXQGHUVWDQGLQJVRIPRGDILQLOXVHDVDQµHQKDQFHPHQW¶in the student domain 
were problematised by several individuals who thought that using the drug would 
imply they had a problem, inadequacy or inability to cope. This raises questions about 
the definition of modafinil use as enhancement, as if there has to be a problem for use 
to be justified- FDQGUXJXVHVWLOOEHWKRXJKWRIDVDQµHQKaQFHPHQW¶RUGRHVLWEHFRPH
more therapeutic and restorative? 
 
 ³«HYHU\RQHZRXOGSUHIHULIWKH\FRXOGFRQFHQWUDWHPRUHDQGSHUIRUPEHWWHU
EXW«,VWLOOZRXOGQ
WZDQWWRGRLWEHFDXVHLW
VEDVLFDOO\implying that you can't 
cope with being able to concentrate yourself, which is kind of saying that you've 
got problems´6-RVHSK 
 
Another respondent described how she would feel pity towards those students who 
were not alert enough to take an exam without using a drug.  
 
³,
GIHHODELWVRUU\IRUWKHPWKDWWhey couldn't just do it without [drugs] and that 
WKH\
UHQRWDFWXDOO\DOHUWHQRXJKWRWDNHDQH[DPZLWKRXWVWLPXODQWV´6
Emma) 
 
In summary, in LWVFRQILJXUDWLRQDVDVWXG\DLGUHVSRQGHQWV¶RSLQLRQVFODVKHGDVWR
whether the users of modafinil should be thought of as ambitious and competitive 
individuals striving to get ahead or cheats abusing or misusing the drug to gain an 
unfair advantage over others. Safety, efficacy, fairness and legality of substance use 
emerged as prominent ethical and social considerations related to this type of usage. 
Often it was other concerns and considerations, for example, fears surrounding 
potential health risks that lessened the appeal of modafinil rather than any ethical 
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objections to the chemical enhancement of cognition. Despite much scepticism that 
the drug would be an efficacious cognitive enhancer, most respondents said they 
might still consider trying it, provided they could find enough information to reassure 
them it would not be harmful and there was nothing to say they should not use it.  
 
Summary and conclusions 
 
In student discourse, student life was depicted as varied and flexible. Tension was 
observed in the data between two different, yet overlapping, understandings of sleep: 
sleep as a period of rest and relaxation that is natural and vital to health and 
wellbeing; and sleep as an inconvenient waste of time that can be dispensed with. 
Although students considered sleep to be important and acknowledged various forms 
of normative advice about sleep, work-life balance was prioritised in their accounts. All 
of the students interviewed admitted that they cut back on sleep for education, 
employment or recreational purposes. Sleep timing and duration were ultimately 
considered to be flexible and for the most part under individual control.  
 
Descriptions of complex social and technological networks utilised in order to control 
sleep and enhance alertness in daily life featured strongly in the data. The extent to 
which students rely on existing technologies to wake them up and promote alert 
wakefulness at personally desirable times was particularly striking. Individuals 
demonstrated a wealth of lay knowledge and expertise governing their own sleepy 
bodies and cognitive functioning through a variety of technologies including the regular 
consumption of OTC pharmaceutical products and food-stuffs to negotiate sleep, work 
and health in their everyday lives. This was considered the norm and not of social or 
ethical significance. Although problems with sleepiness and alertness were well 
documented and medical expertise was valued and respected, typically, students¶ own 
sleep problems were not pathologised or medicalised in their accounts. In addition, 
there was little concern that lapses in attention would cause them to miss out on 
aspects of their education. 
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)RXUFRPSOH[PRGDILQLOXVHUFRQILJXUDWLRQVGRPLQDWHGVWXGHQWV¶DFFRXQWV,QHDFKof 
the four configurations discussed, the use of the technology was framed in a slightly 
different way, and the user assumed to have a different set of motivations and 
intentions for using the drug. By consequence, each configuration came along with its 
own set of social and ethical considerations which influenced the perceived 
acceptability of modafinil use in each case. When modafinil was discussed as a 
technology that can be used outside of medical control, students debated the 
legitimacy and acceptability of using the drug to improve individual performance and 
capacities, or for recreation and pleasure seeking activities.  Configurations of 
modafinil as a substitute for caffeine or a replacement for sleep were intertwined with 
notions of consumerism, individual responsibility and lifestyle choices. When framed 
as a study aid modafinil use was thought about in terms of performance improvement.  
When understood as a medicine, bearing similarity to shift workers accounts, modafinil 
use was constructed in relation to notions of normality, health and illness which were 
used to legitimate drug use. However, concerns over safety of the drug, future health 
risks, possible addiction or dependency to the drug were prominent elements of all 
configurations. Legality was also an important consideration and featured strongly in 
the justifications both for and against drug use that were given. 
 
As in the shift workers discourse, imagined users of and uses for the drug were 
embedded within narratives about past technological failures, existing technologies 
and other strategies for cutting back on sleep, promoting wakefulness and improving 
cognition, and elaborate visions of the future. These strategies functioned as rhetorical 
devices for students to explore hopes, promises, concerns and fears surrounding the 
availability of a new technology that could potentially be used to control sleep and 
enhance cognition (Borup, 2006; Brown & Micheal, 2005). Respondents envisaged 
how the use of enhancement drugs could impact on individuals, families, British 
society and culture. They imagined both positive and negative impacts this new 
technology could have, although in most cases their fears and concerns far 
outweighed any hopes and promises that were expressed. Interestingly, when asked 
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what impacts they thought this technology could have on society, it was the wake-
promoting effects of modafinil that fuelled visions of the future. The potential impacts 
that the cognition enhancing effects of the drug could have on society were rarely 
mentioned.  
 
Modafinil was introduced to students as a prescription drug and despite the different 
uses and users that were imagined, most respondents returned to this configuration in 
their assessment how the drug should be used. In their accounts passage through a 
medical encounter and diagnosis of a disorder were seen as legitimating use of the 
drug. Therapeutic use was clearly differentiated from an enhancing use of the drug. 
Users of the drug who were not considered to be ill or impaired were typically 
reconfigured not as patients; but as cheats or abusers using the technology for the 
wrong reasons. Further to this, the whole idea of enhancement in the student domain 
was problematised to some extent with some students reasoning that the use of a 
drug to improve alertness or performance would imply the existence of a problem in 
the first instance.  
 
Contrary to this, it was also evident that modafinil does fit into existing ways of 
managing sleep and wakefulness outside of medical control, especially when 
configured as a substitute for caffeine. In this instance the technology was easily 
assimilated into existing socio-technical networks and an existing user group readily 
imagined.  When modafinil was positioned alongside existing wake-promoting 
technologies such as caffeine, it was thought about in a framework of consumption 
and lifestyle choice, as opposed to medicine, therapy or enhancement. Clearly this 
form of pharmaceutical consumption could be described as cognitive enhancement- 
as the substance is being taken with the goal of extending or improving mental 
capacities in the absence of illness, disease or disorder. Such usage was not 
considered controversial by prospective users, providing that safety and efficacy of the 
technology could be assured. In fact, opposition to cognitive enhancement as a 
FRQFHSWZDVIDLUO\ZHDNDQGLQVWHDGVWXGHQWV¶DFFRXQWVZHUHGRPLQDWHGE\LQWULJXH
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and temptation. Often it was other concerns and considerations, for example, fears 
surrounding potential health risks that lessened the appeal of modafinil and promoted 
calls for it to be under medical supervision rather than any ethical objections to the 
chemical enhancement of cognition.  
 
Respondents were unsure as to whether modafinil should be made available to 
students, even in the case of those students who said they would take the drug and 
thought they would benefit from it. The dominant position adopted in the data was one 
of deference to medical control. Respondents concluded that as long as scientific and 
medical experts believe the technology should remain prescription only, it should only 
be used to treat illness.  
 
The data presented in this chapter has demonstrated how the same technology could 
potentially be used in several different, perhaps even contradictory, ways and for 
several different purposes in one specific domain of social life by one prospective user 
group. The sociological analysis of rituals and routines was important in understanding 
how new technology as either medical intervention or OTC consumer product fit into 
the everyday lives of prospective users. Of significance in the data was how several of 
the purported uses and frameworks within which drug use was understood fall outside 
of the therapy-enhancement dichotomy that structures the ethical and to some extent, 
media debates about cognition enhancing drugs.  It was evident that technologies 
come with scripts for how and by whom they should be used (Odshoorn & Pinch, 
2006). Although alternative uses for the technology can be easily imagined and such 
scripts can be re-written by the user (Akrich, 1992; Mallard, 2005), it is apparent that 
the way in which new technologies are framed and made available to prospective 
users has a strong impact on the way use is understood and the intent behind use is 
rationalised. This also impacts upon the normative judgements made and perceived 
acceptability of their use. 
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Chapter 8: Conclusions 
 
Introduction 
 
Informed by previous work in both medical sociology and neuroethics, the aim of this 
thesis is to explore the social and ethical issues relevant to the pharmaceutical 
augmentation of human cognitive functioning. An STS perspective was adopted and 
the wake-promoting drug modafinil used as a case study to determine how 
sociotechnical spaces for µtherapy¶ and µenhancement¶ are being constructed and 
negotiated in different domains of social life. The core research question this project 
aims to address is: How is the use of the drug modafinil to augment human cognition 
understood within the mass media, by researchers and potential users, and what 
implications does this have for debates about enhancement technologies? 
 
The study attempted to: establish the ways in which modafinil is represented in the 
mass media and how this impacts upon views of the legitimacy of its use across 
different contexts; describe how the use and users of the technology are framed within 
medical and scientific discourse; analyse the ways in which prospective users of 
modafinil understand, position and negotiate use of the drug in the context of their 
everyday lives; and to explore the implication of these empirical findings for normative 
debates about the idea of cognitive enhancement and social science debates about 
(bio)medicalisation. 
 
The aims of the study were operationalised into specific research questions. These 
included the following: How are sleep, cognition and the body conceptualised in 
different social contexts and by different stakeholder groups? How is modafinil use 
understood, positioned and negotiated in each of these domains? What sociotechnical 
scripts are associated with modafinil use and how is it positioned as a medical or non-
medical technology?  According to what norms do different groups believe that 
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augmentation of the mind should take place? What role is given to medical authority in 
deciding if particular uses are acceptable?  
 
This chapter aims to draw the empirical findings of the study together and assess if, in 
the light of these empirical findings, the maintenance of a therapy/ enhancement 
dichotomy remains viable when discussing the various uses of cognition enhancing 
drugs and to discuss the implications of these findings for the process of 
(bio)medicalisation. 
 
Summary of findings 
 
Empirical work was conducted in two stages. Firstly, frame analysis using a metaphor-
based approach was used to analyse media data to uncover the cultural framing of 
modafinil. Use of the drug was situated within four discursive domains in the media: 
patient, sports, recreation and work. Each discourse was built up around the specific 
GHSOR\PHQWRIWKHPHWDSKRULFDOIUDPHVµZDU¶µFRPPRGLW\¶DQGµFRPSHWLWLRQ¶WKDW
impacted upon how modafinil use was portrayed in terms of therapy or enhancement 
and the level of engagement with a medical rhetoric. The media analysis clearly 
demonstrated the importance of social context when considering the socio-ethical 
implications of new technologies. The war frame dominated patient discourse in which 
use of modafinil was framed in exclusively medical terms as a legitimate and desirable 
way to fight sleepiness. Through competition metaphors use of modafinil in a sporting 
context was heavily criticised and depicted as an illegitimate performance 
enhancement falling outside of medical authority. Use of modafinil in the workplace 
and use in a recreational context emerged as boundary cases, where use of the drug 
was framed as neither exclusively therapeutic nor enhancing and normative reaction 
was mixed. 
 
Secondly, informed through the results of the media analysis, interviews were 
conducted with three stakeholder groups in order to further explore modafinil use in 
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these boundary cases. A wider discursive approach drawing on elements of frame 
analysis and grounded theory was used to analyse interview data.  
 
Scientists and clinicians were interviewed who were familiar with the use of drug in 
either a research or clinical setting to investigate the scientific and medical framing of 
modafinil. Modafinil was positioned as a therapeutic substance by sleep experts that 
should be under medical authority and control. All uses of modafinil outside of medical 
control that were imagined were constructed as illegitimate uses of the drug, usually 
on the grounds of risks to health unmonitored or unregulated use of the substance 
could have. Surprisingly, the war frames dominant in media discourse were rarely 
found in medico-scientific discourse. Instead sleep experts tended to frame sleep 
disorders as bio-psycho-social problems. Although the biological body was usually 
spoken about through the use of biomedical language, the socio-cultural context in 
which sleep disorders arise, are defined and become problematic for the individual (as 
biological, psychological and/or social problems) was overtly referred to and 
recognised. This was reflected in how modafinil use was understood and positioned 
by the expert community. Rather than framing modafinil as the optimal way to fight 
sleepiness and regain normality as was the case in the media discourse, sleep 
experts constructed modafinil as a short term medical solution that could help some 
individuals depending on their particular biological problem, social situation and 
personal preference.  
 
These findings suggest that many human behaviours and functions associated with 
sleep and cognition are indeed being colonised by various forms scientific and medical 
expertise (Williams, 2002; Conrad, 2007), defined in biomedical terms and subjected 
to biomedical interventions (Fox & Ward, 2008; Moirea, 2006; Dement & Vaughan, 
2000). Despite this, a number of alternative but complementary explanatory models 
co-exist and are supported within the domain of scientific medicine. These models 
FRPELQHNQRZOHGJHFODLPVIURPWKHGLIIHUHQWµH[SHUW¶GLVFLSOLQHV(e.g. neuroscience, 
genetics, psychology, psychiatry and so on) to explain the nature of sleep and 
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cognition problems and suggest strategies for their management or resolution, 
perhaps reflecting claims that biomedical knowledge and practice have a rather more 
µGLIIXVHDQGGLVWULEXWHG¶QDWXUHWKDQLs often acknowledged (Weiner & Martin, 2008; 
Pickersgill, 2009). 
 
Interviews were also conducted with shift workers and students who were depicted as 
existing or future users of the drug in media and bioethical debates. Interviews with 
prospective user groups aimed to situate understandings of and attitudes towards 
modafinil use in social context in an attempt to further explore the emerging social and 
ethical issues as defined by potential users. Again, the strong metaphorical references 
to war, commodity and competition found in the media debates were largely absent in 
the talk of potential users.  
 
Overall, modafinil use and users were configured in many different ways by those 
interviewed. The four most prominent configurations found in the shift worker 
discourse positioned modafinil as: a medicine, an OTC pharmaceutical product, a 
safety tool, and a performance enhancing drug. In the first two of these configurations, 
modafinil was constructed as a treatment (whether administered by a medical 
professional or accessed independently) for those with impairments or clinical 
disorder. In both instances, use of the drug was conceptualised as acting to restore 
impaired functioning and return the individual to a normal level of health. Alternatively, 
when configured as a safety tool, modafinil was understood as a way to boost 
cognitive performance, alertness and reduce tiredness, but as a means of achieving 
higher levels of safety, rather than performance, in the workplace.  
 
)RXUFRQILJXUDWLRQVRIPRGDILQLOXVHDQGXVHUVDOVRGRPLQDWHGVWXGHQWV¶DFFRXQWV
Modafinil was positioned as: a medical treatment, a replacement for sleep, a substitute 
for caffeine, and a study aid. Student discourse was dominated by notions of 
autonomy and the idea that the individual is responsible for their body and its 
functioning. Respondents understood sleep, bodily functions, cognitive performance 
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and selfhood to be flexible, under their own volition and control. Within this worldview, 
non-medical use of modafinil use was typically referred to a lifestyle choice. 
Regardless of their personal inclination to take the drug, respondents thought that if 
provided with enough information individuals should be able to weigh up the potential 
benefits against potential harms and choose whether or not to use the drug as a 
replacement for sleep or as a cognition enhancer, provided that the substance was 
freely and legally available OTC. Often other concerns and considerations, for 
example fears surrounding potential health risks, lessened the appeal of modafinil 
rather than any strong ethical concerns about use of pharmaceuticals to enhance 
cognition. Although individual autonomy, choice and responsibility for health and 
performance were dominant themes in the student data, medical authority and 
expertise were also respected and valued. Consumption of medical technology for 
purposes other than healing was regularly thought of as abuse of medicine rather than 
enhancement, clearly illustrating the cultural power of medicine in defining legitimate 
spaces for drug use in British culture.  
 
Nisbet and his colleagues argue that the way in which news media frame scientific 
issues can directly influence public opinion (Nisbet, 2007; Nisbet, Scheufele et al., 
2002). Of interest for this research were the messages, behavioural directives and 
bodily narratives that were being made available in the media rather than how this 
information was received or understood by an audience. However, this study found 
that the language, frames and particularly the metaphors used in media discourses 
were largely absent in the talk of those interviewed. Although this finding could call 
LQWRTXHVWLRQWKHLQIOXHQFHRIPHGLDIUDPLQJRQWKHZD\WKHµPDVVSXEOLF¶SHUFHLYHDQG
evaluate scientific information, further research clearly needs to be carried out in this 
area. Alternative explanations for this disconnect are possible, media coverage of 
modafinil has not been extensive to date and many respondents had not heard of the 
drug prior to the interview so it is unlikely they would have been exposed to the media 
discourse surrounding it.  
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To summarise, the analysis of the ways in which modafinil use was positioned and 
various uses were negotiated in both media and stakeholder discourse shows how 
different groups can conceptualise the same technology in very different ways 
depending on who is doing the defining, who the imagined users are, the purpose for 
and specific context of use. The implications that these findings have for the 
therapy/enhancement distinction upheld in neuroethical debates about human 
enhancement will be returned to later. In the next section the ways in which modafinil 
use and users were conceptualised will be discussed in more depth. 
 
Drugs, culture and scripts for use 
 
The notion of the technological script is well-established within STS. This study has 
attempted to apply the idea to pharmaceutical drugs rather than computers, speed 
bumps, or door closers (Latour, 1992; Johnson, 1988; Winner, 1980; Woolgar, 1991). 
From an STS perspective, for successful integration, a technology must be built in 
conjunction with an environment in which it can function. In other words, for a 
technology to be successfully adopted in a particular social context it must be 
constructed in conjunction with that context in which it must become the right tool for 
the job. As technologies are designed, developed and used in the social world, in 
order to study the prospective uses of modafinil, it was both important and necessary 
to first uncover the complex social and technological networks already utilized in order 
to control sleep and enhance alertness in daily lives of citizens. 
 
The STS framework adopted to analyse modafinil as a wake-promoting technology in 
its imagined contexts of use therefore took into account: the society and network of 
DUWHIDFWVZLWKLQZKLFKWKHWHFKQRORJ\ZRXOGEHHPEHGGHGKRZSRWHQWLDOXVHUVµUHDG¶
the technology and its configurations; and how putative users and the future impact of 
their likely actions were configured in the process. Particular attention was given to the 
ways in which socio-ethical dilemmas regarding the uses of psychopharmaceuticals 
DURVHDQGZHUHUHVROYHGLIDWDOOLQYLVLRQVRIDµFRJQLWLYHO\HQKDQFHGIXWXUH¶ 
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Configuring the technology and the user 
 
From the analysis conducted it appears that drugs are not only embedded with 
technological scripts for how and by whom they are to be used (Akrich, 1992), but also 
strong cultural scripts relating to legitimacy and acceptability of when, where, for what 
purpose they should be used. As imagined and reported in media and bioethics 
discourse, pharmaceuticals such as modafinil could potentially be put to many uses 
throughout various domains of social life (Lakoff, 2005). However, even though this 
might be the case, technologies are not neutral artefacts (Winner, 1980).  Medical 
technologies embody various social and cultural understandings of the kinds of bodies 
they are interacting with, the disease, illness or trait being targeted, and what is 
normal or desirable (Nichter & Vockovitch, 1994). They are designed and developed 
for specific uses with a specific group of users in mind (Woolgar, 1991). Modafinil was, 
first and foremost, developed under stringent regulations as a medicinal product to be 
used under medical supervision for the treatment of a specific symptom of one or 
more medically defined disorders. It exists in pill form, is packaged in a small box 
which includes instructions for how and by whom it should be used like other 
medicinal products, and is usually dispensed by a pharmacist in the UK upon receipt 
of a medical prescription.  
 
This configuration, of modafinil as a medicine and users as patients who have been 
assessed and prescribed the drug by a medical professional, was found to some 
extent across the discourse of all three stakeholder groups interviewed and in the 
PHGLDGDWD,QWKHVFLHQWLVWV¶GLVFRXUVHWKLVZDVWKHGRPLQDQWFRQILJXUDWLRQRI
modafinil. The drug was clearly configured as a medicine which should be used to 
treat or protect against ill health, legitimate users were identified as patients and all 
other uses outside of medical authority considered as being abuse of prescription 
medication.  
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Although alternative scripts for use were acknowledged and discussed by scientists 
and clinicians, reading the technological script of modafinil in this way clearly defined 
the drug as a medicinal, therapeutic substance whilst at the same time excluding other 
possibilities of use on a normative level. Chemical augmentation of brain functioning 
was only viewed as acceptable when following medical norms that set standards of 
health, illness and normality. Visions of the past and of the future guided responses in 
this domain. Some respondents drew on stories of drugs that were once thought to be 
safe but later turned out to have adverse consequences to argue that modafinil use by 
those without illness should be approached with caution. Others projected into the 
future envisioning the impact widespread availability of modafinil could have on 
society to imagine how the drug could be abused, misused and lead to population 
health problems upstream. The social and ethical considerations raised were framed 
E\GRPLQDQWPHGLFDOXQGHUVWDQGLQJVRIWKHµKHDOWK\ERG\¶DQGWKHµKHDOWK\PLQG¶ 
 
The scientific and medical experts did not automatically perceive pharmaceuticals as 
the most desirable technological fix to sleep or cognition problems and these were not 
SULYLOHJHGDERYHRWKHUIRUPVRIµUHDVRQ¶,QVWHDGWKLVIRUPRIWHFKQRORJ\FDUULHG
forward with it the scars of a long history of failures, unanticipated harms, and social 
disrepute (Brown, 2005). As such, scientists and clinicians did not expect that new 
drugs would be miracle cures, golden nuggets or silver bullets. Instead, more modest 
hopes were proposed: that these drugs, in combination with other non-
pharmacological interventions and behavioural changes, might be the best solution 
currently at hand to help some people in some way. 
 
In the shift workers discourse two alternative modafinil/user configurations were 
present that scripted legitimate ways the drug could potentially be used by shift 
workers outside of medical authority. In the first of these, modafinil was configured as 
a therapeutic substance that could be accessed outside of the medical encounter as a 
strategy for relieving impairment or suffering in the absence of clinical disorder. In this 
configuration users were constructed as consumers whom, through a process of self-
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monitoring might choose to take the drug to mediate their own sleepiness/alertness. 
The technological script was, however, still read as a way of restoring a normal level 
of functioning. This configuration of technology and imagined users was more 
problematic than understandings of modafinil as a medicine as reVSRQGHQWV¶
frequently conceptualised pharmaceXWLFDOXVHDVDµODVWUHVRUW¶DQG raised concerns 
over the amount of drugs available OTC. In a second configuration, modafinil was 
positioned as a safety tool. Legitimate users were (re)configured as responsible and 
altruistic adults taking the drug for the benefit of others. Within this frame, safety was 
the most important consideration in the legitimation of drug use. 
 
Three further technology-user configurations were imagined in the student discourse. 
In these modafinil was configured as: a substitute for caffeine and users were 
constructed as (ir)responsible consumers; a replacement for sleep with the future user 
configured as the (anti)social (ab)user; and as a study aid where users were 
positioned as either competitive individuals or cheats. In each of these configurations, 
the acceptability of modafinil use was negotiated, contested and debated by students. 
It was apparent in the data that modafinil could easily fit into existing ways of 
managing sleep and wakefulness outside of medical control, especially when 
configured as substitute for caffeine. In this instance, the technology was easily 
assimilated into existing socio-technical networks and an existing user group readily 
imagined. However, the means to achieving enhanced wakefulness was important to 
respondents and there was a strong tendency to associate drug taking with illness, 
addiction and health risks in their accounts. 
 
$FULWLFDODQDO\VLVRIVKLIWZRUNHUV¶DQGVWXGHQWV¶SHUFHSWLRQVRIPRGDILQLOUevealed how 
the role of new technology is negotiated within the social context of its use, being 
understood in relation to individualised routines and private rituals that are intricately 
related to existing technologies and cultural practices, values and norms. Modafinil 
then, fits into these existing practices in various ways depending upon cultural 
conceptions of normality, values of individuality and the pursuit of health, wealth and
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happiness in the modern world. A contextualised understanding of such phenomena 
goes some way to explaining why particular social and ethical issues surrounding 
pharmaceutical augmentation of cognition were deemed relevant to these 
communities in the conduct of their everyday lives. 
 
In summary, each configuration of technology and imagined user framed the 
technology and constructed the prospective users in a slightly different way and came 
along with its own normative framework. Therefore, although technologies are not 
neutral and are designed, produced and marketed for a specific purpose with specific 
users in mind, alternative scripts for use can be imagined and realised as the 
technology travels between different domains of social life. The legitimacy of use is 
linked to the specific social norms operating within and between social groups and 
alternative uses may be considered controversial or inappropriate to those outside of 
the social sphere. Importantly, this demonstrates that although norms may overlap to 
some degree, there is no universal set of norms defining and delimiting how modafinil 
should be used in contemporary society. 
 
Although different technology/user configurations may be readily imagined, the next 
section will reflect upon the process of transformation that a technology must undergo 
to move from medicinal drug to enhancement tool.  
 
From therapy to enhancement? 
 
At present modafinil is a medical technology under medical authority and control in the 
UK. Medical norms play a role in setting social norms through the labelling of the 
abnormal, the therapeutic and ill health (Parsons, 1959). Medical technologies come 
with scripts for how and why they should be used: to relieve pain and suffering, to 
attempt to restore normality with the goal of achieving health or preventing illness. 
Although some medical procedures or interventions may be thought of as more 
enhancing than therapeutic (e.g. some cosmetic surgery procedures) there is always 
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some problem, deficit or difficulty they are aiming to mend. To extend, improve and 
advance the individual body or brain beyond this normal, healthy level without a 
SK\VLFDOSV\FKRORJLFDORUVRFLDOSUREOHPWRµIL[¶LVRIWHQFRQVLGHUHGWREHEH\RQGWKH
goal of therapeutic enterprise and thus becomes socially, ethically and morally 
questionable. Whilst some technological interventions presently available are clearly 
enhancing with little therapeutic benefit (e.g. teeth whitening, botox- although there is 
DGHILQHGµSUREOHP¶KHUHLQERWKFDVHVWKDWWKHLQWHUYHQWLRQIL[HVWRGRZLWKVRFLDO
stigma and appearance) the acceptability of an enhancement is intricately related to 
medical social control for it is the medical community that defines who is a legitimate 
patient and in need of treatment. Both therapy and enhancement are defined in 
relation to health: therapy as restoring health and enhancement as making one better 
than well. 
 
The transformation from medical technology to consumer product is by no means 
straightforward or easily accomplished. The technology must travel from the medical 
domain, relinquishing its cultural script as a measured, controlled, specific and potent 
therapy, to enter other social worlds. In this process the technological script for how 
the technology should be used may remain intact (for modafinil is still a pill that must 
be taken orally), but new cultural meaning must be accrued or along the way, in a 
sense µUH-VFULSWLQJ¶WKHWHFKQRORJLHVSXUSRVHRIXVH7KHLQQRYDWRUVRIWKHWHFKQRORJ\
must find a niche and the users a problem which it is able to fix, or a deficit it can 
restore in these other domains of VRFLDOOLIH7REHFRPHDQµHQKDQFHPHQW¶D
technology that will make one better than well, something which will boost, better, 
extend and improve body, mind or performance above the norm, the task becomes 
even more complex. For if nothing is wrong why does one need to become better? 
Here individual social goals, aspirations, dreams and desires come to the fore. The 
technology must become a way to liberate, release (Schwartz- Cowen, 1985) and 
enable the individual to recreate and transform themselves in their own image for their 
own personal goals (Rose, 1999), whilst at the same time not posing a risk to health, 
safety and wellbeing. 
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Although by definition enhancement is not therapy, medical experts (and those with 
related professional expertise who operate on the periphery of the medicine) still have 
cultural authority and power over definitions of health, how to achieve, attain, damage 
or pose a risk to health. So, for something to be culturally acceptable as an 
µHQKDQFHPHQW¶EHWKLVDIRRGVXEVWDQFHGUXJ, over the counter pharmaceutical 
product or herbal remedy), it is assumed to have been certified as safe for 
consumption by this expert community or at least for the risks to health to have been 
established and outlined before it is made available as a consumer product, therefore 
HQDEOLQJWKHLQGLYLGXDOWRPDNHDQµLQIRUPHGFKRLFH¶'UXJVZKLFKDUHQRWVDIHRUSRVH
a greater risk than benefit to health are not certified as safe for consumption, even in 
moderation, and are classified as illegal. People still choose to take illegal drugs for 
their own pleasure and for recreational purposes, and do not always follow expert 
recommendations about how and in which quantity other drugs and foodstuffs should 
be consumed. However, the data shows that when they do so it is perceived to be at 
their own risk and this is typically viewed as abuse, irresponsible behaviour or 
potentially damaging to health.  
 
The extent to which a drug is able to move from therapy to enhancement and leave 
behind cultural images of addiction, disease, side-effects, health and social problems 
is debatable. Such a transformation has taken place with other technologies. For 
instance, as discussed in Chapter 2, the vibrator has successfully been transformed 
from clinical treatment for the (then) medical disorder hysteria to a device used to 
enhance sexual pleasure in the private lives of ordinary citizens (Maines, 2001). A 
more contemporary case is that of contraceptive pills which, once only available on 
discretion of a doctor, are now on their way to becoming OTC products; available to 
all. Nonetheless, of paramount concern is safety. Contraceptives, vibrators and coffee 
have all been around for many years, since before the birth of many of those 
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interviewed, and are consumed regularly by millions without any significant concern 
for adverse health effects37.  
 
Modafinil was identified as different from these other technologies by respondents 
because it is a relatively new substance yet to enter popular usage. It is delivered in 
pill form which sets it apart from most foodstuffs (with the notable exception of caffeine 
pills) and mechanical technologies (e.g. alarm clocks) used to control sleep and boost 
cognition. Instead, it was likened to other medicines, pills, drugs and tablets that are 
available in various forms in British society and was positioned in line with these 
cultural scripts. How the substance is regulated, controlled and presented to the 
potential user (as either medicine or consumer product) and what this implies in 
relation to health benefits and the safety of consumption were important 
considerations in whether the chemical augmentation of cognition was considered to 
be legitimate or not. 
 
The role of medical authority in defining legitimate spaces for drug use will be 
discussed in the next section before moving on to consider the potential impacts of 
this type of technology on notions of self-governance and identity and the wider social 
and ethical issues that this raises. 
 
Medicalisation of sleep and cognition 
 
Whereas in neuroethical discourse it was the impact modafinil could have on the brain 
(and notions of the self) that dominated ethical discussion, the discourse of 
prospective users was more focused on the potential impact of the technology on 
sleep. Tension was observed throughout the data between two different, yet 
overlapping, understandings of sleep: sleep as a period of rest and relaxation that is 
natural and vital to health and wellbeing; and sleep as an inconvenient waste of time 
                                                          
37
 Despite caffeine being linked to a range of health problems in the scientific and medical literatures, this 
was rarely acknowledged by its users. The possible health risks associated with contraceptive pills are more 
frequently acknowledged.  
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that can be dispensed with. Although in general terms, sleep was considered 
important, all respondents admitted cutting back on sleep for education, employment 
and recreational purposes. 
 
To some extent this study confirms the findings of other research in the sociology of 
VOHHSµWKDWVOHHSLVLQGHHGDQRWKHUFKDSWHULQWKHPHGLFDOLVDWLRQVWRU\¶:LOOLDPV et al, 
2008b).  This is especially evident with the emergence of the relatively new condition: 
shift work sleep disorder. However, such medicalisation is controversial within the 
expert community as the data shows that SWSD was flexibly interpreted as a disease 
GHILQLWLRQ&ULWLFVRIPRGDILQLODQG6:6'YRLFHGFRQFHUQVRISRWHQWLDOµGLVHDVH
PRQJHULQJ¶:RORVKLQ	6FKZDUW]WKDWDQHZGLVRUGHUKDVEHHQFUHDWHGLQ
part by the manufacturers of the drug, in order to expand the market for their product 
and increase sales.  
 
The shifting engines of medicalisation  
 
Current debates within medical sociology point to WKHµVKLIWLQJHQJLQHV¶RI
medicalisation (Conrad, 2007) and discuss how new drivers of the process include: 
the patient-consumer in search of diagnosis or a technological fix for a variety of self-
diagnosed problems (Tomnes, 2006; Furedi, 2006), the pharmaceutical industry 
aiming to expand their markets in order to sell more drugs and make more money 
(Moynihan et al, 2002); cultural influences such as the Internet and media which often 
cast problems and their solutions in the rhetoric of medicine (Kroll-Smith, 2003), 
contributing to the process on a conceptual level by encouraging problems to be 
thought about in medical terms.  
 
When taking an STS approach to focus on the interaction between technology and 
prospective users it becomes apparent that not only are the drivers and engines of 
medicalisation changing, the medical profession is also changing the discourses and 
frames it uses to promote understandings of health (in relation to sleep at least). The 
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analysis confirms claims in medical sociology that there is a changing discourse within 
medicine to focus on choice as patients are encouraged to become experts on their 
own illnesses (Rose, 2007). Most significantly, the data illustrates how a balance is 
being struck between biological or genetic determinism and social determinism, with 
individual differences and pathologies being explained through bio-psycho-social 
worldviews which take into account the biological, genetic, chemical and physical 
make-up of an individual, their psychological states and socio-cultural environments. 
This is reflected in the solutions posited for contemporary problems such as SWSD 
which include not only pharmacological therapies, but behavioural strategies, based 
upon negotiations between expert advice offered by medical/ psychological experts 
DQGH[SHUWNQRZOHGJHRIWKHSDWLHQWFRQVXPHU¶VRZQVRFLDOHQYLURQPHnt, demand and 
desires.  
 
This indicates that instead of the medical imperialism exposed in the 1970s where 
scientific and medical professionals were accused of indiscriminately and illegitimately 
extending medical dominance (Zola, 1972; Friedson, 1970; Illich, 1975), such actors 
can, to some extent, EHWKRXJKWRIDVµSXWWLQJWKHEUDNHVRQ¶PHGLFDOLVDWLRQ&RQUDG
2007). This, of course, could still serve professional interests, speculatively, by 
keeping a defined and secure medical sphere within which medical professionals can 
keep hold of their knowledge, power and expertise. For if the medical sphere becomes 
too large and all-encompassing it may also become too diffuse, difficult to control and 
thus open to more challenges from other forms of knowledge. On the other hand, one 
could see the increasing involvement of the patient/ consumer in medical care and era 
of patient choice as akin to the exertion of medical dominance, albeit in a new liberal, 
patient friendly way. 
 
As Rose (1994) suggests, a paradoxical situation ensues: individuals have control 
over their own bodies and choose how they live their lives, choosing when to engage 
with medicine and which interventions are most appropriate to them in the context of 
their everyday lives. But at the same time, scientific medicine defines states of 
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normality, health and wellbeing, issuing guidelines, advice and recommendations how 
WROLYHRQH¶V life. Therefore, the non-SDWLHQWVWKRVHµDWULVN¶RIIXWXUHLOOQHVVDUHKHOG
responsible for maintaining their own health, but to do this they must have access to 
and follow expert advice (e.g. eating the correct diet, do the recommended amount of 
exercise, get enough sleep, give up smoking, limit their alcohol intake). Those that do 
not follow this protocol are held (at least partially) culpable for any resulting health 
problems that could have been avoided if they had been a responsible citizen and 
cared for themselves appropriately (i.e. contemporary debates in the UK about 
whether people with alcohol or smoking-induced illnesses should be treated on the 
NHS). Individuals are free to choose how they live their lives as long as they choose 
the path set out by scientific medicine, or else they are penalised by being denied 
access to some services or held morally culpable for their health problems. Therefore, 
although individualised routines and rituals are important in understanding how new 
medical technologies are accepted or resisted, the extent to which these escape the 
dominant and normalising discourses of society is questionable (Seale et al, 2007). 
 
Medicine and culture 
 
$FFRUGLQJWR:LOOLDPVDQG&RQUDGDQDO\VWVRXJKWWRXVHµPHGLFDOLVDWLRQ¶DVD
descriptive term to explain how a particular phenomenon comes to be thought about, 
recognised and treated as a medical problem (Williams et al, 2009, Conrad, 2007), not 
in attempts to explain why this may have occurred. However, one cannot ignore the 
normative and cultural values allied to medical authority and expertise. In all strands of 
the data collected it was evident that the medicalisation of sleep was accompanied by 
powerful images of illness, healing and (ab)normality which acted to make drug use 
appear socially acceptable.  The normative connotations of medicalisation were that 
those bodies designated as ill, defective or not performing to the medical standard of 
normalcy should yield to medical authority, advice and technology in order to regain a 
level of normality. The technology in question in this study can clearly be used in a 
non-medical setting for non-therapeutic purposes, as demonstrated in the media data 
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through the case of sport and controversy surrounding athletes taking the drug. 
However, without illness or impairment it appeared more difficult to justify the use of 
neurotechnologies to alter cognitive processes. 
 
Interestingly, in the work and student contexts, engagement with a medical rhetoric 
was mixed, but so was normative reaction to drug use. Some contemporary scholars 
argue that the social role of medicine is changing from an institution that cares for and 
heals the sick to a tool for self-improvement in a society where one can (re)create 
themselves and their bodies in the fashion they choose (Clarke et al, 2003; Negrin, 
2002; Rose, 1994; Gray, 2002). Despite the fact that modafinil is a drug that has been 
researched, developed, designed and marketed as a medicine, use of the drug 
outside of a medical context was often imagined and has been realised (e.g. 
controversy about sportspersons taking the drug; journalists exploring the idea of a 
sleepless society; stories of ambitious business (wo)men forsaking sleep in order to 
get ahead in the workplace). Arguments were present, in the media data in particular, 
as to why this type of technology could be beneficial outside of the medical domain as 
a consumer product to reduce the need for sleep and boost cognitive performance. 
 
However, within scientific and medical discourse, based upon institutional norms and 
strong traditions of drug development with the goal of healing, it was difficult for these 
stakeholders to read the technological script attached to a drug in any other way than 
it being a medicine. Similarly, in the data of prospective users, drugs, tablets and pills 
ZHUHVWLOOXQGHUVWRRGZLWKLQDZLGHUPHGLFDOIUDPHZRUNUHODWHGWRQRWLRQVRIµQRUPDOLW\¶
UDWKHUWKDQµLPSURYHPHQW¶DQGSRVLWLRQHGDVWHFKQRORJLHVWREHXVHGIRUWKHJRDORI
restoring health or preventing illness- not as enhancements. The data shows how 
technological scripts operate within specific socio-technical niches (Borup et al., 2006) 
and are, to some extent at least, constrained by the norms operating within that 
domain of use. 
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Implications for modafinil use and users 
 
Members of both prospective user groups who were interviewed questioned the 
appeal of extending wakefulness and the need for cognitive enhancement in their daily 
lives. Imagined users and uses of the drug were embedded within elaborate visions of 
future worlds. Such visions functioned as a device for prospective users to explore 
hopes, promises, concerns and fears surrounding the availability of enhancement 
GUXJV7KURXJKWKHILJXUHRIWKHµIXWXUHXVHU¶:LONLH	0LFKDHOYLVLRQVRI
G\VWRSLDQIXWXUHVZHUHFRQVWUXFWHGZKLFKDFWHGWRMXVWLI\UHVSRQGHQW¶VDWWLWXGHVLQWKH
present. Overall, medical monitoring and control of the drug was thought of as the best 
way to ensure benefits were afforded to those that really needed them whilst 
preventing abuse, dependency and dangers to health. Interestingly, when 
respondents were asked what impacts this type of technology could have on society, it 
was the wake-promoting effects of modafinil that fuelled visions of the future. The 
potential cognitive enhancing effects of the drug were rarely mentioned. 
 
Although there was a general acceptance of the competence of medical professionals 
to decide who should and should not have access to modafinil, many of those 
LQWHUYLHZHGWKRXJKWWKDWWDNLQJDSLOOIRUWKLVW\SHRISUREOHPVKRXOGEHDµODVWUHVRUW¶WR
be used in times of crises or if the individual was experiencing severe problems or 
distress rather than a first line intervention. Notions of self-governance and individual 
responsibility for varying states of somnolence were prevalent in interview accounts. 
Individuals demonstrated a wealth of lay knowledge and expertise governing their own 
sleepy bodies and cognitive functioning through a variety of technologies including the 
regular consumption of OTC pharmaceutical products and food-stuffs to negotiate 
sleep, work and health in their everyday lives.  
 
:ROSHDUJXHVWKDWµFOHDUO\, some of the top selling drugs in the world today are being 
used by patients who fit no traditional definition of pathology, yet still see in their own 
IXQFWLRQLQJDGHILFLWWKDWWKHVHGUXJVDGGUHVV¶,QWKHPRVWSDUWWKHGDWD
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appears congruent with this position. Those experiencing some sort of deficit saw 
pharmaceutical treatment as one part of the solution for them, whether accessed 
independently or through a medical consultation. 
 
Additionally, respondents thought that if a substance was freely available to them it 
must have been certified as safe for their consumption. On the other hand, if a 
substance was mandated via prescription respondents believed this also to be for 
good reason. Modafinil was introduced to respondents as a prescription drug and 
despite the different uses and users that were imagined, most respondents returned to 
this configuration in their assessment how the drug should be used. In this sense, the 
data fits with other research that suggests that there are times when the consumerist 
role is rejected with preference towards a more traditional role of recipient of expert 
knowledge (Lupton, 2003). µPassive¶ patients go to the doctor for information and 
expert advice, with both groups appreciating the asymmetry in knowledge and do not 
identify (or perhaps even resist) themselves as consumers in this context.  
 
Similarly, most respondents said they would take modafinil if it was prescribed to them 
by a medical professional, but would not attempt to buy or take the drug if it remained 
a prescription medication and would judge others for doing so. Drawing heavily on 
medical rhetoric, use of modafinil by those without problems or impairments was 
regularly constructed as abuse of prescription medication. In addition, understandings 
RIPRGDILQLOXVHDVDQµHQKDQFHPHQW¶WHFKQRORJ\ZHUHSUREOHPDWLVHGE\VHYHUDO
individuals who thought that using the drug would imply they had a problem, 
inadequacy or inability to cope. However, it was also apparent in the data that the 
same individual can act as both consumer of health care and passive patient 
depending on context (Stevenson et al, 2008). This point is discussed further in the 
following section. 
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Pharmaceuticalisation, subjectivity and technologies of the self 
 
$OWKRXJK1LN5RVH¶V work can be criticised for its lack of empirical grounding, echoes 
RIWKHµQHZUHJLPHRIWKHDFWLYHDXWRQRPRXVFKRRVLQJVHOI¶KHSURSRVHV
were found in the data, most notably in the student discourse. Rose argues that the 
lives of citizens are governed through the choices they themselves make, where 
individuals are free to the extent they choose a life of responsible selfhood guided by 
cultural norms and expert advice. New biomedical techniques of intervention open up 
new possibilities for action on the self, creating new choices, identities and 
SRVVLELOLWLHV7KHVHWHFKQRORJLHVµWUDQVODWHWKHJRDOVRISROLWLFDOVRFLDODQGHFRQRPLF
DXWKRULWLHVLQWRWKHFKRLFHVDQGFRPPLWPHQWVRILQGLYLGXDOV¶,QLWV
configurations as a study-aid, a replacement for sleep and a substitute for caffeine, 
modafinil use was positioned outside of the medical domain. In these instances, the 
use of the substance was constructed as a technological optimisation, a way to alter 
or adjust oneself in order to enhance performance, productivity or pleasure.  
 
When use of the technology was considered in the context of other wake-promoting or 
cognition boosting technologies (i.e. caffeine) by potential end users use of the 
substance it became less ethically contentious. However, the pharmaceuticalisation of 
sleep (Williams et al, 2008a) was not accepted uncritically. Scientists and clinicians 
maintained their position that modafinil is a medicinal drug, not a foodstuff or 
replacement for caffeine, again on the grounds of safety. For potential end-users, if 
modafinil was to become available for them to purchase on the supermarket shelves 
like caffeine pills and energy drinks are today, they assumed the substance would be 
safe for consumption. Therefore purchase of the technology would be an act of 
consumerism and augmentation of cognition or sleep considered to be a lifestyle 
choice. 
 
Therefore, whereas medicalisation of sleepiness generally acted to legitimate the 
application of a pharmaceutical solution for sleep/alertness problems on the grounds 
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of regaining normality, pharmaceuticalisation to extend capacities or functioning 
without medical control and expert guidance was more problematic. Although such 
configurations were regularly imagined, as discussed in the above section, modafinil 
could not easily escape its association with medicine and previous cultural script as a 
medicinal drug. The majority of the respondents said that presently, they would not 
choose to take a cognition-enhancing drug to serve such purposes. Without an 
obvious deficit to restore respondents questioned why they would need to take the 
drug in the first instance.  
 
Despite this, the temptation built into enhancement technologies was alluded to by 
many respondents. The expectation that improved cognition will lead to better, more 
productive, efficient and successful citizens is deeply entrenched in the neuroethics 
OLWHUDWXUH8VLQJWKHWHUPµHQKDQFHPHQW¶WRGHVFULEHWKHDFWLRQRIQHZ
neurotechnologies actually does a lot of normative work in and of itself. For some the 
ZRUGHQKDQFHPHQWLVLQWHUSUHWHGWROLWHUDOO\PHDQµEHWWHU¶DQGWKHGLIILFXOW\RIDUJXLQJ
against something that will make one better was acknowledged in the data. Overall, 
opposition to cognitive enhancement as a concept was fairly weak. Positive impacts of 
this technology were imagined in terms of health, wealth and productivity, provided the 
technology was safe, legal, and available at relatively little cost. In fact, two thirds of 
students interviewed said they would be more tempted to take modafinil for its 
prospective performance enhancing effects than as a replacement for sleep.  
 
Despite this, individuals rarely thought of modafinil use LQWHUPVRIµLPSURYHPHQW¶RUDQ
µHQKDQFHPHQW¶WKDWZRXOGPDNHWKHP µEHWWHUWKDQZHOO¶RUWUDQVIRrm them in some way 
beyond current levels of possibility. Instead, non-medical use of the drug was 
positioned within a culturally available narrative currently occupied by caffeinated 
products, energy drinks, various vitamin and herbal wares and foodstuffs: a way for 
one to attempt to increase alertness if finding it otherwise difficult at socially desirable 
times. How pharmaceutical products are perceived by consumers may be dependent 
on the product in question and the context in which its use is sought (Stevenson et al, 
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2008). This was evident in the data with many respondents displaying uncertainty 
about modafinil because they were unfamiliar with the substance, yet being 
comfortable with the chemical augmentation of sleep and cognition through other 
more established pharmaceutical technologies. 
 
There was however, one instance in which members of all three stakeholder groups 
thought that the extra-medical pharmaceuticalisation of cognition would be socially 
desirable and appropriate. This was the case of acute use in emergency situations 
(e.g. natural disaster) where modafinil could potentially be used to enhance the 
cognition of users without clinical disorder. When the technology was placed into this 
context it ceased to become medicine and was instead understood as a type of safety 
apparatus. Here, potential users thought that the dangers posed by the drug would be 
outweighed by other threats to health and life. Often, no illness was deemed 
necessary for drug consumption and in some instances OTC availability of such a 
substance thought appropriate. This formation of technology and user was quite 
GLIIHUHQWIURPWKHµPHGLFLQHDVHQKDQFHPHQW¶FRQILJXUDWLRQGLVFXVVHGE\&ODUNHet al 
(2003), as use of the drug was justified on the grounds of public safety with the goal of 
helping others, rather than individual health promotion and improvement of bodies for 
purposes of self-fulfilment.  
 
Although safety is often dismissed as a practical issue that requires little consideration 
in the neuroethics discourse, it appears that outside of medical uses for the drug 
issues of safety are paramount, forming both obstacle and endorsement to the 
technological manipulation of sleepiness/alertness. For instance, when health and 
safety were considered to be under threat drug use was endorsed, whereas if the 
consequences of use were thought to pose a greater threat to the health or safety of 
the user, use of the drug was condemned. The extent to which the formation of 
modafinil as safety tool goes beyond medicine is also open to debate, as the scientists 
and clinicians interviewed conceptualised the drug as a way of preventing harm or 
LOOQHVVVWLOOSUHVFULEHGE\PHGLFDOSURIHVVLRQDOVWRWKRVHLQQHHG$OOµHQKDQFHPHQW¶
281 
 
uses of the drug by those who were not suffering or under threat of harm were denied 
as viable applications of the substance by medico-scientific professionals. Instead, the 
social role of medicine was depicted as encompassing the treatment of illness or 
disorder, the prevention of ill health and the protection from harm to health. 
 
The analysis presented here shows that when thinking about the framing of 
pharmaceuticals in terms of therapy and enhancement it is actually very difficult to go 
µEH\RQGPHGLFDOLVDWLRQ¶DV:LOOLDPV et al (2008a) propose. Issues of 
µSKDUPDFHXWLFDOLVDWLRQ¶XQGRXEWHGO\RYHUODSZLWKDQGDUHERXQGXSLQSURFHVVHVRI
medicalisation and their normative connotations. This is especially the case when the 
technology in question has been developed, is marketed, regulated and used as a 
medicine. Whilst medicalisation acted to legitimise use of the drug under specific 
circumstances, there was evidence of resistance towards pharmaceuticalisation of 
cognition for those without problems or impairments. At present it appears difficult to 
justify using medLFDOWHFKQRORJ\IRUWKHJRDORIµHQKDQFHPHQW¶RULPSURYHPHQWZLWKRXW
the moral imperative of restoring, maintaining or protecting health (of self or others). In 
the case of new medical technologies such as modafinil that are approved for the 
treatment of sSHFLILFFRQGLWLRQVEXWFDQEHXVHGDVµHQKDQFHPHQWV¶IRURWKHU
capacities, medicalisation of some degree may in fact be a requirement in the 
legitimation of technological/pharmaceutical intervention whilst medical professionals 
DFWDVµJDWHNHHSHUV¶&RQUDG, 2007) for their delivery. Conversely, for OTC use to be 
accepted demedicalisation may be a requirement. The technology must no longer be 
thought of as a medicine and be reframed or re-scripted in a different way in order to 
gain a new identity and cultural script for how, when, and whom it should be used by 
(i.e. as a foodstuff, recreational drug, consumer product). 
 
Re-thinking the therapy-enhancement debate 
 
This thesis has taken an empirical approach to explore the complex social contexts in 
which modafinil could be used as therapy, enhancement (or otherwise) from the 
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perspective of the media, scientists and clinicians, shift workers and students. It has 
found that the way we live our modern lives acts to both create and constrain 
particular understandings of sleep, wakefulness and the body. A contextualised 
understanding of these phenomena shapes which particular social and ethical issues 
surrounding pharmaceutical augmentation of cognition are deemed relevant by these 
communities in the conduct of their everyday lives and how they make normative 
judgments.  
 
The idea of improving one¶s cognitive abilities did not elicit as much excitement from 
or appeal to prospective users as perhaps the neuroethics literature and media 
coverage suggest. However, the potential effects the drug could have on one¶s need 
to sleep did provoke a strong reaction in both potential end-users of the drug and 
scientists and clinicians who work in close proximity to the substance. Reactions to 
modafinil as a wake-promoting substance were mixed and ranged from surprise and 
intrigue to fear and unease. However, the strongest feature across the interview data 
was that of disbelief and scepticism that the drug as an enhancement technology 
would work and not be harmful on a biological, psychological or social level.  
 
Throughout the data there was a strong qualitative difference in the social and ethical 
issues raised in each social context and user/technology configuration that was 
LPDJLQHG7KHUHDUHFOHDUO\GLIIHUHQWIRUPVRIµHQKDQFHPHQW¶DQGLQGHHGZD\VWR
GHILQHZKDWµHQKDQFHPHQW¶LV(PSLULFDOO\WKHLPDJLQHGFRQWH[WLQZKLFKWKH
technology would be used impacted upon how both use and user were framed with 
context of use and type of user assuming more importance in ethical decision making 
than the impact of the technology at a biological level (Conrad, 2007).  
 
Of significance in the interview data was how in several of the imagined 
configurations, the discussion of modafinil use and users appeared to bypass the 
dichotomies of health and illness, normal and abnormal, and therapy and 
enhancement that structure the neuroethical, and to some extent, media debates 
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around human enhancement. The fluidity between such concepts and blurredness of 
any boundaries between them has long been recognised and is often acknowledged 
by social scientists and ethicists alike. Some scholars involved in ethical debates 
argue that to maintain a distinction between therapy and enhancement is helpful, 
useful or required at the analytical level, whilst others think that it is necessary at a 
practical level to contain further medicalisation or indeed pharmaceuticalisation of 
HYHU\GD\OLIH7KH3UHVLGHQW¶V&RXQFLORQ%LRHWKLFV7DQQVMR'HHV
Daniels, 2000). This study shows that although useful in an analytical sense, it is also 
extremely limiting to uphold a therapy- enhancement dichotomy as the analyst may be 
blinded towards other ways in which use of the technology is positioned, negotiated, 
realised and resisted by potential users in the context of their daily lives. 
 
On this count, the most striking case in the data was that of acute use in emergency 
situations. In this context, the potential consequences of excessive sleepiness and 
cognitive impairment were framed in such a way that the normative positions 
emerging across data did not rely on the concept of normality nor the distinction 
between therapeutic and enhancing uses of the drug. Instead justification was often 
sought through appeals to wider non-medical narratives relating to both individual and 
public safety.  
 
Over the past thirty years, a bioethical enterprise has proliferated and become 
SURIHVVLRQDOO\HVWDEOLVKHGDVDQµREMHFWLYH¶PHDQVWRDUELWUDWHFRQWHQWLRXVLVVXHV
arising from the prospect and development of new knowledge and technologies 
(Rose, 2007; Armstrong, 2006). However, it is apparent from the data collected in this 
study that the ethical debate around the uses of new neurotechnologies thus far 
comes with its own worldview, inscribing the technology in question and imagined or 
actual users with its own ideology. Many different types of prospective user of 
FRJQLWLRQHQKDQFLQJGUXJVDUHLPDJLQHGLQHWKLFDOGHEDWHVIURPWKHµVXUURXQGHG
VROLGHU¶WRWKHµGURZV\GRFWRU¶7KURXJKRXWWKHQHXURHWKLFVGLVFRXUVHZHDUHSUHVHQWHd 
with an image of society that is skill driven and knowledge-based where one¶s success 
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correlates with their cognitive abilities (Rose, 2002; Esposito, 2005, Glannon, 2008).  
Enhanced cognitive capacities are thought of as a competitive good that can give 
some people an advantage over others in gaining employment, advancing careers 
and earning a higher income.  The pursuit of cognitive enhancement is assumed to be 
desirable and in increasing demand and these assumptions play an important role in 
framing the issues arising in ethical discussions.  
 
Often, the idea of cognitive enhancement is problematised, deconstructed and 
debated in neuroethical debates whereas its counterpart, therapy, is left unscathed. In 
the case of modafinil, the data gathered from both scientists and clinicians and 
putative recipients of the drug indicated that such therapeutic uses of the drug would 
be less straightforward than imagined in neuroethical debates. Disorder was 
considered to not only reside in the individual brain and its processes, instead being 
constructed as resulting from a combination of bio-psycho-social factors and cultural 
IRUPDWLRQV3KDUPDFHXWLFDOWHFKQRORJLHVWKHQZHUHRIWHQVHHQDVDµODVWUHVRUW¶RU
RQHRSWLRQRIPDQ\FHUWDLQO\QRWDVDµILUVWOLQHLQWHUYHQWLRQ¶DVVXJJHVWHGE\5RVH
2007 p.222) or the only way to properly treat and manage cognitive disorder. 
 
How new technologies fit into the existing sociotechnical networks operating in the 
everyday lives of potential patients/consumers is paramount to understanding the 
social and ethical issues that are raised. For the ordinary postman, caller centre 
operative, the retail assistant or undergraduate student going about their daily 
business, a drug to boost cognitive performance does not appear to create as much 
enthusiasm as it does for the analytic philosopher or the busy academic. A technology 
that allows one to further control sleep and alertness, in addition to caffeine, alarm 
clocks, pillows, herbal remedies, sleeping pills and CPAP devices can be more easily 
assimilated onto the daily lives of citizens. However, the technology in question in this 
study is a pharmaceutical pill that does not easily escape its technological and cultural 
scripts as a medicine that should be used to treat disease. 
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Pharmaceuticals are technologies coded with various social and cultural 
understandings about the social lives, relationships, self image and characteristics of 
their consumers (Rose, 2007; Lakoff, 2005, Kramer, 1993). The medicalisation and 
pharmaceuticalisation of daily life alongside the domestication of pharmaceutical 
consumption therefore affects the ways in which elements of everyday life are 
XQGHUVWRRGDQGSUREOHPDWLVHG$OWKRXJKWKHYHU\ZRUGµHQKDQFHPHQW¶VXJJHVWVWKDW
technological optimisation and shaping of the self is a positive process- allowing the 
individual to free themselves from the constraints of their biology and transform their 
identity, there is still a form of biomedical governance at work shaping desires for how 
bodies, brains and identities should be transformed (Clarke et al, 2003; Wehling, 
2005).  
 
In summary, situating cognitive enhancement in social context allowed some key 
assumptions found in neuroethical debates to be questioned. Firstly, that there is this 
widespread desire to use cognitive enhancing drugs to enhance performance beyond 
a normal level (as predominantly, drug use was thought of in terms of treatment or 
protection, not enhancement). It was also evident that in the neuroethics literature 
cognitive enhancement is too easily equated with beneficence at the individual level. 
Through the configuration of modafinil as a safety tool that could be used acutely by 
some shift workers in particular, this notion was questioned with drug use seen as a 
move towards safety and providing better care for others whilst potentially putting 
individual health at risk. It also emerged just to what extent therapy and enhancement 
are qualitatively different as respondents did not perceive a need for enhancement in 
the same way those with problems have a need for treatment. 
 
Therefore, the findings of this study strongly suggest that understanding and debating 
the use of new neurotechnologies within a therapy-enhancement dichotomy is 
insufficient and inadequate. Instead, one has to take into account the multiple ways in 
which drug use and users may be configured across different domains of social life. 
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Limitations of the research 
 
&RJQLWLRQHQKDQFLQJWHFKQRORJLHVFDQEHWKRXJKWRIDVµHPHUJLQJWHFKQRORJLHV¶WKDW
are yet to be widely introduced in the UK, and although modafinil is available as a 
prescription drug, it is not well known outside of the scientific and medical domains. 
Researching how modafinil was thought about and its use positioned and negotiated 
in social context therefore posed a particular methodological problem for the study. 
This was addressed through a focus on the way in which uses and users of the drug 
were imagined (as opposed to assessing the way in which the substance was actually 
used) by those interviewed (Borup et al, 2006; Brown & Michael, 2005; Wilkie & 
Michael, 2009; Weiner, M.S). Of particular importance were the ways in which roles 
for the technology were embedded (both explicitly and implicitly) in projections of 
future users (which could be the interviewees themselves or imagined others) and 
their likely characteristics, attributes and motivations (Woolgar, 1991; Akrich, 1992; 
Lindsay, 2005).  
 
In order to engage prospective stakeholders in conversation about a technology that 
they had not heard of before, it was necessary to provide them with some information 
about that technology and the contexts in which it could be put to use. Although 
measures were taken to provide a balanced and accurate summary of information 
about the technology that is currently available in the public domain, it is also 
important to recognise that interviews are social encounters (Dingwall, 1997). 
Therefore, the opinions expressed during an interview may, in a sense, reflect the 
questions that were asked by the interviewer, the information that was given to the 
respondent and how this was framed. This means that when presented with further 
information or thinking about modafinil use in different (or real) social and political 
conditions, the respondent may not necessarily provide the same opinions, attitudes 
and evaluations of modafinil and its uses. During analysis of interview data it was 
evident that people can and do hold conflicting sentiments towards modafinil use and 
users at the same time. This ambivalence towards the drug and its prospective uses 
287 
 
was apparent across all three of the stakeholder groups interviewed. The STS 
approach, used to analyse the data, drew attention to the contention that the impact, 
use and interpretation of a technology is neither certain nor fixed and that different 
interpretations can exist side by side (Stirling, 2008; Singleton & Michael, 1993) and 
vary over time (Morrison, 2008). The analysis illustrated the ambivalence that exists 
towards technologies such as modafinil and was particularly useful in highlighting 
some of the complexities involved in evaluating the perceived legitimacy of uses of the 
technology within and between different social groups. According to Kearnes and 
Wynne (2007) public ambivalence about emerging technologies can be used as a 
µFUHDWLYHUHVRXUFH¶7KH\VXJJHVWWKDWSXEOLFYDOXHVFRXOGEHLQFRUSRUDWHGLQWRWKH
development and trajectory of new and emerging technologies at an early stage, 
increasing the role of public participation and engagement in contemporary science 
policy. Knowledge about imagined futures may therefore be used to shape present 
policies, perceptions and products or to critically evaluate them. 
 
A fundamental limitation with using case studies in social research is the plausibility of 
generalising results and extending the findings of the investigation to other similar 
cases (Hammersley, 1985). The implications of this are that the results obtained 
through the study of this particular case will not be directly generalisable to other 
forms of cognition enhancer. However, it has been possible to gain an understanding 
of how decisions are made about the acceptability of different uses for enhancement 
technologies and how these are negotiated in social context. This research, alongside 
previous studies of other cognitive enhancing lifestyle drugs, such as Ritalin (Singh, 
2004; 2007) and Prozac (Rose, 2003), have demonstrated the distinctive contribution 
that social scientists can make to the bioethical analysis of pharmacological advances. 
Further empirical research is required to assess the extent to which the availability of 
technologies such as modafinil are contributing to the pharmaceuticalisation of daily 
life at both the macro and micro levels. However, the findings of this research 
contribute towards an empirical evidence base for ethical and policy debates on 
cognitive enhancement. Therefore, the results of this research could be used to inform 
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future regulatory and policy debate regarding cognitive enhancement technologies in 
general.  
 
Concluding comments 
 
As neurotechnologies continue to be developed and use proliferates both inside the 
clinical encounter and beyond, important questions are raised about the extent to 
which policy should promote or control their use. It has been argued that the 
deployment of ethical expertise is increasingly becoming the mechanism through 
which public concerns about new and emerging technologies are adjudicated (Rose, 
2007; Armstrong, 2006; Pellegrino, 1999; Salter & Jones, 2004).Through an 
assessment of how prospective users of modafinil make decisions regarding its 
legitimacy, it has been possible to gain some awareness of the narratives that are 
being threatened by dominant neuro(ethical) discourses. 
 
At present, medical professionals are gatekeepers for modafinil, therefore it is 
ultimately up to this community to decide who has access to the substance, for which 
(psycho-bio-socially defined) problem it becomes a solution, and the appropriateness 
of use. This too has political implications for future uses of the drug, as medical and 
scientific experts will undoubtedly be called upon to provide testimony if the drug was 
ever to be (re)considered for over the counter use. As the analysis shows, 
pharmaceuticals such as modafinil could potentially be put to many uses throughout 
various domains of social life. In which contexts the pharmaceuticalisation of 
sleep/cognition is culturally legitimate remains open to debate. As with any 
technological development, technology can flexibly interpreted by users in local 
contexts and therefore how the technology fits into existing practices and socio-
technical networks operating within specific contexts can only be uncovered by 
speaking to a variety of users (Hoffmaster, 2001). An analysis of how different actors 
frame the uses of new neurotechnologies and their related social and ethical 
implications is of importance in understanding the acceptability of such compounds in 
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different social arenas. Increased understanding of the diverse ways in which 
prospective users accept or reject new technology may contribute towards more 
accurate assessments of the social implications of the proliferation of cognition 
enhancing drugs and help in the development of sound policies (Hoffmaster, 2001). 
 
From this study, at present it appears that although many different types of use and 
user of modafinil can be readily imagined, acceptability of use is normatively 
constrained through medical discourse as modafinil does not easily escape its cultural 
script as a medicinal product, ultimately bound to health, expert knowledge and 
medical authority. As discussed by Borup et al, (2006) expectations of the future user 
are literally and materially scripted into technologies and socio-technical systems. 
There is still a strong cultural tendency to associate drug taking with illness, addiction, 
dependency and risks to health which may provide a barrier to widespread 
psychopharmaceutical use outside of medical authority.  
 
At present, demand for and desirability of cognition enhancing drugs may be far less 
abundant than imagined in ethical debates. How this could change in the future, as 
new knowledge, technologies and techniques for explaining, intervening and 
manipulating bodies and brains are developed and deployed, both within and beyond 
the medical encounter, is open to debate. Perhaps in the future, cognition enhancing 
drugs will come to be accepted as part and parcel of everyday life and new uses and 
user groups may emerge. Only with passage of time will we truly be able to tell if the 
chemical enhancement of normal bodies and brains flourishes in society and if indeed 
FRQVXPHUVFRPHWRVHHWKHVHGUXJVDVµPDJLFEXOOHWV¶WRUHVROYHWKHLUHYHU\GD\
problems. 
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Appendix II: Contact letters 
 
Scientists and clinicians 
 
Each email sent out to scientists and clinicians was personalised to reflect the interest 
of the individual in question and altered accordingly depending upon whether they 
were contacted directly at their place of work or through their attendance at 
WorldSleep 07. A generic form of the letter is included below: 
 
Dear XXXX 
 
I am a postgraduate research student based at the Institute for Science and 
Society at the University of Nottingham. For my doctoral research (funded by 
the Wellcome Trust) I am investigating the relationship between sleep and 
health from a sociological perspective, and the role of medicine in mediating this 
relationship. For further details of the project see attached summary. 
 
I am currently interviewing clinicians, physicians, and academics with an active 
interest in sleep and was hoping that you would be interested in taking part in 
this research. If so, the interview will be informal and last about one hour. We 
can either arrange to meet up or I can conduct the interview over the telephone 
if you would prefer. All responses will be anonymised and treated as 
confidential. If you would like to take part or require any further information 
about my research please do not hesitate to get in touch. In addition, if you think 
any of your colleagues at XXXX might be interested in taking part please feel 
free to pass on my contact details. 
 
Thank-you for your time and I hope to hear from you soon. 
Yours sincerely, 
Catherine Coveney 
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Shift workers 
Shift workers were recruited for the study via a social networking website. The 
information provided to participants on this website was as follows: 
Hi, 
 I am conducting a study at the University of Nottingham funded by the UK 
medical charity the Wellcome Trust about attitudes towards sleep, work and 
health in the UK. I am interested in talking to people of any age and in any 
occupation that do shift work. So, if you or any of your friends or family work 
hours outside of the traditional 9am-5pm working day and would to take part in 
WKHVWXG\,¶GORYHWRKHDUIURP\RX 
 
Your participation in the research will involve a short and informal interview with 
me lasting approximately one hour. I would like to talk to you about your 
experiences of shift work and attitudes towards sleep and health in general.  We 
can either arrange to meet up or I can conduct the interview over the telephone 
if you would prefer. Everything you say will be treated as confidential and your 
identity will be anonymised.  
 
If you have any questions or would like any more information about the study 
please get in touch. I look forward to hearing from you and thanks again, 
Katie 
 
Students 
6WXGHQWVZHUHFRQWDFWHGYLDWKH8QLYHUVLW\RI1RWWLQJKDP¶VLQWHUQDOHPDLOV\VWHP7KH
following email was sent out to prospective interviewees and followed up with a 
second email to set a date and time for the interview. 
Title of email: Invitation to participate in research study 
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I am a postgraduate research student based at the Institute for Science and 
Society at the University of Nottingham. I am writing to enlist your help in a 
research project investigating attitudes toward sleep, work and health in a 24/7 
society.  I am interested in talking to current students about student life in 2008. 
I was hoping that you would be interested in taking part in this research. I 
appreciate that everybody's time is in short supply, but by taking part in this 
study, you will be playing an important role in this research. 
 
All that your participation will require is taking part in an informal interview 
lasting approximately one hour about your experiences as a student and 
attitudes towards sleep and health in general. All responses will be anonymised 
and treated as strictly confidential. You will receive a £5 gift voucher as 
compensation for your time. 
 
If you are interested in taking part or would like some more information about 
the study then please get in touch.  I will be conducting interviews on weekdays 
between 10am and 4pm in the Law & Social Sciences Building, University Park 
from Monday 24th November to Friday 12th December 2008. Please indicate 
your preferred date and time. 
 
Thank- you for your time and I hope to hear from you soon, 
 
Catherine Coveney
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Appendix III: Table of interviewees 
Name* Organisation Specialism 
1. Scientists and Clinicians 
1. Adrian UK University Sleep scientist,  neuroscience of 
sleep 
2. Bernard USA research institute Sleep scientist, psychiatry and 
psychology 
3. Charlie USA university Clinician, psychiatry and BSM 
4. Dan USA sleep clinic/ USA 
university 
Clinician, sleep biology and 
sleep medicine 
5. Edward USA university/ USA 
sleep clinic 
Clinician, clinical psychology 
and sleep medicine  
6. Fay USA university Sleep scientist, sleep 
deprivation 
7. Jane UK university Sleep scientist, circadian biology 
8. Harry UK research institute Clinician, behavioural sleep 
medicine 
9. Isobel UK research institute Sleep scientist, CBT for sleep 
disorders 
10. Gemma UK research institute/ 
EU university 
Sleep scientist, sleep disorders  
11. Karen UK research institute Sleep scientist, sleep disorders 
12. Lin UK research institute Clinician, clinical psychology 
13. Mas UK private sleep clinic Clinician, sleep medicine, 
neuropsychiatry 
14. Gita UK private sleep clinic Clinician, psychotherapy for 
sleep management  
15. Orla 
 
UK private sleep clinic Sleep scientist, clinical 
psychology 
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2. Shift workers 
1. Kim Nurse  
2. Hannah Support worker Mental health support worker 
and part-time retail assistant 
3. Toby Airport worker  
4. Hamish Medical doctor Hospital based medical doctor 
 5. David Medical doctor Hospital based medical doctor 
6. Mo Postal worker  
7. Karolina Nurse  
8. Paul  Factory worker  
9. Alan Retail staff  
10. Edie Call centre operative  
11. Matt Police officer  
3. Students  
S1. Mike University of Nottingham  Undergraduate student 
S2. Kerry University of Nottingham Undergraduate student 
S3. Dave University of Nottingham Undergraduate student 
S4. Emma University of Nottingham Undergraduate student 
S5. Joseph University of Nottingham Undergraduate student 
S6. Louise University of Nottingham Undergraduate student 
S7. Daniel University of Nottingham Undergraduate student 
S8. Bella University of Nottingham Undergraduate student 
S9. James University of Nottingham Undergraduate student 
S10. Lizzy University of Nottingham Undergraduate student 
S11. Stephen University of Nottingham Undergraduate student 
S12. Chris University of Nottingham Undergraduate student 
S13. Nick University of Nottingham Undergraduate student 
S14. Susie University of Nottingham Undergraduate student 
*Names have been changed to protect respondents¶ anonymity  
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Appendix IV: Interview Guides 
 
All of the interviews began with the provision of information about the study 
and respondents were asked to verbally confirm that they had consented to 
participate. The following passage was read: 
 
The interview will be divided into four main sections, firstly I would like to ask you a bit 
about you, followed by some general questions about sleep and health, moving on to 
talk about treatments for sleep problems and ending with some questions about the 
future. 
 
Before we stDUWWKHLQWHUYLHZ,¶GOLNHto inform you that this interview forms part of my 
PhD research and sections of it may be reproduced in my thesis or any subsequent 
papers derived from my thesis. With your permission, I will be using a digital voice 
recorder to record the interview and this recording will be stored by the University of 
Nottingham for up to 7 years before being destroyed in accordance with current 
research guidelines. However, I will be the only person allowed access to it and 
everything you say during the interview will be kept confidential and your responses 
will be anonymised as far as possible.You have the right to withdraw from the study at 
any time, in which case the interview data will be destroyed. I will send you a full 
transcript of the interview once it has been transcribed and you are free to retract any 
part of it prior to the data being used. After all of that, would you still like to go ahead? 
 
SECTION 1: ABOUT YOU 
Scientists 
Can you tell me a bit about your own research area?  
Have you always worked on sleep, how did you get interested in this topic? 
What are you currently working on? 
Clinicians 
To start with can you tell me a bit about XXXX and your role here? 
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What kind of patients do you see? 
Are these people usually self-presenting or referred via their GP? 
 
Shift workers 
Can you tell me a bit about your job? 
Do you always work the same shifts or rotate? 
How long have you been working shifts for? 
Do you have a choice in the shifts you work? 
On a typical day what time do you have to get up to be at work? What time do you 
arrive home? 
Do you enjoy shift work? 
What are the benefits of working outside of the traditional 9-5 working day? 
 
Students 
Which course you are on? How many hours do you work on an average week? 
Do you have a part-time job as well as studying? If so, what hours do you work? 
What do you do in your leisure time, when you are not studying or working? 
How often do you go out in the evenings? How many late nights would you have in an 
average week? 
Do you ever stay up late or get up early to do university work, for example revising for 
exams or if you have a deadline? 
Do you enjoy student life? What is good about it? Is there anything you would 
change? 
 
SECTION 2: SLEEP, COGNITION AND HEALTH 
Scientists/ Clinicians 
What is sleep?  
What are the known functions of sleep? 
What is considered to be a normal sleep/wake cycle?  
x How much sleep should we be getting? 
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x Is it normal to wake during the night or feel sleepy during the daytime? 
:KDWIDFWRUVFDQLQIOXHQFHDQLQGLYLGXDO¶VVOHHSZDNHF\FOH" 
$QGKRZLPSRUWDQWLVVOHHSWRDQLQGLYLGXDO¶VKHDOWKDQGZHOOEHLQJ" 
 
Shift workers and students 
How does shift work/ being at university impact upon your normal sleep patterns? 
What kind of things do you do to help you wake up or fall asleep? 
Do you find it easy to stay awake and alert at work/ university? 
Do you ever fall asleep at work/ university? How do you keep yourself awake? 
What would happen if you did fall asleep at work/ university? 
How important is getting enough sleep to you? 
How much is enough sleep? 
How important do you think sleep is to your overall health? 
 
SECTION 3: SLEEP DISORDERS AND TREATMENTS 
3a. Responsibility for sleep regulation 
Scientists and clinicians 
Are sleep related problems are widely recognised by the medical community as 
medical problems in the UK? 
Do you agree with media claims that sleep deprivation is a social problem in the UK?  
Are there particular groups at risk of excessive daytime sleepiness or is it something 
everyone should be aware of? 
Can excessive sleepiness or disrupted sleep wake cycles arise solely as a result of 
RQH¶VOLIHVW\OHRUZRXOGWKHUHDOZD\VEHVRPHNLQGRIXQGHUO\LQJSDWKRORJ\"$UH
certain individuals more at risk? 
 
Shift workers and students (asked as appropriate) 
Has your employer given you any information about how to manage your sleep when 
working nights/ early morning shifts? Have you ever asked for any information about 
this kind of thing? 
321 
 
Does your place of work have any policies or procedures that you know of in place to 
prevent employees developing sleep problems? 
Do you think you have any problems with sleep? 
Have you or would you ever think of seeking medical advice for sleep problems? 
Why/why not? 
 
3b. Shift work sleep disorder 
$UH\RXIDPLOLDUZLWKµVKLIWZRUNVOHHSGLVRUGHU"¶ 
And to your knowledge is this disorder widely recognised as a legitimate medical 
disorder in the UK, as it is in the US? 
Do you think this disorder needs wider recognition? 
 
Shift workers and students 
Have you heard of shift work sleep disorder?  
It is sleep disorder that some shift workers develop as a result of working shifts. The 
main symptoms are excessive sleepiness whilst working and insomnia when trying to 
get to sleep after the shift has finished. Are you surprised that this exists as a medical 
disorder? 
 
3c. Modafinil and wake-promoting drugs in general 
Are you familiar with the wake-promoting drug modafinil (Provigil)? 
Do you think that if these drugs become widely used in the management of a variety of 
sleep disorders that there will be a spread of use to other groups? 
Do you think that pharmaceuticals should be used in preference to other 
interventions? 
Do you think that wakefulness drugs (such as modafinil) should be under medical 
supervision or available as consumer products (as caffeine is)? 
In the case of excessive sleepiness associated with shift work, do you think doctors 
should prescribe drugs (i.e modafinil)?  
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Shift workers and students 
Have you ever heard of modafinil?  It is a wake-promoting drug that is used to treat 
sleep disorders like narcolepsy where people fall asleep all the time and it is also 
licensed to treat shift work sleep disorder. It has been tested since 1991 and can keep 
healthy people awake for up to 72 hours with little reported side effects. 
Do you think that this type of tablet should be sold in supermarkets and available for 
anyone to take, or be a type of medicine prescribed by the doctor for only those shift 
workers that needed it the most? 
 
SECTION 4: PERSONAL OPINIONS 
 In the final section all respondents were asked similar questions about 
wakefulness drugs and their use in some possible future scenarios.  
 
If there was a tablet that you could take that would allow you to stay awake and be 
more alert (but still let you fall asleep after work) would you consider taking it? 
How about if these drugs or tablets not only kept you awake but made you think 
clearer, concentrate better, improved your memory and problem solving planning skills 
and things like that so made you more effective at your work. Do you think you would 
take them then? 
What impact could the widespread availability of drugs like modafinil have on society? 
Do you think that wakefulness drugs (i.e modafinil) should be available in employment, 
education and for recreation- either now or in the future? 
Do you think that people should be expected to or encouraged by employers in certain 
jobs to take drugs at work? 
How would you feel if you found out that other people you work/study with were taking 
drugs to improve their performance at work/university? 
What do you think about athletes or sports persons taking these kind of drugs so that 
they can stay awake and train longer? 
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If these drugs were widely available do you think people would take them so that they 
could for instance, go to work all day and then have a night out and then go to work 
the next day and not feel sleepy? 
Who do you think these sorts of wakefulness drugs should be available to? 
 
Closing questions/ statement: all respondents were asked if there was anything 
else they would like to add and thanked for their participation in the study. 
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